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Constipation in cancer and palliative care is frequent, poorly managed and has a profound adverse 
effect on patients' lives.  This qualitative study explores factors contributing to the suboptimal 
management of constipation and identifies strategies to alleviate it.  In a three-staged action 
research study data were collected from 11 patient interviews, 26 health care professionals (HCPs) 
during six focus group meetings and a Constipation Management Clinic (CMC), comprising a 
cohort of 29 patients, which was developed as part of this study. 
The findings from stage one, patient interviews, confirm that the management of constipation in 
patients with cancer and palliative care is suboptimal partly due to HCPs’ poor knowledge and 
ambivalent attitudes, inadequate patient education and a lack of a concordant approach to 
management.  Patients described feeling abandoned, their condition trivialised and many suffered 
considerable distress and embarrassment.  In stage two, focus groups of HCPs were questioned on 
their understanding of the condition, its impact and their strategies for treatment.  Findings from 
the patient interviews were fed back as a means of education and to facilitate discussion.  The 
focus groups confirmed the findings from the patient interviews.  It was therefore possible to 
postulate that constipation management would be improved by redressing the educational needs of 
HCPs, imparting knowledge to patients and working to develop a partnership approach. 
To test this a CMC was developed during stage three.  Patients with severe and intractable 
constipation were recruited to a nurse-led clinic that adopted a patient-focused, education-based 
management strategy which also encompassed a concordant approach to laxative 
recommendations.  Following attendance there was an immediate improvement in bowel function 
in all patients who became more autonomous and concordant with their treatment regimens.  
Aims of the study were to improve the research’s skills and knowledge in research methodology in 
the cancer and palliative care setting, identify factors leading to the suboptimal management of 
constipation and to explore ways in which to alleviate the condition in patients with cancer.  
Throughout the project the action research methodology incorporated concurrent dissemination of 
findings to HCPs allowing them to discuss and assist with the evolution of the research and to 
modify their own practices to the benefit of patients generally.  
This research demonstrates the advantages of adopting an action research approach when 
identifying strategies to reduce the incidence of constipation in patients with cancer and the 
importance of paying attention to detail when trying to manage this frequent and distressing 
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Introduction to the study 
 
1.1 Introduction 
In order to afford the reader with an appreciation of the conditions and setting in which this study 
was undertaken, this Chapter outlines the researcher’s professional role and the Unit in which she 
practises.  The Unit, as a cancer and palliative care service provision, is outlined followed by an 
exposure of the nature of the multi-professional team and the researcher’s role and responsibilities 
therein.  The researcher’s clinical observations, that underpinned the research, are then presented 
along with their relevance to effective clinical practice.  These observations are followed by a brief 
introduction to cancer, palliative care and constipation which is further developed in the literature 
review.  Finally, to guide the reader through the three stages of this research a summary of the 
different chapters that comprise this thesis are offered. 
 
This study adopted an action research methodology to explore the multifaceted problems identified 
in constipation in patients with cancer as there appeared to be disparity between patients’ and 
HCPs’ attitudes and management strategies.   
 
1.2 The research setting 
1.2.1 The Unit 
This study was undertaken by a research nurse practising full-time in a 16-bedded inpatient unit 
for patients with advanced cancer.  The Unit also comprises day care and outpatient services.  The 
Unit works collaboratively with the adjacent cancer centre and is a key specialist palliative care 
provider within a cancer network serving a population of 1.3 million people.  Additionally, the 
Unit serves its local geographical community and the health care professionals (HCPs) therein.   
 
The Unit’s service users comprise patients, their family/friends and HCPs, including those from 
other providers such as hospitals, hospices and the community (for example; General Practitioners 
(GPs), Macmillan and district nurses).  Service users are afforded the expertise from the varying 




1.2.2 The Multi-disciplinary team 
The MDT includes doctors, nurses, health care assistants, complementary therapists, occupational 
therapist, physiotherapist, art therapist, social workers, counsellors and volunteer workers, and is 
headed by the clinical director who is also the cancer network lead specialist palliative care 
consultant.  The status and skills mix of MDT members is wide ranging and includes junior 
doctors, specialist registrars (SpR) and pre-registration nurses who practise on the Unit as part of 
their rotational training.  The MDT work collaboratively and uphold the philosophy of ‘the team’ 
approach.  Most members participated in this study and many acted as core members.   
 
In an attempt to explore HCP perceptions further the researcher instigated and worked 
collaboratively with a core team group which accommodated participation by transient MDT 
members.   This study’s core MDT members consisted mainly of doctors and nurses (practising on 
the Unit) who shared responsibility for planning and implementing agreed goals of this research 
(Payne 2000).  The study’s MDT welcomed all HCPs keen to participate in the group even if their 
involvement was limited or short-term due to rotation and work commitments.  The advantages of 
this approach are that the varying team members afforded different personal and professional 
values, beliefs, skills and experiences (Reel and Hutchings 2007; Payne 2000; O’Neill and Squire 
2001) many of whom were senior and had practiced in a variety of settings, for example 
community GPs and general ward nurses, thus affording the study guidance and validation of 
findings.   The latter is an important consideration as Moss et al (1998) suggest that patients with 
cancer have contact with about 20 hospital professionals in addition to their primary HCPs.  
During MDT meeting members pooled their knowledge, expertise and experiences (Cook et al 
2001; Barrett and Keeping 2005) and made joint decisions based upon shared professional view 
(Payne 2000; Handy 2001) thus bringing appropriate guidance and direction  to the study.   
 
In relation to this study, the researcher was facilitator and MDT team member (Meyer 2000) and 
adopted a lead role within the MDT as Reel and Hutchings (2007) note that in health and social 
care ineffective leadership may result in poor (or lack of) communication, mistrust, personal 
conflict and/or opposing views.  The researcher ensured that members were kept informed of the 
study’s progress, held regular meetings and keep ultimate goals and objectives in mind and focus.  
Team members were encouraged and supported as the researcher was mindful of the view of Reel 
and Hutchings (2007) who note that members of the MDT who feel valued and trusted also 
engender a sense of pride and loyalty, thus enabling an MDT collaborative venture (McCray 2002) 
in which those involved share the common purpose of improving the management of constipation 




Over the course of this study the core MDT members remained static.  Additional members joined 
the team at key stages, for example community teams, who participated more directly in this study 
by affording ideas, making referrals and utilising the researcher as a source of support and advice 
when faced with problems managing constipation during their own practices. 
 
1.2.3 The researcher’s role and responsibilities 
Part of the researcher’s role within the MDT is to develop and embrace a philosophy of research 
and audit within the Unit.  The researcher is responsible for the management of commercial 
randomised controlled trials (RCTs), the recruitment of patients to these studies and the initiation 
and administration of audits and surveys.  The RCTs evaluate drugs for symptom management in 
patients with cancer whereas the scope of audits and surveys is wide-ranging.  These projects are 
either qualitative, quantitative or both.  The work varies from clinical to non-clinical, for example, 
auditing HCPs management of syringe drivers to surveying patients’ satisfaction with their 
inpatient stay.  Health care professionals take the lead on projects and receive support and training 
from the researcher.  With the exception of RCTs, project findings are disseminated through an 
established programme of meetings including HCP journal clubs, training sessions, clinical 
governance meetings and network conferences.  These setting were also utilised for the 
dissemination of findings from this study.   
 
Research and audit aims to achieve and maintain high standards of care for patients with cancer, 
optimal symptom management and provide equitable service to users through a process 
comprising problem identification and resolution.  However, the problems of constipation and its 
management appeared to be multifaceted as illustrated in the researcher’s following observational 
findings and vignettes which also serve to illustrate the background to this study.   
 
1.3 Observations in a clinical setting 
The study had various triggers.  During observational studies, led by the researcher, in an oncology 
and palliative care ward it was noted that constipation was poorly managed by HCPs.  Most 
patients were predisposed to constipation but this was rarely recorded in the nursing or medical 
notes.  Drugs known to cause or exacerbate constipation were prescribed but without prophylactic 
laxatives.  The prescribing of laxatives was haphazard as was their administration.   
 
Health care professionals appeared ambivalent and disinterested in constipation other than the 
opportunity to be rather flippant about it.  It was noted that patients only reported being 
constipated once it had become problematic.  When constipation was severe, HCPs attributed 
blame to the patient for being non-compliant with laxatives.  It appeared that HCPs’ patient 
17 
 
assessment was not conducive to identifying constipation as it inevitably relied on the individual 
reporting the condition. 
 
The researcher observed that during drugs round nurses frequently asked patients if they wanted 
laxatives and over half the doses were omitted without further exploration with the patient.  A 
bowel motion within the previous 24-hours was the most common reason patients declined 
laxatives, however, no consideration was given to stool size, consistency or ease of defecation.  
Issues of concern are that these practices negated the benefits of prophylactic laxative use, each 
dose omission could have constituted a drug error and HCPs failed to make appropriate patient 
assessment.  It appeared that neither HCPs nor patients were aware of the importance of 




The observational evidence was supported by the following vignettes which are presented as 
addition evidence of the poor management of constipation generally and locally within the Unit. 
No. 1 – Mrs Morris (aged 56) chemotherapy patient 
Over a period of 18 months Mrs Morris had not been appropriately assessed for constipation 
despite having several predisposing factors. Three weeks prior to the following incident Mrs 
Morris denied having constipation.  On an emergency admission Mrs Morris was found to have a 
perforated bowel resulting from faecal impaction.  Mrs Morris survived the surgery and asked to 
see the researcher.  Mrs Morris reported that she had not admitted being constipated because it was 
so severe that she had to resort to the digital removal of her faeces.  Mrs Morris said she felt 
embarrassed and ashamed.  She had never used prophylactic laxatives because their use and role 
had never been explained to her. 
 
No. 2 – Mrs Oliver (aged 83) palliative care patient 
Mrs Oliver repeatedly told her General Practitioner (GP) and district nurse about feeling 
constipated and ‘leaking’ with diarrhoea.  Mrs Oliver reported that the HCPs had not examined her 
abdomen or felt in her rectum to assess her symptoms.  Despite her poor fluid intake Mrs Oliver 
was prescribed ispaghula husk which she found intolerable and made her retch, however, out of 
desperation she persevered.  Mrs Oliver was referred to a continence nurse who she reported 
“...just turned up unexpectedly about 10 days later.” Mrs Oliver described her embarrassment and 
fear as the continence nurse spoke to her “… he was a very tall young man and he came into my 
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house, I didn’t know who he was at first.  He said he had heard that I was dirtying my knickers 
and wanted to know what size pads I wanted.”  Mrs Oliver never sought help again.  She died a 
year later following unsuccessful surgery for a perforated bowel resulting from faecal impaction.  
The surgeon reported that Mrs Oliver had been constipated for so long that faeces had adhered to 
the bowel wall and, and as result, tissue necrosis had occurred.   
 
In summary, these observations indicate that constipation is inadequately managed in patients with 
advanced cancer and that patients fail to report its presence until it becomes severe.  Constipation 
is a common problem the incidence of which increases in patients with cancer and further still for 




Cancer is predominantly a disease of the elderly affecting approximately 75% of those aged over 
60 (Office of National Statistics 2007) the incidence of which is predicted to rise 30% by 2020 
(Møller et al 2007).  The most common cancers (breast, lung, colorectal and prostate) account for 
just over half the new cases of malignant cancer registered in 2004 (Office of National Statistics 
2007).  Cancer causes 25% of all deaths and one in three people will develop the disease (Office of 
National Statistics 2007; The NHS Cancer Plan (Department of Health (DH) 2000).  A diagnosis 
of cancer does not always result in death but for those with advanced or non-curative disease 
oncology treatments may be limited. Patients with advanced cancer often endure complex physical 
symptoms and/or psychological burdens that require palliative care support. 
 
1.4.2 Palliative care 
Palliative care is available to all patients whose disease is not responding to active treatment.  In 
the cancer setting palliative care is available at any stage during the course of the illness and in 
conjunction with anticancer treatment.  The goal of palliative care is achievement of the best 
possible quality of life through palliation of physical and psychological symptoms especially when 
these needs have not been met in the non-specialist setting.  The incidence of constipation is at its 
highest in the terminal phase but death often precedes its palliation.  Constipation is a common 





Constipation is more common in westernised societies than the Third World.  Constipation affects 
between 2% and 27% of the Western population; the incidence of which rises to between 24% and 
100% in patients with cancer.  This vast discrepancy in epidemiological data is partially due to the 
problems of defining, identifying and reporting constipation. In research studies, constipation lacks 
objective definition and there is discordance between patients and HCPs on what constitutes 
constipation.  Similarly, management strategies on constipation vary.  It is noteworthy that there 
are a number of laxatives that can alleviate constipation but these are currently not used 
prophylactically or in optimal doses. 
 
1.4.4 The problems 
Constipation is frequently present in patients with advanced cancer but is rarely identified as being 
important.  Prophylactic laxative prescribing is minimal, consistent laxative use by patients is rare 
and in many instances, HCPs fail to identify constipation as a problem.  Patients and HCPs 
underestimate the consequences of constipation and lack any depth of knowledge in relation to its 
management.  Constipation is inefficiently managed in patients with advanced cancer and the 
profound impact is detrimental to patients’ quality of life. The existing body of evidence suggests 
that the management of constipation in advanced cancer is poorly managed among doctors, nurses 
and other healthcare professionals and it is rarely managed according to guidelines. 
 
1.5 Study initiation 
The catalysts for this study were the researcher’s lack of research knowledge and her observations 
during nursing practice that constipation in patients with cancer was poorly managed.  A year prior 
to undertaking this study the researcher commenced her role at the Unit as Research and Audit 
Sister.  At this time she was aware of her limited knowledge on research methodology and 
methods.  The Unit’s Clinical Director, a representative from the university and the researcher met 
to identify an appropriate course to support her in her role.   It was agreed that the researcher 
combine the academic element of this study (research methodology and methods) and the data 
collection element of her chosen topic (constipation in patients with cancer) to provide a 





1.6 Stages of the research 
1.6.1 Identifying the problem – stage one 
In an attempt to explore the problem further the observations outlined previously were debated 
with the MDT members.  A consensus was reached that patient interviews should be conducted to 
identify the patients’ experiences of constipation and thus provide appropriate baseline data on 
which to plan further interventions.  The MDT considered that the successful management of 
constipation lay within the key elements of constipation assessment, appropriate laxative therapy 
and education.   To confirm these theories and identify any further contributory factors, patient 
interviews were conducted to obtain patients’ opinions, thus exploring their perceptions, 
experiences and management strategies of constipation.   
 
This process was informed by a review of the literature which is presented in Chapter 2.  It 
includes a more in-depth exploration of constipation and the effects on the individual.  The range 
and use of laxatives are examined and the reasons why they are not taken consistently or at optimal 
doses are considered.  This introduces and debates the concepts of compliance and concordance 
and how these apply to the adherence to laxative regimens. 
 
Similarly, the methodological debates are presented in Chapter 3 and embody much of the 
groundwork that was undertaken to inform the study and provide the researcher with the 
appropriate levels of research understanding and skills to conduct it.  Chapter 4 highlights the 
generic methods that were used throughout the study.  These methods represent processes common 
to all stages whereas, to avoid confusion, the more specific methods are introduced as they were 
established at each stage of the study.   Chapter 5 reports the findings of the patient interviews and 
forms the base qualitative information to inform this action research.  
 
1.6.2 Exploring the scope of the problem – stage two 
Stage two of the study consisted of focus groups that intended to establish HCPs’ perceptions of 
constipation management, offer a method of dissemination and act as a member checking process 
to establish the trustworthiness of the data collected.  The findings from stage one suggested that 
patients felt ‘let down’ by their HCPs as they perceived them as ambivalent and disinterested in 
managing constipation. Management strategies afforded to patients appeared ineffective and 
lacked coordination.  Health care professional focus groups were conducted to provide feedback 





The rationale for the focus group, the specific methods used and the findings of the focus groups 
are presented in Chapter 6.  The findings from stages one and two present conflicting management 
strategies between the two groups, often one blaming the other for any disparity.   
 
1.6.3 The intervention – stage three 
In light of the findings from stage one and two the MDT supported the researcher’s proposal that a 
nurse-led clinic should be established.  The development and implementation of the CMC was 
achieved as a direct result of the increased contributions of MDT members who worked 
collaboratively to reduce the incidents and severity of the condition in patients with cancer.  From 
a patient perspective, the clinic provided a mechanism through which objectives identified during 
stages one and two were redressed.   Details of the processes used are outlined in Chapter 7 
whereas Chapter 8 presents the detailed analysis and overall evaluation of the nurse-led clinic 
outcomes and also includes the dissemination of information to the MDT, HCPs working on the 
Unit and to the wider HCP audience.   
 
This action research is concluded in Chapter 9 which offers an overall discussion and draws 
together the main themes as they emerged from the three stages of the study.  Here the researcher 
evaluates the effectiveness of the study and builds a rational for the recommendations for practice 
that comprise Chapter 10.  
 
Figure 1 shows the three stages of this researcher over the study’s trajectory and the simultaneous 
nature of dissemination that occurred throughout. 
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Figure 1 – Core elements and simultaneous processes employed during this action research 
study exploring the management of constipation in patients with cancer. 
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As inherent within an action research approach each stage of this study evolved over time and 
components were incorporated based on the findings at each stage and during developmental 
periods.   For example, the need to review the contemporaneous literature on laxatives was not 
identified until following stage two and during development of the Constipation Management 
Clinic.  Thus Chapter 2 and subsequent literature reviewed in this thesis reflects these study 
timelines.  Figure 2 shows the periods of data collection only, however project planning mainly 
occurred between these episodes whereas data analysis took place simultaneously throughout.    
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Chapter 1 has introduced, set the context and outlined the rationale of the study as it is situated 
within cancer and palliative care and in context with the researcher’s professional role and nursing 
experience.   A brief insight has been given which exposes that constipation is poorly managed, 
patients’ and HCPs’ knowledge is inadequate, patients are not appropriately assessed, concordance 
has not been adopted and management of the condition in the community is fragmented.  These 









For simplicity throughout this thesis: 
 
• Patients with cancer 
The term ‘patients with cancer’ comprise those with the diagnosis 
regardless of stage of disease, thus encompassing those with advanced 
cancer and/or receiving palliative care.   
 
• The ‘Unit’ 
The ‘Unit’ refers to the specialist palliative care unit in which the researcher 
practiced and coordinated this research. 
• Health care professional (HCP) 
The term ‘health care professional’ denotes a physician, nurse, therapist or 
other individual who is both trained in a particular discipline of health care 
and directly involved in the delivery of clinical care to patients.   
 
• The multidisciplinary team (MDT) 
The multidisciplinary team is a group of HCPs from different disciplines 
and/or settings who work collaboratively as a group with specific aims and 
objectives.  
 
• Defining the team for this research 
Due to the transient nature of many HCPs difficulties arose in identifying a 
static group for this research, therefore, throughout the remainder of this 
thesis the MDT refers to HCPs who contributed directly to this study in 
terms of working collaboratively by affording direction, opinions and 





Constipation: literature expressing the scope of the problem 
 
2.1 Introduction  
This Chapter examines defecation as it presents in the general population and aligns this with the 
varying types of constipation and exacerbating factors in patients with advanced cancer.  The 
incidence of constipation as it occurs in the general population is contrasted with the increasing 
prevalence at the end of life.  Constipation presents several major problems in the clinical setting 
and these are discussed, including definition, subjectivity versus objectivity, reliability of data, 
disparity in perceptions, under reporting and suboptimal treatment.  The causes of constipation in 
advanced cancer are also established together with some of the profound consequences patients 
often endure.  The use, role, efficacy and side effects of laxatives are explored followed by the use 
of constipation identification and assessment tools.  Finally, compliance and concordance is 
debated in order to provide a framework for improving the management of constipation in patients 
with advanced cancer. 
 
2.2 Definitions 
In order to appreciate the extent of the abnormality constipation represents it is necessary to define 
normal stool form and frequency in the general population and as perceived by individuals.  In this 
thesis the term ‘bowel movement’ refers to stool defecation. 
2.2.1 Normal bowel frequency and stool form 
Most adults report at least one bowel movement in 24 hours (Connell et al 1965; Everhart et al 
1989).  Heaton et al (1992) report that this conventional norm of a regular 24 hour cycle is only 
seen in approximately 40% of men and 33% of women and over half the population had irregular 
bowel habits ranging from less than one to over 21 per week.  Normal stools are usually 
considered to be types 3 and 4, based on the Bristol Stool Form Scale (Lewis and Heaton 1997) 
(Appendix 1), because they are the ones associated with least urgency, straining and feelings of 
incomplete evacuation, however, these were only present in 62% of men and 57% of women 
(Heaton et al 1992).  Heaton et al’s (1992) study excluded older people because of the likelihood 
that they would have problems with eyesight, hearing, mobility and/or transport to clinics.  
Therefore, the study is not representative of the general population as many will be aged 65 and 
over, a factor in itself that predisposes them to constipation and/or cancer and thus a group 
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particularly in need of constipation resolution (Long et al 1995; Petticrew et al 2001; Petticrew 
1997). 
 
Bassotti et al (2004) prospectively studied bowel frequency in the general population over a four 
week period using diaries to collect data based on the Rome II Criteria (Drossman et al 2000; 
Longstreth et al 2006).  Patients reported on their bowel frequency and associated requirements 
including straining during defecation, incomplete emptying and/or difficult evacuation, manual 
manoeuvres to facilitate defecation, lumpy or hard stools and the use of laxatives.  There was a 
large variation in bowel movement frequency ranging between one to three per day and one 
evacuation every four days.  Less than 5% reported fewer than three evacuations each week.    
 
Bassotti et al (2004) regarded the 61% response rate in their study as high and attributed this to its 
prospective nature and simplistic format of the diary, thus preserving reliability of bowel habit 
data, which may otherwise be considered as unreliable.  One can postulate that some of the sample 
in Bassotti et al’s (2004) and Heaton et al’s (1992) studies would have a degree of constipation, 
however, as no data on the individual perceptions were collected any correlation of opinions is 
unknown.   
 
Defecation patterns show that 90% of people in Western countries have between three bowel 
movements a day to three per week (Connell et al 1965; Everhart et al 1989; Heaton et al 1992; 
Bassotti et al 2004) and it is this definition of ‘normal’ frequency that continues to prevail in 
health care literature (Bandolier 1997).  Johanson et al (1989) state that 62% of the general 
population believe that a bowel movement each day is essential.  To be considered normal, a stool 
should be solid, moist and easy to pass.  However, normal bowel frequency is subject to personal 




The word constipation is based on the Latin word constipare and means ‘crowd together’.  
Historically, constipation was proffered as a basic explanation of disease, the notion being that 
poisonous material was released from decomposing waste in the intestines (Ebbell 1937 cited by 
Prather and Ortiz-Camacho 1998).  Throughout human history constipation and bowel irregularity 
has been considered dangerous to health (Whorton 2000) and its aetiology and management has 
perplexed the medical profession (Prather and Ortiz-Camacho 1998; Heaton et al 1992).  Sir 
Arthur Hurst laid the conventional foundations to the scientific approach to ‘Constipation and 
Allied Disorders’ over a century ago (Avery Jones 1972).  However, constipation still presents 
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challenging problems in healthcare with painful and debilitating consequences to patients and is 
poorly managed by HCPs in multiple clinical settings (Heaton et al 1992; Bassotti et al 2004). 
 
Constipation is commonly categorised into either primary or secondary.  Primary constipation 
occurs where there is no underlying causative illness and is also called idiopathic (self originated, 
of unknown causation) or simple constipation (Hsieh 2005; Wright and Thomas 1995; Chey 2005; 
Stark 1999).  Primary constipation is associated with lifestyle factors which include insufficient 
fibre in the diet, inadequate food and/or fluid intake, lack of exercise/mobility and environmental 
issues such as lack of privacy when toileting (Rao 2003; Koch et al 1997; Rao et al 1998; Fallon 
and O’Neill 1997; Nettina 1996; Long et al 1995; Winney 1998).  When an endocrine, metabolic, 
neurological, psychiatric, structural or iatrogenic (inadvertently caused, for example as a result of 
drug use) explanation can be identified, constipation is said to be secondary (Prather and Ortiz-
Camacho 1998; Schiller 2001).   
 
In summary, bowel frequency is variable but it is generally accepted that the norm is between three 
bowel movements a day to three per week.  Constipation can be either primary or secondary, the 
aetiology of which is not always evident.  The nature and/or type of pre-existing bowel habit could 
serve to inform patients’ history and management strategies, therefore was explored in this 
research.  A substantial number of patients with cancer will experience primary and/or secondary 
constipation. 
 
2.3 Epidemiology of constipation 
There is wide variability in epidemiological studies due to the poor definition of ‘constipation’, 
different data ascertainment methods (Higgins and Johanson 2004) such as mailed questionnaires 
and telephone interviews and the unreliability of individuals’ self-reported information.  Thus, 
constipation is probably understated but affords an indication of the extent of its occurrence.   
2.3.1 The general population 
Constipation is a common problem affecting between 2% and 27% of the population in Western 
countries (Stewart et al 1999; Pare et al 2001; Higgins and Johnson 2004; Thompson and Heaton 
1980; Talley et al 1993; Johanson et al 1989; Lemob and Camilleri 2003).  Constipation is more 
prevalent in elderly people, in women and in Caucasians.  Severe constipation is found almost 
exclusively in women (Preston and Lennard-Jones 1986; Sandier et al 1990; Pare et al 2001; 
Stewart et al 1999) the incidence of which increases with age (Johnason et al 1989; Read et al 
1995).  It is generally accepted that constipation is a complaint affecting around 10% of the adult 
population in general but approaching 20% of the elderly (Thompson and Heaton 1980). 
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2.3.2 Patients with advanced cancer 
Studies indicate that 70% to 100% of patients with cancer have a problem with constipation (Potter 
and Higginson 2002; Walsh et al 2000; McMillan and Tittle 1995; Weitzner et al 1997; McMillan 
and Weitzner 1998; Tittle and McMillan 1994).  In hospice settings the prevalence of constipation 
ranges from 24% to 84% (Walsh 1984; Donnelly and Walsh 1995; Addington-Hall et al 1991; 
Vainio and Auvinen 1996; Sykes 1998a).  For example, in a prospective study using the self-
reported Constipation Assessment Scale (McMillan and Williams 1989), 63% of patients had 
some degree of constipation on admission, of which 19% was rated as severe (McMillan 2002).  
By week two the presence of constipation had increased to 68% and those with severe constipation 
had risen to 22%.  McMillan’s (2002) study criteria excluded patients who did not have 
constipation documented as a problem on admission.  It is unwise to assume that because 
constipation is not documented in records that patients are not experiencing it.  It is well recorded 
that many patients fail to report their constipation unless specifically asked. 
 
Constipation occurs in approximately 40% of patients referred to palliative care services (Curtis et 
al 1991) and up to 90% of patients treated with opioids (Twycross and Lack 1983; Walsh 1984; 
Sykes 1998a) and represents a significant problem in 40-50% of cases (Walsh 1984; Glare and 
Lickiss 1992).  Constipation is more common in patients who are terminally ill with cancer than 
those dying from other causes (Sykes 1998b). 
 
In summary, constipation appears to be a problem in the general population, the incidence and 
severity of which significantly increases in patients with advanced cancer.  Prevention and 
alleviation of constipation in patients with advanced cancer was explored in this research as, 
according to Sykes (2004) it is preventable and treatable in this group but achievement of this is 
often impaired by clinical methodological considerations.  
 
2.4 Causes of constipation 
Constipation is often multi-factorial especially in patients with cancer and knowledge of the 
aetiology underpins management strategies.  The main causes of constipation in patients with 





Table 1  – Causes of constipation in advanced cancer (Mancini and Bruera 1998). 
 
Although constipation is not a physiological consequence of normal ageing, decreased mobility 
and other co-morbid medical conditions contribute to its increased prevalence in older adults 
(Hsieh 2005).  The elderly and patients with advanced cancer are particularly prone to constipation 
resulting from dehydration.  The recommended daily fluid intake is three litres each day (Otto 
1997; Nettina 1996; Long et al 1995) however many patients will fail to achieve this.  Likewise, 
the reduced mobility of many people suffering from cancer also predisposes them to constipation 
as reduced activity has been identified as a cause of constipation (Royle and Walsh 1992; Hill et al 
1998; Winney 1998; Fallon and O’Neill 1997).  Some cancer treatment drugs are well recognised 
as causing constipation and are key contributors to constipation in patients with cancer regardless 
of their age.  Thus, the relatively advanced age of most cancer patients predisposes them to 




Pelvic tumour mass 
Radiation fibrosis 




Anticholinergic (i.e. antispasmodics, antidepressants, haloperidol, antacids) 





Anticancer agents (vinca alkaloids) 
 
Metabolic disturbances 








Spinal cord involvement 














morbidity and use of constipating drug, especially opioids.  However, Thorpe (2001) notes that 
dietary modifications, increasing fluids and exercise are important but are not usually sufficient to 
overcome opioid-induced constipation. 
 
Drugs commonly used and known to cause and/or exacerbate constipation in patients with 
advanced cancer include chemotherapy agents, antiemetics and analgesics.  Constipation may 
result in patients who have received neurotoxic chemotherapy agents, such as vinca alkaloids, 
epotoside and cisplatin, each of which may cause autonomic dysfunction (Tipton and Skeel 1999; 
Otto 1997) and reduce gastrointestinal transit time (Sharma 1998) leading to high faecal impaction 
(Long et al 1995).  Up to 35% of patients receiving vinca alkaloids become constipated and 70% 
of those given carboplatin (Smith 2001).   
 
Antiemetic drugs, especially those classed as 5-HT3 antagonists1 which slows intestinal transit 
time (Talley et al 1990) are frequently used for the prevention of chemotherapy induced nausea 
and vomiting (de Wit et al 2005) and for symptom palliation in advanced cancer.  However, they 
often induce and/or exacerbate constipation (Ding et al 2007; Blackwell and Harding 1989; Bhatia 
et al 2003).   
 
Opioids are the mainstay in the treatment of moderate to severe pain and are used extensively for 
the treatment of pain in patients with cancer (Quigley 2005; Portenoy 1994).  Opioids decrease 
gastrointestinal motility and increase fluid absorption from the intestines.  The increase in fluid 
absorption is further enhanced by the slowed gastrointestinal transit time (Fakata and Lipman 
2005; Yuan et al 1997).  The main issues of gastrointestinal aetiology that are directly associated 
with opioid induced constipation are reduced and or retarded peristalsis and the alteration in the 
production and resorption2 of gut secretions (Long et al 1995; Nettina 1996; Otto 1997).  The lack 
of peristalsis is exacerbated further by opioid induced increased bowel muscle tone which slows 
down transit time and facilitates absorption of fluid from the faeces, thus hard stools and peristaltic 
insufficiency (Hull 1988).   
 
The extent of constipation and its tolerability is patient variable and may be affected by opioid 
dose (Fakata and Lipman 2005).  Patients may require modification in strategies as constipation is 
more easily prevented than treated using appropriate laxative therapies (Sykes 2004; Tipton and 
Skeel 1999). 
 
                                                 
1 The 5-HT3 antagonists are a class of medications which act as receptor antagonists at the 5-hydroxytryptamine-3 receptor (5-HT3 
receptor), a subtype of serotonin receptor found in terminals of the vagus nerve and in certain areas of the brain (de Wit 2005). 
2 The loss of substance through physiologic or pathologic means (Mosby2001). 
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In summary, constipation in patients with advanced cancer is multi-factorial and includes primary 
and secondary aetiologies.  Some drugs significantly compromise bowel function but their use is 
essential in an attempt to prolong life (chemotherapy agents) and in managing other symptoms for 
example pain, nausea and vomiting.  Drugs are necessary for symptom alleviation and may 
prolong life.  The routine prescribing and prophylactic use of laxatives is rarely adopted and 
consequently has a profound impact on patients.   
  
2.5 Complications of constipation 
There are several complications associated with constipation (Table 2).  Two issues often 
presenting in patients with advanced cancer are establishing whether the individual is suffering 
with faecal impaction or tumour obstruction and differentiating between dirarrhoea and overflow.  
The clinical management of these will differ depending on diagnosis but this is often problematic.  




















Table 2 – Potential complications of constipation 
 
 
Abdominal pain, cramps, bloating and/or distension, gastric fullness 
Increase of liver or retroperitoneal pain 






Overflow diarrhoea (which can lead to electrolyte disturbance) 
Fatigue, malaise, headaches 
Confusion, restlessness 
Rectal tearing, fissure, and haemorrhoids 
Straining to defecate in the constipated patient, which can lead to: 
o Haemorrhoids 
o Fainting 
o Cardiac irregularities 
o Movement of a deep vein thrombus to the pulmonary veins (pulmonary 
embolus) 
o In severe cases, sudden cardiac death due to cardiac abnormalities 
 
 
Campbell et al 1993; Glare and Lickiss 1992; Kollef and Neelon-Kollef 1991; Lamers 2000; 
McGuire et al 1950; Ross 1995; Trohman et al 1986; Winney 1998; Mancini and Bruera 1998; 
Pappagallo 2001; Maestri-Banks and Burns 1996; Norton 1996; Powell and Davies 1999; 
Ripamonti and Bruera 2002. 
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2.5.1 Faecal impaction versus obstruction 
Failure to prevent constipation, together with its aetiology and other predisposing factors 
discussed, result in patients with cancer also being at risk of developing faecal impaction.  Faecal 
impaction may develop as a result of severe constipation and is an accumulation of hardened or 
inspissated (thickened or hardened through absorption of the liquid portion) faeces in the large 
bowel and/or rectum that the individual is unable to move (Twycross and Wilcock 2001: Mosby 
2001).  Major factors that precipitate faecal impaction are opioid use, prolonged inactivity and 
reduced diet and fluids (Cefalu et al 1981).  Faecal impaction can lead to bowel obstruction and 
consequently ischemia and may result in bowel perforation and even death (Drew and Herdson 
1997; Shammi and Remington 1997; Freudenreich and Goff 2000).   
 
Bowel obstruction can occur as a result of faecal impaction or be tumour related.  Tumour 
obstruction occurs when the cancer mass enlarges and compresses intestines externally or blocks 
the intestines internally.  Sykes (1998a) identified specific causes in the terminally-ill including 
local gastrointestinal obstruction due to tumour, partial and/or complete bowel obstruction, 
depression and neurological symptoms such as spinal cord compression. The incidence of 
obstruction was noted by Tsuneto et al (1998) who found that malignant intestinal obstruction was 
a frequent complication of abdominal and pelvic cancers and developed in 16% of patients who 
died in a hospice.  Mercadante (1997) and Baines (1997) agreed and both authors state that 
colorectal, gastric, ovarian and uterine cancers are most commonly associated with malignant 
intestinal obstruction.  Tsuneto et al (1998) found that malignant intestinal obstruction developed 
in 63% of patients with gastric cancer, 45% with ovarian cancer and 40% with colorectal cancer.  
Awareness of the presence of partial or complete malignant bowel obstruction is important as the 
management of the individual’s constipation (which may or may not co-exist) may not be possible 
and pursuing its alleviation may result in more harm than good such as exacerbation of symptoms 
and increasing risk of bowel perforation (Tsuneto et al 1998).  
 
Both faecal impaction and tumour obstruction may result in complete or partial blockage.  
Differentiating between the two can be problematic as patients with tumour related obstruction 
may exhibit symptoms similar to constipation, therefore any constipation management strategies in 
patients with advanced cancer should encompass a diagnostic element in order to identify and 
exclude those with malignant bowel obstruction as they will require alternative management.  
There is strong evidence that the oral treatment of faecal impaction is highly effective (Culbert et 
al 1998).  When the diagnosis of constipation is unclear an abdominal x-ray may be required 
(Bruera et al 1994; Starreveld et al 1990; Smith and Lewis 1990; McKay et al 1983; Baines 1997).  
Faecal impaction or rectal obstruction causes increased production of mucus, which may present 
as a rectal discharge or diarrhoea (Goldfinger 1991). 
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2.5.2 Faecal incontinence: diarrhoea versus overflow 
One of the side effects of constipation, especially when severe, is faecal incontinence.  Faecal 
incontinence refers to the failure of the voluntary control of the anal sphincter, with involuntary 
passage of faeces, flatus and liquidity of faecal discharge.  The constipated mass in the bowel 
becomes so hard and difficult to pass that any watery substance much higher up in the bowel 
passes round the blockage and leaks out of the rectum (Francombe et al 2001) this is often referred 
to as ‘overflow’.  In the clinical setting overflow is often reported as ‘diarrhoea’.  Faecal 
incontinence can be as a result of constipation but in clinical practice this association is rarely 
identified.   
 
In a community based sample of 6,959 individuals Nelson et al (1995) conducted a telephone 
survey to determine the prevalence and characteristics associated with anal incontinence.  Anal 
incontinence was defined as the involuntary passing of solid faeces, liquid faeces, or gas which 
were reported in 36% of the sample within the study.  They found that sufferers of anal 
incontinence were predominantly those aged over 65 (30%) and female (63%).  Overall 36% of 
the sample reported experiencing incontinence of solid faeces and 54% of liquid faeces.  In a 
systematic review faecal incontinence was considered a major problem affecting between 11-15% 
of people in the community (Macmillan et al 2004).  These figures need to be interpreted with 
caution because the relevant studies are hampered by possible under-reporting and by a lack of a 
consensus definition (Madoff et al 2004; Nelson et al 1995).  Nelson et al (1995) found that the 
independent risk factors identified were female sex, advancing age, poor general health and 
physical limitations, all of which are also predisposing factors in cancer, palliative care and 
constipation.  However, there appears to have been no attempt to establish whether or not any of 
these patients may have been experiencing simultaneous periods of constipation or any medical 
diagnosis that may have affected their bowel function.  
  
Knowledge of constipation in this sample would have highlighted a group that potentially had 
been experiencing ‘overflow’ diarrhoea.  Given the large sample size in Nelson et al’s (1995) 
study and the high incidence of cancer and constipation in the general population, it is likely that 
the sample included patients with a diagnosis of cancer, constipation or both.  In contrast 
Francombe et al (2001) reported the prevalence of faecal incontinence to be at least 2% of the 
general population, the incidence of which increased to 7% in those over 65 years of age.  They 
further postulated that the true incidence was probably much higher but is often not reported 
because of the stigma associated with the problem.  Johanson and Lafferty (1996) found that only 
one third of patients identified as having faecal incontinence had ever discussed the problem with a 




Diarrhoea and/or faecal incontinence care are common problems that may be secondary to 
constipation, thus when caring for patients with advanced cancer it is important to be aware of the 
potential for misdiagnosis.  Patients may use descriptors such as diarrhoea, overflow or faecal 
incontinence as a rationale for why they believe they are not constipated.  Patients may not 
volunteer information on faecal incontinence and eliciting such information may be facilitated by 
utilisation of a constipation assessment tool. 
 
In summary, constipation often leads to multiple symptoms and complications in patients with 
advanced cancer.  Bowel obstruction profoundly impacts on patients and presents clinical 
problems as its aetiologies cannot be established on subjective data alone and may be 
misdiagnosed as constipation despite the increased incidence of tumour related obstruction in 
some cancers.  Similarly, a diagnosis of constipation may be rejected inadvertently when diarrhoea 




2.6 Laxative treatments 
The role and use of laxatives in the management of constipation is well recognised and commonly 
accepted in both professional care and in the general population.  Purgative use has been a 
mainstay of medical therapy for the last two millennia (Duncan 2000).  Although the use of 
laxatives is commonplace most HCPs appear to lack an in-depth understanding of them.  The 
following oral laxatives and their overall efficacy are discussed in the management of constipation 
generally and more specifically in patients with advanced cancer.   
 
2.6.1 Types of laxatives 
Laxatives are classified according to their mode of action and comprise various drugs and 
preparations including bulk-forming, stimulant laxatives, faecal softeners and osmotics (British 
National Formulary (BNF) 2005).  Although other laxatives (such as bowel cleansing solutions) 
and novel treatments (for example some prokinetics, prosecretors and antibiotics) have been used 
to treat constipation they are not part of routine management and are excluded from the following. 
 
Most laxatives are safe when used occasionally (Anton 2002) although all can have significant 
adverse effects, for example they may hinder the absorption of vitamins and may upset the 
electrolyte balance (Long et al 1995).  The classical adverse effect of laxatives is diarrhoea and 
there are no features that absolutely differentiate this type of diarrhoea from any other (Anton 
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Laxative Adverse effect Reference 
Danthron 
Hepatotoxicity, contact dermatitis, may colour 
urine pink or red as well as staining the 
perianal skin pink or red. 
Tolman et al (1976); Harland 
and Mortimer (1992); BNF 





Possible hepatotoxic effects 
Enhances uptake of drugs such as 
erythromycin. 
Abramowiecz (1997); 
Donowitz and Binder (1975); 
Dujovne et al (1972); BNF 
(2005); BNF (2008) 
Ispaghula husk 
(psyllium) 
Oesophageal obstruction in patients with 
dysphagia, gastrointestinal obstruction, 
anaphylaxis, asthma, shortness of breath, 
wheezing, urticaria. 
Noble and Grannis (1984); 
BNF (2005); BNF (2008); 
Nelson (1987); Vaswani et al 
(1996); Jagjivan et al (1988) 
Lactulose Flatulence, abdominal: distension, rumbling pain, cramp. 
Attar et al (1999); BNF 
(2005); BNF (2008) 
Liquid paraffin 
Associated with lipoid pneumonia as a result 
of aspiration of the oil, anal seepage of oily 
material, abdominal cramping, flatulence. 
Fallon and O’Neill (1997); 
Xing and Soffer (2001); 
Bandla et al (1999); BNF 
(2005); BNF (2008) 
Polyethylene glycol 
Cramping, nausea, unpleasant taste, flatulence, 
loose stools, abdominal: pain, bloating, 
rumbling. 
Andorsky and Goldner 
(1990); Attar et al (1999); 
BNF (2005); BNF (2008) 
Senna Hepatotoxicity, diarrhoea, flatulence, abdominal: distension, rumbling, pain, cramp. 
Beuers et al (1991); BNF 
BNF (2005); BNF (2008) 
Senna plus lactulose Diarrhoea, flatulence, abdominal: distension, rumbling, pain, cramp. 
Agra et al (1998); Sykes 
(1991); BNF (2005); BNF 
(2008)
 
Table 3 – Adverse effects of laxatives 
 
2.6.2 Efficacy of oral laxatives 
Various reviews present conflicting evidence about the efficacy of laxatives.  The reviews differ in 
their primary samples, which are chronic constipation in adults (Ramkumar and Rao 2005; 
Tramonte et al 1997), constipation in the elderly (Petticrew et al 1997), constipation in palliative 
care (Miles et al 2007) and opioid induced bowel dysfunction in cancer patients (Tamayo and 
Diaz-Zuluaga 2004). 
 
These patient samples are diverse insomuch as chronic constipation reflects longevity of the 
condition regardless of cause, whereas opioid use, the elderly, cancer and/or palliative care allude 
to its possible aetiologies.  It is explicit that elderly patients and opioid users were included in 
those studies assessing chronic constipation, therefore representative of patients in this study as 
many will be elderly, may have experienced chronic constipation during their lives and developed 
constipation as a result of cancer and/or its treatments and disease progression.  Petticrew et al 
(1997) suggested that in the elderly any kind of laxative can increase stool frequency by about 1.4 
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bowel actions per week compared with a placebo.  As the following two systematic reviews, 
Ramkumar and Rao (2005) and Miles et al (2007), present contemporary data they are discussed 
in more detail and comparisons made with other studies where appropriate. 
 
Ramkumar and Rao (2005) examined randomised controlled trials (RCT) (period 1996 to 2006) 
that compared one agent with a placebo or compared two separate agents for efficacy and safety.  
The strength of evidence and grading of recommendations were determined using established 
methodological criteria by Schoenfeld et al (1998) and Jadad et al (1996).  The results suggested 
there was good evidence to support the use and efficacy of polyethylene glycol in the treatment of 
constipation and lactulose and ispaghula husk were found to be efficacious and are moderately 
recommended in the treatment of constipation.  There was poor evidence, to support the use of the 
other laxatives (considered for this study as outlined above) either due to poor study design, 
limited numbers and/or lack of efficacy. 
 
The evidence to support laxative efficacy is impaired partially due to the varying study designs in 
which the intervention dose varied between studies.  For example, pysllium doses ranged between 
3.5g and 24g per day and in 2 studies the dose was not known.  A further consideration is that 
Ramkumar and Rao (2005) identified their aim which ‘…was to undertake a systematic review of 
the efficacy and safety of traditional medical therapies for chronic constipation….’ However, 
given the studies’ designs, that of cross-over RCTs, it may be that some patients were not 
constipated at the point of cross-over as this may have been alleviated by the initial laxative used.  
Whilst it is acknowledged that a ‘washout’ period is explicit in some trials, the duration of this 
period varied and was only two days in some cases and needs to be considered given the ‘time to 
effect’ (Appendix 2) of some laxatives, which is further affected by gastrointestinal transit time.   
 
2.6.3 Efficacy of laxatives in patients with advanced cancer 
Miles et al (2007) state that the treatment of constipation in palliative care is based on inadequate 
experimental evidence as few RCTs make direct comparisons between different classes and/or 
combinations of laxatives.  In their comprehensive literature search (period 1996 to 2005) and 
utilisation of two established methodological quality scales by Jadad et al (1996) and Rinck et al 
(1997) only four studies were identified.  One of these studies compared a laxative not commonly 
available in England (Miles et al 2007) and is therefore excluded from the following discussion.   
 
Agra et al (1998) compared senna with lactulose in a randomly assigned sample of 75 terminally 
ill patients.  No significant difference was noted in efficacy between these two groups.  These 
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findings were confirmed by Tamayo and Diaz-Zuluaga (2004) who further found that senna plus 
lactulose produced a superior effect, thus reinforcing the previous findings by Sykes (1991). 
 
Sykes (1991) compared senna plus lactulose to co-danthramer which were randomly assigned in a 
crossover trial to 51 hospice patients with cancer.  The dose was titrated according to response.  
Lactulose plus senna produced a superior effect in relation to bowel movement but caused more 
diarrhoea than co-danthramer.  No significant differences were found between the opioid and non-
opioid users, however, the latter group had a greater stool frequency (Sykes 1991).  Furthermore, 
Sykes (1991) found senna plus lactulose equally as effective as magnesium hydroxide combined 
with liquid paraffin in 118 hospice patients with cancer.   
 
Whilst the efficacy of laxatives are not contested it is important to be aware that they are the most 
common cause of diarrhoea in palliative care (Twycross and Lack 1986) thus warranting patient 
monitoring and dose titration. 
 
In summary, by comparing and contrasting the aforementioned two contemporary and systematic 
reviews and other studies, it is possible to extrapolate the following valuable considerations which 
will be referred to in this study.  These include laxative efficacy, side effects and formulation, 
outcome measures and rescue laxative use.  Some oral laxatives are efficacious provided they are 
used consistently and in optimal doses.  Laxative dose is variable in individuals and may require 
titration.  Formulation, dose frequency and adverse effects impact on individuals consistent use 
and may need periodical modification.  In the aforementioned studies, outcome measures on 
laxative efficacy, adverse effects, stool form and frequency were based on patient self-reports and 
supplementary data obtained using constipation risk and assessment tools. 
 
 
2.7 Clinical methodological considerations 
2.7.1  Defining constipation 
Constipation is poorly defined (Harari et al 1993).  There is no single definition of constipation 
and an attempt to collate published definitions of constipation provides a list of signs, symptoms, 




















Table 4 – Descriptors used to define constipation. 
 
People most commonly define constipation by one or more descriptors.  Constipation is often 
defined as fewer than three bowel movements a week though symptoms like straining, passing 
hard stools and inability to defecate when desired, together with abdominal pain also form part of 
the diagnosis (Bandolier 1997).  The extent to which these symptoms coexist in individuals varies.  
Cimprach (1985) suggested that using a single parameter, such as frequency of stool, is too 
simplistic and that it is also important to assess consistency, size and ease of passage during 
defecation.  Individuals vary in the importance they give to the different components of 
constipation when assessing their own bowel function and may introduce factors such as 
abdominal bloating (Sykes 1994).  Defining constipation is also hindered by its overwhelming 
subjectivity.  
 
2.7.2  Subjectivity versus objectivity 
Clinical and epidemiological studies in constipation are largely based on subjective self-reporting 
(Potter and Higginson 2002; Everhart et al 1989; Drossman et al 1982; Sandler and Drossman 
1987; Rendtorff and Kashgarian 1967).  Constipation is seldom measured objectively due to the 
unpleasant nature of standard techniques (stool collection) or radiation exposure (x-rays), or both 
(Phillips 1991).  Whilst 100-200g is regarded as an average daily defecation weight (Humes 2001) 
such measures are rarely alluded to in the literature.  Similarly, transit time is rarely measured but 
 
Frequency:  the number of bowel motions per day/week, often described as ‘infrequent’ 
 
Nature of stools/consistency:  small hard rock, pellets, scybala (hardened masses of 
faeces), large bulky mass, watery/loose stools, diarrhoea, dry stools 
 
Ease of passage:  pain on defecation, difficult evacuation, the amount of physical exertion 
to aid/facilitate defecation, dyschezia (excessive straining) 
 
Sensation of incomplete bowel evacuation:  tensemus, ineffectual defecation/evacuation, 
anorectal obstruction or blockage  
 
Manual manoeuvres to facilitate defecation:  digital removal of faeces, perineal support 
 
Duration of defecation:  prolonged periods on the toilet, frequent visits to the toilet 
 




Norton 1996; McMillan and Williams 1989; Ross 1998; Tortora and Grabowski 2000; 
Mallett and Dougherty 2000; Woodruff 1993; Anton 2002; Nelson et al 1995; Drossman 
1999; Maestri-Banks and Burns 1996; Winney 1998; Barloon and Lu 1997. 
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Sykes (1990) notes that food residual in the bowel is normally 1-2 days whereas in hospice 
patients with cancer this be between 4-12 days. 
 
Individuals’ expectations of ‘normal’ stool form and frequency vary.  For example, a bowel 
motion every three days with minimal straining may be ‘quite normal’ to one person but another 
may regard this as being constipated because their bowel had not opened daily (Ashraf et al 1996; 
The Medicines Resource Centre (MeReC) 1994).  A few hard pellets passed daily could be normal 
to one person whereas another may consider this as being constipated.  Maestri-Banks and Burns 
(1996) and Potter and Higginson (2002) contend that as the individual is the only one to be fully 
aware of their bowel function the logical definition to use is theirs, thus self-reported constipation   
 
Bassotti et al (2004) note that in their study on bowel habits, symptomatic individuals may have 
been more likely to participate than asymptomatic patients.  This is an important consideration 
given the subjectivity of constipation as patients may not report and/or proactively manage the 
condition if they do not perceive themselves to be constipated.  Ultimately this may affect their 
recruitment into research studies and lead to data bias.  
 
In contemporary healthcare research studies, including those of Addison et al (2003), Stewart et al 
(1999) and Pare (2001), self-reported constipation is supplemented with data elicited using an 
assessment tool to afford an objective component and strengthen findings.  Generally, HCPs are 
dependent on the patients’ recollection of bowel history, which may be inaccurate particularly with 
regards to bowel frequency (Drossman et al 1982; Manning et al 1976).   
  
2.7.3 Reliability and dependability of data 
Self-reported constipation may describe real or imagined disturbance of bowel function and is 
considered unreliable.  Manning et al (1976) collected bowel frequency data during the normal 
clinic interview in a randomly selected sample of 150 patients attending general medical outpatient 
clinics.  Findings show that patients with six or less bowel actions per week tended to significantly 
underestimate bowel frequency whilst those with more frequent bowel actions tended to 
overestimate.   The results suggest that retrospective bowel habit data are unlikely to elicit accurate 
information on bowel function and frequency.  Heaton et al (1992) found moderately good 
agreement between reported and recorded information as 80% of people who claimed a once daily 
habit showed evidence on their recorded forms whereas claims of a twice daily habit were 
confirmed in 50% of cases (Heaton et al 1992).   
 
Constipation cannot be defined or diagnosed by bowel frequency alone (Ashraf et al 1996; MeReC 
1994; Drossman et al 1982; Manning et al 1976).  The complexities of obtaining reliable data may 
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be partly due to the difference between patients’ perceptions and clinical definitions as there is 




Recognising constipation can be a challenge because of the lack of clear definition and because 
there is a disconnection between patients’ definitions of constipation and those of clinicians (Boyle 
1970; Herz et al 1996; Cash 2005).  Clinicians need to understand not only the symptom-based 
criteria for constipation but also the other complaints and descriptors that patients may use to 
define their constipation (Cash 2005).  Ambiguous and contrasting definitions add to the 
complexity of constipation and this is impeded further by the ‘professional’ versus ‘patient’ 
viewpoint.   
 
Health care professionals and the body of scientific literature define constipation in terms of a 
‘gastrointestinal disorder’ or as a ‘common medical condition’ (Anton 2002), the severity of which 
is most commonly associated with the frequency of defecation over a given time, for example 
Lembo and Camilleri (2003) classify severe constipation as only two bowel movements a month.   
 
Using a questionnaire Boyle (1970) showed wide variation in doctors’ and patients’ definitions of 
constipation.  Of the five statements used there was variation both between groups (patients and 
doctors) and within each group as to the definition of constipation (Table 5).   
 
 
Definition Patients Doctors 
Passing a lot of wind by the back passage 
Passing loose bowel motions 
Passing dark-coloured motion 
Difficulty in opening one’s bowels 












Table 5 – Distribution of definitions of constipation, (Table VIII in Boyle 1970) 
 
The problems with Boyle’s (1970) study is that the descriptors were limited and respondents were 
only able to choose one item despite all criteria being associated with constipation.  This study 
could be considered an outdated source but has face validity (Polit and Beck 2008) and supports 
the observations of the researcher and therefore underpins this study.  More recently Herz et al 
(1996) studied 531 randomly selected patients (attending a clinic for complaints other than 
constipation) and 57 doctors.  Patients’ and physicians’ concordance on several aspects of 
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constipation (including definitions, attitudes and management strategies) were compared.  They 
found that severe constipation, whether secondary to a diagnosed disease or as a separate entity, 
was easily identified by patient and doctor alike but difficulty arose between normal defecations 
and non-severe constipation.  This ‘grey area’ (Herz et al 1996) was considered to be of particular 
importance in this study as the suboptimal management of constipation per se often results in it 
becoming increasingly severe.  Fifty percent of patients understood constipation differently from 
accepted medical definitions with 27% of patients considering it as defecation every two days or 
less and 25% as hard stools alone.  In contrast all the doctors defined constipation as defecation 
less than every three days, sometimes in combination with hard stools.   
 
Herz et al (1996) found it unsurprising that patients complaining of constipation often met with the 
scepticism of the doctor and left the consultation dissatisfied with the care that they received.  As a 
result patients frequently treated their constipation themselves and interpreted the doctors’ lack of 
action as an indication of the value they placed on their symptoms and by implication that the 
patients’ concerns were unimportant and nothing of concern.   
 
In the above studies it is important to consider how individuals’ personal and subjective 
experience may have affected their responses.  For example, doctors and nurses undertake several 
years of training underpinned by research and evidence-based practice which tends to be more 
quantitative and objectively focused.  Thus it may be that HCPs are preoccupied with ascertaining 
factual and/or objective data rather that identifying and understanding patients’ concerns.  For 
example, a patient who reports opening their bowels every two days would not, in the studies by 
Boyle (1970) and Herz et al (1996) be regarded as constipated.  However, if the patients’ stools are 
small in size, hard, painful to pass and result in incomplete defecation arguably the patient is 
suffering with constipation.   
 
In summary, there is no single or clear definition of constipation.  People often use more than one 
descriptor that differ and coexist to varying degrees in individuals.  The overriding subjectivity of 
constipation and unreliability of self-reported data impedes its definition and identification.  
Diagnosis of constipation should not be solely based on bowel frequency as this is more likely to 
indicate extreme severity.  There is poor concordance on HCPs’ and patients’ classification of 
constipation but it is generally accepted that self-reported is the most appropriate definition to use 
however, it appears that HCPs fail to acknowledge the significance of patients’ concerns.  




2.7.5 Reporting constipation 
In a prospective study McMillan and Tittle (1995) found that 84% of hospice patients had some 
degree of constipation but it was only recorded as a problem in 29% of patients’ charts.  The study 
suggests that constipation is under-assessed and under-reported by both physicians and nurses, a 
finding which is further supported by Glare and Lickiss (1992) who state that when continually 
under-managed constipation contributes to unnecessary morbidity and mortality.  The under-
recording of constipation may be due to nurses’ poor understanding of constipation.  This is best 
illustrated in the study by Moore et al (1996) who used a constipation questionnaire that included 
questions on medication, medical diagnosis, signs, symptoms, pharmacological and non-
pharmacological interventions.  Only 43% of items were answered correctly thus illustrating a gap 
in nurses’ knowledge (Moore et al 1996).   
 
Doctors require a greater deviation from the norm than do their patients and in the clinical context.  
More than 50% of the patients presenting with constipation are referring to something other than 
the entity that the doctor recognises as constipation (Herz et al 1996).  The result is that 
constipation may worsen insidiously and, if left untreated, may become severe and/or lead to 
faecal impaction (Nettina 1996), especially when exacerbated by illness and/or medications.  As a 
result constipation is seldom resolved until it becomes a significant problem to the individual 
(Ross 1998) and may have been prevented in patients with advanced cancer by appropriate HCP 
patient assessment and clinical intervention.  
 
2.7.6 Treatment 
Constipation in patients with advanced cancer is foreseeable and preventable (Sykes 2004).  
Laxatives should be started concurrently with opioids (Palliative Care Formulary 2007; Bouvy et 
al  2002; West Midlands Palliative Care Physicians 2003; BNF 2005; BNF 2008; Sykes 1998b) as 
reflected in the following extract, but evidence suggests this occurs in less than half the cases. 
 
“…constipation is a very common cause of distress and is almost invariable after 
administration of an opioid.  It should be prevented, if possible, by regular 
administration of laxatives, a faecal softener with a peristaltic stimulant (e.g. Co-
danthramer) or lactulose solution with a senna preparation should be used…” 
(BNF, 2006 p 16) 
 
Over 90% of patients with cancer spend most of their last year of life at home (Addington-Hall and 
McCarthy 1995) and the co-prescribing of laxatives with opioids by community teams is 
paramount in order to prevent and/or alleviate constipation.  However, Oxenham et al (2003) state 
that the co-prescribing of laxatives with opioids in patients with cancer remains suboptimal.  Over 
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88% of GP practices in Lanarkshire (UK) and 541 of their patients were studied.  The co-
prescribing of laxatives with strong opioids occurred in less than 50% of cases.  Given the 
recommendations advocating the co-prescribing of laxatives with strong and weak opioids 
Oxenham et al’s (2003) study appears to underestimate the extent of the problem.  The provision 
of laxatives needs to be supported by knowledge of their efficacy, time to effect and consistent 
use.  When medicines that doctors prescribe fail to produce the benefits they expect they often 
respond by varying the dose or selecting an alternative medicine (Marinker and Shaw 2003) 
without exploring the reasons for lack of efficacy.  This may be partly due to HCPs’ poor 
knowledge about the use and role of laxatives as Miles et al (2007) report that there are a limited 
number of eligible studies pertaining to laxative use in the management of constipation for 
palliative care patients, thus its’ management is based on inadequate research evidence (Miles et al 
2007).  When laxatives are prescribed patients often fail to take them. 
 
2.7.7 Laxative use 
Approximately half of the drugs prescribed for patients with long-term conditions are not taken as 
prescribed (Haynes et al 1996; Cox et al 2002; Haynes et al 2005; Marinker and Shaw 2003).  
Laxatives are more often omitted than other drugs (Townsend et al 2003) partly due to a perceived 
lack of efficacy and over 21% of terminally ill patients either omitted and/or reduced their laxative 
dose (Zeppetella 1999).  
 
Lack of laxative efficacy may partly be due to patients’ failure to use them consistently, thus not 
taking a therapeutic and/or efficacious dose.  Historically, patients use or non-use of medications 
was discussed in terms of ‘compliance’, however, more recently the term ‘concordance’ is used 
due to the benefits afforded by the patient-clinician shared decision making and choices based on 
individuals’ understanding of the other persons preferences. 
 
2.7.8 Constipation identification and assessment 
Terminally ill cancer patients have many risk factors for constipation but its routine assessment in 
this population is insufficient (Bruera et al 1994).  Specialised tools have been developed to 
facilitate an individualised approach to the assessment and prevention of constipation.  A number 
of tools are specifically designed to measure constipation whereas others include constipation as a 
symptom within another assessment tool.  It is widely accepted that patient assessment is an 
essential aspect of care planning (Hartweg 1990; Holt 1995; Hyde et al 1999; Ross 1998) yet lack 
of nursing literature surrounding assessment in relation to prevention of constipation suggests 




The Rome Criteria were originally developed in 1987 by a group of gastroenterologists 
investigating the high prevalence of gastrointestinal functional disturbances.  Consensus was 
reached on how to identify and define ‘functional gastrointestinal disorders’.  The criteria are 
summarised in Table 6.  In an attempt to standardise the definition of constipation and impose 
some definitional uniformity for clinical research, the Rome II Criteria were further developed and 
set forth criteria for the diagnosis of chronic constipation in 1999 which include a description of 
chronicity, symptoms and the use of manual manoeuvres to assist defecation (Drossman et al 
2000).  The Rome II Criteria were utilised in this study due to its potential to obtain 
comprehensive data on patients’ constipation and their management strategies, especially when 
certain aspects have been forgotten or not reported due to its embarrassing and sensitive nature.   
 
          
Table 6 – Extract from the The Rome Diagnostic Criteria (Drossman et al 2000; Longstreth 2006). 
 
 
Nurses use constipation assessment tools as a means of obtaining data about an individual’s bowel 
function.  For example, the Constipation Assessment Scale (McMillan and Williams 1989) 
comprises eight questions which are rated by the patient as either ‘no problem’, ‘some                       
problem’ or ‘severe problem’.  Tools can be useful for establishing patients’ ‘normal’ patterns of 
defecation, identifying those at risk of developing constipation, monitoring stool consistency, 
frequency of defecation and acting as an evaluation of interventions or therapies (Richmond and 
Wright 2004).  There are two major issues of concern with constipation assessment tools, their 
lack of comprehensiveness (Richmond and Wright 2004) and poor utilisation by nurses (White 
1995; Richmond 2003; Zernike and Henderson 1999).  Tools alone will not assist the reduction of 
constipation but there is evidence that they may improve the identification and management of 
 
Rome Diagnostic Criteria 
Constipation is defined by the occurrence of two or more of the following for at 
least 12 weeks in the last 12 months: 
 
• Straining in more than half of all defections 
• Lumpy or hard stools in more than a quarter of all defecations 
• Sensations of incomplete evacuation in more than half of defecations 
• Sensation of anorectal obstruction or blockage in more than half of 
defecations 
• Manual manoeuvres to facilitate more than half of defecations (e.g. digital 
evacuation or perineal support) 
• Bowel frequency of less than three a week 
• Loose stools are not present and there are insufficient criteria for irritable 
bowel syndrome               
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constipation when utilised with a co-existing appropriate ethos of care (Zernike and Henderson 
1999). 
 
A prerequisite to the prevention of constipation is the assessment of the risk (Richmond and 
Wright 2004).  A literature review of potential risk factors for constipation concluded that (despite 
the abundance of literature) there were no objective comprehensive risk assessment tools for 
constipation (Richmond and Wright 2004).  The authors do not make it clear what is meant by 
‘objective comprehensive risk’ or how often it would be used in light of evidence that suggests 
that nurses rarely utilise constipation assessment tools.  Reasons for lack of use include the 
assumption that nurses should intuitively be able to identify patients at risk of constipation (White 
1995).  There also appears to be a gap in nurses’ knowledge and understanding of constipation 
(George et al 1996; Moore et al 1996; Richmond and Devlin 2003) possibly due to nurses being 
reluctant to pursue expertise in bowel and related subjects, such as faeces, which is often regarded 
as an unclean or foul substance (Robinson-Wolf 1996). 
 
The graphic representation afforded by the Bristol Stool Form Scale (Lewis and Heaton 1997) 
provides nurses with a tool for obtaining data about patients’ stool form and consistency, whereas 
other nursing tools are based solely on subjective descriptions.  The Bristol Stool Form Scale is a 
straightforward objective tool that measures ‘transit time’ (the time it takes for the food that is 
eaten to travel to the anus) and involves no exposure to radiation or stool handling (Lewis and 
Heaton 1997).  Therefore the Bristol Stool Form Scale has the potential to guide nurses in their 
practice and assessment of constipation utilising a more contemporary and objective approach, in 
conjunction with patients’ self-reported subjective reports.  
 
The drawback with constipation assessment tools is that they are predominantly symptom-based 
and may not include other complaints and descriptors used by individuals to define their 
constipation (Cash 2005) and self-reported constipation is more common than in studies using 
Rome II criteria (Higgins and Johanson 2004; Pare et al 2001).  Generally, patients do not 
volunteer information on bowel habit unless specifically asked (McMillan and Tittle 1995; 
McMillan 2002) and this omission by HCPs may be one of the exacerbating factors to the  
condition. 
 
In summary, specialist tools have been developed in an attempt to diagnose constipation and 
identify those at risk.  Tools lack comprehensiveness partly due to the problems of defining 
constipation.  Elements of the Rome II criteria and use of the Bristol Stool Form Scale may assist 
the affirmation of confirmation by introducing an objective component to patients’ self-reported 
constipation.  The assumption that nurses should intuitively identify patients at risk is discounted 
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by the apparent knowledge gap in a condition regarded as unclean and unlikely to be reported by 
patients unless specifically asked.  
 
When patient self-reported constipation is acknowledged by HCPs as a condition worthy of 
treating laxatives may be prescribed.  However, when laxatives are prescribed patients appear 
reticent to take them.  
 
2.7.9 Compliance versus concordance: the debate 
Patients’ non-compliance or non-concordance with prescribed medications presents a major health 
concern and represents a serious therapeutic deficit for patients (DH 2004).  Marinker and Shaw 
(2003) describe compliance as the degree to which patients follow their prescribed drug regimen.  
Haynes et al (1996) expand further and describe non-compliance as being either intentional or 
involuntary depending on the quality of the information given, the impact of the regimen on daily 
life or their social isolation.  Zeppetella (1999) adds that non-compliance takes several forms such 
as not collecting a prescription, not taking the medication, errors in dosage, timing and sequencing 
of administration and taking of additional non-prescribed medication.  
 
Methods of measuring compliance vary from residual pill counting, measuring blood or urine 
levels for drug metabolites and interviewing.  Most studies in respect to patient compliance with 
drug regimens rely on patient self-reporting (Zeppetella 1999).  The value of such studies therefore 
could be considered limited as the accuracy of the self-reported data could be flawed through 
understatement or lacking truth.   
 
The DH (2004) drew on various studies and noted that patients are more likely to benefit from 
their prescribed medication when they fully understand and accept their diagnosis, agree with the 
proposed treatments and therefore adhere to their prescribed drug regimen.  To this end, 
concordance has been more recently used to define the process of successful prescribing and 
medicine taking, based on partnership, process and agreement between patient and a HCP about 
whether, when and how medicines are to be taken (Jones 2003; Marinker and Shaw 2003; Elwyn 
et al 2003).  Key to this process is that the doctor identifies and understands the patient’s views of 
taking the medication and explains the importance of the treatment.  Based on shared decision 
making patients gain an understanding of the consequences of keeping (or not keeping) to the 
treatment (Jones 2003; Marinker 1997; Elwyn et al 1999).  By respecting patients’ beliefs and 
wishes and having an appreciation of each others’ points of view leads to an agreement on 




The DH (2004) endorsed and adopted the principles of concordance as being pivotal to the doctor 
patient relationship.  The Medicines Partnership is an initiative supported by the DH (2004) and is 
aimed at enabling patients to obtain the optimum benefit from their medicines by fully involving 
them as partners in decisions about treatment and then supporting them through the process of 
medicine taking.  The processes necessary to achieve this are described as concordance which is 
still considered a new approach to the prescribing and taking of medicines based on partnership 
(DH 2004) and is in contrast to compliance which is the following of instructions. 
 
The beliefs and attitudes of HCPs play a central part in the achievement of concordance.  The DH 
(2004) identifies the existence of compliance programmes focused on the practical difficulties of 
medicine taking.  This document notes that the differences between the patient's beliefs and 
understanding of the diagnosis and proposed treatment and those of the HCP are crucially 
important and central to the patient’s concordance.  The HCP has a set of beliefs in relation to the 
appropriateness of particular medicines and how they should be used, which is based on a 
biomedical model.  These beliefs are shaped by the content of professional training and on the 
evidence from a large body of scientific research.  
 
Zeppetella (1999) states that a shift from the outdated notion of compliance and towards that of 
concordance appears a logical route forward.  Prescribing should be perceived as an alliance in 
which the patient actively participates and medications are selected not only for the clinical 
indication but also as considered appropriate for the patients, their life style and preferences.   
 
Weiss and Britten (2003) suggest that not all HCPs will embrace concordance as some will have 
concerns regarding affording the patients’ views primacy.  They go on to suggest that another 
concern for HCPs is time.  The discussion of patients’ views may lead to the requirement for 
longer consultations that would prove impracticable in many primary care settings.  This resonates 
with findings of the DH (2007) that the average length of GP consultations increased from 8.4 
minutes 1992/3 to 11.7 in 2006/7 and that the surgery practice nurse consultation increased to 15.5 
minutes.  Therefore increased time to achieve concordance was problematic (Weiss and Britten 
2003). 
 
Heath (2003) believes that until HCPs accept that the patient alone has the right to decide whether 
or not they will take a drug the move from the concept of compliance to that of concordance will 
continue to be cosmetic.  It is debatable whether HCPs fully appreciate the meaning of 
concordance and therefore may not be equipped to promote it thus patients are failing to benefit 




2.7.10 Medication adherence 
Patients’ failure to take their medications may be intentional or involuntary (Weiss and Britten 
2003).  Patients have different but equally cogent and coherent sets of ideas about their own 
illness, medicines in general and their medicines in particular (Beardon et al 1993; Marinker and 
Shaw 2003).  These are based on their own preferences, priorities, beliefs, attitudes and life 
experience.  There are many reasons why patients do not take their medicines and this may also 
include practical difficulties such as getting to a pharmacy, opening containers and remembering 
to take the medicines (Elwyn et al 2003).  
 
Better informed patients may decline certain drugs if they remain unconvinced of their 
appropriateness or efficacy (Coulter 2002).  The ‘benefits versus harm’ of a drug’s use are central 
to the discussions on concordance (Jones 2003).  In a study of 106 patients receiving palliative 
care Zeppetella (1999) found that 33% took less medication than prescribed.  Although this was 
usually analgesia it covered the whole spectrum of medication.  One of the reasons given for not 
taking medication was concerns about adverse effects.  Seventeen percent of respondents took 
additional medication instead to compensate for any ‘gaps’ that they perceived in their drug 
regimens.  Townsend et al (2003) support these findings for example, one patient in their study 
omitted her pain killers in preference to retiring to bed as a management strategy.  This was in 
spite of her husband urging her to take the pain-killers as these would have enabled her to be up 
and 'normal' thus preventing their three small daughters returning from school and seeing their 
mother in bed.  Additionally, drugs were frequently used to facilitate the ability to perform 
activities to fulfil social roles, for example, as grandparents and parents.  The maintenance of 
social role and self-identity were perceived as important reasons for suppressing distressing 
symptoms by taking drugs (Townsend et al 2003).  Conversely, Townsend et al (2003) express the 
psychosocial dilemma that often presents to patients that using drugs in this way may also 
symbolise ‘ill health’ and act as an indicator of dysfunction and overall affirmation of the severity 
and progress of a chronic illness and thereby presents a threat to, or loss of, identity.  Townsend et 
al (2003) report that one of the key reasons for omitting drugs could lie in patients’ desires to live 
life in the absence of illness and drugs, however, the study fails to acknowledge if, by omitting 
their medications, this desire is fulfilled to any degree.   
 
The DH (2004) highlights the importance of patients having the opportunity to air their concern in 
regard to any medicines and have these addressed and states that the patient’s beliefs about the 
medicine, or medicines in general, for example, that medicines are unnatural, harmful, addictive, 
or that they wear off over time and are therefore not worth taking, also contribute to non-
adherence.  In similar vein, Griffith (1990) notes that elderly patients are particularly at risk from 
the dangers of non-compliance as the illnesses and conditions that they suffer from often require 
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multiple and long-term therapy. In addition, poor memory, communication difficulties and 
deficient manipulative skills, as in rheumatoid arthritis, may complicate the situation.  Drossman et 
al (2000) note that psychosocial factors are an important consideration in patient adherence 
because they are modulators of the patient’s experience and behaviour thus affecting outcome.   
 
Some patients expressed ambivalence to taking drugs in a number of ways.  One tension was 
between the use of a regular drug regimen and a more flexible regimen as people self regulated 
their drug use in an attempt to gain equilibrium, relief from symptoms, or sense of a ‘normal’ life.  
Further ambivalence was shown in patients expressing reluctance to take drugs and their inability 
to be ‘free’ of them.  Drugs both enabled respondents to continue to function in social roles and 
acted as a marker for their inability to perform such roles.  Drug use was discussed in moral terms 
to show how people remained competent though seriously challenged by their illnesses, were 
stoical in their response to illness and were sensitive in their roles as family members.  
 
Research has shown a widespread cultural belief that drugs should be as little used as possible 
(Britten 1996; Conrad 1985; Donovan and Blake 1992; Morgan 1996; Rogers et al 1998; Britten 
1994).  For example, in a sample of 544 people drawn from four general practices, 86% agreed 
with the statement “I would prefer not to take any medicine if I can avoid it,” and 58% agreed with 
“I always take as small a dose as possible.”  Conversely, only 24% agreed with the statement “I 
would be happy to take a medicine over a long period of time,” 26% agreed with “If I'm feeling ill 
I like to take medicine,” and 15% agreed with “When you are ill you should always take a 
medicine” (Britten et al 2002). 
 
Zeppetella (1999) identifies that many patients with advanced cancer do not take their medications 
even though they are in pain or some level of discomfort.  Of particular interest to this study is 
that, second to opioids, over 21% of terminally ill patients either omitted and/or reduced their 
laxative dose.  The overall aim of this study was to identify the drugs prescribed to terminally ill 
patients living at home and to assess their compliance with treatment.  It was a small-scale study 
but illustrates several issues relating to compliance which are of specific interest to this study.  The 
sample of 111 patients had been referred to the community palliative care team and mainly 
comprised of patients with malignant disease (92%).  The sample had a mean age of 66.4 years 
(range 34-92 years).  In addition to the main aim of assessing compliance, data were also collected 
on whether or not patients had any information about their medication, whether any additional 
non-prescribed medications were being used and if so, the underpinning reasons for doing so.   
 
Using semi-structured interviews and ‘pill counting’ the study revealed that 106 patients were 
prescribed a total of 597 drugs.  Sixty percent of patients were non-compliant with their 
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medications.  Over 90% of patients had two or more prescribers.  The mean number of prescribed 
drugs per patient was 5.6 (range 1-16) in which 20% of patients were prescribed eight or more 
drugs.  Having an excessive number of drugs exacerbated non-adherence as regimens were 
complex, difficult to follow and interfered with the patients normal activities of living.  The most 
common reason given for taking less medication than prescribed was offered by 34% of patients 
who felt the drug was ineffective and therefore not worth taking.  
 
Twenty-four percent of patients experienced unfavourable events and 24% reported having 
anxieties about possible adverse events.  A number of other factors that were important to patients 
and determined whether they took a particular drug or not, including disliking the taste, not having 
instructions, agreement on a particular regimen and consideration of such characteristics as the 
ability to take tablets or use inhalers.  Once or twice daily preparations were preferred as they were 
less intrusive to the patients’ lifestyles.  Zeppetella (1999) concludes and stresses the importance 
of the prescribing process in the improvement of the levels of compliance, stating that patients 
were much more likely to take their medications if this did not interfere with their daily activities 
and if clear instructions for use were offered by the prescriber.  Furthermore compliance was 
greatly enhanced if the patients were made aware of possible side effects, advised of means of 
minimising them and actions to be taken if they persisted.  The study also identified that patients 
were more likely to take their drugs if the prescriber had taken time to explore possible fears, for 
example potential addiction and if instruction regarding what actions should to be taken if the 
treatment was, or became, ineffective.  Zeppetella (1999) suggests that countless terminally ill 
patients do not adhere to prescribed treatments and frequently search for their own remedies based 
on their life experiences (lay knowledge) or the experiences of those around them.   
 
Townsend et al (2003) examined attitudes towards multiple drug use among patients with four or 
more chronic morbidities (patient with cancer often have multiple morbidity and polypharmacy).  
Twenty three people participated in this study by completing symptom diaries and participating in 
semi-structured interviews.  All respondents expressed their dislike of drugs to some extent and 
drug use was often portrayed as the "last resort."  Drugs occupied a central role in patients’ lives 
and, despite acknowledging a dependence on drugs to live as ‘normal’ a life as possible 
respondents expressed an aversion to taking drugs for various reasons.  Although some drug 
regimens were complex some respondents felt this was the means by which they could gain a 
degree of relief from distressing symptoms and only one respondent reported that his combined 
drug regimen was not a problem. 
 
It is explicit from the aforementioned studies that patient education and information is lacking and 
this is likely to exacerbate their non-adherence with laxatives.  Despite the suggestion by Beardon 
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et al (1993) that symptomatic patients with cancer prefer medications that alleviate their 
symptoms, in relation to constipation the emphasis is on its prevention rather than treatment, thus, 
individuals would be asymptomatic.  In addition, the insidious nature of constipation may result in 
individuals being unaware that the condition is imminent, thus ultimately requiring treatment 
rather than prevention.  These studies illustrate that patients do not like taking medicines if they 
can be avoided and may further explain some patients’ reluctance to take prophylactic laxatives 
unless they fully understand the purpose and benefits.  
 
2.7.11 Health care professionals’ perceptions 
Health care professionals acknowledge constipation as being the most common reason for non-
compliance with opioids and as a result patients unnecessarily endure pain (Abbas and Abbas 
2003).  Findings indicate that 55% of HCPs believe that non-compliance with opioids was a 
problem for 15-50% of patients and 10% felt that non-compliance was a problem in over 50% of 
patients with cancer related pain.  When invited to relate their thoughts regarding the reasons for 
non-compliance 75% of HCPs considered that patients failed to take their opioid therapy for fear 
of developing intractable constipation. 
 
Doctors may initiate the discussion about treatment but then often dominate the discussion.  When 
prescribed medicines fail to produce the expected benefit doctors vary the dose or select an 
alternate drug and focus almost exclusively on improving the quality of their own prescribing 
options rather than addressing the issue of patient compliance/concordance (Marinker and Shaw 
2003). 
 
Health care professionals do not always name the drug they prescribe and may not describe how 
new drugs differ in mechanism or purpose from those previously prescribed to a patient, thus 
failing to investigate the patients' understanding of a treatment or explore their concerns about 
drugs (Elwyn et al 2003).  Marinker and Shaw (2003) state that concordance cannot be achieved 
by doctors acquiring new communication skills alone.  Doctors and patients must learn how to "do 
concordance" not only on the basis of established evidence but also from their own reflective 
experiences. 
  
In summary, the term compliance has been used to describe the level of patients’ obedience with 
HCPs instructions and adhering to their prescribed medications.  However, more recently the term 
concordance has been used to emphasise the patient-HCP partnership and agreement on drug 
regimen founded in respect of each other’s opinions and in which the patient has been fully 
consulted and understands the implications especially in relation of omitting and/or ceasing the 
drug’s use.  It appears that the term 'concordance' has been introduced in an attempt to reduce the 
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incidence of non-compliance with prescribed medication (Elwyn et al 2003).  For the evolving 
concept of concordance to succeed a change in practice is required.  The emphasis should turn to 
patients' needs and wants and how these influence the way they take their medicines (Jones 2003).  
It is clear that the patients' beliefs, values and attitudes influence whether and the manner in which 
they take their prescribed drugs (Britten et al 2002; Elwyn et al 2003). 
 
Concordance may not always be easy to achieve but without exploring and addressing these issues 
patients may not be able to obtain optimum benefit from the prescribed treatment.  In reality 
however, few HCPs appear to know the meaning of concordance and it is often used as an 
alternative to compliance.  Used interchangeably and without an appreciation of the concept of 
'concordance' this approach fails to acknowledge the need to encompass patients’ beliefs and 
wishes as part of the patient-healthcare agreement.  Jones (2003) confirms this view stating that 
concordance has been hard to put into practice and one reason for this is that most health 
professionals either have not heard of the term or do not understand it. 
 
Poor adherence with medications presents problems in health care and increases significantly in 
patients with advanced cancer who are more likely to omit laxatives than any other drug.  Factors 
influencing patients’ drug use include the provision of information about their illness and/or drug, 
impact on life, physical ability to collect and/or administer, lack of agreement on regimen (such as 
choice of laxative and timing), the perceived lack of efficacy and poor knowledge about the 
consequences of their non-use.  Patients therefore may mistakenly believe that their reasons for 
omitting or ceasing laxative use are justifiable, for example that they lack efficacy, that taking a 
smaller than recommended dose is acceptable and a tendency to avoid their use unless 
symptomatic.  It is well recognised by HCPs that in an attempt to avoid constipation patients omit 
their opioids and endure further unnecessary suffering.  
 
Concordance is an approach that aims to redress and prevent  problems through a collaborative 
working partnership between HCPs and patients.  However, it appears that time constraints may 
suppress the process and contribute to its poor adoption by HCP who continue to dominate 
discussions around prescribing and are failing to explore patients’ concerns, understandings and 
expectations from their laxative regimens.  
 
2.8 Summary 
This Chapter highlights the complexities arising when discussing bowel frequency, defining 
constipation and the incidence within the general population and in those with cancer.  The 
prevalence of constipation is generally accepted to be 2% to 27% of the general population in the 
Western World and commonly presents in elderly people.  Due to transitional aetiologies the 
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incidence of constipation increases from 51% to 100% in those with advanced cancer with a 
tendency to escalate over the disease progression. 
 
Identification of constipation can be problematic due to its subjective nature and individuals 
varying components of what constitutes constipation.  Often patients themselves are unaware that 
they are constipated and symptoms such as diarrhoea/overflow may mask an underlying problem 
of constipation.  
 
Tools used to identify and measure constipation may be useful but they need to be used in 
conjunction with patients’ self-reports which may be unreliable.  The majority of nurses have an 
inadequate understanding of bowel function and there is a disparity between HCPs and patients in 
defining constipation.  Health care professionals and patients are often talking about different 
entities when discussing constipation, each varying the components and attribution of severity.  
Patients are dissatisfied with care received and it is therefore understandable why patients fail to 
report constipation to HCPs until it becomes a profound problem. 
 
The causes and specific problems that arise in the management of constipation in patients with 
cancer have been examined along with the need to retain the use of constipating drugs such as 
chemotherapy agents, antiemetics and opioids.  Laxatives were discussed and their efficacy 
established in patients with advanced cancer, however, the prophylactic use is considered 
infrequent due to poor HCP prescribing and patient non-adherence with regimens. 
 
The debates around the constructs of compliance and concordance have been discussed along with 
identification of the rationales as to why so many patients do not take their prescribed medications 
in general and their laxatives specifically.  The elements required to achieve concordance and the 
nature of the necessary partnerships were examined. 
 
The aforementioned literature and concepts influenced this research as prior knowledge of 
pertinent findings informed all stages of this action research study and the resultant patient 
interviews, HCP focus groups and the CMC.  The clinic’s interventions and outcomes measures 
utilised the contemporary findings in this Chapter.  The role of the prescriber in the successful 
achievement of a partnership with patients and thereby their concordance with medications is 
highlighted as this also directly influenced the clinic and its processes. 
 
Laxatives were presented as their efficacy and an in-depth knowledge of the individual functions 
and side effects proved to be essential in the successful planning, organisation and operation 
during the clinic stage of the research process.  This information was central to the nurse/patient 
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dialogue in the clinic consultations and fundamental in achieving optimum outcomes for patients.  
This background expertise also became pivotal in the educational aspects that formed one of the 
key elements of this study through dissemination to HCPs in the local palliative care unit, 
regionally and nationally.   
 
Overall, this Chapter serves several purposes.  Initially, the identification and analysis of the 
existing body of knowledge equipped the researcher with the level of knowledge and 
understanding to enable appropriate and informative feedback to the MDT and gain support to 
progress the study to its next step, a process that is central to an action research philosophy.  The 
review also presents a general backdrop to the study and affords the reader an insight into the 
extent and problem of constipation as it presents in patients with advanced cancer. 
 
Although constipation is a common concern for both providers and consumers of health care in 
hospital and community settings, the associated problems appear to be continually underestimated 
by HCPs, to the point that unmanaged constipation contributes to unnecessary morbidity.  The 
next stage of this study was to identify a methodology and methods that improve the management 
of constipation in patients with cancer and addressed the issues surrounding poor HCPs’ 
knowledge and/or practice.  Constipation in cancer can be anticipated and is largely preventable 
but insufficient attention is paid to a condition that is considered to be mundane and embarrassing 
(Sykes 2004).  A great deal could be achieved immediately by improved patient information, the 
initiation of laxative therapy from the onset, (before constipation becomes problematic and/or 
intractable), identification of appropriate laxative regimens and titration and attention to the 








This Chapter offers an examination of the methodology selected as a framework for the 
study, that of action research.  The researcher will examine the philosophical basis of action 
research and explain the rationale for the process of establishing the data as perceived by the 
individual suffering from constipation.  The continuing debate concerning the scientific 
worth of quantitative and qualitative processes is outlined to strengthen the rationale for the 
selection of methodology.  The Chapter will also include the essence of the quantitative 
versus qualitative debate and will identify some of the main or potential benefits and 
disadvantages of each approach.  The discussion will include the identification of some key 
concepts to justify the use of action research as an appropriate methodology for the study.  
 
To this end, May (2001) states that the methodology of the research process needs to be 
expounded to establish the philosophical stance adopted by the researcher and to guide and 
set the parameters of any study.  Therefore, in this Chapter the interface and relationship 
between action research and other conceptions of research is considered.  It is important to 
consider this carefully since the well debated proposition that professional practical decision-
making must be rooted in ‘research’ or ‘evidence’ usually refers to notions of research and 
evidence that are in many ways not conductive to action research.  Action research 
emphasises that practice should be based on research and evidence however it identifies and 
interprets key elements of the research in dissimilar ways, to other methodologies, with 
important practical consequences (Kemmis and McTaggart 2000; Hart and Bond 1995). 
 
3.2 The philosophical debate 
There is a significant interest and debate in the role of philosophical positions and paradigms 
in the process of conducting research.  A paradigm can be described as a school of thought, a 
set of ideas or a world view (Polit and Beck 2008) however, in reality it is much more than 
this to the researcher (Parahoo 2006).  A theoretical paradigm provides a structure for the 
research, influencing a number of factors, including the phenomena to be researched, the 
method and the means by which the data are analysed and interpreted.  Paradigms for human 
inquiry are often characterised in terms of ways in which they respond to basic philosophical 
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questions: ontologic, epistemologic, axiologic and methodologic.  These are examined in 
some depth in the following sections. 
 
3.2.1 Quantitative versus qualitative debate 
Polit and Beck (2004) believe that disciplined research inquiry in professional nursing is 
conducted and can be generally located within two broad paradigms and their associated 
methodologies.  This section gives a brief outline of the key constructs and detail of the 
debate regarding the philosophy and the overall rigour and application of the research 
process to this study exploring the management of constipation in patients with cancer. 
 
Winter and Munn-Giddins (2001) assert that there are two forms of social research that are 
commonly contrasted with each other; namely quantitative (based on numerical data) and 
qualitative (based on linguistic data).  To position action research, and thereby this study 
within this debate, both philosophical approaches need to be examined.  These theoretical 
approaches to research provide different, but in many ways, complementary forms of inquiry 
from the philosophical stances of ‘positivism’ and ‘humanism/interpretivism’.  The 
following sections highlight and debate these polar philosophical positions within research, 
whilst acknowledging that the arguments presented represent extremes of a continuum, but 
are nonetheless adopted here to depict the fundamental differences of approach.   
 
Despite the differences noted, quantitative and qualitative research methodologies have 
many similarities since both require researcher expertise, involve rigour in implementation 
and result in the generation of scientific knowledge (Parahoo 2006).  However, researchers 
in all areas of study continue to debate the effectiveness and value of these polar positions in 
eliciting the truth.  Although overall research design is inevitably defined as either 
quantitative or qualitative, a combination of approach is often preferred to enable a problem 
to be fully explored (Silverman 2001).  Nonetheless, the researcher will outline the 
fundamental differences and expose the debate surrounding them, thereby establishing the 
philosophical basis of the chosen methodology, whilst acknowledging that such a wide 
difference in perspective seldom exists in reality (Silverman 2001).  
 
Distinguishing between quantitative and qualitative approaches can be problematic as the 
commonly accepted idea that quantitative research is concerned with numbers, quantity and 
measurement, is overly simplistic (Polit and Beck 2008).  Similarly over generalised is the 
use of sample; although quantitative researchers typically use large, probability samples and 
qualitative researchers use small, non-probability samples, this is not always the case. In 
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order to establish whether a study is quantitative or qualitative it is necessary to examine the 
three constituent parts of the conceptual paradigm described by Parahoo (2006).  These 
components are the core philosophical assumptions underpinning the study (or ontology and 
epistemology), the methods of data collection and the techniques of data analysis (or 
methodology).  Each element is considered in the following text.  
 
3.3 Establishing the truth: Ontological perspective  
3.3.1 Determinism versus meaning 
The ontology of research pertains to the nature of reality (Polit and Beck 2008).  Within a 
positivist paradigm there is an assumption that a reality exists and that there is a factual 
world which is determined by natural causes (Polit and Beck 2008).  The polar position is 
adopted by humanism/interpretivism where reality is perceived to be multiple and subjective, 
constructed by and peculiar to individuals.  The positivist paradigm underlines the scientific 
approach which assumes that there is a fixed, orderly reality that can be objectively studied, 
often associated with quantitative research (Polit and Beck 2004), whereas the ‘interpretivist’ 
researcher understands and appreciates the value of non-statistical data to create a 
reconstructed understanding of the social world.   
 
Quantitative researchers generally advocate that the ‘truth or fact’ is total and that there is a 
single reality that can be defined and measured and assert that true objective accounts of the 
world can be given (Denzin and Lincoln 1994).  To achieve this truth the researcher must 
remain totally objective to ‘discover’ truth and by so doing the values, feelings and personal 
perceptions cannot enter into the measurement of reality (Silverman 2001).  Medical 
researchers usually adopt this totally objective stance as they strive towards precise scientific 
solutions to medical problems and this is often the preferred methodology in most research 
focused upon the care of people with cancer.  
 
Conversely, qualitative research is thought to result in a softer or unscientific approach to the 
research process (Kamhawi and Weaver 2003).  It has evolved from the behavioural and 
social sciences which promote the understanding of the uniqueness and holistic nature of 
people (Walliman 2006).  Such research is often considered to lack the hard, scientific rigor 
of quantitative perspectives and is therefore considered to be less reliable (Polit and Beck 
2008; Parahoo 2006; Burns and Grove 2003).  The philosophical base of qualitative research 
is interpretive, humanistic or naturalistic and is concerned with appreciating the meaning of 
social interactions (Fielding 2001; Cuff et al 1992).  Streubert and Carpenter 1995).  
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Generally, as illustrated above, qualitative researchers believe that truth is both complex and 
dynamic and can only be established by people in their natural environments (Streubert and 
Carpenter 1995; Hodder 2000).  This is the most appropriate approach for this research, the 
management of constipation in patients with cancer, as the intention is to explore individuals 
within the context of their world, experiences and beliefs. 
 
3.3.2 Objectivity versus subjectivity (epistemology/axiology) 
The epistemology of any research relates to the relationship between the researcher and those 
being studied (Polit and Beck 2008).  Polit and Beck (2008) note that within the positivist 
paradigm the researcher is independent from those being studied and thus the findings of the 
study are not influenced by them.  In contrast, within a naturalistic/intrepretivistic paradigm 
the researcher interacts with the respondents and therefore the findings are a creation of that 
interaction and are by nature subjective.   
 
The axiologic differences between the paradigms are established through the management of 
biases and values (Polit and Beck 2008).  Empirical scientists, researching within the 
positivist paradigm, argue that the study of any phenomena must be controlled and devoid of 
subjectivity (Streubert and Carpenter 1995).  Polit and Hungler (1999) propound that 
empiricism is the most important characteristic of positivism and that only evidence that can 
be gathered, directly or indirectly, through the human senses can be called facts and used to 
underpin and generate knowledge.  It is clear that this definition of empiricism implies that 
constructs such as anxiety, social support, satisfaction, well-being and so forth cannot be 
empirically investigated (Parahoo 2006).  Nonetheless, such studies have been conducted 
and it has been possible to do so because although the word empiricism has come to be allied 
with the scientific approach, it is nevertheless the case that researchers in both traditions 
gather and analyse external evidence that is collected through their senses and therefore 
consider their research to be empirical (Parahoo 2006).  However, in the main, empirical, 
quantitative research is considered to produce a hard or precise science that is based on rigor, 
objectivity and control (Parahoo 2006; Polit and Beck 2004).  
 
An interpretivistic/humanistic research approach does not attempt to apply control to reduce 
biases to such a degree.  Such researchers assume that knowledge is maximised when the 
distance between the inquirer and respondent is minimised.  It is the voices and 
interpretations of those studied that are crucial to gaining knowledge of the area of study and 
subjective interactions are the primary way to access them.  The findings from this form of 
inquiry are the product of the interaction between the inquirer and the respondents.  In this 
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study a participatory approach to investigate current practice using research techniques and 
instigate change to enhance the quality of management constipation in a vulnerable client 
group was adopted.  Participants’ experiences and views are a valuable component of the 
process. 
 
3.4 Reduction versus induction 
The main intention of quantitative research is to be concise and reductionistic (Munhall 
2007; Polit and Beck 2008; Parahoo 2006).  Reductionism involves reducing the whole into 
parts so that those elements can be examined, usually individually. This is achieved by the 
quantitative researcher remaining detached from the study and taking care not to affect the 
outcome with their own values, thereby establishing objectivity (Cormack 2000; Streubert 
and Carpenter 1995; Polit and Beck 2008).  On the other hand, qualitative research normally 
has a broad focus and aims to promote an understanding of the whole rather than the 
individual parts (Lofland 1971; Brockopp and Hastings-Tolsma 2003; Fielding 2001).  This 
breadth of investigation is considered to be the cornerstone of the approach adopted for this 
study and has enabled the researcher to fully explore the research question from the 
respondents’ perspectives.  To achieve this, the use of observation, communication and 
interaction were essential for data collection. 
 
The qualitative, action research process of this study required the researcher to play an active 
part in the process (LoBiondo and Haber 1994; Flick 2002).  In qualitative research, the data 
gathered represent the shared interpretations of the researcher and respondents with no 
attempt made to control the interaction.  Morse (1994a) states that in qualitative research, 
variables should not be controlled and that, by the nature of the process, the researcher may 
not be able to determine the variables until the final stages of the study.  The data are 
therefore subjective and incorporate the perceptions of both the respondents and the 
researcher (Polit and Beck 2008; Burns and Grove 1997; Morse 1994b; Boswell and Cannon 
2007).  The researcher is mindful that data gathered in this way are inevitably influenced by 
the values and perceptions of the researcher and are therefore subjective.  However, this 
subjectivity is considered to be essential to promote an in-depth understanding of the human 
experience of constipation as it appears to the individual affected by it (Burns and Grove 
1997).  The increased possibility of researcher bias (DePoy and Gitlin 2005) is 
acknowledged and the resultant importance of establishing a level of dependability to 





3.5 Challenges for evidence in palliative care 
The most robust evidence is traditionally considered to come from randomised controlled 
trials (RCTs) because they are more likely to inform us than mislead us.  Randomised 
controlled trials have become the gold standard for judging whether a treatment does more 
harm than good (Sackett et al 1996).  However, what consitutes ‘best evidence’ has attracted 
criticism in some areas of medical and public health research (Williams and Garner 2002; 
Concato et al 2000) as there is controversy about the reliance on RCTs to evaluate health 
interventions and a tendency to downgarde the contribtion of qualitative studies.  Rychetnik 
et al (2002) argue against the current emphasis on RCTs for complex multi-faceted health 
interventions as difficulties arise in interpreting their results, particularly when there is a 
blurred distinction between failure to demonstrate effectiveness or good evidence of 
ineffectiveness.    Thus recent debate has emerged about how to apply current accepted 
levels of evidence to emering areas of health care research such as pallative care (Rychetnik 
et al 2002). 
 
Randomised controlled trials have been found to be a useful and trustworthy methodology to 
investigate the efficacy of medication treatments (Grande and Todd 2000) however, they 
have inherent problems that limit their use in palliative care.  For example, RCTs favour 
relatively simple, standarised and unvarying interventions that focus on highly selected 
populations and outcomes (Rochon et al 2005; Murray and Callahan 2003) which, according 
to  Williams and Garner (2002) unfortunately implies that only factors that can be measured 
are recognised as important.  Furthermore, this approach reinforces a dismissive attitude 
towards qualitative research by oversimplyfing the complex nature of clinical care, and as a 
consequence, many groups are excluded from RCTs (Raphael 2000; Williams and Garner 
2002; Rychetnic et al 2002). 
 
One of the key principles of RCTs is a state of clinical equipoise, which means that no 
preference for any particular treatment can occur (King 2000) thus rendering them 
inappropriate to test complex interventions such as those encountered in qualitative studies 
which are not amenable to blinding.  Furthermore, RCTs tend to de-contextualise individual 
risk factors and ignore significant societal changes and the diversity or cultural norms that 
influence outcomes.  For example, patients with constipation have varying management 
strategies based on their experiences, beliefs, expectations and definitions of what constitutes 




In contrast to the homogenous population and simplicty of RCTs (as outlined above), 
palliative care patients are a diverse group with mixed morbidities, receive multiple 
treatments, are often elderly and have a limited prognosis.  Thus, although RCTs are 
considered the gold standard in evidence based medicine they are too rigid and present a 
number of methdological difficulties in patients with cancer and palliative care who endure  
complex physical, psychological, existential and spiritual problems faced by patients, 
families and professionals (Bennett and Ahmedzai 2000; Hudson et al 2001; King 2000; 
Harding and Higginson 2003; Grande and Todd 2000).  These difficulties include patient 
recruitment, gate-keeping by professionals (for example, reluctance to enrol their patients in 
research studies), small sample sizes, high attrition rates, rapidly changing clinical situations 
and limited survival times (King 2000; Harding and Higginson 2003; Grande and Todd 
2000; Green and Thorogood 2004). 
 
Bennett and Ahmedzai (2000) highlight that the focus of research in palliative care is often 
on the effectiveness of services on populations rather than the effect of treaments on patients.  
It is difficult to define the intervention precisely and uniformly, thus reflecting a more 
pragmatic approach, such as comparing a new service with best current practice (Grande and 
Todd 2000).  However, as previously highlighted, the implementation of best practice in 
relation to constipation management is poorly adopted by HCPs, therefore this study 
considers ways in which patient outcomes can be optimised together with improving 
clinicians practices.  To this end, this study harnesses the view of  Raphael (2000) who 
argues that evidence-based practice is translated easily to the needs of the ‘real’ patients seen 
in practices and communites and thus outlines three forms of knowledge: 
 
• Instrumental knowledge is developed through tradtional scientific approaches.  It is 
concerned with controlling physical and social environments as is attempted in 
RCTs.  This pathway is reflected by dotted lines in Figure 3. 
• Interactive knowledge is derived from sharing lived experiences and is concerned 
with understanding and the connections among human beings. 
• Critical knowledge is dervived from reflection and action on what is right and just.  
It is concerned with raising consciousness about the causes of problems and means 
of alleviating them  This model considers contexual factors such as physcial, 







































Figure 3 -  A framework for equity-based evidence adapted to palliative care (dotted lines 
represent pathway for RCT-based evidence).  Adapted from Kemp et al. (2002). 
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Of particular importance and relevance to this study is the view advocated by Kemp et al 
(2002) and reflected in Figure 3, that it is necessary to address confounding factors instead of 
controlling them, addressing the capacity to comply instead of compliance, consideration of 
health gains instead of outcome, and using multiple forms of knowledge instead of one form 
of knowledge. 
 
Aoun and Kristjanson (2005) acknowldge the need for the gold standard of evidence in the 
mainstream medical model of RCTs and, even with the inherent difficulties, as outlined 
above, recognise their importance in palliative care.  However, alternative designs may offer 
more feasible research that can be successfully implemented in palliative care, thus affording 
clincial evidence in situations where an RCT is not feasible (Aunon and Krisjanson 2005). 
 
 
3.6 Action research 
This section will give a brief outline of the foundations of action research and offer some 
definitions as they applied to this study.  An overview of its processes and principles, stating 
when it is appropriate to use, and situating it within a practice research paradigm is included.  
The rationale for the choice of action research to direct this study is given.  The role of the 
action research tools, the researcher and the ethical considerations are discussed.  The 
application of action research within a social healthcare setting, nursing, is explored.  An 
exposure of the key concepts as they informed this action research study will be highlighted. 
 
3.6.1 Evolution of action research 
One of the founders of the Gestalt school, Kurt Lewin (1890-1947) is universally recognised 
as the founder of modern social psychology and is also generally credited as the person who 
coined the term ‘action research’ (Lewin 1946).  The term describes work that “did not 
separate the investigation from the action needed to solve the problem” (McFarland and 
Stansell 1993, p14).   
 
Meyer (2000) notes that in general terms Lewin was concerned with social problems and 
specifically with intergroup relations and minority problems in the USA.  Marrow (1969 
p178) writes that Lewin focused on participative group processes for addressing conflict, 
crises, and change, generally within organisations and ‘he wanted to reach beyond the mere 
description of group life and to investigate the conditions and forces which bring about 
change or resist it’.  Greathouse (1997) adds that Lewin acknowledged that for change to 
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take place, the total situation has to be taken into account and warns that if isolated facts are 
used, a misrepresented picture could develop.  Noffke and Stevenson (1995, p.2), describe 
the process described by Lewin as cyclical, involving a “non-linear pattern of planning, 
acting, observing, and reflecting on the changes in the social situations” in a continuum of a 
spiral of steps.  Each step and spiral is compared and contrasted to the previous ones by 
reflecting on and analysing the outcomes and then modifying the actions as an ongoing 
process; also described as comparative research.  McNiff and Whitehead (2006) write that 
Lewin emphasised direct professional/client collaboration and affirmed the role of group 
relations as a basis for problem-solving.  He was an avid proponent of the principle that 
decisions are best implemented by those who contribute to the making of them (McNiff and 
Whitehead 2006).  This concept is pivotal to action research and to this particular study.  
 
In summary, the origins of action research may be varied but the overall philosophy remains 
similar in that the understanding that action research is participatory.  There is collaboration 
between researchers and the study participants in the definition of the problem, the selection 
of an approach and research methods, the analysis of the data and the application to practice 
(Denzin and Lincoln 2005).  Researchers specifically seek to empower people through the 
process of constructing and using knowledge, thus ultimately improving practice (Denzin 
and Lincoln 2000; Zuber-Skerritt 1991). 
 
3.6.2 Definitions and key components of action research 
Action research is known by many other names including, participatory research, 
collaborative inquiry, emancipatory research, action learning, and contextural action 
research, but all are variations of a similar process (Dick 1999; Green and Thorogood 2004; 
Kemmis and McTaggart 1992).  Meyer (2000) suggests that action research is not easily 
defined and argues that it is a style rather than a specific methodology.   
 
Action research is a form of social research that involves people in a process of change, 
including an understanding of how human beings interact with one another and how they 
respond to events and situations (Dick 1999; Meyer 2000; Winter and Munn-Giddings 2001; 
Green and Thorogood 2004; deVaus 2002).  Action research is a multi dimensional process 
based on professional, organisational or community action and encompasses practical work 
that is also a form of learning for those involved (Winter and Munn-Giddings 2001; Smits 
1997).  By combining these processes, Winter and Munn-Giddings (2001) state that the 
‘theory’ and ‘practice’ gap phenomenon is minimised and ‘action’ and ‘research’ are 
maximised.  By acknowledging and understanding these elements it is possible to appreciate 
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the argument by Winter and Munn-Giddings (2001) that action research is concerned just as 
much with the process of inquiry as with its findings, and that by adopting them the impact 
on relationships should be both positive and illuminating.  In addition the insights gained by 
the researcher from the practical involvement in the research process, is both a contrast and 
complement to objective data collected as part of the research.   
 
Meyer (2002) opines that action research is identified with research in which the researcher/s 
works explicitly with and for people rather than undertaking research on them.  Meyer 
(2002) continues and adds that its strength lies in its focus on generating solutions to 
practical problems and its ability to empower practitioners, encouraging them to engage with 
research and subsequent development, implementation or change activities (McNiff et al 
1996). 
 
McNiff and Whitehead (2006) enhance the definition of Meyer (2002) and purport that, 
action research can be described as a family of research methodologies, which pursue action 
(or change) and research (or understanding) at the same time.  Essentially, McNiff and 
Whitehead (2006) also argue that action research is a form of inquiry that enables 
practitioners to investigate and evaluate their work.  They describe action research as 
‘learning by doing’ whereby a group of people identify a problem, employ research 
techniques to examine it, introduce a change or intervention to resolve the problem, evaluate 
their efforts, and if not satisfied, amend the action and try again (Kemmis and McTaggart 
1992). 
 
As a problem-solving approach it could be argued that action research is undertaken on a 
daily basis to solve common problems, but this is often subconscious and no more than a 
passing action (Reason and Bradbury 2006).  In contrast however, Carr and Kemmis (1986) 
define action research as a form of self-reflective inquiry undertaken by participants in social 
situations with the intention of improving, rationalising and justifying their practices, and in 
addition, improve their understanding of practices in the context where those practices are 
carried out.  As Carr and Kemmis (1986, p.28) state, action researchers "...see the 
development of theory or understanding as a by-product of the improvement of real 
situations, rather than application as a by-product of advances in 'pure' theory."   This is a 
means to generate ideas (theory) that are relevant locally - to the people who are involved in 
the research, and to the environment in which it has taken place.  However, action research is 
sometimes criticised for not generating theory that can be generalised globally, though this is 
a feature of any local intervention.  In contrast, action research is “the study of a social 




Taylor and White (2000) and Zuber-Skerritt (1991) define some of the attributes that make 
action research uniquely different from simply just problem solving.  For example, action 
research aims to contribute both to the practical concerns of people in a problematic situation 
whilst simultaneously furthering the social scientific knowledge base.  This dual 
commitment in action research provides an opportunity for collaboration with members of 
the system, in changing practice, in what is agreed by participants as a desirable direction 
(Meyer 2000; Parahoo 2006).  Accomplishing these goals requires the active collaboration of 
researcher and client, and thus stresses the importance of co-learning as a primary aspect of 
the research process (Meyer 2000; McNiff and Whitehead 2006; Polit and Beck 2008; 
Zuber-Skerritt 1991; Reason and Bradbury 2006).   
 
What separates this type of research from general professional practices or daily problem-
solving is the emphasis on scientific study, whereby the researcher examines the problem 
systematically and ensures that the intervention is informed by theoretical considerations 
(Waterman et al 1995; Williamson and Prosser 2002; Rolfe 1996; Glasson et al 2006).  As a 
result, much of the researcher’s time is spent on refining the methodological tools to suit the 
needs of the situation, whilst simultaneously collecting, analysing and presenting data on an 
ongoing, cyclical basis (Polit and Beck 2008; O’Brien 1998; Meyer 2000). 
  
As indicated above most definitions of action research incorporate the following three 
elements; a participatory nature, a democratic drive and a concurrent contribution to change 
(Meyer 2002).  Meyer (2002) argues that participation is essential to action research and it 
requires that participants recognise the need to change and are prepared to actively 
participate in the research and the change process.  O’Brien (1998) agrees and states that 
people are more willing to apply what they have learned when they do it themselves.  Meyer 
(2002) states that the separation or distance between the researcher and the researched that is 
observed in other research methodologies may not be so apparent in action research.  The 
research design must be continually negotiated with participants and adopt a democratic 
stance. 
 
In action research all participants should be regarded as being equal (Meyer 2002).  
Throughout any action research study findings should be reported and disseminated to 
participants for corroboration, validation and to inform the next stage of the study.  This 
evolving style of research is therefore responsive to any arising situations and commonly 
involves collaborative spirals of planning, acting, observing, reflecting and re-planning.  
Meyer (2002) warns that this level of equality and collaboration can be difficult to achieve in 
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many health care settings and argues that an action researcher in nursing needs to be able to 
work across traditional professional boundaries and with various HCPs.  To achieve this 
advanced interpersonal skills are required in addition to research ability.  
 
Action research takes place in real world situations and aims to solve actual problems, it also 
acknowledges that the initiating researcher makes no attempt to remain objective, but openly 
acknowledges their bias to the other participants (Waterman et al 1995; Coghlan and 
Brannick 2001; Polit and Beck 2008).  
 
3.6.3 Principles of action research 
Winter (1989) highlights six key principles of action research; reflective critique, dialectical 
critique, collaborative resource, risk, plural structure, and theory, practice, transformation. 
The comprehensiveness of Winter’s (1989) principles provides a framework around which 
action research can be practically applied, are cogent to and subsequently informed this 
study.  Each are discussed as follows and supported by other authors: 
  
• Reflexive critique provides an account of a situation.  These may include notes, 
transcripts or official documents.  The implication is that these are factually true 
accounts from the teller and are based on their personal interpretations, biases, 
assumptions and concerns upon which judgments are made.  In this way, practical 
accounts can give rise to theoretical considerations (Williamson and Prosser 2002).  
  
• Collaborative resource denotes that participants in an action research project are co-
researchers (Meyer 2002).  The principle of collaborative resource presupposes that 
each person’s ideas are equally relevant and are potential resources for creating 
interpretive categories of analysis, negotiated among the participants (Meyer 2002).  
This approach also strives to avoid the skewing of credibility that may be held by the 
idea-holder, and provides insight by accepting the contradictions both between many 
viewpoints and within a single viewpoint (Winter 1989).  
  
• Risk addresses the change process that can potentially threaten all previously 
established ways of doing things and may result in fears among the practitioners 
(Coghlan and Brannick 2001; Williamson and Prosser 2002).  As individuals we are 
all uniquely different and as such, fears may arise as to how we are perceived by 
others during open discussion of our interpretations, ideas and judgments.  This fear 
should be allayed by initiators of action research by pointing out that they too, will 
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be subject to the same fears and process and, regardless of outcome learning will 
take place for all those taking part (Winter 1989; Green and Thorogood 2004).  
 
• The nature of this research approach embodies a multiplicity of views, commentaries 
and critiques, leading to multiple possible actions and interpretations.  The process, 
by its nature results in many accounts being made explicit by those participating and 
a range of options for action can be presented.  A report, therefore, acts as a support 
for ongoing discussion among collaborators, rather than a final conclusion of fact 
(Winter 1989).  
 
• In action research, theory informs practice and practice refines theory in a 
continuous transformation (McNiff and Whitehead 2006; Polit and Beck 2008).  
Winter (1989) describes this as theory-practice transformation in his sixth and final 
principal of the action research process.  In any setting, people’s actions are based on 
implicitly (expressed indirectly) held assumptions, theories and hypotheses; and with 
every observed result, theoretical knowledge is improved.  The two are intertwined 
aspects of a single change process (Dick 1999).  It is the researcher’s responsibility 
to make explicit (precisely and clearly expressed, leaving nothing to implication) the 
theoretical explanations for the actions; and to question the basis of those 
explanations.  The ensuing practical applications that follow are subject to further 
analysis in a transforming cycle that continuously alternates the emphasis between 
theory and practice (Green and Thorogood 2004).  
 
In summary, and of particular interest to this study, action research is a wide and diverse 
approach to research (Meyer 2002; McNiff and Whitehead 2006), therefore it is inevitable 
that what and how it is comprised is widely debated in the literature.  However, in general 
terms action research involves practitioners establishing new ideas related to developments, 
changes or enhancements in practice and proffering these as their own theories of practice 
(Meyer 2000; Williamson and Prosser 2002; McNiff and Whitehead 2006).  Action research 
is an emergent process, usually qualitative (Dick 1999), which develops and generally takes 
form as understanding of a phenomenon increases.  It is also an interactive, step-by-step 
process that converges towards an enhanced understanding of what happens in a particular 
situation.  Action research is also participative in as much that it is based on the premise that 
any changes in practice are most effectively achieved when those affected by that change are 
directly involved in its planning and implementation, thus participation in an action research 
is collaborative in nature.  Each stage results from discussion and agreement amongst 
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participants, thus it is essentially democratic in nature, which is sometimes difficult to 
achieve within the delivery of health care.   
 
3.6.4 Rationale for action research 
There are a number of reasons why the researcher elected to use action research for this 
study.  Williamson and Prosser (2002) argue that action research is emergent in nursing and 
health care as a means of changing practice and generating new knowledge.  As noted in the 
introduction, the researcher is a practitioner, working as a research and audit sister in a 
palliative care setting.  Part of this role is to examine current practices using research 
activities that may result in the initiation of change to enhance the quality of life of the 
patients, both in the hospital and follow-up community settings.  Dick (1999) argues that 
when practitioners use action research they are offered the potential to increase the amount 
they learn consciously from their experience and has direct and obvious relevance to 
practice.  It can also generate some worthwhile outcomes for the patients that feed directly 
into their care therefore the approach seemed the most appropriate (Meyer 2000; Glasson et 
al 2006).  
 
Meyer (2002) argues that there is an increasing concern about the theory practice gap in 
clinical practice and argues that practitioners have to rely on their intuition and experience 
since traditional scientific knowledge often does not appear to correspond to the uniqueness 
of the situation.  Meyer (2002) argues that action research can be considered as an approach 
that can address this in as much as it can draw on intuition and experience and can generate 
findings that are meaningful and useful to practitioners.  This approach is also cogent with 
the current requirements of clinical governance and therefore an important component of this 
researcher’s role. 
 
3.7 The action research process used in this study 
This section sets out to debate the framework for the emerging framework for this study.  
Mindful of the underpinning philosophy of action research the researcher examined various 
models.  There are mostly similarities between models but also some slight differences, 
therefore the following paragraphs introduce the models that greatly influenced the study.  
As advocted by O’Brien (1998) these comprise firstly the model as described by Lewin and 
secondly include an outline of an action research model originating from Susman (1983).   
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3.7.1 Advantages of action research 
The research action process alternates continuously between inquiry and action, between 
practice and innovative thinking based on practical decision-making and evaluative 
reflection (Dick 1999; Hart 2000).  Dick (1999) highlights Lewin’s four-stage spiral of steps 
that comprised his framework for action research as planning, acting, observing and 
reflecting.  Lewin acknowledges that the planning stage usually starts with a general idea and 
a desire to reach a certain objective, although exactly how to achieve the objective is often 
not clear (Dick 1999).  Therefore, the first step involves examining the idea carefully 
including any available evidence (Dick 1999; Williamson and Prosser 2002; Glasson et al 
2006).   
 
In the initial stage more fact-finding is often required and two main items emerge which are 
an overall plan of how to reach the objective and a decision in regard to the first step of 
action which are observing and reflecting (Dick 1999; Williamson and Prosser 2002; 
Glasson et al 2006).  The first step calls for a broad fact-finding and may involve different 
groups, problems or communities.  Lewin (1946) advocates that once the initial planning has 
taken place, the next stage, action, can be devoted to executing the first step towards the 
overall plan and progress to the observing and evaluation of the action.  Lewin (1946) argues 
that this process shows whether what has been achieved is above or below expectation and 
secondly, it gives the planners an opportunity to learn (Glasson et al 2006; Meyer 2002).  
Furthermore, participants gather new general insight, including any strengths and 
weaknesses of certain actions.  The fact-finding process should ultimately serve as a basis for 
modifying the next step and the ‘overall plan’ (Meyer 2002).  Thus it would appear that as 
the steps progress and the research progresses, the components and direction of the research 
become more focused and specific to the problem being investigated and solutions presented 
to solve them (MacIsaac 1995; Dick 1999).  
 
Lewin’s ‘steps’ (Figure 4) are composed of planning, executing (acting), fact-finding 
(reconnaissance) and reflecting which are supported by Kemmis (cited in Hopkins 1985 and 
















Figure 4 - Simple action research protocol after Kemmis (cited in Hopkins 1985 and 
MacIsaac 1995). 
 
As noted earlier the model of Susman (1983) is similar but rather than four describes five 
phases to be conducted within each research cycle (Figure 5).  Initially, a problem is 
identified and data is collected for a more detailed diagnosis.  This is followed by a 
collective postulation of several possible solutions, from which a single plan of action 
emerges and is implemented.  The results of the intervention are collected and analysed and 
the findings are interpreted in the light of how successful the action has been.  At this point, 
the problem is reassessed and the process begins another cycle.  This process continues until 





























Based on these two models the author elected to use the model as suggested by Susman 
(1983) but felt that a further step of dissemination should be added to ensure that any 
emerging change to practice was fed back to all participants not only locally throughout the 





Figure 6 – Modified action research utilised for this study. 
 
The primary focus of action research is the solving of real problems arising from genuine 
situations rather than contrived or experimental studies.  When a situation is too ambiguous 
to frame a precise research question, action research can be used to pilot research, thus 
facilitating a more flexible approach than used by social scientists.  Action research is often 
used by practitioners seeking to improve their own knowledge and practice.  It is particularly 
appropriate to studies which may have more than one possible interpretation or require 
flexibility in order for change to take place quickly and holistically (O’Brien 1998). 
According to Winter and Munn-Giddings (2001) although we live in a culture where 
research is conventionally regarded as a specialised role, action research is a form of inquiry 
that can be undertaken by those who are not specialist researchers. Furthermore, the theory 
and application of action research also provides a framework for researchers who lack the 
methodological knowledge to deal with problems arising from practice, research and their 





3.7.2 Action research as reflective decision making  
At the outset it is imperative to bear in mind that one of the most important characteristics of 
action research involves negotiating ‘collaborative’ methods and strategies of working, based 
on principles of partnership, mutual respect and equality, among people who usually interact 
within a set of hierarchical power relations (Glasson et al 2006; Meyer 2002).  This may 
remain the case even if the aim of the action research is to develop and set up a joint project 
with a group of peers, professional colleagues, service users, or community members (Meyer 
2002; Polit and Beck 2008).  Another important concept of action research is that its value 
evolves as much from the quality of the reflection it stimulates as from the 
comprehensiveness of the data collected (McNiff and Whitehead 2006).  In other words, as 
new and useful insights can be generated from critical reflection on a few carefully selected 
incidents or responses the researcher is not required to gather a considerable amount of data 
(Winter 1989).  However, the process of ‘critical reflection’ can be problematic and difficult 
to achieve in reality.  One of the main challenges may result from an inability to divorce 
current, ingrained modes of thought and routines from those being introduced as new and 
enhanced practices (Williamson and Prosser 2002; Glasson et al 2006).  Many aspects of the 
situation will remain familiar and previously tried and trusted interpretations or practices will 
spring to mind and may be difficult to ignore and thus change.  Therefore the group needs to 
work carefully and systematically to permit alternative perspectives to emerge (Dick 1999). 
 
A useful indication of what might be involved is provided by the work of Hart (1995) 
relating to ‘innovative thinking’, who suggests that the ways in which professionals consider 
a practical situation frequently includes a number of ‘questioning moves’ in response to their 
first interpretation of an event, which are indicated as follows:  
 
1. Making connections  -  what contextual influences are at work here? 
2. Contradicting  -  is there a contrasting way in which this might be understood? 
3. Taking the other’s view  -  what might be the logic and purpose of the other 
person’s response from within their own frame of reference? 
4. Noting the impact of feeling  -  how do I feel about this, and what do these 
feelings tell me about what is going on here? 
5. Suspending judgement  -  what else do I need to find out about before making a 
judgement about this? 
 





The researcher found this particular approach to critical thinking useful at all stages of the 
action research process.  Having examined the principles of action research and the 
component parts of the process this practical framework worked well as an adjunct to other 
more complex perspectives.  It was made use of as a reference point during the planning 
stages, collaborating with peers and respondents, throughout data collection and the 
subsequent analysis of the data gathered.  
 
3.7.3 Action research tools  
Action research is a holistic approach to problem-solving rather than a single method for 
collecting and analysing data (Winter and Munn-Giddings 2001).   As a result, it allows for 
several different research tools to be used, either simultaneously or alone, which may change 
as the project is conducted (McNiff and Whitehead 2006).  These various methods, which 
are generally common to the qualitative research paradigm, include participant observation, 
keeping field notes, a research journal, document collection and analysis, recordings, 
questionnaire surveys, structured and unstructured interviews, and case studies (O’Brien, 
1998).  All these action research tools were used to a varying degree throughout the study to 
find and bring together the type and level of data to drive the research forward and to achieve 
the resultant change in practice.  The use of interviews, focus groups and field notes are in 
Chapter 4, Methods.  However, the use of observation is included here as it was one of the 
catalysts for the study and was used concurrently throughout. 
 
3.7.4 Observation as a tool 
Using an action research approach and pre-study the researcher/practitioner observes 
phenomena that influence and may even instigate the research.  These observations can be 
either overt or covert (Polit and Beck 2008) and conducted consciously or subconsciously.  
Few scientists believe that their observations are non-reactive and that even observation 
alone in some way changes the object being observed or at least the context in which it is 
understood (Reynolds and Leininger 1995; Carr and Kemmis 1986).  The impact of change 
on the ‘observers’ and those being ‘observed’ will vary depending on the circumstances 
under which observations take place but are none the less valuable in theory and practice 
(Carr and Kemmis 1986).  It is important that the researcher is aware that there are 
differences in how the ‘observer’ and the ‘observed’ perceive themselves in relation to the 
research and the kind of acquired and resultant ‘knowledge’ (Carr and Kemmis 1986; Polit 




existing skills and knowledge, therefore a subject who views himself or herself as a 
participant, co-operator or collaborator seeks to acquire knowledge and improve practice 
(Carr and Kemmis 1986) thus also harnessing the philosophy of action research and meeting 
one of this study’s aims, the improvement of local HCP practice.  In contrast, Green and 
Thorogood (2004) advocate that the key characteristic of observational design is that the 
researcher does not intervene (or at least deliberately) and seeks instead to document what 
happens in everyday natural occurring situations, the resultant data being talk and behaviour 
of those being studied.  Although such an approach was used pre-study, during this research 
benefits were afforded to patients and HCPs following the researcher’s concurrent 
observations thus requiring her to deliberately intervene when necessary in order to improve 
patient outcomes and HCPs practice. 
 
3.8 Role of the action researcher 
The role of the primary action researcher is to facilitate and implement the research in such a 
manner as to produce a mutually agreeable outcome for all participants, (Williamson and 
Prosser 2002; Glasson et al 2006) with the process being maintained by them.  To 
accomplish this the primary researcher may have to adopt a variety of roles at different 
stages of the research process, for example, planner, facilitator, leader, observer, catalyser, 
designer, teacher, listener, synthesiser and reporter (O’Brien 1998; McNiff and Whitehead 
2006).  The ultimate aim however, is to nurture co-participants to the point where they 
understand the methods and are able to take responsibility for the process without the 
support of the primary researcher (O’Brien 1999).  Central to the process is the primary 
researcher’s role of facilitating dialogue and fostering a reflective analysis approach among 
participants and providing them with periodic reports and the final report when the research 
has concluded (Dick 1999; Meyer 2002). 
 
3.9 The application of action research in healthcare 
Action research lends itself to the needs of patients and the nursing process, within the social 
context of their constantly changing and turbulent environments.  Nurses are encouraged to 
do and be involved in clinical research as it aims to promote and develop their nursing skills, 
ensures quality of patient services and nurtures innovation in practice (Manley 1997).  
However, Greenwood (1994) argues that traditional positivistic nursing research is failing to 
improve nursing practice, clinical nurses do not perceive research findings as important 
because they cannot see any relevance to the own practice.  Thus, previous dissatisfaction 




that aim to produce knowledge that is seen to be valid in helping people to improve a 
practical situation.   
 
To improve practice Nolan (1993) argues that change in the current climate, the ‘top-down’ 
generation of knowledge so characteristic of traditional research, will need to be substituted 
with a more open and participative ‘bottom-up’ approach such as action research.  The 
justification for using action research is that it provides a sense of ownership, while also 
focusing on values, beliefs and team-building among those involved (Squire 2001).  It also 
ensures both the quality of patient services and the nurturing of innovation in practice 
(Winter and Munn-Giddings 2001).  The theoretical framework by Lewin (1946) also 
provides nurses with the opportunity to analyse problems, devise programmes of action 
designed to solve problems and/or improve standards, carry out and evaluate these plans, and 
learn more about research in the process (Winter and Munn-Giddings 2001). 
 
3.10 Summary 
This Chapter has explored the various elements that have been put together to form the basis 
or philosophical underpinnings of the study.  May (2001) contends that the conceptual 
framework influences all aspects of research and must be maintained throughout the process 
from the initial line of inquiry, the design of study and methods used for the interpretation of 
data.  
 
The rationale for the researcher’s approach has been established and includes the most 
appropriate approach to elicit meaningful data to explain the research problem and 
implement resultant changes to practice.  A debate locating the study within the wider 
research arena has been presented to offer the reader an opportunity to appreciate the 
philosophical stances adopted throughout.  A sequential action research methodology was 
adopted as this was considered to be the most effective approach to gain a view of the world 
from the perspective of the individual experiencing constipation rather than a composite 
experience reported by the researcher. 
 
The utility of action research to the advancement of professional practice has been explored.  
Since action research is a form of research closely linked to practice, practitioners and 
service users can readily undertake it, which makes it particularly useful for this study.  
Within the social dimension of healthcare, nurses are often faced with patients who have 
complex problems that are capricious in their presentation and diverse in management 




outcomes.  To improve nursing theory, practice and patient outcomes, nurses are 
increasingly being encouraged to undertake and be involved in research.  To this end, action 
research provides an ideal framework whereby nurses can learn the research process 
experientially whilst practising in the nursing role with its inherent biases (which is explored 
in Chapter 4, Methods).  The philosophy of action research is congruent with this study and 
it combines the production of knowledge with the process of changing practice (Hart and 
Bond 2005) and findings were shared with participants throughout the process of the study, 
so that discussion informed subsequent changes (Green and Thorogood 2004). 
 
The principles and procedures of this type of research and epistemological underpinnings 
have been described, along with the evolution of the practice.  An outline of the tools has 
been offered alongside the theory of critical reflection which underpinned the whole process 
from its inception through to the implementation of new practices.  
 
Therefore, this research is essentially a medium scale action research study to which the 
researcher brings her nursing experience of working with cancer and palliative care patients 
who also have severe constipation.  The general approach adopted in order to achieve this is 
directed by the basic tenets of intereptivism and this has been fully examined within the 
discussion.  Having examined the underpinning philosophical basis of the research design, 









Within the philosophy of action research, where collaboration is central (McNiff and 
Whitehead 2006; Glasson et al 2006) key issues based on the previous Chapters were 
informally discussed with several HCPs practising within the Unit.  These HCPs considered 
that the project was worth pursuing and subsequently formal discussions took place with the 
Unit’s MDT and the adjacent cancer centre lead research nurse.  The meetings commenced 
with the researcher presenting an outline of the findings from Chapters 1 and 2 followed by a 
discussion relating to the identification of appropriate research methods to take the study 
forward. 
  
Feedback from this group generated support and interest in the research whilst also providing 
direction and focus to the study (Reason and Bradbury 2006).  For example, the study 
originally intended to explore patients with advanced cancer whom were known to the Unit’s 
MDT, however the lead research nurse suggested including all the patients with a 
malignancy as constipation management was often problematic.  The latter provided equity 
of opportunity to patients and helped increase the sample size which is often difficult in this 
client group, especially when limited to those receiving palliative care (Addington-Hall 
2002; Bennett and Ahmedzai 2000; Hudson et al 2001; King 2000; Harding and Higginson 
2003; Grande and Todd 2000).   
 
The MDT members agreed with a number of issues presented during the meetings and, on 
reflection, reported similarities in their own practices.  For example, that patients were 
perceived as non-compliant and that laxatives were rarely administered as prescribed, 
therefore, establishing a need for the research and embracing the philosophy of action 
research in that it aimed to redress local HCP practices through the research process.  The 
MDT suggested exploring the patients’ perspectives as, in their experience, patients rarely 
articulated how bad their constipation had been and the reason for this reticence was 
unknown.   
 
Three distinct stages developed subsequent to and as a result of each other.  These are; 1) 




perspectives, enable a  degree of dissemination of the emergent findings and also to add 
credibility, dependability and conformability to same, and finally 3) the organisation and 
subsequent operation of a nurse-led clinic specialising in the management of constipation for 
patients with cancer.  Methods were chosen and developed to best meet the needs of each 
sample, whilst also facilitating the gathering of appropriate data to inform the study and 
implement change.   
 
This Chapter describes the methods applied by the researcher to the identified area of study.  
The aim of any methods section is to communicate what actions were undertaken to solve 
the research problem or to answer research questions (Polit and Beck 2008).  Without 
discussion of the data collection methods the accuracy and validity of the conclusions may 
be subject to challenge which may negate the research itself (Parahoo 2006; DePoy and 
Gitlin 2005; Polit and Beck 2008).   
 
Within the chosen methodological framework the methods evolved and varied over the 
course of this study, therefore, this Chapter mainly concentrates on the patient interviews 
stage, but also includes generic methods that are applicable to the whole study, for example 
Ethics and data analysis.  Deviation from generic methods appear in the relevant Chapters, 
for example, it was necessary to amend the patient consent form and this modification is 
discussed in Chapter 7.  Presenting the methods this way is considered to be the most 
appropriate approach otherwise the reader will be challenged to establish the order in which 
the study operated and/or their suitability, which varied depending on their application.  
Thus, some of the methods adopted for the HCP focus groups and the CMC will be 
presented in Chapters 6 and 7 respectively and are shown graphically (Figure 1) to illustrate 
the course of the research and simultaneousness of key elements and processes. 
 
Initially it was not known what course this research would take nor all the methods that 
would ultimately be used, therefore, this section primarily focuses on patient interviews and 
associated methods including field notes and data management.  As the research evolved, the 
following methods were adopted or modified to meet the needs of the focus groups and 
CMC and are therefore presented here as generic methods.  Subsequent methods used appear 
in either Chapter 6 (HCP focus groups) or Chapter 7 (CMC processes and methods) as they 
are unique to these stages. 
 
Methods are specific research techniques that fit with the theories, approaches and 
methodologies being used (Silverman 2001; Freshwater and Bishop 2004; Polit and Beck 




researcher to use a combination of methods which are outlined below.  Action research 
promotes the use of methods deemed most appropriate to address the identified problem 
(Reason and Bradbury 2006), the initial method used was that of in-depth patient interviews.  
Following the patient interviews, as guided by the evolving action research methodology, 
focus groups emerged as the most effective method of obtaining the views of HCPs (Chapter 
6), followed by a nurse-led clinic (Chapters 7 and 8) incorporating patient education as an 
intervention to facilitate change as an outcome of the CMC. 
 
The following section presents the methods used during in-depth patient interviews to 
explore their perceptions, attitudes and management strategies    
 
4.2 Obtaining Ethical approval 
4.2.1 Nursing ethics 
The proliferation of nursing research has led to ethical concerns and debates because the line 
of demarcation between what constitutes the expected practice of nursing and the collection 
of research information has become less distinct and ethical requirements sometimes conflict 
with methodological considerations (Polit and Beck 2008; Hawley 2007).  To assist the 
researcher and to protect the interests of respondents various codes of ethics have been 
developed to guide the research process (Freshwater and Bishop 2004).  The nursing 
profession operates within clear parameters of professional conduct and consequently, as a 
nurse, the researcher was conversant with the ethical requirements for this study.   
 
In addition, the ethical principles of beneficence (the duty to do good; prevent harm and 
remove harm) and nonmaleficence (the obligation not to inflict harm intentionally) informed 
and guided the research (Beauchamp and Childress 2001; Wengraf 2001).  For example, 
Hawley (2007) notes that all people are vulnerable at some time in their life and this usually 
occurs when a person is dependent on others and often this is as a result of serious illness.  
The sample in this study are both vulnerable and frequently experience transient symptoms 
such as pain.  Therefore an attempt to alleviate any distress would take priority over the 
research proceedings (Beauchamp and Childress 2001; Wengraf 2001).   
 
Due to cancer and/or its treatments, some patients may lack adequate decision-making 
capacity to give consent for research, for example due to cognitive impairment (Sandgren et 
al 2006).  Cognitive impairment is a complication of advanced cancer that can occur several 




impairment and determining if a patient’s function is impaired is a challenge, especially 
because impairment is usually subtle (Vardy et al 2007).  There is poor correlation between 
the patients’ perception of their cognitive impairment and the objective tests (Vardy et al 
2006).  Given the aforementioned evidence and the MDT members experiences with the 
client group a consensus was reached that any formal attempt at assessing cognitive function 
would be unreliable.  Therefore, patients were only excluded if cognitive failure or confusion 
presented overtly.   
 
Therefore, only patients who were able to give their informed consent were included.  The 
study was conducted in accordance with the Declaration of Helsinki (World Medical 
Associaton 2000; Bassotti et al 2004) and Good Clinical Practice Guidelines and the Nursing 
and Midwifery Council (NMC 2004) throughout.  Periodical ‘Good Clinical Practice’ 
training and update were maintained (Appendix 3 and 4) throughout this research. 
 
4.2.2 Ethical Considerations of action research  
In addition to the overarching ethical and moral requirements of nursing research, action 
research has its own specific implications and thus considerations.  Action research is 
conducted in real-world circumstances and involves close and open communication among 
the participants therefore researchers must pay close attention to the specific ethical 
considerations that may present.  To this end, the following principles, adapted from Winter 
(1996) and O’Brien (1999), were adhered to in this research:  
 
o The researcher must ensure that the relevant persons, committees and authorities 
have been consulted and that the principles guiding the work are accepted in advance 
of the research process. 
o All participants must be permitted to influence the process and outcomes. 
o The development of the work must remain visible and open to suggestions from 
others. 
o The wishes of those who do not wish to participate must be respected. 
o Permission of the participants must be obtained before making examining 
documents produced for purposes other than the proposed action research. 
o Descriptions of others’ work and points of view must be negotiated with those 
concerned before being published. 
o The researcher must accept responsibility for maintaining confidentiality. 
o Decisions made about the direction of the research and the probable outcomes 




o Researchers are explicit about the nature of the research process from the beginning, 
including all personal biases and interests.  
 
4.2.3 The process of gaining ethical approval 
As a starting point and to obtain a more expert view and guidance on the proposed study a 
meeting was convened with members of the local Research and Development department.  
The research needed ethical approval for two reasons, firstly because the interviews were to 
be audio taped and secondly because of the study’s academic component necessitating 
external review by the University.  As the research was conducted within the palliative care 
unit and adjacent cancer centre it was only necessary to obtain approval from the Local 
Research Ethics Committee (LREC).  Obtaining an ethical approval proved to be time 
consuming and spanned a period of several months due to delays in feedback from 
colleagues, postponed meetings and changes to the application process itself that was new to 
the local Research and Development personnel, thus causing further delays.  The study 
proposal, flyer (Appendix 5), patient information sheet (Appendix 6), patient consent form 
(Appendix 7) and the completed 60 page Central Office for Research Ethics Committees 
(COREC) (DH 2005) application form were submitted to LREC in February 2003.  
Following minor changes (Appendix 8), ethical approval (Appendix 9) was received and 
data collection commenced in July 2003. 
 
Due to the nature of the action research cycle, it was not always clear which direction and 
methods the study would take during its course, therefore, throughout the study any planned 
changes and developments were brought to the attention of the Research and Development 
department for advice on whether a referral for ethical revision/amendment was necessary.  
The sole amendment arising relates to the CMC and is therefore discussed during the 
planning of the CMC (Chapter 7). 
 
4.2.4 Consent and confidentiality 
Aveyard and Hawley (2005) describe the purpose of informed consent as an 
acknowledgment by individuals that they understand the patient information given, 
appreciate the nature and context in which the research is being undertaken and understand 
their commitment and obligations.  Individuals must be given time to consider the 
implications of their participation and be provided with an opportunity to ask questions and 
have these answered appropriately and honestly (Faden and Beauchamp 1986).  Coercion 




any time (Aveyard and Hawley 2005).  Once these criteria are met individuals are said to 
have been ‘informed’ and their subsequent signing of the consent is their agreement to 
participate within the boundaries of the information given.  For example, if a patient were to 
consent but subsequently express a wish not to have the interview taped their data would be 
withdrawn from the study.   
 
When the researcher met a potential participant for the first time the aims and objectives of 
the research were explained and a copy of the patient information sheet was given for them 
to review (Hawley 2007).  A minimum of 24-hours elapsed before contact was made again, 
thus allowing patients time to read the document and consider any questions that they may 
have and whether or not they wished to proceed.  A second meeting took place with those 
keen to proceed and at which time all questions answered.  It was reiterated to patients that 
their consent and participation was purely voluntary and that they were free to discontinue at 
any time without explanation, that the interview would be audio taped, and that 
confidentiality would be maintained at all times and may be used in research publications 
and dissemination (Townsend et al 2003).  Furthermore, in anticipation that some patients 
may subsequently want to withdraw from the study, the researcher inquired post interview if 
they were still in agreement that their data be used.  This was to ensure that any sensitive 
data conveyed that may subsequently lead to distress or embarrassment could be discarded at 
the patient’s request.   
 
Following the interview the subject of patient anonymity arose.  This relates to the process 
involved in ensuring that it was impossible for anyone other than the researcher being able to 
identify an individual by name (Hawley 2007).  The researcher purchased three nine-sided 
dice containing the numbers 1 to 9.  These were thrown twelve times to generate arbitrary 
three digit numbers.  A book was used to list these unique numbers and subsequently each 
patient was allocated a code.  All data pertaining to each respondent were only identifiable 
by the allocated code number.  The book containing the codes and corresponding names was 
locked in a filing cabinet in the researcher’s office. 
 
4.3 Interviews 
The following section examines the use of interviews as one of the main methods of data 
collection within the study.  A rationale for the chosen approach is offered along with a 
discussion highlighting the strengths and weaknesses of the method.  The actual process used 
within the research is explained including the use of probes and prompts used by the 





4.3.1 The nature of interviewing 
By conducting patient interviews the researcher aimed to elicit respondents’ perceptions 
about their constipation and its management, including attitudes and experiences.  Morse et 
al (2001), Denzin and Lincoln (2003a) and Elliot (2005) believe that it is possible to 
explicitly obtain these perceptions from individuals and concur that such data are 
meaningful.  One of the ways in which researchers endeavour to achieve this and understand 
the way in which people view their world, experiences and beliefs is through the interview 
process (DePoy and Gitlin 2005).  Bowling (2002) describes the interviewer as an instrument 
through which the subject is allowed to present their truth from their perspective.  
Essentially, if the interview is flawed, the data are flawed (Morse et al 2001; Polit and Beck 
2008; Parahoo 2006).  Knowledge of the advantages and disadvantages of communication 
together with the interview process provides researchers with techniques to explore and elicit 
a deep understanding and appreciation of the interviewee’s perspective and thereby optimise 
the value of the data to be analysed (Potter 1996). 
 
The choice of an interviewing approach was not difficult to determine as the most 
appropriate for this stage of the study.  Fielding (1993) identifies three main types of 
interviewing technique which vary in degree of structure from standardised or structured 
interviews through semi-standardised or semi-structured and finally to non-standardised or 
non-structured interviews.  Polit and Beck (2008) note that structured interviews are suitable 
when the parameters of the sample are known or can be approximated in relation to the 
research topic and where there is no danger of loss of meaning as a result of imposing a 
standardised way of asking questions.  A more unstructured technique is also considered by 
Potter (2002) to be valuable where the subject matter is sensitive or complicated.  In these 
circumstances, researchers are able to customise and pinpoint their questions together with 
any further explanation and satisfy themselves that the individual respondent has sufficiently 
grasped the issues to reach a considered view (Wengraf 2001).   
 
The researcher was confident that this more ‘conversational’ approach established rapport 
(Elliot 2005) with those respondents who otherwise might be hesitant to expand upon their 
personal experiences of constipation.  Wengraf (2001) adds a slightly different perspective 
and includes a lightly structured interview.  This option involves an interview that focuses on 
the process of recounting experiences of situations in a more narrative fashion.  The latter 
option was instrumental in the chosen approach but included a minimal amount of direction 




objective of this research was to explore the patients’ perspectives of their constipation and 
to identify appropriate treatments regimens this more flexible approach helped to facilitate 
the gathering of more detailed data for subsequent use in qualitative analysis. 
 
The researcher was aware when planning and undertaking the interviews of the work of 
Fielding (2001), who notes that there are two principles that inform research interviews.  
Firstly, questions should be open-ended to capture spontaneous responses and secondly, 
respondents should be encouraged to identify their experiences and underlying attitudes, 
beliefs and values, which influence the management of their constipation.  This approach 
was considered necessary in this particular research to elicit the depth of information 
required.  The researcher was conscious of the inability of some respondents to fully 
articulate their experiences and requirements of treatment due to shyness, a lack of practise 
of being interviewed or embarrassment.   
 
Silverman (2001) suggests that a common problem in non-structured interviews is that 
respondents give answers that they feel the interviewer wants to hear or that over-anxiety 
leads to a need to impress which can distort their responses (Lofland 1971; Fielding 2001).  
Polit and Beck (2004) and de Laine (2000) all propound that, ideally, an interviewer should 
be a neutral agent through whom questions and answers are passed.  However, they note that 
this ideal is difficult to achieve in this instance as both respondents and interviewers interact 
as humans, which can affect the subjects’ responses and introduce what is referred to as a 
bias or reactivity.  Polit et al (2001) state that the problem of reactivity is merely one aspect 
of a more general phenomenon that cannot be eradicated; the general context of the 
interviewee experience affects what people say and do.  However, all accounts must be 
interpreted in terms of the context in which they were produced.  The researcher therefore 
adopted a loosely structured interview approach generally not guiding the responses of the 
respondents but ensuring that they maintained the parameters of the study throughout.   
 
4.3.2 Location of interviews 
One factor that puts subjects at ease and gives them more control is to have the interview in 
their own home (Zola 1986).  Promoting control can also foster self-esteem and make the 
individual feel valued, useful and confident (Carpenter 2007).  Whilst the respondents home 
might not always be the most convenient for the interviewer it would give some choice and 
control to the subject thereby emphasising the action research processes of working in 
partnership and sharing of the research process with the participants, in this instance the 





In order to be as flexible as possible it was agreed by the MDT that respondents could 
choose to be interviewed either at their home or in a room within the Unit.  The room 
identified in the Unit was quiet, had comfortable chairs, access to refreshments, support from 
other HCPs should they become unwell/distressed and other resources such as vomit bowls.  
However, the view offered by Zola (1986) is that in settings such as clinics, nursing homes 
or hospitals, subjects are likely to be less confident and able to offer frank response because 
they are less comfortable in the setting. 
 
The flexibility afforded to patients ensured that they were able to choose where they would 
like to be interviewed, thus minimising the potential burden of travelling to the Unit and/or 
promoting control and optimising data outcomes.  For those choosing to be interviewed in 
their own home the MDT raised the issue of potential harm to the researcher in terms of 
safety when practising in the community (Hitchcock et al 2003), therefore the researcher 
initiated a checking process whereby her whereabouts and contact telephone numbers were 
known by nominated colleagues when conducting domiciliary visits. 
 
4.3.3 Duration of interviews 
The duration of interviews is an important consideration in order to maintain focus.  Fielding 
(2001) advocates 60 minutes as the maximum duration for interviews whereas Holloway and 
Wheeler (1996) suggest that the participants themselves should determine the length of time.  
Therefore, one hour per interview was allocated in the knowledge that this would vary 
depending on individuals’ contributions, their wellbeing, ability to focus, until the topic had 
been exhausted and/or respondents wanted to stop. 
 
It was also important to limit the number of interviews that were conducted each day to 
reduce resultant stresses on the interviewer, thereby setting aside an appropriate amount of 
time to focus on each respondent and the nature of their experiences.  The rationale for this 
was twofold; firstly it reduced the strain of undertaking in-depth interviews for the researcher 
freeing her mind for each one to ensure that the process was optimised, and secondly to 
manage other work pressures by creating protected time away from other audit and research 
commitments.  The protection of time also eliminated the possibility of interruption that 





4.3.4 Maintaining patients’ comfort 
Investigating peoples’ personal habits and practices about their bowel management can be 
extremely intrusive.  Therefore, in planning and during the interviews the researcher took 
into account the need not to guide the respondent into areas of discussion that might 
engender feelings of embarrassment or emotional discomfort.  From an ethical and 
professional perspective it would be extremely unprofessional and inappropriate to engender 
informant distress regardless of the fact that psychological support was available.  Gathering 
information in these conditions would comprise an unacceptable professional practice (NMC 
2007) and any consequential loss of data is fully accepted and deemed to be outside the 
scope of this study and not necessary for its success.  However, if respondents freely 
volunteered sensitive information, without evidence of distress, the data were included as the 
researcher considered that it must have been important to the respondent for them to have 
raised the point. 
 
Due to the nature of cancer and/or its treatments, co-morbidities and prevailing symptoms 
(for example pain, fatigue, nausea and vomiting), were potential problems and therefore a 
major issue of concern to the researcher.  Acutely aware of these problems and mindful of 
her professional nursing role and duty of care towards patients, the researcher ensured that 
their comfort was paramount (NMC 2004).  For example, if a respondent became 
symptomatic the interview would be suspended, or discontinued if necessary, until the 
symptom had been alleviated. 
 
For inpatients, interviews were not conducted during or around drug rounds or meal times.  
Outpatients were encouraged to take their medications as prescribed or as needed during the 
interview.  All respondents were provided with refreshments and given a choice of seating.  
The room temperature and air flow was regulated using a fan.  There was easy access to 
vomit bowls and tissues and any additional HCP support if needed.  It was not possible 
influence the home environment, other than to encourage patients to take their medications 




On meeting respondents for the interview the researcher introduced herself by giving her 
name, title and role within the Unit and this research.  Respondents were greeted (shook their 




researcher simultaneously made an objective assessment of the individuals’ mobility and any 
obvious distress, such as breathlessness, to ensure any discomfort was addressed before the 
interview started.  During this introductory stage time was afforded to respondents to relax 
and take any medications required and an informal chat often ensued in which patients 
appeared relaxed.  Barr (2007) highlights the importance of the patient-clinician therapeutic 
relationship which is built on respect, trust and working collaboratively which is 
strengthened by accurate information and communication. 
 
Immediately preceding the interview the researcher reiterated to respondents that their 
involvement was purely voluntary and that anonymity and confidentially would be 
maintained at all times, and that they could discontinue the interview at any time without 
explanation.  In addition, respondents were advised that, during the interview, there were no 
right or wrong answers and it was their experiences, beliefs and attitudes that were of interest 
as these potentially could help alleviate problems for patients in the future.  In essence, 
patients were encouraged to engage in conversation and to freely express themselves and use 
any words they considered appropriate to describe their thoughts, experiences and concerns. 
  
Following consent, which all patients gave, the interview commenced.  The researcher 
considers that rapport was good and appropriate on the basis that patients appeared relaxed 
throughout and freely discussed their management strategies that may have otherwise been 
considered personal and intrusive, thus implying trust. 
 
Respondents were invited to commence the interview by relating their current circumstances 
with regard to their constipation to afford them an entrée into the interview, and to make 
them feel more relaxed and build their confidence by encouraging the telling of their 
experiences.  There were a number of advantages in applying this flexible approach, in 
particular participants could take more ownership of the interaction and an equal exchange of 
knowledge could be maintained throughout the process (Wengraf 2001). 
 
4.3.6 Wording of questions 
To encourage full and frank response to questions and enhance the overall flow of the 
interview the researcher adopted a non-judgemental and open stance.  The questions were 
carefully crafted so that the respondents could not offer wide-ranging answers that they did 
not feel to be ‘good’ or ‘bad’ (Silverman 2001).  Polit and Beck (2008) and Silverman 
(2001) note that respondents often give answers that they feel are either acceptable or desired 




bias or perceptual inaccuracy and thereby heighten the credibility, dependability, 
confirmability and transferability of the data.  Aware of the sensitive nature of the discussion 
the researcher reiterated to respondents that there were no right or wrong answers.  
Respondents were encouraged to speak about their beliefs, expectations and experiences.   
 
It became apparent during the pilot interviews that open questions were needed as a means of 
getting the interview underway and the following were identified to guide the process, for 
example; 
 
o What does constipation mean to you? 
o How does constipation affect you? 
o What bothers you most about being constipated? 
o Who helps you manage your constipation? 
 
It was anticipated that these questions alone would not elicit the rich in-depth data required, 
however, their use was aimed at conveying a sense of the type of information required and, 
once asked, patients were given time to answer without interruption from the researcher.  
Salient points offered by respondents were noted by the researcher and explored further 
during the latter part of the interview.  
 
4.3.7 Probes and prompts 
The researcher used a series of prompts and probes to provide some direction to the 
interviews.  These tools enabled the conversation to evolve in more depth and the emerging 
issues to be explored further.  The use of cues and prompts were as neutral as possible as 
advocated by Fielding (1993) and de Laine (2000) who suggest that knowing when and how 
to probe is essential in order interview effectively and therefore provide meaningful data. 
 
Denzin and Lincoln (2003b) suggest that researchers frequently neglect to give positive 
reinforcement to subjects for fear of biasing the response.  However, in this study the 
researcher found that in encouraging a full response it was useful to reinforce the 
respondents’ contributions without biasing the response by using comments such as; “That is 
the kind of information we need” or “Yes, that is really helpful for us to know”, as prompts 
to promote responses, thus not indicative of bias or judgement.  As the researcher did not 
intend to bias the findings in any way, caution was maintained by not showing agreement or 
disagreement with the content of response, therefore, the method of probing and prompting 




interviewees sought confirmation that their response was appropriate, the researcher 
responded by reminding them that there were no right or wrong answers.  This resulted in the 
conversation being explored further and enabled the respondent to feel at ease.  The 
advantages of using this flexible unstructured approach during the interviews had been 
established during the pilot interviews which are discussed later.  Difficulties with probes 
and prompts had been overcome during this stage and the researcher established a firm 
process of extracting in-depth information by creating the conditions for the respondent to 
develop answers more fully (Fielding 1993; de Laine 2000; Holloway 2005). 
 
Another technique suggested by the MDT and used by the researcher to elicit additional data 
was the use of the word ‘else’ in a question.  Once the respondent has answered a question 
and was no longer speaking the researcher repeated the same question incorporating the 
word ‘else’.  For example “And how else do you feel your constipation may have been 
alleviated?  The use of this approach commenced on the fourth interview and appeared to 
generate more data than on the previous three when used in conjunction with open questions.  
This technique may have helped patients identify all contributing factors rather than just 
articulating what they perceived to be the most obvious.  It was usually only necessary to 
repeat the ‘else’ question once or twice before respondents appeared to impart all that they 
could or wanted to.   
  
4.3.8 Allowing time 
It was vital to allow an appropriate amount of time for each interview (Wengraf 2001) to 
ensure respondents had time to relax and were not rushed.  For elderly and frail patients it 
was necessary to allow time for movement and general preparation for each interview to 
ensure that they were comfortable and ‘put at ease’.  Rapport may be destroyed if the 
interviewer becomes annoyed or impatient when the patient/respondent is slow to provide 
the necessary information (Haug and Ory 1987) and this ultimately negatively affects the 
quality of response and data.  Preparing for the interview, for example ensuring patients were 
asymptomatic, medications were administered as prescribed and that refreshments were 
available, were time-consuming but necessary to optimise respondents comfort. 
 
Slowness of response in elderly persons is often taken as lack of intellectual capacity, 
however, in their research Gress and Bhar (1984) show that the decrease in psychological 
function related to mental capacity among healthy adults is minimal and without the pressure 
of time older adults perform as well as younger subjects.  Knowledge of this underscores the 




Therefore, any slowness in response was managed in a constructive manner as any display of 
frustration would devalue the importance of the subjects’ contribution and thus interfere with 
the credibility of the study (Domarad and Buschmann 1995). 
 
The researcher was also mindful of possible sensory impairments which are common in the 
older person but which can also present in younger age groups.  The National Institute of 
Ageing (1990) note that 50% of people aged over 65 can expect hearing problems and may 
mask or be aware of the deficit often resulting in inappropriate answers to questions, 
speaking too loudly, or too softly, frequently seeking clarification of questions and 
inappropriate interpretation of topic content.  Domarad and Buschmann (1995) proffer 
interviewing techniques which can increase self-esteem in the older adult are: nonjudgmental 
wording of questions; providing positive reinforcement; giving the individual control; 
matching gender; allowing time; adapting to hearing and vision impairments; and adapting to 
reading deficits.  Therefore great care was taken to accommodate for any hearing, vision and 
reading difficulties.  This involved time issues but also the setting identified for each 
interview was required to maximise hearing potential e.g. free as possible from competing 
background noise. 
 
4.3.9 Management of ambiguous responses 
One of the advantages of using an unstructured interview approach to data collection is the 
ability to clarify ambiguous responses (Polit and Beck 2008).  Vague responses such as 
being constipated for ‘a while’ or taking laxatives ‘most of the time’ needed to be made clear 
in order to identify possible contributory factors to constipation and thereby enable 
appropriate management strategies to be developed.  In clarification the researcher asked 
closed-questions (based on information already ascertained) for example, “Within the last 
month or over a month?” or “Do you open your bowels less than three times a week or more 
than three times a week?” 
 
The use of closed-questioning proved very useful and, as the interviews progressed, replaced 
open-ended questions when quantitative data were required to inform the research process, 
for example “Are you suffering with constipation at the moment?”.  In contrast, situations 
arose where the researcher deemed that clarification was not required, for example, when 
asked “How long have you been suffering with constipation?” the researcher was not sure 
which of the following applied: “four years” or “for years”.  In these instances, clarification 
was not sought as the patient’s interpretation of the question indicated that constipation was 





4.3.10 Managing deviation from the topic 
During the pilot interviews, the researcher became aware that deviation from the topic 
occurred but this was often short-lived and returned to the topic of constipation resumed.  In 
contrast, some deviations were time consuming and, in one case, the respondent became so 
immersed in her life history, spoke at length about why she had been in Uganda and the 
medical histories of all her family members.  Such deviations were irrelevant and consumed 
valuable time.  Keen not to offend the respondent and, potentially jeopardise the credibility 
of data, the researcher continued this particular interview and subsequently sought guidance 
on handling such deviation from two medical colleagues.  The doctors reported that 
deviation is common in patient-doctor consultations and they suggested the following 
technique that reflects on what the respondent had said and then reply, “That is very 
interesting and I am interested to know more.  Perhaps we can continue after the interview, is 
that OK?”  This approach was used during subsequent interviews and  positively received by 
respondents and the researcher continued with the interview by drawing on relevant data 
already discussed and asking a specific question, such as “How do you feel your constipation 
may have been alleviated?” thus bringing the discussion back to the topic of constipation.   
 
4.3.11 Pilot interviews 
Four pilot interviews were conducted to test the processes and resources.  Two experts 
assisting in the development and preparation of the research participated and thereafter two 
further interviews were conducted with patients who understood and acknowledged that their 
participation was as a pilot to test the process.  This included testing the equipment and 
facilities and assessing the acceptability and wording of interview contents.   
 
Initiating the conversation about constipation was difficult as respondents reported that they 
did not know where to start or exactly what information was required.  The researcher briefly 
explained a few details (Chapter 2) about constipation including the prevalence, causes and 
exacerbating factors.  Thereafter respondents were asked open questions about their 
experiences and management strategies.  Only a couple of questions were required before an 
open and frank conversation ensued.  Once the respondent was speaking the researcher 
listened and made notes as necessary until the point being discussed had been exhausted and 






The process worked well as respondents spoke most of the time and raised key issues that 
informed the formal interviews.  For example, one room was unsuitable as people often 
intruded despite an ‘engaged’ sign displayed on the door.  The room was also noisy and had 
large windows that led to distraction when passers-by peered in.  A pilot data sheet proved to 
be time consuming and distracted from the interview and was therefore discarded.  A second 
room within the Unit was found to be suitable for the interviews and it had easy access to 
resources (for example, bowels and tissues) and was more secluded.  Only a hand-held tape 
recorder, note pad and pen were used during the interview, thus full attention was given to 
the respondent and the interview process. 
 
The two patients participating in the pilot stage reported that they had found the interview 
therapeutic and, having articulated their concerns in much more depth than they had been 
able to in the past, commented that they would like their data included in the research 
findings.  As these patients had consented their data was included in the interview findings, 
Chapter 5.   
 
4.4 Observation and field notes 
The researcher used her observational skills and made a written note of what she perceived 
to be key issues throughout this research.  These notes acted as evidence to remind the 
researcher what happened in the past and, cumulatively, used then to generate themes.  For 
example, patients and HCPs’ attitudes, unsubstantiated accounts of blame, suboptimal 
prescribing and/or laxative dispensing and peoples’ interactions.  As a starting point, 
observation proved to be an important data collection and experiential learning experience 
that informed the study within the action research framework (Reason and Bradbury 2006).  
Notes were taken on observations and were encompassed in the study’s field notes. 
 
Field notes were taken and maintained prior to and throughout this research.  Polit and Beck 
(2008) and Richardson (2000) state that field notes are much broader, more analytic and 
more interpretive than a simple listing of occurrences as they require the observers 
participating to synthesise and understand the data.  The researcher’s field notes comprised 
observational notes, methodological notes (for example ideas on data collection methods), 
theoretical notes (such as connections and postulations) and personal notes (including 
frustrations, pleasure, anxieties and doubts) concurrently throughout this study (Richardson 
2000).   Field notes were usually lengthy and time-consuming to prepare and the researcher 
was disciplined to maintain consistency in order to provide a wealth of detail, the meaning 





Prior to the initiation of this study the researcher’s notes were predominantly reflective thus 
affording personal experiences, reflections and progress during nursing practice arising from 
methodological and theoretical concerns as highlighted in Chapter 1.  In contrast, field notes 
taken throughout this research reflected and focused more on the encounters with 
respondents and HCPs.  Notes were taken during interviews to supplement the spoken word 
and act as an aide-mémoire to add context to the data gathered.  Additionally, rather than 
interrupting a respondent during the interview the researcher made salient notes that were 
reflected upon and discussed later during the conversation.    
 
Field notes made during dissemination were in the form of delegates’ feedback about the 
content of a presentation, reflections on practice, creative criticism, objections and issues of 
concern.  Discussions often ensued between delegates and these were also noted.  All 
delegates were advised that field notes were being taken and would be used in this study but 
the source of the narratives would remain confidential.  Field notes were initially 
handwritten, as soon as possible, in order to retain as much contextual information as the 
researcher could remember, then subsequently analysed and themed.  These data contained 
information regarding the environmental setting, the communication between groups of 
individuals and researcher, and the researcher’s assessment of the interview experience, such 
as the quality of the interaction and any significant issues that arose. 
 
The aforementioned utilisation of field notes continued throughout the research to capture 
contemporary data relating to the study, advantages and disadvantages of the process and 
data specifically pertinent to HCPs and their practices, beliefs and attitudes.  Although the 
process of observation, participation and record keeping were exhausting and labour-
intensive (Polit and Beck 2008) their significance to this study warrants their inclusion.  To 
make the totality of field notes collected throughout this study manageable the data were 
transcribed verbatim into a computer (McCall 2000) and afford a thematic analysis (Emerson 
et al 1995).  Field notes findings are presented and discussed in more details in Chapters 8 
and 9 relating to the CMC and dissemination of study findings in general. 
 
4.5 Data management 
The following section gives an insight into how the data were collected, managed and 
analysed.  Member checking of the resultant themes in included as this formed part of the 
validation process.  In preparation for data analysis component the researcher attended a 





4.5.1 Data transcription 
An audio tape recorder was used to record the interviews and subsequently these were 
transcribed.  An important consideration when analysing data is to determine whether to 
transcribe verbatim or selective transcription (Silverman 2001; Polit and Beck 2008).  
Verbatim transcription offers the advantage that all the information is available for 
subsequent analysis (Elliot 2005) whereas there is a danger that important data can be lost 
and the researcher may be unaware of significant points after the event if a more selective 
approach is adopted.  In contrast, verbatim transcription can be extremely laborious and time 
consuming.   
 
The researcher chose to transcribe the tapes verbatim often replaying sections to ensure 
accuracy.  Tapes were transcribed into a Microsoft Word document within 48-hours of the 
interview to optimise the researcher’s recall of non-verbal events such as respondents 
indicating parts of their body.  This was a valuable process as it enabled a much greater level 
of understanding and the researcher was able to immerse herself in the data. 
 
During computer transcription, the ‘return’ key (the significance of this will be discussed 
later) was used at the end of each question or statement so that data were in a simple format 
for data checking and subsequent analysis in Microsoft Excel.  Each document was named 
respectively based on subject unique identifier, for example ‘Interview 4351’, Interview 
7856’ ‘Interview 2462’ and so on.  All documents were proof read and offered to each 
participant to ensure the contents were both valid and reliable accounts of what had been 
discussed during the interview.  Four interviewees read their transcripts and no errors or 
discrepancies were found.  When asked, none of the interviewees wanted to change or 
withdraw any of their narrative in contrast they were keen that their data were used as part of 
this research.  Each document was printed and read several times over the ensuing few days 
so that the researcher became familiar with the data and theorise on major themes and 
relationships between themes.  Preliminary notes were made on the printed sheets.  
 
4.5.2 Preparing interview data for analysis 
Microsoft Excel was used for data storage and retrieval.  The process of themeing was 
guided by a grounded theory approach and conducted manually by the researcher using 
Microsoft Word software instead of stationery consumables (for example paper, pen, scissors 




themes and sub-themes were created but instead of using highlighter pens and ‘cutting up’ 
sheets of paper (as if coding manually) Microsoft Excel software was used for speedy 
retrieval of data.  This proved to be a flexible approach that permitted narratives to be 
reflected in more than one theme or sub-theme, ensured the researcher became immersed in 
the emergent themes and afforded the opportunity to theorise and make relationships 
contextual with the research setting as these components are often lost when using computer-
assisted qualitative analysis computer programmes (Lee and Fielding 1991). 
 
Following the aforementioned transcribing process each document was transferred to a 
Microsoft Excel worksheet in preparation for data analysis.  This Excel file (which may 
contain several worksheets) was arbitrarily named ‘JACK’ for ease of identification.  The 
Excel worksheet was an accumulative file, that is, by the end of the interviews all patient 
narratives were contained therein.  Each document was transferred to Excel and analysed in 
chronological order following each interview. 
 
Each interview transcript was opened in Microsoft Word.  The ‘control’ key and letter ‘A’ 
were depressed simultaneously to select all the text contained in the Word document.  This 
was then pasted into the Excel worksheet document using ‘control’ and ‘V’ simultaneously.  
As previously mentioned, because the ‘return’ key was used following each question and/or 
statement during transcribing, the narratives copied into Excel drop into individual cells 
(which will be discussed later), thus giving the flexibility of analysing each question, 
statement and response individually. 
  
To ensure that data could be accurately identified to the interviewee, maintain its 
chronological order and facilitate the exclusion of non-relevant data, (such as duplication or 
confirmation), it was necessary to insert three additional data columns into the worksheet 
(Appendix 11).  These columns are headed Col. A, Col. B, Col. C and Col. D.  Col. A 
contained a consecutive line number starting from 1; Col. B the patient identifier number; 
Col. C all the narratives; and Col. D relevance of the narrative.  Each line of data (which at 
this early stage consisted of only columns A-D), is referred to as a ‘record’.  In total there 
were 2,400 records containing text that were subsequently reviewed manually by the 
researcher whom entered ‘Yes’ or ‘No’ in Col. D thus indicating whether or not the 
corresponding narratives were to be analysed. 
 
The Excel ‘filter’ function was then used to exclude unwanted narratives and retain those for 




themed.  In excel ‘filtering’ is enabled by choosing the following from the programme’s 
menus and sub-menus: Data, Filter, Autofilter. 
 
Using the filter process enabled the researcher a fast and reliable way of separating out those 
data that were relevant from the non-relevant narratives.  For example, in 150 instances the 
narrative commenced with either ‘Yes…’ or ‘OK…’ as a reaffirmation  or in 
acknowledgement of the previous narrative, therefore ‘No’ was entered in column D 
(adjacent to the corresponding narrative) to indicate the narrative was not required for 
analysis.  In total 1,450 records were excluded and 950 narratives were ultimately retained 
and analysed. 
 
Microsoft Excel facilitates the use of several workbooks within each file, therefore the 
master file, JACK, contained several worksheets.  The first worksheet was named ‘raw data’ 
and ‘read-only’ which means no changes or deletions could be made in error – thus retaining 
all the original text in patient and chronological order for cross-checking and clarification.  
The ‘raw data’ worksheet was then copied into a second worksheet named ‘main themes’ 
and the process of filtering and ‘theming’ commenced.   
 
4.5.3 Coding and theme allocation 
The worksheet developed into a large table with successive narratives down the left and 
columns, containing named themes, across the top.  As additional themes emerged these 
were subsequently added as new columns with corresponding names.  By entering ‘Yes’ in 
the corresponding narrative and theme it became possible to utilise the filter function and 
extract all narratives pertinent to each main theme.  For example, by the end of the ‘theming’ 
process 174 narratives contained references to how patients reported that their constipation 
had affected them.  These 174 pieces of data were then sub-themed further, for example how 
it affects patients physically, psychologically, affects of quality of life (to name but a few) by 
utilising the aforementioned filtering process. 
 
As previously stated, each patient’s interview data were transcribed and themed on an 
individual basis and subsequently to each other.  Therefore the process of content analysis 
was manageable and enabled the process of creating and adding additional themes for each 
interviewee in a controllable and methodological way.  For example, for the first 
interviewee, Alice, had a total 142 narratives (records) that were then filtered to exclude non-
relevant and erroneous data.  The resultant relevant data were then given preliminary themes 





The process of theming continued patient by patient and, simultaneously, main themes (level 
1) emerged (which are presented and discussed in Chapter 5, interview findings) and were 
created to form a structure and theoretical hierarchy based on frequency of discussions 
and/or implied importance.  For example, the main theme ‘drugs’ contained the most 
narratives whereas ‘benefits of constipation’ was only mentioned once.  The resultant main 
themes concluded following the ninth interviewee as no new themes or sub-themes were 
emerging, however, three further interviews were conducted to ensure theme saturation had 
occurred (Gray 2004; Parahoo 2006; Polit and Beck 2008). 
 
4.5.4 Member checking identified themes 
A process of member checking had previously been undertaken with patients to summarise 
the main points that were highlighted in each interview.  This second stage of member 
checking was conducted by two senior colleagues who agreed to read some transcripts in 
order to establish the credibility, dependability and confirmability of the themes and sub-
themes identified by the researcher.  Both checkers were conversant with qualitative research 
and proficient in analysing narrative data and, following their valuable contributions and 
comments, subsequently agreed with the themes and sub-themes identified.  Thereafter, the 
overarching themes were also presented to HCPs during the focus groups; a process that 
provided another layer of member checking and validation which will be discussed in 
Chapter 6, HCPs Focus Groups.  However, it is worth noting that no further clarification or 
rejection of the overarching themes were proffered by the latter group, thus agreement 
arising in contributory factors leading to the suboptimal management of constipation in 
patients with cancer, which will be identified in Chapter 5, Interview findings. 
 
Throughout the process, the researcher was aware that sub-themes (level 2) were emerging 
and these too were processed.  As a safety precaution, all data files were back-up (copied) 
periodically onto a separate computer and password protected so that only the researcher 
could access the data. 
 
4.6 Trustworthiness and validation 
The quality and robustness of the data are issues that all researchers struggle with.  No matter 
the chosen methodology any research needs to be evaluated against certain criteria to ensure 






Polit and Hungler (1999) describe trustworthiness as a term that is used in the evaluation of 
qualitative data.  However, it is not universally used or indeed recognised within qualitative 
research but the general concept of validation of data is addressed in various ways by most 
authors (Morse et al; 2001; Angen 2000; Mishler 1991).  By way of explanation, Morse et al 
(2001) identify current and past debates regarding the use of traditional techniques for 
establishing rigor in research, including reliability, validity and validation.  Leininger (1994) 
contributes to the debate by arguing the importance of preserving and maintaining the 
purposes, goals and philosophical assumptions of the qualitative research paradigm and of 
using qualitative research methods and criteria appropriate to that paradigm.  From this 
proposition Morse et al (2001) conclude that the use of quantitative criteria such as validity 
and reliability remains inappropriate for qualitative studies.  However, May (2001) and 
Silverman (2001) amongst others have continued to use traditional terminology, including 
‘reliability’ and ‘validity’.  Morse (1999) adds to this point of view by arguing that, by not 
using traditional quantitative evaluative criteria and terminology, qualitative researchers are 
losing ground in the world of evidence. 
  
The reasons why such measures need to apply are straightforward and return to the central 
focus of qualitative research.  Polit and Beck (2008) believe that making critical assessments 
of the reality of a situation places a heavy responsibility on all researchers.  As the general 
orientation of this research is one of interpretivism it means that most observation is 
informed by a stance or ‘appreciation’ of trying to understand phenomena from the 
respondents’ perspective.  This approach identifies respondents, not the outsiders, or 
researchers, as experts regarding their situation, in this instance the management of their 
constipation.  However, Fielding (2001) notes that researchers must interpret the data and in 
so doing inevitably use their own frame of reference to do so.  He emphasises this point by 
arguing that researchers are never detached observers and their views are inescapably 
relative and directed by their own perspectives. 
 
It is therefore difficult to establish a method by which an audience can have any direct way 
of validating claims made by the researcher.  It can therefore be debated that objective 
observation is impossible to achieve in any research.  Thus the evaluation and understanding 
of situations and phenomena generally is derived from experience and the researcher, by 
sharing the respondent’s world, applies that ingrained personal and professional experience 
introspectively to the data.  As a result although the researcher’s description and conclusions 




findings by its very nature cannot be examined.  Qualitative researchers therefore use tests of 
congruence or verifiability to assess the rigor of their processes.   
 
Maxwell (1992) discusses five types of understanding or validity that may emerge from a 
qualitative study: descriptive, interpretive, theoretical, generalisable and evaluative.  Polit et 
al (2001) address the trustworthiness of data from a slightly different perspective.  They 
argue that the central question underlying the concepts of validity and reliability are whether 
the data reflects the truth.  Polit and Beck (2004) and Polit et al (2001) note that many 
qualitative nurse researchers seek to evaluate the quality of their data and their findings 
through the procedures outlined by Lincoln and Guba (1985) who suggest four criteria for 
establishing the trustworthiness of qualitative data and the ensuing analysis; credibility, 
dependability, confirmability and transferability.   
 
4.6.2 Issues of trustworthiness 
Credibility is viewed as an overriding goal of qualitative research.  It refers to the confidence 
in the truth of the data and the interpretations of them.  Qualitative researchers must strive to 
establish confidence in the truth of the findings for the particular participants and the 
contexts in the research.  Credibility involves two aspects, firstly that the research should be 
conducted in a way that enhances the believability of the findings and secondly that the 
researcher takes steps to demonstrate credibility to external readers (Polit and Beck 2008; 
Denzin and Lincoln 2003b, Green and Browne 2005).   
 
The second criterion identified above is that of the dependability of the research.  This 
essentially refers to the stability (reliability) of data over time and over conditions and 
whether the findings can be replicated or repeated.  It is generally accepted that credibility 
cannot be attained in the absence of dependability (Polit and Beck 2008; Denzin and Lincoln 
2003b; Green and Browne 2005).  The interviewer who gathers credible data obtains 
believable data which accurately portrays the situation from the subject's point of view 
(Domarad and Buschmann 1995).   
 
Confirmability refers to the objectivity or the potential for congruence between two or more 
independent people in regard to the accuracy, relevance or meaning of the data.  The criteria 
are concerned with establishing that the data represent the information that the participants or 
respondents provided and that the interpretations represent the truth (Brewer 2000).  To such 




conditions of the inquiry and not the biases, motivations or perspectives of the researcher 
(Green and Browne 2005). 
 
The fourth criterion is that of transferability which essentially refers to the generalisability of 
the data, that is the extent to which the findings can be transferred to or have applicability in 
other settings or groups (Polit and Beck 2008; Parahoo 2006).  The responsibility of the 
researcher is to provide sufficient descriptive data in the research to enable readers to 
evaluate the applicability of the findings to other contexts.  
 
4.6.3 Rigour of the interview process 
The researcher recognised fully that the dependability of the process was not particularly 
rigorous but was confident that the credibility and confirmability as suggested by Polit and 
Beck (2008) were robust.  The rich and plentiful data obtained from each interview reflected 
the detailed experiences of the individual and was invaluable for this qualitative study and 
consistent with the philosophy of the process.  The researcher is aware of the debates that 
continue concerning the use of this non-standardised approach to gathering information 
(Polit and Beck 2008; Polit and Hungler 1999; Morse 1994a; Burns and Grove 1997; Morse 
and Field 1995).  Nonetheless, the lack of structure was viewed positively to gain a good 
breadth of response.  
 
4.6.4 Interview bias  
A well-established and longstanding body of opinion in the field of methodological research 
warns of the many effects the interviewer could have on the respondent’s statements which 
could distort the results obtained.  While advocates of non-standardised interviewing value 
and analyse the proactive part played in the discussion by the interviewer, proponents of 
standardised approaches regard these effects as undesirable.  They seek to devise and 
maintain methods of quality control that could minimise the distorting impact of the 
interviewer on what the respondent feels able to say.  Silverman (2001) identifies the 
Hawthorne or Halo effects that may influence the rigour of the interview and thereby lead to 
inaccuracies and misinterpretations.  Polit and Hungler (1999) concur and describing the 
Hawthorne effect as the bias or change of behaviour introduced as a result of the respondents 
being aware that they are under study and the Halo effect as being when the researcher 





Polit and Beck (2008) acknowledge this possible researcher bias by noting that an active 
commitment to a particular perspective during the interview certainly affects results but 
argues that it is also easy to overstate the problem when, in fact, it may not be present.  In a 
slightly different vein, Gilbert (2001) notes that much of what is considered interviewer bias 
is more correctly interviewer difference, which is inherent in the fact that interviewers are 
human actors in the same way as respondents.  Whatever the approach, it is sensible to take 
into account some of the key debates regarding possible bias.  The researcher was therefore 
conscious throughout all interviews of the potential for bias being introduced and 
consequently made every effort to reduce it by remaining as ‘neutral’ as possible throughout 
each encounter as previously highlighted. 
 
On completion of each interview and by way of closure to the event, the researcher spent 
some time with the respondents summarising the key points raised.  This process of data 
corroboration is described by Lincoln and Guba (1985) as member checking and can be 
considered an important technique for establishing the rigour of qualitative data.  In a 
member check, the researcher provides feedback to study participants by describing the 
emerging data and the interpretations that might be placed upon it (Polit and Beck 2008).  
The processes of member checking was completed post each interview and will be revisited 
as a concept later in the research where focus groups were conducted to test the credibility 
and generally test the emerging data from the interview stage.  Lincoln and Guba (1985) and 
Denzin and Lincoln (2003b) state that if researchers maintain that their interpretations of 
meanings are good representations of the realities expressed, respondents should be afforded 
an opportunity to react to them.  By so doing, every effort was made to ensure that 
appropriate emphasis was attributed to each issue thereby accurately reflecting the depth of 
feeling and viewpoint.  This proved to be a useful process and assisted greatly in the 
establishment of the overall findings of the research project. 
 
To engender confidence and to augment the credibility (Polit and Beck 2008) of the findings, 
the process of analysis and the consequent emerging themes were debated with colleagues 
working within the specialist field of palliative care referred to above (focus groups).  These 
specialists, from a variety of care professions, were able to confirm and generally verify the 
interpretation of the data and by so doing, enhanced the rigour of the process.  This member 






4.7 Sample identification 
Sampling is the process of selecting a portion of the population to represent its total.  The 
sample is therefore a subset of the total population (Polit et al 2001; Parahoo 2006).  In 
nursing and social research the sample is usually people (Polit et al 2001; Fielding 2001) and 
is used rather than the total population because it is more cost-effective and efficient (Clough 
and Nutbrown 2002; Polit and Beck 2008).  Reasonably accurate information can be 
obtained from a sample that can then be generalised to the total population (Polit and Beck 
2004; Parahoo 2006), however Fielding (2001) states that the researcher must refrain from 
drawing conclusions about a particular problem based on faulty samples.  The representation 
and transferability or generalisation to the total population is more suited to quantitative 
research whereas qualitative researchers are not preoccupied with issues of transferability of 
results (Denzin and Lincoln 2003b; Elliot 2005).  As this study aimed to change local 
practice rather than be generalised to the total population the researcher considered that the 
sampling process used was appropriate. 
 
4.7.1 Inclusion and exclusion criteria   
Polit and Beck (2004) state that in identifying a sample the researcher should be specific 
about the criteria that define who are included in order to gather meaningful data.  This 
identification of the parameters of the sample is essential to leave an audit trail thereby 
increasing the rigour of the study (Gray 2004).   
 
A contentious point debated by the MDT related to the cause of constipation.  Whilst some 
team members wanted to focus on opioid induced constipation, others regarded secondary 
constipation as being definitive enough.  The researcher raised concerns with these issues 
including the difficulties of differentiating between aetiologies, all patients with cancer are 
predisposed to constipation, and a pre-cancer diagnosis of  primary constipation may have 
been superseded by cancer related secondary constipation.  The researcher proposed that all 
patients with cancer, regardless of cause, should be considered for inclusion as there was no 
evidence to suggest that beliefs, attitudes and management strategies varied between 
aetiological groups.  The MDT concurred and agreed the following inclusion criteria: 
patients with a diagnosis of cancer aged 18 and over, able to give informed consent and have 
experienced constipation.  Patients would, based on a medical opinion, be excluded if they 





4.7.2 Sample size 
The study aimed to interview between 10 and 15 patients.  This number was considered to be 
adequate to achieve effective results as Polit and Beck (2004) propound that it is usually 
impractical for the researcher to use large samples for obtaining data in qualitative studies.  
This non-probability, convenience sampling method was considered to be the most effective 
to ensure that the issues involved in an in-depth qualitative study of this nature were fully 
addressed (deVaus 1991; Polit and Beck 2004; Arber 1993).  
 
4.7.3 Sample bias 
This mode of non-probability, convenience or volunteer sample identification is used widely 
where there may be difficulty in readily identifying a sufficient number of potential 
participants (Morse et al 2001; Polit and Beck 2004).  In this qualitative study the researcher 
was less interested in obtaining a representative sample of people than achieving a broad and 
diverse group that represented various experiences of the effects of constipation and its 
management in cancer care.  This sampling process is congruent with the overarching 
philosophy of the study whereby the purpose is to contribute to an understanding of the 
phenomena rather than to seek representation and generalisation of findings as commonly 
accepted (Parahoo 2006; Polit and Beck 2008).  Having noted that generalisation is not vital 
to the results the researcher will draw on the opinions of Silverman (2004), Porter (1996) and 
Brewer (2000) and make some generalisations in the findings Chapters regarding the data 
gathered. 
  
The researcher acknowledges that this form of non-probability, convenience or volunteer 
sampling (Parahoo 2006) has inherent biases in as much that the group is self-selecting and 
may represent those individuals that have their own agenda (Polit and Beck 2006, Burns and 
Grove 1997, Streubert and Carpenter 1995).  Parahoo (2006) and Polit and Beck (2004) state 
that using volunteers is perhaps the least robust of sampling, as the researcher has little 
control over the selection of interviewees and is instead dependent upon people volunteering 
to take part.  Although the weaknesses of the process are well documented in the research 
literature, this possible compromise in sample selection, according to Polit and Beck (2004), 
can be considered the norm within most disciplines.  Nonetheless, this sampling strategy was 
considered efficacious, as it is often considered that the issues of bias and generalisation are 






To support this from a qualitative perspective, Silverman (2001) states that the purpose of 
sampling is to study a representative subsection of a precisely defined population in order to 
make inferences about the whole population.  However, he goes on to note that such 
sampling procedures are usually unavailable in qualitative research.  Agar (1986) contributes 
to this discussion by concluding that when research assumes a ‘learning role’ it does not 
always make sense for the researcher to be concerned with a process that is scientific.  Agar 
(1986) purports that the main thrust of the research often involves inquiry regarding ‘what is 
going on here?’ rather than a technical examination of cause and effect and thus does not 
depend upon the pretence of scientific control.  Therefore, within the framework of this 
research, any bias in the sample was considered to be acceptable to ask the question ‘what is 
going on here’ in a general sense and make some kind of inference or generalisation to the 
total population. 
 
4.7.4 Study promotion 
Following Ethical approval raising awareness of the research took on a more formal 
approach and a letter (Appendix 12) was sent to named individuals in line with local practice 
and as required by the Trust’s Research and Development department.  It was impractical to 
directly inform all HCPs about the study however, some senior doctors and nurses had been 
made aware as they were also Ethics Committee members.  The flyer was displayed in 
prominent areas and the senior pharmacist suggested holding a supply of referral cards at the 
pharmacy department for distribution to outpatients with their medications, which were 
dispensed at the hospital pharmacy. 
 
Once the research was underway, the researcher took the opportunity to maintain and raise 
awareness of the study and its progress at clinical governance meetings, research and audit 
meetings and other meetings when the opportunity arose and as part of the Unit’s 
educational programme.  This process acted as a reminder to staff and encouraged new and 
enthusiastic staff to contribute to the research and/or make referrals. 
 
4.8 Summary 
This Chapter has introduced the methods used during the patient interviews, many of which 
were subsequently utilised during the latter two stages of the research.  The study initiation 
process proved useful as it provided the opportunity for MDT members and other HCPs 
practising locally to become involved in the research, thus influencing outcomes and 




were unable to dedicate time to the study due to their own commitments and workload 
pressures but were otherwise in favour of the research.  Meetings were often time-consuming 
and difficult to arrange due to HCPs other commitment but nonetheless ensured the MDT 
were kept informed and involved in the evolving research and its findings.  
 
Ethics have been discussed in detail to convey the importance of the necessary components, 
including the researcher’s obligations and maintaining patients’ best interest.  Confirmation 
that these had been met were confirmed by the The Ethics Committee Members who 
approved this study and stated that, in their opinions, there was insufficient research 
exploring constipation in patients with cancer, thus a worthwhile study. 
 
The appropriateness of the methods used during the patient interviews has been discussed 
and their suitability confirmed.  The transition from pre-study, non-reactive observation to 
research being more proactive with observational finding influence and guided the study in 
the form of field notes has been highlighted, along with the gathering of field notes which 
provided additional in-depth data that were subsequently themed and disseminated. 
 
The researcher has examined and detailed the generic methods used throughout the study.  
These elements present the nature of methods in research to set the scene.  Key ethical 
implications have been introduced and the processes of gaining the required approval 
outlined.  The processes adopted by the researcher have been highlighted in some detail to 
underscore the importance of maintaining the physical and psychological comfort of the 
patients throughout the interviews.  The methods of data collection have been explained and 
these include the use of observation as a method that was used throughout the study; from its 
inception to the CMC and the interview methods used in stage one of the study as they 
represent the initial stage in the action research process.  The processes followed are 
explained in detail to afford a clear understanding of each step and the underpinning 
rationale for their adoption as being appropriate data collection approaches to capture the 
type of data required to inform this study.  Sampling issues are highlighted as they applied to 
stage one of the study and include the inclusion and exclusion criteria.  The issues of 
trustworthiness are discussed and the measures taken by the researcher to strengthen the 
rigour, through the use of member checking of data and the process of this action research 
are emphasised to reinforce the value and accuracy of the overall findings of the study.  The 
system and actions involved in the analysis of the data are exposed to illustrate the process of 
content analysis and explain how the main themes emerged.  Some of these issues are 






Interview process and findings 
 
5.1 Introduction 
This Chapter reports the findings of the interviews.  Initially an overview of interview 
process is presented including referrals, sample demographics, location and duration of 
interviews followed by data preparation and analysis.  An outline of the interview findings is 
given followed by the emergent main themes and rationale why only some main themes are 
analysed and presented.  Relevant themes are then presented along with the respondents’ 
narratives as extracts to illustrate salient points and highlight contextual relationships where 
necessary.  Included in the core themes are: benefits of talking about constipation, 
respondents’ perceptions of HCPs’ negativity, laxative use, misconceptions and fragmented 
and inappropriate after care.  A brief summary is given at the end of each section and the 
main points will be drawn together to give an overall summary at the end of the Chapter and 
present the rationale for the next stage of this research. 
 
5.2 The overall process 
5.2.1 Referrals 
Over a nine-month period, 17 patients expressed an interest in participating in the interviews.  
Eleven patients self-referred and six were received via a HCP.  Six patients were excluded as 
they either did not have a cancer diagnosis or entered the terminal phase shortly after 
registering their interest.  The remaining 11 patients who met the inclusion criteria were 
given the patient information sheet and subsequently consented and recruited into the 
interviewing stage of this research.  Three copies of the consent form were signed (Polit and 
Beck 2008) of which one was filed in the patient’s medical notes, one was retained by the 
researcher and one kept by the patient.  None of the patients wished to withdraw completely 
or in part (any extracts) from the study.   
 
5.2.2 Patient demographics 
The interview sample comprised seven females and four males.  Their average age was 66 
(range 60-74 years) and the cancer diagnosis varied as shown in the following WHO 




(2), Female genital organs (2), Male genital organs (1), Digestive organs (3), Head & Neck 
(1).   
 
5.2.3 Location and duration of interviews 
Ten respondents chose to be interviewed in the Unit and in seven cases this was because they 
were comfortable with the setting, regularly used its day care facilities and were familiar 
with the staff.  In contrast to the view of Zola (1986) respondents did not appear to be 
lacking in confidence or frankness during the interviews.  It may be that the ambiance and 
pre-established affinity most respondents had with the Unit and its staff resulted in 
individuals feeling confident and relaxed, thus affording candid and open discussion.  Two 
interviews took place in the respondents’ home due to their immobility and difficulties with 
transport.  There was no difference in the quality of data obtained between locations. 
 
Allowing time ensured data were obtained at a pace to suit respondent’s needs, thus enabling 
the contemplation of facts and events which contributed to their story telling.  Allowing time 
emerged as being one of the main advantages of the discussions around constipation as, in 
the past, being rushed was reported as one of the main barriers to articulating their concerns.  
Interviews lasted between 40-60 minutes and in all instances came to a natural end, that is, 
all issues considered by participants to be relevant and of concern had, in their opinions, 
been expressed. 
 
5.2.4 The data 
As discussed in Chapter 4 (Methods), 11 interview tapes were transcribed verbatim.  
Transcripts were offered back to respondents for checking but in most cases respondents 
declined to read them on the basis that the documents were lengthy.  Five respondents 
preferred the researcher paraphrasing the transcripts and clarified points where necessary.  
Two respondents chose to read their transcripts in their entirety and reported that they were a 
true account of the interview.   
 
The cycle of allocating themes continued until the ninth interview at which point saturation 
had occurred, that is, no new themes or sub-themes emerged.  Table 7 shows an extract of 
the main themes (level 1) and the number of corresponding narratives.  These narratives 
were then sub-themed (level 2) and when necessary into a third level.  Table 8 shows the 
sub-themes (level 2) for ‘drugs’.  Some narratives were coded to more than one category to 









How constipation affects me 174 
Assumptions / beliefs / attitudes / desires 97 
 Interactions with others 68 
 Information seeking / received 49 
 Methods to alleviate / pain endurance 46 
 Causes of constipation 40 
 Past medical history 38 
 Unresolved issues 38 
 Recollection 35 
 Frequency 35 
 BO if not eating / unwell 31 
 Anatomy and physiology 23 
 Definition / What constipation means to me 22 
 Difficulties talking with others 22 
 Descriptions of stool 22 
 How long have you been/suffered with constipation 21 
 Bowels at the moment 20 
 Descriptions of self 15 
 
Table 7 – Extract of main themes (level 1) 
 
 
Types, names and descriptions of drugs  89
Frequency of use 70 
Effects of drugs 64 
Interactions, help, information received 44 
Source of drugs 24 
Experimenting with laxatives 17 
Unanswered questions / assumptions  11 
Laxative use - prevent or treat constipation 8 
Reasons laxatives not taken 2 
 




5.3 Interview findings 
Respondents engaged in in-depth discussions about their constipation and its management.  
Interviews were semi-structured as planned.  Prompts and probes were used minimally as in 
all cases respondents dominated the conversation as they spoke intently about their beliefs, 
attitudes and experiences with constipation, including their definitions, management 
strategies, concerns and wishes.  Respondents reported that, for the first time, a HCP had 
listened to their concerns, believed what they had said, provided reassurance and support.   
 
The emergent themes were useful in establishing a wealth of data that informed various 
stages of this research.  A comprehensive and variable representation of constipation 
management in patients with cancer developed and was subsequently presented and debated 
with the MDT.  Due to the enormity of the data it was not possible to explore all the issues in 
detail and, in the MDT’s opinion some themes were of minimal value due to their historical 
nature and were therefore excluded from further analysis.  For example, ‘past medical 
history’ (level 1) contained narratives about previous illnesses, diagnostic tests and/or 
constipation as a child, and thus their relevance during the interview was often a mechanism 
through which respondents were able to formulate facts, timelines and events.  In contrast, 
those reporting co-morbid conditions, such as a heart condition, were noted as such data 
informed the choice of the individuals’ laxative regimen but is otherwise excluded from the 
remainder of this Chapter.  
 
All respondents sought advice during the interviews.  Although proffering support and 
advice was not anticipated during this stage of the study, the researcher was of the opinion 
that the advice was simple, straightforward and consisted basic nursing advice.  Therefore, 
withholding such information from respondents would have been unethical.  The remainder 
of this Chapter presents the main issues that were considered most relevant to this study 
followed by a discussion and recommendations for the next stage of this research. 
 
5.3.1 A therapeutic discussion 
Respondents reported that they found the interview itself beneficial as it had enabled them to 
‘off-load’ as if voiding themselves of what had become their sole responsibility and distress 
as shown in the following extracts; 
 
“...it’s a lot less annoying when at least someone listens.”  (Carol) 
 





“Just talking to you (the researcher) is good you know, it helps a lot.”  
(Alice). 
 
“Thank heavens I’ve found someone who understands what I am going 
through.  It’s a relief just to get it off your chest …”   (Kathy). 
 
Some respondents were anxious and said that they had felt ‘stupid’ in the past when 
discussing constipation with HCPs but this had now been alleviated, possibly due to the 
researcher’s empathic approach and supporting comments.  Positive reinforcement was used 
throughout as necessary, for example, respondents were advised that their experiences were 
common and that constipation in patients with cancer was an important symptom that 
warranted further exploration and this was being achieved through their valuable 
contributions during the interviews (Denzin and Lincoln 2003b).   
 
 “I feel better for knowing that other people have the same problems as me.  
I needed to know if what I was doing was wrong but I didn’t like to ask 
anyone else.” (Betty) 
 
“I don’t feel so stupid now, I was beginning to feel like it was my 
imagination and nobody else really seemed to believe me.”  (Linda)  
 
“... then you feel stupid and wish you hadn’t mentioned it (being 
constipated).”  (Matthew) 
 
The interviewer was non-judgemental and avoided negativity and humour relating to 
constipation and it may be that this approach enabled respondents to feel more at ease and 
comfortable when exposing their experiences and concerns, thus they spoke more frankly 
and openly.  Respondents reported that they had found the interview a positive experience 
and, when asked, none wanted to withdraw any of their narratives despite its sensitive nature 
and data and expressing criticisms of their HCPs. 
 
Respondents expressed their sentiments of feeling ‘stupid’ and disbelieved by HCPs who 
they regarded as being more knowledgeable about health care issues than themselves.  
Explicit within respondents’ narratives was a perception that they were subservient in the 
HCP-patient relationship and thus failed to challenge negative behaviours.  The negative 
sentiments appear to stem from respondents perceptions that HCPs are unhelpful and 
disbelieving of them.  Health care professionals may not realise the impact their approach is 
having on patients.  In light of this point, it is not difficult to see why there is a lack of 





Evidence of frankness 
In contrast to her previous nursing experience, the researcher found respondents to be more 
open and honest about their constipation and its management.  For example, one practice 
deemed extremely personal and embarrassing by respondents was digital removal of faeces.  
In 10 years nursing experience only one patient (as presented in Chapter 1, vignettes) had 
ever reported adopting this practice whereas five respondents volunteered this information 
during the interviews: 
 
 “… and I had to pull it out with my finger in the end, I just didn’t know what 
else to do.”  (Eric) 
 
“Sometimes you know I have to, em sorry this sounds awful, but em, well I 
have to do it with my finger.  I’ve never told anyone that.”  (Alice) 
 
“I don’t mind telling you (the researcher) about it (having to remove faeces 
digitally) because you understand.” (Betty) 
 
It is possible that the rapport, environment, motivation and time afforded to patients during 
the interviews facilitated the openness and frankness explicit throughout the narratives (Barr 
2007).   
 
5.3.2 Patients’ perceptions 
Respondents commented about their previous interactions with HCPs in which they were 
unlikely to have spoken so candidly as HCPs always seemed busy and rushed.  Respondents 
identified several factors that make them reluctant to continue to seek assistance from their 
HCPs.  One of the main barriers was that all respondents reported that their HCPs are 
repeatedly busy, as indicated by the embolded words in the following narratives: 
 
“She (the GP) gave me I think it was like Fybogel, but that seemed to make it 
worse.  I can’t keep going back.  She (the GP) always makes it obvious she 
is busy and you just feel like you shouldn’t be wasting their time with such 
silly things.”  (David). 
 
“You can’t keep pestering them (nurses), they are all so terribly busy ..."  
(Eric) 
 
“There are so many sick people and it takes ages to get to see your GP.  I 
know they are busy…”  (Gillian) 
 
“... all they want to do is scribble on the sheet (prescription form) and get 





As a result of these interactions respondents came to conclusions that subsequently became 
more barriers to seeking help.  For example, that they were wasting HCPs’ time, that 
constipation was unimportant and that other sick people were more important than they 
were.  All respondents had previously attempted to discuss their constipation with at least 
three other HCPs, however, this had always been received with what patients describe as 
negative responses, disinterest and/or ambivalence.  Respondents were resigned to this 
negativity, apparently not knowing what else they could do, for example: 
 
"Well what is there, you just tell the nurse and she comes and gives you a 
little more of the same and says “you’ll be alright tomorrow” and tomorrow 
doesn’t happen.” (Frank).  
 
“I did speak to a doctor about it, I told him I haven’t been for seven weeks 
and he just made a joke of it.” (Betty) 
 
“I’ve told the district nurses but I don’t know what they can do.”  (Gillian) 
 
 “You get the impression that these doctors and nurses see you as a pest 
keeping on about constipation.  You just don’t bother in the end.”  (Alice) 
 
The doctor didn’t seem interested.  What else can I do?”  (Carol). 
 
Respondents appeared to believe that HCPs had no interest in helping to alleviate 
constipation nor were they concerned about the distress the condition caused to patients.  As 
a result of this disinterest HCPs allegedly failed to proffer appropriate support or advice.  
Whilst the issues raised here are also alluded to in Chapters 1 and 2, there are no indications 
as to why HCP ambivalence appears to exist in constipation management, or why patients 
fail to challenge the status quo even when they are severely constipated.  It may be that 
respondents lacked satisfaction with the attitude of their HCPs, were ‘fed up’ with trying to 
seek help, or were unable to convey their concerns and distress when disbelieved or not 
taken seriously.   
 
Only Betty took the contrasting approach that appeared to be borne out of frustration and her 
desire to be less subservient to HCPs as, in her opinion, patients generally were, but without 
good reason.  Betty describes her relationship with doctors as persistent in an attempt to get 
results as she describes;  
 
"I don’t take no being fobbed off from no doctor, I keep going back.  
Because I don’t think people, to be truthful, all the patients are in awe of 
doctors and the medical profession, and I’ve discovered you don’t have to 





Perhaps because of her persistence, Betty felt she was regarded as a ‘pest’ but this did not 
bother her as she felt she benefited from timely appointments and referrals upon her demand.  
Despite Betty’s perseverance her constipation had not abated and she was still seeking 
treatment for this at the time of the interview, 
 
 “I’m gonna go back to my GP because I’m still having trouble with 
constipation.”  (Betty) 
 
For the 11 respondents in this study it appears that even when they made repeated efforts and 
were more demanding of their GP no improvement in their constipation was achieved, 
possibly because GPs may not have and/or employ the fundamental elements (knowledge, 
skills and resources) required by clinicians to deal with constipation in patients with cancer.  
Respondents rationalised why HCPs failed to optimise their constipation management, often 
accepting that nothing more could be done.  However, this was based on the patient as a 
layperson and in the absence of more specialised skills, knowledge and resources which are 
available to HCPs.  The implications are that HCPs may be failing to access supportive 
resources to help with constipation management, thus arguably failing in their duty of care 
towards patients. 
 
Respondents appeared perplexed by the attitudes of HCPs who afforded them with 
disinterest or, at best, a ‘sympathetic ear’ as expressed below; 
 
“I kept telling him (patient’s GP) but he said “with all the things wrong with 
you that (constipation) is the least of your problems.   I suppose he’s right.” 
(Kathy) 
 
“The doctor said “Don’t worry about that (constipation), the nurses will 
sort it out” but they don’t.  The nurses say the doctors need to give me 
something.  It’s a waste of time talking to them.” (Eric). 
 
“My doctor just sort of said “oh dear, what can we do to help?”  I don’t 
know why she’s asking me ‘cos I went to her for help.”  (Alice). 
 
“I have mentioned it so many times in the past that I don’t bother now 
because nobody ever did anything, it just gets ignored like nothing was 
said.”  (Linda). 
 
“Obviously I’m sure if they (hospital nurses and doctors) could have done 
something more to prevent it (constipation) they would have.”  (Gillian). 
 
By their omissions, (such as failing to use evidence based management strategies for 




respondents’ fallacies that constipation was inevitable, difficult to manage and that little or 
nothing could be done to alleviate it.  The reported sympathetic ear did nothing to abate 
patients’ concerns as all respondents remained worried and distressed by the impact of their 
constipation.   
 
Allowing time and encouraging patients to speak openly afforded respondents the 
opportunity to discuss their constipation thoroughly for the first time.  The researcher’s 
interest, time and support was commented upon by several respondents as being beneficial to 
the interview process and an approach that they had not previously encountered when 
attempting to discuss their constipation with other HCPs.  Respondents considered the 
interviews as therapeutic.  
 
5.3.3 Seeking help 
Despite repeated and failed attempts to seek help from HCPs, respondents continued to be 
very anxious regarding their constipation, but considered that they had no one else to refer to 
for support and advice.   
 
“I do tell them you know (doctors at the GP surgery) and they give me this 
stuff (laxatives) but really what else can they do?”  (Linda) 
 
“Who else is there to talk to?”  (Kathy) 
 
“I’ve told my GP but he just gives me more of the same (laxative).  I don’t 
think he really knows what to do with me.”  (Mathew) 
 
“I’ve just moaned to my husband, it stresses him too.”  (Alice) 
 
“My daughter tries to help, she goes to the health shop.  She has spent a lot 
of money and I don’t like that but she likes to feel she is helping.”  (Gillian) 
 
“… it worries my wife too which makes me feel worse.”  (Frank) 
 
“What’s the point (talking with the GP).  She’s not really interested.  She 
just says “Oh, well try this (another laxative)” and the same thing happens”.  
(Carol) 
 
“…  I mean it’s not as if there is somewhere you can go specifically for 
constipation is there?  A bit like going to the dentist, you go there to get your 
teeth sorted or go over there (the oncology department) to get your chemo.”  
(Betty). 
 
“I don’t think anything can be done.  If it could they would be doing it 





Despite its private and sensitive nature respondents felt that at times their constipation had 
become so bad that they would have spoken to anyone who would listen.  Many respondents 
appeared reconciled to the fact that there was no one else to turn to for help and reported a 
desire to seek help, for example: 
 
“Who could I talk to that I hadn’t already told?”  (Betty) 
 
“No one is really interested.  It would be nice though if they were, then 
maybe they could help.  It’s good to off-load and see what other people 
think.”  (Alice) 
 
“I would love to talk to someone who has had the same problems as me or 
someone who knows something about it (constipation).”  (Eric) 
 
“If there was someone out there who could help me then I want to talk to 
them.  Do you know if there is somewhere, or er, or anyone who deals with 
constipation?”  (Linda) 
 
 
Although respondents appeared accepting of their plight with constipation, the opportunity to 
discuss it further with the researcher demonstrated a change from being ‘resigned’ to 
‘optimism’ that additional help and information was available, which was in contrast to any 
discussions they had previously had with HCPs. 
 
Respondents identified the researcher as a person who could potentially help them and 
opportunistically during the interviews asked questions about management strategies for 
constipation.  Respondents keenly sought guidance and advice, especially reassurance 
relating to whether or not management strategies they had employed were acceptable and/or 
adopted by other patients, as expressed in the following examples; 
 
“Well, you are doing this research so perhaps I should ask you.  What else 
can I do?”  (Eric) 
 
“I thought I was going mad.  These things are awful but it’s nice to know I’m 
not the only one who suffers and has to do it (remove faeces digitally).  I 
thought I was the only person who had to do it.  Cos you can’t really ask 
anyone else can you?  …  What else can I do cos I don’t like having to take it 
out myself?”  (Linda) 
 
“I know you are doing this research and you must know something about it 
so is there anything I can do to get rid of it (constipation)?”  (Alice) 
 
“Have you come across any other people who have to take laxatives every 





“I know it sounds bloody awful but I just had to do it (remove faeces 
digitally).  Do other people have to do it?.”  (Frank) 
 
 
The researcher was able to answer many of respondents questions, thereafter, they generally 
became more talkative and started to assimilate the new information with their experiences, 
thus theorising on how their constipation may have been better managed.   
 
Respondents implicitly portrayed HCPs’ negativity in regards to constipation management.  
HCPs support consisted of, at best, a sympathetic ear or an alternative laxative.  It appears 
that respondents never received ongoing assessment of their constipation or laxative 
regimens, thus efficacy of the latter never appropriately established, as it cannot be assumed 
that a laxative lacks efficacy if the regimen is flawed, for example, suboptimal dose and/or 
inconsistent use. 
 
Respondents were passive recipients of poor assessment and management of their 
constipation and felt that they had no one else to talk to leaving them helpless and troubled. 
 
5.3.4 Improving management 
Some respondents made suggestions based on their own experiences and thoughts based on 
their beliefs about what may have helped them overcome problems in the past.  In particular 
was the suggestion that a clinic solely for constipation management could be developed that 
included support and advice as this was currently unavailable, for example; 
 
“That’s what needs to be done, a clinic for constipation.  It would be useful 
you know.”  (Betty) 
 
“There needs to be somewhere to go to and find out more about it 
(constipation).  Somewhere for patients like me I mean.”  (Eric) 
 
“I know this is why you are doing this research and I think it needs to be 
done.  You may not be able to help me but things need to improve.”  (Kathy) 
 
“Well, I wish someone had told me that before (following a brief explanation 
of how laxatives work) and I might not be in such a mess now.  When we’ve 
finished here (the interview) can I come and see you to talk about my 
constipation?”  (Linda) 
 
It appeared that by talking about constipation with patients and identifying their issues of 




interaction itself.  Furthermore, respondents freely made suggestions, based on their 
experiences, which ultimately contributed to the development of this research and fitting 
well with the action research methodology.   
 
5.3.5 Laxative use 
All respondents had used at least two types of laxatives (such as senna, lactulose, ispaghula 
husk, polyethylene glycol and co-danthrusate) and the majority of whom still had supplies at 
home.  For example, respondents reported having between one to four bottles of lactulose, 
loads of senna, boxes of ispagula husk or polyethylene glycol.   
 
Based on respondents verbal account of their regimens, it appears that that none of the 
respondents were taking laxatives on a daily basis nor were they on appropriate regimens as 
recommended in national recommendations and guidelines.  These apparent suboptimal 
doses were further supported by evidence on the ‘current medications’ lists carried by half of 
the respondents.  From these lists, the researcher noted that laxatives were prescribed at 
minimal doses and in some cases only entered on the ‘as required’ section of the sheet.  
Whilst further supplementary data were obtained from medical and/or nursing notes when 
available, these were often incomplete.   
 
Identifying patients’ laxative use 
Overall obtaining a laxative use history was problematic as all respondents had some 
difficulty in giving a comprehensive account of their medication use per se.  For example, 
not being able to remember a drug’s name, dose used, what the medication was being used 
for or when they had last used it.   
 
 “There is a lot of stuff I have never heard of before … they are all technical 
names, I don’t know the purpose of many of them” (Carol). 
 
“I can’t remember what the fruity flavour medicine was for.” (Linda).   
 
“But then the medication I was on after the operation… … I can’t remember 
now but mainly painkillers, … (steroids … anti-nausea … anti-diarrhoea) … 
and other tablets.  I think there was another tablet to stop constipation or 
something like that, I can’t remember what it was was.”  (Eric). 
 
“Oh, I don’t know, it was ages ago.”  (Betty) 
 
Eliciting information on drug name and their use was often aided by discussing related 




and constipation.  Furthermore descriptors were generally given about the formulation type 
as reflected in the following narratives, which were used by respondents in an attempt to 
identify laxatives they had used.   
 
“She gave me this white medicine…” (Alice). 
 
 “…a tiny chocolately sort of substance.” (Eric). 
   
“It’s in a packet, you mix it with water…”  (Linda) 
 
“It looks like a bullet.  Yellow”.  (Gillian) 
 
Respondents were unable to name these laxatives and appeared to look inquisitively at the 
researcher for assistance in identifying them.  It may be that respondents were overwhelmed 
by the variety, quantity and role of their medications (as identified in the literature review, 
Chapter 2) and that this was compounded further by lack of familiarity with the drug’s name.  
There was an apparent lack of patients’ knowledge and understanding about laxatives 
throughout the data.   
 
It was not possible to accurately identify patients’ laxative use based on their descriptions.  
For example, more than one laxative is in powder/granular form and needs to be mixed with 
water.  The description of a ‘white’ laxative was perplexing and on further exploration (two 
days and three phone calls later), it transpired that the ‘white medicine’ described by Alice 
above was in fact not white but a transparent pale yellow liquid.  Therefore, attempts to 
identify laxatives based solely on patients’ description may be unreliable and incomplete. 
 
Frequency of laxative use 
Although some patients were able to identify laxatives used in the past, it may be that 
additional ones had been used without respondents being aware that the medication was a 
laxative.  Furthermore, when asked, respondents may have unknowingly omitted to provide a 
comprehensive account of their drug/medicine use because they did not consider them 
relevant or to be part of their drug regimen, for example; 
 
 “… a tablet from the chemist, it’s not a drug, it’s to do with constipation 
actually.”  (Frank).  (It transpired that this was senna.) 
 
“Well, I didn’t get it from the doctor.  I’ve got some other stuff but it’s not 






Out of all the medications laxatives were considered least important and overwhelmingly 
respondents reported that they only took them ‘as required’ and/or because ‘they didn’t work 
anyway’.  In support of this respondents described how they had taken a laxative for a 
minimal period of time with little or no effect.  Out of desperation, more or alternative 
laxatives would be tried, again for minimal periods of time, for example 2-3 days.   
 
“Like, if I took it yesterday I should take another one this morning, but I 
think, ‘oh no, I’m going ‘here’ or ‘there’, and em, so I don’t take it, I don’t 
follow it through properly.”  (Carol) 
 
“At the moment, yeah, I went, to be truthful I tried four or five nights without 
taking the laxatives and I began to get more and more blocked and yesterday 
was so bad that I could not strain hard enough to push, it was really 
uncomfortable, I thought I was going to split my bottom it was so painful.  So 
I had to take the laxatives.”  (Betty) 
 
“I keep it (senna) in the house in case we needed it, but as I say, we are not 
people who take laxatives regularly.”  (Alice) 
 
“I didn’t take my laxative, I thought I’d try a few days without first but then I 
had to take it for a couple of days.  Maybe tonight I won’t take one because I 
want to get off of laxatives.”  (Frank) 
 
“Usually if I take Senokot or something like that just, but I mean I’m not a 
person who has to dose every week or anything like that.”  (Eric) 
 
“… by the third day then I am really beginning to panic a bit.  I think I 
should and that’s when I usually take something on the second night, milpar 
or a senokot whatever's handy, and it usually works over the third day.”  
(Linda) 
 
The cycle would continue until defecation occurred then laxative use would cease.  It 
appears that laxatives were only used to treat an episode of constipation but never used to 
prevent it, the assumption being that this management strategy was both correct; ‘take 
laxatives once you are constipated’, and appropriate; 2-3 days use of laxatives would, or at 
least should, have alleviated their constipation.  Preventative use of laxatives was not a 
concept any of the respondents had considered, in contrast, weaning oneself off was 
considered a goal for fear of dependency on them.  The side effects and dislike of some 
laxatives often deterred their use, for example; abdominal cramps, the size and quantity of 
some capsules, the taste of some liquid formulations.  
 
“I used to take that (senna) but it gave me gripe pains.”  (Linda) 
 
“Lactulose is so sweet and makes me feel sick.  I’m not taking that again.”  
(Frank) 
 





“Have you seen the size of those tables?  Sometimes I had to take four but I 
just can’t.  It takes ages to get one down.”  (Gillian) 
 
“I can’t remember the name, that stuff in the packet, it made me wretch 
actually.   I tried it for a few days but just couldn’t get on with it..”  (David) 
 
“With some of them I find I get gripe pains which sort of makes things worse 
really.”  (Carol) 
 
“… and he (the GP) already gave me this so I can’t just go back and say I 




Despite being daunted by these side effects, respondents felt that having overcome obstacles 
of obtaining laxatives all respondents expressed a reluctance to ask for alternatives because 
they had already tried various ones without success, and felt that their doctor would perceive 
them as being a nuisance. 
 
None of the respondents gave a clear record of their laxative use but could readily describe 
the formulation (liquid, tablet, or capsule), colour and give an indication of dose (based on 
number of teaspoons or quantity of tablets/capsules).  Approximate duration of laxative use 
was established along with any associated side effect of a particular laxative.  
 
Regularity of use 
The frequency of laxative use varied between respondents although they all expressed 
similar patterns, which was intermittent and infrequent use.  From the respondents’ 
perspectives, however, laxative use was often described as being ‘regular’ and subsequently 
the use of this word, in relation to laxative use, was identified by the researcher as being 
ambiguous and a cause for concern. 
 
Although most patients reported taking their laxatives ‘regularly’ this was negated by the 
additional instruction to take them ‘as required’ or ‘when you need them’.  This apparent 
contradiction is highlighted in the following extracts, which are in response to the researcher 
asking: “Do you take laxatives regularly?”  
 





“Yes, I take laxatives all the time and I don’t think I should have to so that’s 
why, as I say, I‘m trying to wean myself off that’s why I experiment …” 
(patient stops taking laxatives for days at a time).  (Betty) 
 
“Yes, I took them regularly for about four or it may have been five days but 
nothing happened so I thought what’s the point.”  (Betty) 
 
“Yes, I do.  …. Oh, well not when I’ve had my bowels open, obviously.”  
(Mathew) 
 
It appears that the definition of the word ‘regular (-ly)’ may be leading to some ambiguity 
which is not surprising given its meaning: normal, customary, in conformity with a fixed 
procedure, occurring at fixed intervals, periodic, daily, everyday, and habitual (Collins 
Dictionary 2006).  When considering the two key components ‘laxative prescribing’ (which 
includes frequency of use) and the definition of ‘regular’, it could be argued that patients 
who have been advised to take laxatives ‘as required’ are conforming with a fixed procedure, 
thus ‘regularly’.   
 
Therefore, when assessing laxative use assumptions and interpretations cannot be made 
based on patients reports of regularity of use.  In clinical practice experience has shown that 
clinicians often ask patients ‘Do you take your laxatives regularly?’ without further 
exploration or definition of what ‘regular’ means to the individual.  Based on experience, the 
researcher postulates that in most cases HCPs assume ‘regular/ly’ to mean ‘daily’.  Specific 
exploration on this point is outside the remit of this research but is alluded to in Chapter 6, 
HCPs Focus Groups. 
 
Prophylaxis 
It appears that patients only took laxatives on a daily basis for a few days to try and resolve 
an episode of constipation.  Once stools became softer and/or bowel movements commenced 
then laxative use would cease.  The cycle of stopping and starting laxatives subsequently 
ensued in often 3-4 day cycles, sometimes longer, until satisfactory defecation occurred, at 
which point, laxative use would stop completely until the respondent felt constipated again.   
 
So whilst patients reported taking their laxatives ‘daily’ it appears, in fact, that none of the 
patients took their laxatives every single day without omission, nor with the concept of 
preventing constipation.  Essentially, prophylactic use of laxatives was not a concept known 
to patients pre-interview.  However, as each interview evolved it appeared that implicit 
information had been processed by respondents who suddenly became aware that if they had 




occurred or may have been less severe.  As respondents had reported that they had taken 
their laxatives ‘when they needed them’ with varying success, the researcher posed the 
question either (as appropriate):  “Did you ever consider taking laxatives every day?” or 
alternatively “What do you think would have happened if you had taken laxatives every 
day?” respondents replied; 
 
“Well, maybe I wouldn’t be so constipated.”  (Eric) 
 
“I haven’t thought about it before now.  But thinking about it – it is obvious 
really.  I feel such a fool, why didn’t I work that out?”  (Linda). 
 
“Em, well, yes I suppose so.  It does make sense…”  (Gillian) 
 
“Well if it’s OK to do that then I will.  I’ve been trying to wean myself off 
you see.  Nobody told me to do that before, do you think I should then?”  
(Betty) 
 
The responses to the researcher’s latter question suggest that respondents react positively to 
the idea that they need to take laxatives ‘every day’ and that if they had done so then perhaps 
their constipation would not have become so severe.  From the patients’ perspective, not 
having thought about the need to take laxatives ‘every day’ is an interesting thought because 
although most respondents report taking them every day it is evident from the narrative that 
respondents did not.  On some occasions the latter became clear when respondents appended 
their narrative with “...  obviously only when I need to...” or “When I’m constipated”   
 
In all cases respondents reported taking their laxatives ‘every day’ but implicit within these 
narratives was their assumption that the researcher knew this was not the case, thus it was 
still not clear under which circumstances they would be taken.  To overcome this ambiguity, 
the researcher was more precise during the discussion by asking “Do you take your laxatives 
every day whether you think you need them or not?” or “In the last two weeks have you 
taken a laxative every day without omission, that is at least on 14 consecutive days?”  The 
response to both these questions was “No” despite all respondents stating that they took 
laxatives regularly. 
 
Patients who become constipated due to insufficient laxative use are viewed by HCPs as 
non-compliant.  Therefore, although HCPs are aware of the disparity between compliance 
and concordance it may be that with sufficient information, advice and encouragement 
patients would become more diligent with their laxative regimens because they understand 





As established in the literature review, laxatives need to be taken daily and at therapeutic 
doses in order to optimise efficacy, however, neither of these principles applied to the 
interviewees.  It may be that patients expect laxatives to work within a short time period and 
resolve their constipation in the same way that taking, for example, a dose or two of 
paracetamol usually resolves a headache.  It may also be that verbal instructions and the 
‘directions for use’, (as written on laxative packaging), are too broad and vague to meet the 
needs of patients with cancer, especially those with disease related exacerbating factors as 
previously discussed. 
 
Respondents reported having supplies of unused laxatives, which they had stopped using for 
a variety of reasons including dislike of taste and/lack of efficacy, that are known to be 
efficacious if use prophylactically and at optimal doses (Miles et al 2007).  When laxatives 
were being taken they were used intermittently and at minimal doses.  Side effects and 
dislike of formulation/taste often resulted in their disuse.  In most cases respondents were 
unable to give a comprehensive account of their laxative use, partly due to problems of 
naming drugs per se.  However, on further discussion with respondents it appears they are 
open to suggestion that laxatives do work if taken consistently, without omission and 
prophylactically. 
 
5.3.6 Patients’ knowledge 
Respondents were generally unaware of the cause of their constipation, often making 
reasonable assumptions and affording some suggestion, including, a poor diet, reduced 
mobility, drugs, cancer, ageing process and genetics.  However, this array of responses was 
an accumulation from all 11 respondents and in five cases respondents did not know what 
may have contributed to their constipation, whilst others proffered more than one cause.  
Only three respondents clearly linked opioid use to their constipation. 
 
In relation to causes of their constipation were the assumptions by respondents that they in 
some way may have been able to alleviate their constipation by increasing their diet as 
expressed in the following examples: 
 
“I don’t think I eat enough.  I just can’t eat like I used to.  It would be nice if 
I could you know, go out and have a nice big meal.”  (David) 
 
“Em, I don’t know really.  If I could go and eat a nice big curry, cos I like 
them, then I’m sure it will get me going.  I don’t do that (eat big meals) these 





“I eat lots of nuts and fruit.  I just don’t understand why …. why I am so 
constipated.”  (Betty) 
 
“What you eat is important.  If you eat rubbish then your bowels won’t work.  
What I don’t understand is I only eat good food, good quality food, I don’t 
eat rubbish, but I still have so much constipation.”   (Eric) 
 
“ I should drink more.  It’s not easy though when you don’t feel like it.  I do 
try.”  (Carol) 
 
“I eat OK but not as much as I used to”.  (Alice)  
 
 
Reduced mobility was identified by most respondents as contributing to their constipation, 
but this was more in the form of a transition over many years as opposed to an acute change.  
For example, in the three following narratives respondents are aged 64, 68 and 79 
respectively, all have advanced cancer and have reduced mobility.  
 
 “As you know I was a cricketer and very active but now, well, lucky if I get 
a round of golf in occasionally.”  (David) 
 
“I just don’t know.  I shouldn’t be constipated.  I used to be a gymnast and I 
was always busy and on the go, I did a lot of sport.  I eat lots of nuts and 
fruit.  I just don’t understand why, when I’m, as I say, I get a lot of exercise, 
why I am so constipated.”  (Betty) 
 
“Well you know, I can’t get around much these days.  I sit in the chair most 
of the time, I can’t walk about much.  So, I suppose that doesn’t help.”  
(Linda) 
 
At the time of these interviews, David had last played golf three months earlier and it was 
unlikely that Betty “got a lot of exercise” as described as she became breathless with 
minimal exertion.  Linda was virtually bed/chair bound and had been for two years.  Thus 
whilst reduced mobility may have exacerbated their constipation it is unlikely to have been 
the sole cause, nor was there much likelihood that their mobility would improve as this 
generally deteriorates as patients become less well.  The challenge is possibly in 
acknowledging respondents frustrations, answering their questions and identifying 
alternative constipation management strategies. 
 
Some respondents appeared to have come to their own conclusions as to what had caused or 
exacerbated their constipation but this had rarely been confirmed, nor discussed, with them 
by a HCP, thus leaving respondents unsure and seeking confirmation, for example: 
 





“Someone said once that the morphine can make you constipated but I don’t 
know.  Does it?”  (Linda) 
 
“All these tablets.”  (Carol) 
 
“Drugs, they make it worse.”  (Kathy) 
  
“Having these painkillers … I’m almost convinced of it.”  (Gillian) 
 
“My mother used to suffer with it so maybe it’s genetic.  Is it?”  (Betty) 
 
 “I don’t know what causes constipation.  What causes cancer?  What 
causes anything?  Who knows, nobody knows do they that’s why you’re 
doing this research.”  (Frank) 
 
Only one patient attributed some element of blame to the HCPs when he complained that, 
whilst an inpatient, the doctors should have been more diligent – not only in preventing his 
constipation but in at least listening to his concerns and responding appropriately rather than 
what appears to be in a dismissive way;  
 
“And also they (the hospital doctors) did not compensate for my morphine.  I 
kept telling them but they didn’t listen to me and I know that (morphine) 
caused it too.  My other medications too, some of them say they can give you 
constipation.  I read the leaflet in the packet.”  (Eric). 
 
Apart from Eric none of the remaining respondents attributed any degree of responsibility 
towards HCPs other than to comment on their attitudes and failure to provide information as 
previously identified.   
 
Some respondents simply did not know why they had become constipated despite having 
several contributory risk factors.  Respondents were perplexed when maintaining a healthy 
diet and fluids failed to alleviate their constipation.  Drugs, especially analgesia, were 
identified as the main culprit in causing or exacerbating constipation and the simple solution 
was to stop taking opioids.  As a result, pain increased, immobility worsened, and quality of 
life deteriorated.   
 
5.3.7 Severe constipation 
Emotionally, patients expressed feelings of sadness, crying, misery, isolation, irritation, and 
anger.  Not feeling oneself and conscious of being constipated all the time was highlighted 
by several patients who were trying to live a normal life, but found being constipated 




not wanting to go out and withdrawing from others because their constipation had become so 
bad.  One patient, Betty, described an experience when she was alone and very frightened 
because she was having to strain so much and for so long in order to try and pass a large hard 
stool that she thought she was going to induce a heart attack. 
 
“… I was sweating, struggling and straining and I thought I was going to 
have a heart attack, I got all flashing lights in front of my eyes.  I was 
frightened because there was no one there, I thought if I fall off the toilet or 
something goes wrong it was just so uncomfortable.”  (Betty) 
 
“Mainly it’s the embarrassment of it, I’ve said that a few times haven’t I.  
It’s the embarrassment of constipation, the discomfort you get with it I know 
sometimes I am quite uncomfortable with it and I know that a good clear out 
will relieve the discomfort.  I just wish there was something I could do, I 
really am quite desperate.”  (Gillian) 
 
“Enduring the pain is better than being constipated but sometimes the pain 
is so bad.  Maybe I just have to put up with it but I do sometimes think they 
wouldn’t let an animal suffer like this, they would put it down.  Maybe that’s 
what should happen to me.”  (Carol) 
 
“… my family were coming over and I had all this stuff dripping out of me, it 
was on the carpet and kept running down my leg.  It was so embarrassing.  I 
had to tell my family because, well, I couldn’t hide it really …”  (Alice)  
 
All respondents recounted how constipation affected them in terms of the physical sensation 
to defecate without actually being able to pass a motion.  This resulted in several failed 
attempts and longer than normal durations sitting on the toilet often with little or no stools 
passed.  Physically, patients endured pain during this process and the inability to push hard 
enough with their rectal muscles, extreme discomfort during defecation, expectations of 
having split their rectum and/or passing blood because their stools had become so hard, large 
and painful to pass.   
 
Repeat episodes of these experiences had engendered negative feelings and a fearful 
anticipation and worry that things were not going to improve and that they would, at some 
point, reoccur.  Patients also expressed a desperation and desire to be rid of the psychological 
and emotional affects of constipation, especially stress, anxiety and the embarrassment of 
faecal incontinence, so that they could maintain some normality and quality of life.  All 
respondents had experienced desperation with their constipation and for many this still 






The following section highlights some of the common misconceptions respondents 
exposed during their interview.  Respondents did not seek confirmation from the 
researcher about these issues but implicitly assumed their thoughts were sound, 
possibly because they were unable to assimilate an alternative point of view.  These 
misconceptions appear never to have been challenged by HCPs possibly because 
respondents had not previously been afforded the opportunity to express them.  
 
False hope 
Descriptors used by respondents when discussing their constipation and associated 
symptoms were reflected in the literature review, however, knowledge of how the 
gastrointestinal system functions was lacking.  For example, having a bowel motion 
(regardless of stool form or size) was always presented as being distressing but, in contrast, 
also used as a measure to support the assumption that their constipation had started to 
alleviate. 
 
“Ah, it’s good when you do go, you feel much better for it and hope it 
doesn’t come back.”  (Alice) 
 
“Well I opened my bowels just two days ago, and em, it was sort of a bit too 
firm but lots of it.  So I can’t be constipated at the moment”  (Linda) 
   
“I’ve had so much of this stuff (diarrhoea) coming out of me and I think 
there can’t be anymore but it keeps coming.  One minute I’m constipated 
and the next this (diarrhoea).  Quite the opposite really.”  (Frank) 
 
“I told my doctor I had diarrhoea and he gave me some Imodium (an anti-
diarrhoea drug) so that will be sorted then.”  (Alice) 
 
Sort of like constipation and diarrhoea at the same time if that is possible?”  
“I don’t know where it keeps coming from.  I haven’t eaten that much.”  
(Eric) 
 
“Being constipated is nice, at least you can go out and not worry about 
having to find a toilet like when you have that overflow diarrhoea.”  (Linda) 
 
“I think something gets stuck in the valve here (indicating right abdomen 
area), if the valves don’t work then it can’t get through.”  (Mathew) 
 
Respondents had assumed that if they were not eating sufficiently they were less likely to 




with being constipated assuming that, eventually, enough faeces would be generated to 
produce a stool.  
 
There were no narratives to suggest that the management strategies for these respondents had 
been improved in any way, nonetheless, the belief existed that their constipation was 
improving.  This false sense of hope, albeit temporary, may in itself be exacerbating 
constipation itself as the urgency to resolve an episode of constipation had subsided.   
 
Pain endurance as a compromise 
Pain endurance in preference to constipation was seen as a compromise that sometimes had 
to be made.  This ultimately resulted in patients unnecessarily suffering with pain but also 
may have done very little to ease their constipation, however, none of the patients were 
aware of this as expressed in the following: 
  
“It’s a balance one has to make.  Take the morphine or be in pain.  I think I 
would sooner be in pain than be constipated.”  (Eric) 
 
“Well, that’s why I kept doing this experiment, to see if when I didn’t take 
the painkillers, would my constipation go (rhetorically speaking), because 
they told me it (the analgesia) would make me constipated”. (Betty). 
 
“When I haven’t been for four days then I stop the painkillers for a while.  
Then I think oh now my leg hurts and I take it (painkillers) again, and well, I 
think what should I do for the best.  I still haven’t been (had bowels open).”  
(Linda). 
 
Implicit within these extracts is the belief that something constructive and positive has taken 
place that, to varying extents, is indicative of constipation relief.  In contrast however, it is 
more likely such actions will exacerbate constipation and result in further symptoms and 
additional unnecessary suffering.  For example, anti-diarrhoeal drugs will exacerbate 
constipation and the patients’ assumptions that diarrhoea was only ever the opposite of 
constipation may result in the latter being neglected and thus becoming severe, the impact of 
which has been established in Chapter 2. 
 
Liquid morphine is less constipating 
The misconception that liquid morphine is less constipating than the tablet formulation 
resulted in one respondent taking much higher doses than may have been necessary, and still 





“Well I take the liquid morphine now so I know that’s OK … (on further 
exploration) but I thought because it was liquid then it wouldn’t make me 
constipated.”  (Eric) 
 
Similarly, the use of anti-diarrhoea drugs were seen as a way of stopping overflow/diarrhoea 
but without any thought as to the consequences of their actions, which is exacerbation of 
constipation.  
 
Assumptions about patients’ knowledge on bowel function 
Whilst the following extract may be regarded as uncommon, it does highlight the importance 
of not making assumption about patients’ knowledge.  One 56 year old gentleman reported 
that only two years ago he learnt that having ones bowels opened did not mean passing urine, 
the latter which he referred as having a ‘whiz’. 
 
“The nurse asked me if I’d opened my bowels and I replied to the nurse 
....“Yes, no problem, I’ve been.”  And it wasn’t until the gentleman in the 
bed next door to me turned round and said “They don’t mean going a whiz3” 
and I said “Well I thought that what’s what opening your bowels meant 
wasn’t it?”  He said “No, the other one, you know as is passing the waste 
matter.  You know, being blunt having a, having a s*** 4.”   Oh, oh, so when 
the nurse came back I called the nurse over and I said “Ah there’s a slight 
misunderstanding.” em, and when I explained to her then she said how long 
have you been in bed since you haven’t been to the toilet and I said “seven 
days”, which it was, I hadn’t actually gone to the toilet.  She said “I suggest 
you go”.  Anyway, they gave me some … (laxatives).”  (Frank) 
 
The above example raises the awareness of the importance of not making assumptions when 
assessing patients’ bowel function with them, as this often leads to confusion and 
misunderstanding.  In the event that the HCP conducted a proper bowel assessment, 
including stool form and frequency, both he/she and the patient would have realised they 
were discussing different things.   
 
Loose stools caused confusion  
The onset of loose stools was thought by some respondents to be partial alleviation of their 
constipation and a hope that things were resolving.  However, when the sensations of 
constipation remained, for example feeling bloated and/or a full rectum, respondents became 
perplexed.   
                                                 
3 This respondent used the word ‘whiz’ to report ‘passing urine’ 





Respondents described being confused by the fact that they had experienced diarrhoea at 
some point during an episode of constipation.  Feeling bloated and having the sensation of a 
full rectum were presented as being still very evident even though they were passing loose 
watery stools.  Eric’s account typifies that of other respondents’ experiences, for example; 
 
“I might not go (have bowels open) for two days and when I did go it would 
be solid then loose at the same time. And the end yeah, it was just sort of 
like, it would be solid and then it would come out watery, followed up by 
watery.    You could say a bit of constipation and diarrhoea at the same time 
if that’s possible?” (David) 
 
None of the respondents had heard of ‘overflow diarrhoea’ and expressed surprise when the 
researcher explained that it is not an uncommon side effect of constipation.  Furthermore, all 
reported that they had experienced overflow diarrhoea and were confused as, in their 
understanding diarrhoea was the opposite of constipation and could not occur 
simultaneously.  Respondents expressed relief that what they had experienced was not 
altogether uncommon and appeared optimistic that the researcher may be able to help them 
overcome this problem, which is some respects was worse than being constipated itself and 
possibly more embarrassing as it was harder to conceal from other people.   
 
Digital removal of faeces was necessary 
In contrast, some respondents reported being extremely embarrassed by another technique 
they found necessary to perform, which was to digitally remove hard faeces from their 
rectum.  For those who discussed removing their faeces digitally they did so in order to 
express to the researcher just how desperate they had become to alleviate their constipation.  
In all cases respondents deemed the practice necessary and some reported feeling ashamed 
and embarrassed, however, the latter was somewhat abated when the researcher conveyed 
that she was aware of their dilemma and acknowledged that the practice was not uncommon 
under such circumstances.  Performing digital removal of faeces always appeared to be 
conducted out of sheer desperation when stools had become so hard and stuck in the anal 
canal.  It is possible that as this research progressed the cessation of having to remove faeces 
digitally may be regarded as an outcome measure. 
 
When is constipation alleviated 
For the purpose of simplicity and to avoid ambiguity the researcher has themed reports of 




gives little or no relief.  ‘Complete’ refers to defecation which, when reported by patients 
implies that their rectal contents have been dispelled and that they ‘feel better’ as a result.  It 
cannot be assumed by the researcher that the rectum has been emptied or that the 
constipation has subsided.  In contrast however, it appears that patients believe this to be the 
case.  Relief following defecation was expressed as pleasurable and how, overall, the patient 
subsequently felt, for example; 
 
“…it’s good when I do go, it’s nice, you know, you feel better for it 
obviously.”  (Alice) 
 
“When I do go I feel a lot better for it.”  (Frank)  
 
“It is just such a relief .”  (Betty) 
 
“I start to look forward to things again, especially having my family around 
and knowing I’m not going to be preoccupied with going to the toilet …”  
(Carol) 
 
One of the main outcomes for those who were able to open their bowels and pass what they 
considered a ‘good amount’ was a sense of being relieved.  This relief also engendered a 
hope that their constipation would not occur again.  Respondents made the assumption that 
by passing a ‘good motion’ their constipation had resolved, thus not attempting to alleviate it 
further or prevent any subsequent onset.  Given respondents assumption that constipation 
had been relieved they made, what they felt was, a logical decision to stop taking their 
laxatives on the basis that these were longer needed.  Given respondents lack of 
understanding about the causes, consequences and nature of constipation it is understandable 
why they assume that laxatives were no longer required, which was also a practice that 
aligned itself with a previously identified desire, which is to wean off laxatives (Chapter 2) 
and not be dependent on their use.  
 
Weaning off laxatives 
Fear of dependence and the weaning off laxatives was considered by respondents to be a 
good reason not to take them.  However, none of the respondents were able to expand further 
on their concerns relating to dependence other than an assumption than ‘one should not need 
to be reliant on them’.  The assumptions made were that faeces would eventually be passed 
for example; 
 





“I’ll just have to put up with it (the constipation) then until I manage to go 
(to the toilet).”  (Mathew) 
 
Maybe I’ll try some prune juice.  That may help push it through.  There’s 
only one way out isn’t there (laughing).”  (Alice) 
 
The interview data was void of any implicit or explicit references to the potential impact and 
acute complications, including death, which can result from constipation (as previously 
discussed: faecal impaction, bowel perforation, and complete intestinal obstruction).  It 
appears that patients also fail to recognise the importance and significance of therapeutic 
constipation management.   
 
Respondents’ misconceptions impaired any potential management of constipation not least 
of all because overwhelmingly they had accepted that nothing further could be done.  When 
motions were passed, regardless of stool form and concerted efforts to expedite the process, 
respondents believed that their constipation had resolved or abated.  Similar, loose stools 
signified constipation abatement.  Management strategies deemed necessary by respondents 
included omitting opioids (thus enduring pain), removing faeces digitally and weaning off of 
laxatives.  Overall, respondents had a poor knowledge about constipation and its 
management exacerbated further by their misconceptions. 
 
5.3.9 Support mechanisms 
Support afforded to respondents varied from family/friend, GP, Macmillan, district nurse, 
hospital clinical nurse specialist, oncologist and/or the palliative care team.  Input from these 
varied and although in some cases an HCP had been assigned respondents reported that they 
had either not met the individual or that their contact was minimal.  
 
Respondents described how HCPs would only temporarily deal with their constipation and 
‘try something different’ before suggesting that they (the respondent as patient) speak with 
someone else if things do not improve.  For example, hospital doctors said the nurses would 
deal with constipation whereas GPs said the district nurse could provide help.  According to 
respondents the problem with the district nurses is that the practitioner would vary on each 
visit and they rarely agreed on management strategies.  Furthermore, district nurses were 
perceived as always being too busy and not really interested in discussing problems with 
constipation other than offering to administer suppositories to promote defecation.  Whilst all 
respondents had resorted to using suppositories at some point they all commented that they 




most cases, the district nurse was much younger than the respondent and in some cases the 
opposite sex.  Both these factors further contributed to respondent embarrassment. 
 
“The district nurse told me to take this medicine (a laxative) and said to try 
it which I did but nothing happened.  When they came the next time, em, I 
think that was about a week later, it was a different nurse and she said “Oh, 
I’ll ask the doctor to give you something else” but nobody mentioned it 
again.  The nurse did say that I need to keep an eye on it (constipation) but 
em, well, I never heard anymore.”  (Gillian). 
 
“A young man came and said I needed suppositories but I wouldn’t let him 
do it.  Maybe I should have but, well, I was a bit frightened to tell you the 
truth.  I’d never met him before and, well, I’m 87.  I just said “what’s the 
point of doing that?” and he muttered something I didn’t quite understand, 
but I didn’t want him to do it anyway.”  (Alice) 
 
“Yes, I would have told my doctor but when I went back there was someone 
else and she said “Oh, well, just try this and she gave me a piece of paper 
and said “take some of this…” (Patient was given a prescription for 
lactulose) which I had already tried and didn’t work before so I didn’t 
bother.  I can’t go back again.”  (Carol) 
 
“The district nurse is very helpful you know, she does try but I don’t always 
see her, sometimes someone else comes and I don’t think they know what to 
do.  The Macmillan nurse sometimes comes but she just said that the district 
nurses will sort it”.  (Linda) 
 
“I kept telling the doctors and he said “Oh, don’t worry about that, the 
nurses will sort it”  (Kathy) 
 
“I told the district nurse and she said “well, what do you expect me to do, 
you need to tell your GP”.  So I called him ..... he said he would visit the 
next day but he didn’t turn up and someone else from the surgery phoned 
that night and I told the whole story again.  She said she would come the 
next day and guess what...  nobody turned up.  Well, I ask you, what else can 
I do.”  (Mathew) 
 
“I have mentioned it, to a few people actually.  I have told my GP, and, em, 
all these people come and go (to patient’s home) and I don’t know who half 
of them are or what they come for.  It’s confusing.  In hospital I had things 
put in my, you know, bottom (suppositories) and, em, yes that’s it, the doctor 
said he didn’t know why they had done that.  My Macmillan nurse said she 
can’t do them (suppositories).”  (Eric) 
 
Respondents implied that on occasions suppositories were administered in the absence of a 
clear explanation of what was being administered or why.  One respondent recalls his 
experience with the medical team during an inpatient episode; 
 
“… every time I said to them about constipation “Oh, don’t worry we will 
take care of that” and they used to inject something behind, kind of cream 




getting your bowels cleaned out.  I was thinking this should not be 
happening because at one stage I was on nearly 100mg of morphine per day, 
you see, but they did not compensate for that, my constipation.”   (David) 
 
All respondents reported that they disliked having suppositories and had felt that the decision 
to administer them had been done in the patients’ absence of clear understanding of why they 
were necessary and/or what the procedure involved.  Furthermore, suppositories failed to 
alleviate their constipation and provided no more than short term relief in some cases.   
 
It is possible that patients are sometimes reticent when discussing constipation management 
with other HCPs and this may result in patients not wholly articulating their knowledge 
about constipation, its management, and their strategies because they had tried to on many 
occasions in the past and had ultimately become ‘fed-up’ with asking.   When asked by the 
researcher if they had ever specifically initiated a consultation with an HCP about 
constipation all respondents implied that this would have been a waste of time based on their 
previous interactions.  In contrast however, patients appeared to allude to their problems with 
constipation in the hope that HCPs would pick-up the cues and show interest and provide 
appropriate support. 
 
“I did mention it (to GP) but he didn’t say anything.  I suppose it’s not really 
that important is it?”  (Alice) 
 
“You get fed up with asking really, telling them and just nothing happens, 
maybe they just think I’m making a fuss but it really does bother me and I 
don’t know what to do.  It is nice though, talking to you (the researcher), at 
least you are interested…”  (Eric) 
 
“Believe me I have tried.  Waste of time.”  (Betty) 
 
It appears that very few patients persevere with seeking advice and support from their HCPs 
as, in the past, this has proved ineffective and generated at best a sympatric ear.  
Respondents felt that HCPs do not take constipation seriously and are ambivalent towards its 
management, GPs reportedly just gave out more prescriptions for alternative laxatives, 
doctors generally put the onus on nurses to ‘deal with things’, and the circle of blaming 
someone else often ensued. 
 
5.4 Discussion 
This patient interview stage of the research worked well and the methods used were helpful 
in eliciting in-depth meaningful data.  The collaborative MDT approach enabled a working 




valuable contributions and support such as making referrals, data analysis, identification and 
prioritising of themes and planning the next stage of the research.  Clinical participants 
(doctors and nurses) reflected upon their own practice and reported modifying these based on 
the findings of this Chapter.   
 
The sample identified met the inclusion criteria and all respondents made valuable 
contributions to this study as several major themes emerged that reflected their beliefs, 
attitudes and perceptions about their constipation and its management, thus meeting the 
overall aim of the patient interviews.  Respondents considered that they had benefitted from 
the interviews because someone was at last interested in their plight, believed them and 
provided support and advice, albeit minimal and informal.  There was no evidence that 
interview location, duration and/or content caused any distress to respondents. 
 
Although constipation is highlighted in the literature review as a very personal subject that 
patients may be reluctant to discuss in-depth, it appears that an environment based on 
patient-clinician discussion can be created that is conducive to supporting patients’ needs 
and wishes.  All respondents reported that they had found the interview itself a positive 
experience and, when asked, none wanted to withdraw any of their comments.  Allowing 
time and encouraging patients to speak openly afforded respondents the opportunity to 
discuss their constipation thoroughly for the first time.  Eight respondents voluntarily 
reported that they found the interview itself therapeutic and attributed this to the time and 
support afforded, and the researcher’s interest in their difficulties with constipation.  Until 
the interviews, respondents believed that no further help could be afforded to them to 
alleviate their constipation.  HCPs were reactive and respondents passive.   
 
It appears from the main themes identified that it may be possible to improve the 
management of constipation in patients with cancer by redressing some of the issues 
presented.  For example, respondents felt that HCPs were too busy, disinterested and/or 
unresponsive, therefore leaving patients feeling that their constipation was unimportant and 
not worth pursuing.  A reticence to challenge such attitudes appears to stem from 
respondents’ assumption that HCPs were more knowledgeable than they were and that 
clinicians had tried all possible management strategies.   
 
Explicit within the data is that HCPs’ negatively influence constipation management.  
Respondents had many unanswered questions, made ill-informed decisions and made 




not work.  Laxatives remained in respondents’ home for use as last resort, their use always 
intermittent and avoided if possible.   
 
Through the interview process respondents became optimistic that help could be afforded 
and took the opportunity to ask questions, seek clarification on their management strategies 
and make suggestions about how improvements could be made.  Towards the latter part of 
each interview respondents were able to identify contributory factors to their own 
constipation and by reflecting identify how, if managed differently, their constipation could 
have been alleviated/prevented.  By exploring these issues with respondents further emergent 
ideas evolved on how constipation may be better managed in the future.  These included 
affording time and having in-depth discussions with patients, providing appropriate advice, 
education and support, especially in the form of continuity of care and follow-up, a 
component clearly absent for all respondents. 
 
Although all respondents had used laxatives and/or had supplies at home, there were 
consistent difficulties in naming these.  It may be possible to elicit a more comprehensive 
account of laxative use by utilising sample laxatives, a theory presented to the MDT 
examined as a method in Chapter 7.  There was no evidence in respondents’ narratives that 
proactive laxative strategies (as discussed in Chapter 2) had ever been explored with them by 
any of their HCPs. Doses of laxatives were suboptimal in all cases, partly because their use 
was intermittent.  None of the respondents used laxatives prophylactically because they were 
unaware of the need to do so.   
 
Patient knowledge and education is an important consideration if constipation management 
strategies are to improve as without this component respondents make their own ill-informed 
assumptions and resultant misconceptions as highlighted throughout this Chapter.   
 
It is unlikely that dietary methods and/or increasing mobility will alleviate constipation to a 
significant degree especially when drug induced and/or in those with advanced disease, 
therefore laxatives need to be used consistently, in optimal doses and prophylactically 
depending on stool form and ease of defecation.  When adopting this regimen it may be 
possible to prevent the onset of severe constipation and the resultant stresses and burdens 
respondents reported enduring.   
 
Fear of repeated episodes of constipation prevailed and unnecessary suffering ensued due to 
inappropriate strategies such as omitting opioids.  Respondents’ misconceptions engendered 




constipation.  Overall, respondents had a poor knowledge about constipation and its 
management and respondents were reluctant to persevere with seeking advice from their 
HCPs due to the inconsistent and fragmented care and attention given to this distressing 
symptom.   
 
The process of improving the management of constipation in patients with cancer is likely to 
be a lengthy process as there are many contributory factors, as highlighted throughout this 
Chapter, many of which it may be possible to redress using a more concordant and consistent 
approach encompassing continuity of care and follow-up.  It may be that by being better 
informed and supported patients’ constipation can be alleviated and/or prevented.   
 
Before the interview respondents appeared to have given up seeking support and were 
enduring constipation in the belief that it was an inevitable consequence of their cancer.  As 
a result of their interview however, respondents were afforded some advice and support but 
in most cases their disease was advanced and life limiting and it was not possible to assess 
the impact of the information given.   
 
5.5 Summary 
As an initial stage in identifying some of the contributory factors to constipation in this client 
group the interviews proved very useful and informed the latter two stages of this research.  
Respondents’ data implicitly and explicitly identify many factors that clearly contributed to 
their constipation.  It may be possible to redress some of these issues using a more patient-
focused and individualised plan of care, encompassing patient education and continuity of 
care.  In order to advance this research the collaborative HCP approach was maintained and 
partnership broadened to include the community teams as respondents identified them as 
negatively influencing constipation.  To this end, the second stage of this research was 
initiated. 
 
5.5.1 The next step: Rationale for HCP focus groups 
It was evident within the data that patients’ perceive HCPs as being negative, (encompassing 
disinterest, ambivalence and failing in their duty of care).  It was decided by the MDT that 
the data should be confirmed and validated by HCPs from both the local primary care 
settings and a wider representation from the Unit.  To achieve this and within the action 
research methodology adopted for this research it was proposed by the MDT that HCP focus 




opportunity to draw the attention of HCPs to some of the issues raised by patients may act as 
a catalyst for improving constipation management, or at least, provide a medium for airing 
contrasting views.  Within this research context, HCPs were given the opportunity to hear 
and comment on the aforementioned patient issues of concern and alleged suboptimal 
practices.  These, together with overall focus groups findings are presented in Chapter 6 
whereby the proposal for a nurse-led clinic specialising in constipation management for 







Focus groups: methods, process and findings 
 
6.1 Introduction 
This Chapter presents the methods and findings from the focus groups that were conducted 
as a result of the interviews.  The key overarching issues of methods such as sampling, audio 
taping, issues of rigour and the process of data collection and analysis are outlined in 
Chapter 4.  The use of focus groups as an additional method used during this stage of the 
research is debated in this Chapter along with its effectivenss, and the actual steps taken are 
described to maintain an audit trail throughout the study.  Having gathered the views of 
patients it was decided by the MDT that the perceptions of HCPs should be captured to 
provide a more inclusive representation of the management of constipation.  The interviews 
had revealed that the patients generally were receiving suboptimal laxative regimens and 
clearly indicated that they considered that the poor communication and/or attitudes of HCPs 
exacerbated management of their constipation.   
 
The use of focus groups greatly enhanced the rigour of the research by introducing an 
element of member checking (Polit and Beck 2008) and presented a forum for the 
dissemination of findings from stage one.  It was anticipated that the focus group data would 
support the interview findings, thus validating the patients’ perceptions or alternatively 
highlight contrasting points of view that may need to be taken into consideration when 
planning the next stage of the research.  Mindful of these requirements the focus groups were 
planned to comprise two elements.  Firstly discussions to determine HCPs’ management 
strategies and to identify their beliefs regarding the contributing factors to constipation in 
patients with cancer and secondly, to provide an opportunity for HCPs to respond to the 
thematic findings from the patient interviews and ascertain the areas of agreement and 
disparity between the two groups.  Overall, by conducting focus groups an element of 
dissemination would be introduced and provide an opportunity to introduce new participants 
to the study, (for example community GPs, Macmillan and district nurses), and work more 
collaboratively with them in reducing constipation in patients with cancer.  Working more 
collaboratively with community HCPs was essential preventing problems of gate-keeping 
which leads to denied access to study participants (Green and Thorogood 2004; Polit and 





6.2 Rationale for focus groups 
Focus groups are an important data collection method frequently used in qualitative research 
(Polit and Beck 2008).  A major advantage of a group format is that it is efficient (Parahoo 
2006).  According to Côté-Arsenault and Morrison-Breedy (2005) the purpose of the focus 
group is to explore and understand the context in which perceptions, beliefs and attitudes 
develop.  To achieve this, focus groups should be small enough for everyone to participate, 
but large enough to elicit a range of responses (Clark 1999; Morrison-Breedy et al 2001; 
Polit and Beck 2008; Krueger 1988).  Focus groups also capitalise on the interaction within a 
group to extract rich experiential data (Asbury 1995) and facilitate the exploration of 
attitudes and perceptions relating to concepts or services that are developed in part by 
interaction with others (Krueger 1993).  Developing the emphasis on interaction, Kitzinger 
(1995) states that group processes can assist people to explore and clarify their views in ways 
that would be less easily accessible in a one to one interview.  Kitzinger (1995) adds that 
when group dynamics work well the participants work alongside the researcher, taking the 
research in new and often unexplored directions.  Polit and Beck (2008) maintain that the 
interviewer (or moderator) plays a critical role in the success of focus group interviews.  It is 
their role to facilitate a dynamic, controlled process that yields meaningful data.  
 
In contrast to the researcher’s informal discussion with HCPs, (which occurred prior to and 
concurrently throughout this research), the focus group discussions facilitated peer 
reviewing, thus affording credibility of the findings and an opportunity to expose any 
diversity of practice between sub-groups.  Participants were encouraged to speak to one 
another, ask questions, exchange anecdotes, and comment on each others’ experiences and 
point of view (Kitzinger 1994) and to encourage a sense of ‘group’ participation when 
exploring and questioning their own practices.  Due to the contentious issues raised so far the 
researcher carefully managed the focus groups to ensure that all the emerging issues were 
explored.  These included inappropriate laxative prescribing, inadequate patient education, 
ambivalence and joviality. 
 
An advantage of focus groups is that they allow the collection of data from several people 
throughout the duration of the meeting, provided each participant has the opportunity to 
speak (Bader and Rossi 2002; Polit and Beck 2008).  A disadvantage of focus groups is that 
dominant participants may over-speak (Kreuger and Casey 2000) and/or disregard other 
group members and it is possible that interruptions will occur resulting in more than one 




dominance and interruptions occurred the researcher struggled to decipher exactly what was 
being said and by whom.  To overcome this, the researcher adopted a strategy of 
acknowledging and expressing her appreciation for the contribution, followed by a 
reaffirmation of the essence of what was being expressed by the speaker, thus clarifying 
detail that might otherwise be lost (Bader and Rossi 2002).  Thereafter, the question or 
statement was purposefully redirected to the remaining participants to gain their opinions.  
This approach proved to be successful throughout the focus group meetings when supremacy 
issues emerged, which was most commonly instigated by senior GPs, who posed a threat of 
overwhelming other participants.   
 
6.3 The sample 
Four focus groups were conducted over a six month period.  A convenience sample was used 
for the focus groups (as in stage one).  Twenty six HCPs from the community teams and the 
palliative care unit participated.  Health care professionals were represented by GPs (4), GP 
Registrars (4), Specialist Palliative Registrars (3), Consultants (2), GP practice nurses (1), 
Macmillan nurses (4), district nurses (5), and ward nurses (3).  A brief overview of the study 
was presented during the introduction to each of the focus group meetings along with 
assurance of the respondents’ confidentiality and anonymity.  The focus group meetings 
were audio taped and lasted no more than an hour.  Polit and Beck (2008) suggest that the 
optimum group size for a focus group is 6-12 people however, Côté-Arsenault and Morrison-
Breedy (2005) and Bader and Rossi (2002) consider that group of five can also be effective.  
In this study the largest focus group comprised of nine participants (GPs, GP Registrars and 
a GP practice nurses) and the smallest group contained five (district nurses and ward nurses).   
District nurses were less able to attend planned focus group meetings due to staff shortages, 
therefore, these were conducted as and when opportunities arose.   
 
6.4 Data analysis 
The focus groups were audio taped and subsequently transcribed verbatim (as discussed in 
Chapter 4).  The coding, analysis of data and theorising occurred simultaneously throughout 
the process to guide thought and to record analytical insights and interpretation. For the 
purpose of describing and presenting substantiation for the conclusions drawn, steps of 
reduction and selective sampling of the data were used.  To lend a context to the analysis of 
the data a note of the nature of the group dynamics was maintained (Carey 1995).  A record 
was maintained of specific comments, jokes, anecdotes, questions, censorship, changes of 




that a sense of the whole group should be reflected in the data analysis by using quotations 
from more than one participant rather than presenting isolated examples from one individual.  
To achieve a member checking of this stage of data collection (Polit and Beck 2008) a copy 
of each transcript was forwarded to a nominated member of each focus group and 
subsequently returned as being a true reflection of the discussion.   
 
6.5 Key findings 
6.5.1 Constipation and humour 
It was evident from the commencement of each focus group that constipation was perceived 
as a ‘humorous’ subject.  Prior to the audio tapes being activated delegates spoke informally 
about their ‘surprise’ that an hour had been allocated to discuss constipation which, in their 
opinion, would take no more that 20 minutes. There was an air of jocularity which became 
the medium through which the researcher relaxed the group, however, once the audio tapes 
were activated and the introduction given, a more formal, less-jovial discussion followed.  
Through this approach a wealth of information was gathered and the researcher was able to 
expose various personal and professional perspectives relating to the management of 
constipation in palliative care. 
 
6.5.2 Sub groups within focus group participants 
Interestingly, but perhaps predictably, four sub groups emerged within the focus group 
participants.  For the purpose of simplicity these are referred to, and represent, the following:  
 
• GP group (GPs and GP Registrars)  
• Community group (Macmillan and district nurses) 
• Specialist palliative care group (specialist palliative registrars and palliative care 
consultants)  
• Ward nurses and GP practice nurses group.   
 
The community and specialist palliative groups adhered more succinctly to issues presented 
for discussion than did the GP group who were inclined to deviate to constipation in the 
general population and in the elderly.  Additionally, the GP group appeared less concerned 
about the impact and management of constipation than the community or specialist palliative 
groups and despite being acutely conscious of the majority of the issues raised during the 




to others, for example to the patient and/or district nurses.  In contrast, the specialist 
palliative group not only acknowledged the prevalence, impact and significance of 
constipation in patients with cancer, they also appeared to assume responsibility for seeking 
to improve the situation by challenging current practices and engaging more fully in this 
research. 
 
6.5.3 Defining and identifying constipation 
Descriptors used to define constipation reflected those identified in the literature review 
(Chapter 2).  However, in contrast to the literature, the absence of a clear definition did not 
indicate a lack of HCPs’ acknowledgement of constipation as a problem in terms of its 
prevalence and management.  Nevertheless, the GP group appeared less conscious of the 
significant impact of constipation on patients with cancer.  Consequently, unless patients 
volunteered the information, it was unlikely to be identified by GPs.  GPs were less proactive 
in identifying constipation in the erroneous belief that it was being managed by district 
nurses.  To support this, GPs made unsubstantiated assumptions, demonstrated in the 
following narratives, that identification and management of constipation in patients with 
cancer falls within the role of the district nurse: 
 
GP 1:  “I think a lot of the problems go to the district nurses anyway, a lot 
more than come to us anyway.” 
 
GP 2 and GP 3:  “Yes, yes.” 
 
GP 1:  “…because they are often going in and seeing the patient.  And they 
go in (to see the patient) often and more regularly than we do.” 
 
GP 3:  “Oh, yes, I agree”  
 
GP 1:  “And they are trained to deal with it (constipation) which we’re not 
particularly.” 
 
GP 2:  “Yes but they can prescribe as well now so they can really manage 
the whole of the problem and, as you say, I don’t think they discuss it so 
much even with us now because they can, (hesitating) eh, I think they can 
prescribe suppositories can’t they?”   
 
GP 1:  “I don’t know what they can prescribe.” 
 
GP 2:  “They are a bit slow about doing rectals.  I have a feeling, you know 
I would have done a rectal and they haven’t, I’m not quite clear what the 
situation is.” 
 





GP 2:  “I don’t know if they (DN’s) do rectals.  They may do.” 
 
GP1:  “Certainly some district nurses do.  I had a discussion with a district 
nurse in the past saying… … If you don’t find anything in the rectum …” 
 
The lack of GPs involvement was perceived by the district nurses as being unsupportive of 
their practice, thus left to ‘get on with it’ without medical support, even when the need arose.  
The community group expected GPs to conduct physical examinations on patients to assist 
the safe and accurate assessment of constipation in patients with cancer.  Only the specialist 
palliative group and Macmillan nurses highlighted the dangers of misdiagnosing bowel 
obstruction which raised issues of responsibility.  There was concern as to who is and should 
be responsible to; a) conduct rectal examinations and b) prescribe rectal enemas.  
Disagreement between the GP group and the community group developed, one placing the 
onus on the other.   
 
The specialist palliative group were not particularly concerned in this GP versus community 
group debate being more interested in the manner in which this discrepancy impacted on the 
patient.  The debates led to the agreed conclusion that patients must be as, if not more, 
confused than they regarding the most appropriate HCP with whom to discuss and receive 
treatment for their constipation.  One area of total agreement was that all participants agreed 
that that by the time patients reported being constipated it had already become a distressing 
symptom and problematic to manage.   
 
6.5.4 Constipation - causes and contributing factors 
There was also overall agreement that patients’ medications, especially opioids, were the 
most likely cause of constipation in patients with cancer, followed by the failure of doctors 
(in primary and secondary care settings) to take preventative measures by prescribing 
laxatives.  Referring to themselves, the GP group reflected on their own practices and what 
they ‘should’ be doing as opposed to what they actually did.  For example:  
 
 GP3: “When we prescribe opioids we should always also educate the 
patient at the same time that this (the opioids) may cause constipation, if you 
are not having regular bowel movements then take the laxatives which 
should be prescribed at the same time.”   
 
GP1: “Education is the problem, we don’t have time for it.  How long 





The failure of GPs to instigate education was perceived as an oversight on their part.  The 
most common rationale offered was that most patients in primary care were non-cancer 
patients and therefore, according to the GPs, prescribed analgesia for short-term use when 
laxatives were not required.  Consequently the need to ensure that laxatives were included 
was not foremost in their minds and could therefore be disregarded when prescribing opioids 
for patients with cancer. 
 
GP 1: “I don’t always remember to co-prescribe laxatives.  Usually I 
wait, well, find out when the patient comes back but em, they don’t usually 
do they?” 
 
GP 3: “Yes, it is easy to forget isn’t it.  I’m probably guilty of that too.” 
 
GPs described themselves as being ‘historically poor’ at providing patient education in 
relation to taking laxatives, or “if truth be told”, other medications.  They also perceived that 
time taken in education was too time consuming and therefore prohibitive.  They founded 
this comment in the context of the current health care climate of limited resources, including 
an average of just 8 minutes per patient consultation.  In contrast the specialist palliative 
group argued that patient education was a major element of their consultations.  However, 
the nature of the education that HCPs offered was unclear and appeared to consist mainly of 
verbal advice.  The HCPs were unable to afford any indication of how, or indeed whether, 
the information had been interpreted or understood by the patient.  Vague and often 
ambiguous instructions, such as ‘take the laxatives as required’ were discussed as 
constituting ‘patient education’.  The consensus gained in all focus groups was that patient 
education was generally both minimal and inappropriate.  Participants advising patients to 
take laxatives ‘as required’ or ‘as needed’ was identified as a common instruction given to 
patients.  However, once debated within the focus group discussions, participants became 
aware of how inappropriate these instructions were.  To support this, HCPs questioned their 
own practice, for example:  
 
GP 2:  “This assumes patients know as much as the doctor ..... Doctors 
should give more explicit instructions to patients ...... we are making 
assumptions about patients’ knowledge”.  
 
GP 1 and 3: (in agreement) 
 
In the absence of appropriate patient education it is not difficult to understand why patients 
become confused by the information offered by HCPs.  Given that all HCPs in the focus 
groups identified causes of constipation and the necessity to take preventative measures in 





GP3:  “Usually, if you are prescribing opioids, what I usually say to the 
patients is one of the common side effects of these drugs is constipation, so if 
you are aware that you are not going as often or the consistency is harder 
then you need to introduce a laxative…”  
 
This statement generally would not have made it clear exactly who would be introducing the 
laxative.  The patient would probably consider that it would be their responsibility rather 
than the HCP.  Other vague statements such as the next quote were commonplace.   
 
GP2:  “I think I usually do tell patients that they need to vary and step up 
their dose of laxatives, increase roughage and fluids....”   
 
These comments not only suggest that HCPs are uncertain of the exact nature of the 
information that they provide, but also demonstrates a lack of insight as regards other 
symptoms to which patients are prone as a result of constipation and/or cancer and its 
treatments.  These symptoms would include nausea/vomiting and the risk of faecal impaction 
which rather than being resolved may be exacerbated by roughage especially when patients 
are unable to tolerate sufficient fluids.  Although the patients interviewed considered that 
HCPs (especially GPs) were reluctant to treat their constipation because they lacked 
knowledge, the HCPs in the focus groups supposed that patients were unwilling to discuss 
constipation, probably for the reason that it was ‘very private’ or because they did not deem 
it important enough to reveal to their GP.   
 
Although patients were described by some HCPs as being non-compliant with laxative 
therapy, it appeared that HCPs acknowledge that they may be partly responsible by not 
providing appropriate information and education.  This may result in patients omitting 
laxatives in the belief that they were no longer required as their constipation had alleviated.  
There was no suggestion that the GP group were keen to address these issues as in their 
opinion this was a role for the district nurses.   
 
GP 3: “The District nurses sort it though ... well, I thought they did 
anyway.” 
 
GP 1: “Well if they don’t they should do.” 
 
GP 2: “Yes I agree.  Has anyone asked them?” 
 
District nurses and Macmillan nurses were critical of GPs for their inadequate and 
inappropriate prescribing patterns of laxatives, especially the choice of laxatives which was 




lactulose, was the thought to be the cheapest but evidence suggest this is not the case 
(Christie et al 2002; Guest and Varney 2004).  Furthermore, community nurses found GPs 
reluctant to undertake domiciliary visits to physically assess cancer patients with 
constipation and opted to prescribe suppositories or enemas that the district nurses were then 
required to administer.  GPs supported this claim and reported that they considered it to be 
the community team’s responsibility to undertake rectal examinations.  District nurses 
commented that generally few DNs possessed the skills and knowledge to conduct physical 
examinations.  Given the risk of bowel obstruction and difficulties differentiating between 
diarrhoea and overflow, the district nurses and Macmillan nurses were eager that the GPs be 
more involved.  Focus group participants reflected the findings of the literature review in that 
differentiating between diarrhoea and overflow is problematic (Anton 2002).  This was 
compounded further by some doctors who prescribed anti-diarrhoea drugs without 
examining patients. The specialist palliative group had become frustrated by this practice but 
felt powerless to change GP practices. 
 
SpR 2:   “Is often difficult explaining to patients why they shouldn’t be 
taking anti-diarrhoea drug when their GP has told them to take it.”  
 
SpR 1:   “Most of the time you find out the GP hasn’t done a PR (rectal 
examination) ...before prescribing these (anti-diarrhoea drugs) which you 
would expect them to.” 
 
SpR 3:   “I phoned a GP once to put him in the picture (having prescribed 
anti-diarrhoea drugs to a severely constipated patient) and he thanked me 
for letting him know.  It seemed to go over his head that what I was actually 
doing was trying very discretely to let him know that he had actually made 
things worse for the patient ....” 
 
DN 1: “... yes, yes.  We’ve told them too but, ah, they don’t seem to listen 
to us.”  
 
DN 2 and Macmillan 1:  (Concur with DN 1 above). 
 
  
6.5.5 HPCs views on patient interview findings 
None of the HCPs were surprised by the findings that emerged from the patients’ interview 
data.  In response, HCPs reiterated the importance of alleviating constipation in patients with 
cancer and raised salient points that needed to be addressed in order to alleviate the problems 
encountered.  When invited to make suggestions several ideas were offered and debated. 
 
Patient education was identified as being essential as this could lead to patients being 




to the complexities arising in patients with cancer, patient education and self-management of 
laxatives would need to be assessed and monitored on an on-going basis.  However, to 
support this, HCPs recognised that their own prescribing practices needed to be improved in 
order to optimise the benefits of patient education.  Improving their own practices was 
voiced as something participants, especially the GPs, would endeavour to address 
immediately.  In addition, it was acknowledged that, in light of the focus groups and patient 
interview findings, constipation was a more serious problem than they had previously 
thought.  The focus groups appeared to have impacted on HCPs who subsequently reported 
their intention to be more diligent in their practices, especially with prescribing.  It appeared 
to be the HCPs means of ‘doing their bit’ however, they were clear in that more importantly;  
 
GP2: “Somebody needs to take responsibly for this problem and these patients …”  .   
 
From the focus group discussions, the researcher felt that a degree of peer reflection and 
enhanced understanding had taken place that would lead to participants improving their 
management of constipation in patients with cancer.  Focus group participants concurred that 
the researcher should explore the feasibility of a nurse-led clinic specialising in constipation 
management for patients with cancer as the next stage of this action research.  The basis of 
the clinic would establish whether the management of constipation in patients with cancer 
could be improved by focusing on some of the issues raised so far. 
 
Comparing and contrasting patients’ views with HCPs 
It is evident from this study thus far that there is disparity between patients’ and HCPs’ 
perceptions, understandings and expectations of how constipation should be managed in 
patients with cancer.  These inconsistencies are evident between patients and their HCPs and 
within HCPs groups; one often blaming the other.  HCPs appear to acknowledge their 
responsibilities, but fail to be proactive with their management strategies.  Overall, patients 
report that nobody bothers with constipation and HCPs acknowledge this. 
 
6.6 Summary 
In summary of this section, the opinions offered were various but generally similar in each of 
the four broad groupings of HCPs represented.  The initial joviality expressed by some HCPs 
abated during the course of the meeting as their attitudes transformed, in the realisation that 
perhaps their practice relating to the management of constipation in this group was 




patients was generally inadequate, often ambiguous and negatively impacted on individuals.  
It became apparent that the responsibility for constipation management in primary care was 
controversial and perhaps outside the scope of this study.  However, those present had 
highlighted a problem that until this meeting had not been debated.  The forum had offered 
the opportunity to share opinion and experience and would therefore go some way to 
disseminate the existence and ethos of this study. 
 
6.6.1 Informing and directing the research 
One of the main purposes of the focus groups was to validate the findings of the interviews 
and in so doing act as a form of member checking.  Therefore, the researcher moved the 
focus groups on to discussion relating to the interview findings and ways in which the study 
could progress.  This engendered a collaborative approach to constipation and its 
management in patients with cancer as focus group delegates afforded the study direction.  
The focus group process also prompted an element of participant self-reflection on his or her 
own practices, thus the first step in improving constipation management in patients with 
cancer.  The utilisation of focus groups as a method widened the spectrum of HCPs as it 
incorporated the community teams and further provided the opportunity for collaboration 
with a group who are more likely to be patients’ primary contact.   
 
The MDT considered that focus group were the most robust action to take for validation of 
interview findings, member checking, dissemination, improving HCP practice and informing 
the next stage of this research, all of which are evident in this Chapter. 
 
6.6.2 Rationale for constipation management clinic 
In relation to HCPs there are several factors contributing to suboptimal constipation 
management in patients with cancer, for example a lack of; knowledge, confidence, insight 
and time.  Furthermore, in cancer care the demands for being knowledgeable and focused on 
a particular client group necessitates that skills and knowledge are refined, rather than broad.  
For example, within the adjacent cancer centre the HCPs tend to be more knowledgeable 
relating to cancer and its treatments; epidemiology, aetiology, survival rates, drug treatments 
and their administration, (for example chemotherapy, Hickman lines), and usually with a 
particular anatomical region such as breast, head and neck, bowel, or ovary.  As a result the 
academic and clinical demands imposed upon such clinicians and the resulting knowledge 
tends to focus more within their chosen speciality, which may be rendering them less 





Thus, unfamiliarity and limited knowledge of the needs of cancer patients with constipation 
results in a lack of confidence when applying management strategies and poor insights into 
the complexities and burdens of this distressing symptom, as reflected in Chapter 2.  This 
strongly indicates that the previous samples in this research, (interviewees and HCPs), have 
the same issues of concern with regards to constipation management and are reflective of the 
current patients and HCPs needs, thus validating the previous findings and confirming the 
need for the clinic and related research. 
 
In light of the evidence thus far (Chapters 2, 5 and 6), constipation constitutes a frequent 
problem in cancer patients and when uncontrolled can lead to severe complications ranging 
from abdominal bloating to bowel perforation.  It appears that constipation is both a 
distressing and underestimated complication in patients with cancer, which is preventable 
and treatable with appropriate laxative use.   
 
After discussion and debate with the MDT it was decided that rather than concentrate on the 
education of HCPs the needs of existing patients with constipation were paramount, 
especially those with a limited prognosis.   Furthermore, as previously highlighted, HCPs 
were not a static group and were often disinterested in constipation and its management and 
thus unlikely to attend educational meetings on the subject.  The aim of the CMC was 
purposefully designed to focus on patients needs in the knowledge that HCPs would be 
encompassed in the process of improving constipation management by way of the post-






The CMC - planning, methods and process evaluation 
 
7.1 Introduction 
This Chapter presents the processes and methods used during the Constipation Management 
Clinic (CMC), which was developed as a result of the findings thus far (Chapters 5 and 6).  
The CMC originated from the evaluation and dissemination of the patient interviews and 
HCPs focus groups, thereby harnessing the ethos of action research.  The collaborative 
approach with the Unit’s MDT and associated HCPs was integral throughout the CMC thus 
providing guidance and support. In addition to direction and assistance the MDT acted as a 
member checking group to ensure that the emerging data were credible and generally 
trustworthy.  They also reported gaining a huge insight and deeper understanding of 
constipation management which they were able to directly utilise to change and underpin 
clinical practice.   
 
Chapter 7 includes the rationale, planning and methods utilised during this interventional 
stage of the research whereas Chapter 8 concentrates on the findings that emerged from the 
CMC data. The development and implementation processes of a clinic specialising in the 
management of constipation in patients with cancer are presented in this Chapter as is an 
explanation of how findings were used to collect supplementary data to triangulate and 
strengthen the emerging issues. An evaluation of the referral process, sample identification 
and recruitment is offered to enable the reader an appreciation of the nature of the methods 
used.  The sample demographics are presented followed by the rationale for why this group 
is appropriate for inclusion into this stage of the study.  As in previous stages throughout the 
CMC the researcher maintained field notes to record salient comments, observations, actions 
and outcomes.  These notes were accumulated and themed (as reflected in Chapter 4) thus 
affording an overall representation of findings.  Extracts illustrate points and highlight 
contextual relationships where necessary throughout this Chapter. 
 
The scope of the CMC preparation is exposed including the personal development of the 
researcher and the CMC framework that was devised in light of the findings of stages one 
and two of the study.  The rationale for the development of specific elements of the CMC 




of consultations, the physical examination and medical support.  The overarching aims of 
this research, reducing constipation in patients with cancer and improving HCPs’ 
management of the condition, were explored concurrently during the CMC.  Within the 
philosophy of action research this Chapter includes an explanation of the methods of 
dissemination of findings to HCPs, thereby affording the opportunity to improve practice and 
facilitating a collaborative approach to improving patient outcomes. 
 
7.2 The objectives of the CMC 
A constipation management clinic was initiated following and consequential of the findings 
of patient interviews and HCP focus groups.  The scope of the clinic was discussed within 
the local MDT within the Unit.  A dedicated patient-focused approach to constipation 
management was subsequently adopted that aimed to decrease the incidence and/or severity 
in patients with cancer.  The objectives are summarised as follows: 
 
• To facilitate an environment in which patients were able to speak at length and 
candidly about their bowel habits and related concerns.   
• To identify individuals’ understandings and management strategies. 
• To examine initiatives to assist the identification of laxatives previously tried. 
• To initiate a comprehensive patient assessment including a physical 
examination. 
• To improve patient education. 
• To provide support and advice. 
• To develop a concordant approach to constipation management. 
• To provide continuity of care. 
 
7.3 Extended Ethical Approval 
Ethical advice was sought for the final stage of the study in relation to patient consent which 
resulted in minor amendments.  
 
• The CMC consultation was not being tape-recorded therefore all reference to this 
was removed from the patient information sheet and consent form.   
 
• Patients needed to consent to the use of their data for academic purposes.  This usage 
was indicated on the patient information sheet and consent forms which were 




It was agreed that patients declining the use of their data would not be recruited into this 
study but would have precisely the same access to the CMC.  It was proposed that the CMC 
was an adjunct to the Unit’s existing services and the researcher’s clinical practice was 
within the scope of the extended nurse role.  These were established by the Ethics 
Committee, the specialist palliative care clinical director and the MDT and full Ethics 
approval for the next step in the action research was gained.   
 
7.4 Preparing for the CMC 
Initially, the researcher embarked on a further literature search and examined the current 
databases but was unable to locate any substantive studies relating to the use of nurse-led 
clinics specifically for the management of constipation in adult patients with cancer.  In 
contrast, there is an abundance of literature providing support and guidance on nurse-led 
clinics (Hatchett 2003) that were reviewed and informed the preparation of the CMC.   
Perhaps the most useful at this stage of the action research was that of Briggs (1997) who 
argues that the most valuable features of nurse-led clinics include direct referral mechanisms, 
assessment and technical skills, freedom to initiate diagnostic tests, prescription of 
medications, increased autonomy and scope for decision making and discharge.  These 
features were used throughout the CMC and are expanded upon in this Chapter.  
Additionally, the researcher attended a conference on nurse-led clinics (Appendix 15) and a 
symposium on coordinating constipation management (Appendix 16). These afforded 
insightful information that were utilised within the CMC.  
 
The growth of nurse-led clinics since the 1980s has enabled nurses to manage their own case 
load of patients with increasing autonomy.  Hatchett (2003) describes nurse-led clinics as an 
educative role in which patients are afforded insights into the significance of their symptoms, 
differentiating between those of concern that require further treatment or adjustment of 
medication and those that may be from alternative causes.  Furthermore, the nurse’s role 
involves the skills of history taking and physical assessment, considering the significance of 
assessment, ordering further investigations as necessary and referring on to colleagues and 
other disciplines as appropriate (Baraniak and Gardner 2001; Hatchett 2003) and encompass 
a patient follow-up element which may be face-to-face or by telephone (Cox and Wilson 
2003).   
 
The government’s nursing strategy supports nurse-led clinics as a way of making a more 
efficient use of health care resources and provide greater access to healthcare for patients 




when undertaking initiatives such as nurse-led clinics must be supported by the collaboration 
with other healthcare providers to ensure a coordinated approach to services and patient 
management.  
 
To widen the basis of support a personalised letter (Appendix 17) and executive copy of the 
study’s aims and objectives (Appendix 18) was forward to all the oncology consultants and 
the senior pharmacist in the adjacent cancer centre as some of their patients would be eligible 
for inclusion in the study.  In the letter, the researcher also sought permission to display 
flyers (Appendix 19) and referral cards in prominent areas within the cancer centre to 
encourage referrals.  Consultants were asked to feedback any objections, concerns or 
suggestions about the study and/or its development to the researcher. 
 
Four oncologists responded to the letter stating that they had no objections and were content 
for the CMC to proceed.  This was considered a general support for the study and an implicit 
reaffirmation of the importance of the management of their patients’ constipation. In addition 
and in accordance with local practice, notification of the extended Ethical approval for this 
study was conveyed to all the oncologists at one of their clinical governance meetings.  A 
colleague, who was central to the MDT and therefore the study reported that a brief outline 
of the study was given, discussions followed and that no objections were received.  Once 
again this general agreement was viewed as an endorsement of the topic area and the 
proposed CMC. 
 
7.5 Researcher’s skills and experience 
During the CMC it was anticipated that the researcher would practise in an extended role that 
focused on the assessment and treatment recommendations for patients with constipation.  
The researcher was aware of her professional responsibilities stipulated by the Nursing & 
Midwifery Council (2004) and that any decisions and actions taken must serve in the 
patients’ best interests and within her level of professional training and experience.  The 
researcher was cognisant of the requirement that nurses must only undertake activities for 
which they have been trained and are competent to perform (UKCC 1996) therefore, in order 
to provide the planned holistic service, for example encompassing a physical examination, 
further training was clearly required.  These are explained in the following paragraphs. 
 
Findings from Chapters 2, 5 and 6 strongly suggested that many patients presenting with 
constipation had not had a physical examination to confirm its presence and/or severity.  




provision of a physical examination would be an important element to include in the CMC as 
it would facilitate a more comprehensive patient assessment and highlight potential problems 
such bowel obstruction which would require urgent medical assessment.  Furthermore, a 
physical assessment might reveal the need for an x-ray and also influence laxative choice 
and dose.  Therefore the medical team suggested that the researcher undertook further 
training to improve her skills and knowledge relating to physical examinations as these 
would afford patients with a more holistic assessment and greater understanding of the 
nature and extent of the problem. 
 
7.5.1 Physical examination 
Although the researcher was proficient at, and had previously performed, digital rectal 
examinations as part of her clinical practice she undertook training by the specialist palliative 
care consultant and his team to learn how to perform an abdominal examination.  Following 
several observed patient physical examinations (by a senior medical team member) the 
researcher was assessed as being competent to conduct simple abdominal and rectal 
examinations.  The researcher’s physical assessment was not intended to be as 
comprehensive as the medical model but to act a mechanism for raising the alarm should 
something more sinister than constipation present, such as bowel obstruction.  The 
researcher remained accountable for her actions (NMC 2008) with overall clinical 
responsibility maintained by the specialist palliative care consultant. 
 
Objective data were collected during the physical examination.  As advised during tutorials 
by the medical team, the researcher checked for abdominal swelling and/or distension, 
sensitivity/tenderness when the abdomen was gently pressed, the inability to digitally 
circumvent a rectal mass and any other abnormalities such as rectal bleeding and/or 
inflammation.  Any of these signs/symptoms may be as a result of, amongst other things, 
bowel obstruction, ascities or bowel perforation.  It was therefore agreed that the Unit’s 
medical team would be informed immediately should any of these symptoms be present. 
 
7.5.2 Laxative prescribing: developing a system  
A great deal of groundwork was necessary in preparation for making recommendations and 
prescribing laxatives as the reasons why patients omit their medication are multiple and need 
to be examined on an individual basis (Zeppetalla 1999; Elwyn et al 2003) and as 
highlighted in Chapters 2 and 5.  Patients’ lack of information regarding their condition and 




(Kennedy 2003), therefore, the CMC aimed to redress any shortfall through patient 
education and information giving based on the individuals' needs.  
 
The MDT debated the most effective system of prescribing within the CMC and reached the 
conclusion that it might be necessary for the researcher to prescribe laxatives to patients not 
currently taking appropriate regimens.  The MDT decided that without this the patient would 
be obliged to return to their GP, or other medical prescriber which would result in further 
delays and negate the ethos of the clinic: holistic constipation management.  The patients 
would be revisiting a situation which had essentially not been successful in resolving their 
constipation in the past.     
 
The MDT debated the requirement for the researcher to undertake supplementary skills 
updating, such as a nurse-prescribing course and guidance on the processes of requesting 
diagnostic tests.  A general consensus was reached that further training would be 
inappropriate given the complexity, time and academic requirements afforded to this study 
and her other work related research and audit commitments.  It was therefore agreed that, in 
partnership with the researcher, the Unit’s medical doctors would endorse/sign prescriptions 
and order any diagnostic tests deemed necessary. Therefore the ultimate responsibility 
remained with the medical team and the CMC could progress in the immediate future.  In the 
event, this system worked effectively as the partnership discussion between the researcher 
and doctors ensured that collaboration and the team approach were maintained within the 
ethos of action research.   Some junior doctors required justification from the researcher 
regarding choice of laxatives which in itself introduced an educational element to the 
encounter. All prescriptions were ultimately endorsed. The team approach ensured that 
patients were afforded a timely and comprehensive CMC service. Prescriptions were 
subsequently dispensed from the hospital pharmacy and therefore could be taken by patients 
within hours of prescribing rather than being delayed by days whilst awaiting further 
appointment with their prescribing GP or oncologist.   
 
7.5.3 Laxative prescribing: establishing the appropriate drug regimen 
To widen her knowledge and understanding of laxatives and their use the researcher revisited 
the literature that had been reviewed at the outset of the study and re-examined it.  It is 
evident in the literature that not all laxatives are appropriate to use in patients with cancer.  
For example, despite the evidence to support the efficacy of psyllium in the treatment of 
chronic constipation, (Ramkumar and Rao 2005), bulk-forming laxatives should not be used 




required amount of water with the administered dose (Tamayo and Diaz-Zuluaga 2004).  
This frequently includes the elderly and those who are dehydrated (Bosshard et al 2004; 
Ginsberg et al 2007).  In the absence of sufficient fluids the osmotic nature of psyllium 
exacerbates dehydration and constipation.  Therefore the use of laxatives containing 
psyllium was avoided. 
 
The drug information afforded to patients during the CMC was subsequently obtained from a 
variety of sources.  These included extrapolation during the literature review, the most recent 
versions of the BNF (2008) and PCF (2007), directly from the drug’s manufacture and 
during discussions with the MDT.  Laxative regimen recommendations included the use of 
senna, lactulose, co-danthrusate and polyethylene glycol.  This list is not an exhaustive but 
affords guidance on those know to be efficacious (Miles et al 2007) to optimise constipation 
management should the need arise.  The safety and efficacy of these recommendations were 
underpinned by the literature review, BNF (2008) and PCF (2007). 
 
Having completed extensive inquiry as to the efficacy of various laxatives the researcher 
considered the existing availability of laxatives to the patients.  As the interview data had 
revealed that most patients had supplies of laxatives in their home and that these had rarely 
been taken appropriately it seemed an appropriate starting point. It is well recorded that 
laxatives work but they are the very ones that are often omitted and or reduced (Townsend et 
al 2003; Zeppetella 1999). The researcher raised this point at the next the MDT meeting 
where it was agreed that these existing supplies could be re-commenced if they formed part 
of the planned regimen provided expiry dates had not been exceeded.  Therefore, 
recommendations for laxative use were initially based on the individual’s existing regimen, 
whereby prescribed laxative medication was adjusted as advocated by the Crown Committee 
(DH 1998), provided its cessation had been due to the individual’s perceived lack of efficacy 
as opposed to difficulties with the formulation.   
 
Thereafter, patients were encouraged to select their laxatives.  Laxative regimens were 
identified using a concordant approach, thus agreement based on the individuals’ informed 
decision and preferences of formulation and frequency of use (Zeppetella 1999; Kennedy 
2003).  Patients’ perseverance with agreed regimens may falter (Heath 2003) if they remain 
unconvinced of laxative efficacy or have negative experiences (Marinker and Shaw 2004) 
therefore, patient information and education was the instrument through which adherence 
was optimised as there is strong evidence that certain laxatives are efficacious provided they 
are taken consistently and at therapeutic doses.   Regimens were not rigid: laxative choice, 




opioid dose.  Self-titration formed part of the regimen in order to empower patients to make 
timely modifications to their dose depending on stool form and ease of defecation.  Drug 
information and support was available 24-hours and reviewed during follow-up CMC 
consultations.  There is evidence to support the benefits of this approach as it ensures 
consistent laxative use, thus its efficacy, and improves patients’ concordance through the 
provision of contemporary drug information. 
 
Benefits of giving information 
Although some information is offered by HCPs most of the information on contraindications, 
side effects, interactions and dose is provided on written patient inserts provided within the 
drug’s packet.  This information is usually produced in minute typeface, unfamiliar wording 
and/or perplexing to individuals.  Patients often consider such information discouraging and 
not beneficial in determining the balance between risks and benefits (Kennedy 2003). 
Therefore during the CMC patients were offered clear verbal and written instructions 
relating to their laxative regimens (Zeppetella 1999).  Pertinent information was given to 
patients in a concerted effort to minimise ambiguity.  For example, the researcher’s advice 
relating to directions for laxative did not include ‘regular’ as individuals interpret this 
differently (Chapter 5).  Similarly, ‘as needed’ was not used as constipation is insidious and 
patients may not be aware that they were becoming constipated.  Patients were advised take 
their laxatives on a daily basis, whether they felt they need them or not and to regulate the 
dose based on stool form and ease of defecation.  To ensure the timely identification of 
subsequent problems (for example bowel obstruction) patients were advised to report any 
changes to their bowel function and/or related symptoms (other than improvements in 
constipation) to the researcher or their primary HCP as soon as possible. 
 
The accuracy of the information given is paramount. Dickinson and Raynor (2003) agree and 
propose that the ideal source of drug information is accurate, up-to-date and practically 
useful.  In the CMC, for example, patients who found liquid formulation unpalatable were 
informed about the various ways of improving the flavour and/or consistency, similarly, 
alternative formulations (liquid to/from tablet) were offered where available. Kennedy 
(2003) and Dickinson and Raynor (2003) support the customisation and personalisation of 
information as there is a need to ensure patients are able to strike a balance between a 
treatment's beneficial and adverse effects, thus making an informed decision based on 
reliable, consistent and understandable information.  To this end, those patients who 
expressed a desire to be ‘weaned off’ laxatives because they thought that they would become 




patients that the use of laxatives was to counterbalance the effects of opioids and redress the 
imbalance caused by other drugs for example, analgesia.  Such an approach is more likely to 
underpin the patient-clinician partnership and improve patient concordance (Kennedy 2003). 
Information about the side effects of laxatives was used to inform patients of actual and 
potential problems as this often reduces anxiety and/or misconceptions (Woolf et al 2005). 
For example, some patients may tolerate flatus whereas others may find it unacceptable, 
therefore, methods to alleviate flatus were explored and/or an alternative laxative identified. 
The patients were therefore forewarned of such possibilities and management advice 
proffered.  Patients’ fears and/or concerns were explored and advice on ‘what to do’ if the 
treatment was, or became, ineffective. In so doing the researcher fostered a concordant 
relationship between herself and the patients. 
 
Reiterating in context: the ‘explosive episode’ 
In preparation and anticipation of the effects of laxative regimens aimed at managing 
‘troublesome constipation’ patients were advised that they might experience an ‘explosive 
episode’ of faeces which could induce, amongst other things, a degree of lethargy.  The 
researcher used the term ‘explosive episode’ as this was how patients had described the 
event in the past.  Patients were advised that such a motion was not uncommon but if it 
caused concern or anxiety, they should telephone the researcher or any member of the 
nursing/medical team using the 24-hour support telephone number.  This offer of access and 
reassurance offered the patient a line of communication (Zeppetella 1999) and the researcher 
an opportunity to reinforce the process of continuing to take medications as prescribed.  
 
In summary, drug information was available and imparted at the time of a consultation. The 
researcher ensured that it was accessible and consistent, high quality and contemporaneous 
(Elwyn et al 2003; Dickinson and Raynor 2003; Kennedy 2003) thus optimising the 
opportunity to improve patient concordance and create a therapeutic regimen to alleviate the 
individual’s constipation.  Information given was straightforward and uncomplicated using 
educational techniques and tools discussed later in this Chapter.  Ultimately, patients were 
informed about the use and role of laxatives which enabled them to adopt a regimen that 
encompassed their prophylactic use of laxatives and the ability to titrate laxatives based on 





7.6 Sample identification and referrals 
To attract potential participants, flyers and referral cards were placed on display boards and 
stands in strategically positioned areas.  Two flyers were placed within the Unit inpatient 
ward and outpatients day centre, three in the adjacent cancer centre (clinic patients waiting 
areas), one in the outpatients department of a local hospital, one in an adjoining cancer 
resource and information centre and one at the hospital pharmacy.  A letter outlining the 
CMC was sent to clinical nurse specialist and local community Macmillan nurses raising 
awareness of the CMC and affording them the opportunity to identify patients they deemed 
appropriate.   
 
Over a 24-month period 44 patients were referred to the CMC.  Thirty patients self-referred 
and 14 were referred by a HCP.  Twenty-nine patients were recruited into this study and of  
the remaining 15, two developed tumour related bowel obstruction and five died prior to 
their initial appointment or were entering the terminal phase of their illness and therefore too 
unwell to attend.  Three patients did not have a diagnosis of cancer and therefore did not 
meet the inclusion criteria and five were unable make the necessary travel arrangements.  
The following patient demographics and subsequent Chapter report on the CMC findings for 
the 29 patients included in this stage of the study.   
 
7.6.1 Self-referral 
Twenty-two patients self-referred, which supports the interview findings where respondents 
highlighted their perceived need for a dedicated CMC from which they would seek support.  
Whilst it is acknowledged that symptomatic patients are more likely to have responded than 
asymptomatic (Bassotti et al 2004) their eagerness reflects their desperation to be free from 
constipation.   
 
“… I did mention it to (another day-care patient) that I was having trouble 
going and she said you helped her and that I should ask to see you.” (KV) 
 
“……actually I was eavesdropping on …….who were talking about it.  I get 
it (constipation) a lot and well, I knew they wouldn’t mind so I laughed and 




Self-referral occurred in response to the flyers and as a result of word-of-mouth 
recommendation of HCPs, family members and other patients.  Some patients advised others 




initiated several more enquiries and self-referrals and introduced a form of snowballing of 
sample (Polit and Beck 2008) where one patient identified others to participate in the CMC. 
 
7.6.2 Referral by an HCP 
Seven patients were referred to the CMC by a HCP and of these four were from colleagues 
practising within the Unit.  These HCPs acknowledged that the management of the patients’ 
constipation had ‘defeated them’.  As previously highlighted, concerns have been identified 
with regard to nursing and medical teams’ knowledge and suboptimal management of 
constipation, therefore, within the action research paradigm it was encouraging that the 
practitioners became ready participants in the research, made appropriate referrals to the 
CMC and participated in constipation management in order to optimise patient outcomes and 
their own learning.  In addition to these referrals from the Unit three referrals were received 
from the community teams (GP, MacMillan and district nurses). The HCPs making these 
referrals had in most cases been those who had contributed to the focus groups or who had a 
colleague who had done so. 
 
7.6.3 Endorsement from doctors 
In the instance when referrals were not received from a doctor (for example self-referral or 
nurse), a courtesy telephone call was made to obtain the doctor’s/consultant’s support and 
ensure there were no known contra indication to the individual’s recruitment, such as known 
or suspected bowel obstruction.  For those without an oncologist and/or whose care had been 
superseded by another specialty, such as palliative care services, the patient’s GP was 
contacted in order to: 
 
• Open up lines of communication and rapport building (especially to GPs who 
may not have known the researcher or her role) 
• Raise awareness of the aims and objectives of the CMC. 
• Inform of the planned interventions, thus preventing any diversity in practice 
between doctor and researcher with regards to the patient’s constipation 
management.   
• Establish patient’s cancer diagnosis and stage, thus giving insight into those with 
or predisposed to tumour related bowel obstruction.  
• Identify any objections doctors may have to the research, especially the planned 
interventions and/or patient’s involvement. 




None of the oncologists or GPs objected to their patients being recruited into the study.  
Following medical approval, patients received a copy of the patient information sheet. In the 
event no information was received from medical members that resulted in any patient being 
ineligible to attend the CMC.  In contrast, doctors welcomed the fact that the researcher was 
prepared to manage the patients’ constipation and in some cases referrals were accompanied 
by wishes of ‘good luck’.  The intonation in these comments, usually from oncologists, was 
rather jovial in manner and from this the researcher deduced that they deemed the 
intervention either not of importance and/or not likely to succeed.  The rationales offered 
were usually based in the problematic nature of the patient and/or that they were unlikely to 
comply with their laxatives or medications generally.  These comments were generally 
related directly to the patient being discussed at the time. To give a flavour of the comments 
made some were jotted down in the filed notes and are presented below: 
“She’s not very compliant with her medications.” (Oncologist 1) 
 
“He is under the psychologist and may be a very difficult patient.”  
(Oncologist 2) 
 
“She is very difficult.  She has seen everyone and plays one off against the 
other, she won’t take her laxatives.” ….. “Happy for you to have a go …if 
you think you can help.” (Oncologist 3) 
 
“I’d be delighted if you could help.” (GP 1) 
 
These comments appear to indicate that the oncologists and the GP considered that the 
patients were in some way deviant as they were non-compliant with their laxative regimen.  
Although the non-compliance labeling is evident in the literature review (Heath 2003; Elwyn 
et al 2003; Weiss and Britten 2003; Marinker and Shaw 2004) and focus groups (Chapter 6) 
the researcher draws attention to the fact that oncologists were not specifically asked about 
their patients’ behaviours nor what may have contributed to their constipation.  The 
narratives were proffered voluntarily and in a defensive manner, perhaps because they had 
knowingly failed in their duty of care.  Evidentially both constipation and non-compliance 
had been identified but not action taken, possibly due to limited resources or a lack of 
knowledge, skills and/or poor attitudes to constipation and its management (Zernike and 







The clinic was successful in attracting an appropriate sample.  All patients recruited had a 
cancer diagnosis and had experienced constipation during their disease progression.  All 
presented with varying degrees of constipation which they had previously reported to one or 
more of their HCPs and in some cases this consisted of their GP, Macmillan nurse, district 
nurse and oncologist.  Three patients had a recent admission via their local Accident and 
Emergency department for treatment of constipation and, following discharge, one man was 
enduring breakthrough pain in preference to risking another episode of constipation 
(example Appendix 20) however, this strategy proved unsuccessful.  In all three cases 
constipation represented and patients self-referred to the CMC. 
 
It was not always possible to offer consultations to patients within 48-hours of their request.  
Some patients sought interim advice from the researcher, however, it was reiterated that the 
advice given should not replace their CMC attendance and in support of this need the clinic’s 
aims and objectives were conveyed.  The resultant conversations established that none of the 
patients were taking laxatives on a daily basis, therefore provisional recommendations were 
made on an individual basis, for example on stool form, frequency, diagnosis and current 
laxative regimen.  The interim advice and the clinic’s aims and objectives were welcomed by 
patients who reported being optimistic their constipation may be relieved.  All 29 patients 
met the inclusion criteria of the study.   
 
7.7.1 Sample demographics 
The sample that was recruited to the CMC comprised 20 females and 9 males were with an 
average age 66 years (range 29-84 years).  Cancer diagnosis, disease stage, co-morbidities 
and type of constipation varied.  Data in some cases were incomplete and overall the MDT 
considered that other than primary cancer diagnosis, based on the WHO International 
Classification of Diseases (1989) malignant categories, further analysis was not required as 
these would not inform the study’s findings further, therefore, primary diagnoses are:  
Respiratory (7), Breast (6), Female genital organs (5), Male genital organs (4), Digestive 
organs (4), Central nervous system (1), Urinary tract (1) and Head & Neck (1). 
 
7.7.2 Initial contact 
The researcher considered it important to develop rapport with the patients prior to attending 
the CMC and used the same approach that had proved successful during the interview stage 




patients feel comfortable about their frankness during the consultation and the belief that the 
discussion itself was therapeutic, all of which are highlighted and debated in Chapters 4 and 
5.  Therefore, on initial contact (telephone or in person) the researcher introduced herself and 
gave a brief overview of the study’s aims and objectives and outlined the CMC’s main 
components.  Patients were welcomed to the clinic and advised that if they did not wish to 
consent to take part in the study would not disadvantage there consultation in any way and 
that they could continue to attend the CMC.  Patients were informed that results could not be 
guaranteed but based on a patient-researcher partnership and collaborative working it may be 
possible to modify existing strategies and empower them to become more proactive in 
managing their constipation, the end result aiming to be alleviation of their constipation.   
 
7.8 Data collection  
The main data collection methods, expounded in the generic methods Chapter, were also 
employed during the data collection process of the CMC. Observation and interviewing 
skills and the recording of field notes honed during the interview and focus group stages of 
the study formed the cornerstone of the CMC data collection. The rationales for 
interviewing, observation and the maintenance of field notes to achieve effective data 
collection have been presented in Chapter 4 so are not revisited here. However, variants of 
these or new strategies that were used are presented in the following sections.  One of these 
new strategies was the reviewing of medical notes and development of a framework to form 
the basis of and guide the consultative interviews that comprised the interface with the 
patients.   Similarly, central to data collection in the CMC, was an understanding of the 
complex and individual nature of constipation and its management in patients with cancer 
which was previously highlighted in Chapters 2, 4, 5 and 6. Therefore to generate 
meaningful data in the CMC it was decided that individual outcome measures needed to be 
established to establish improvement of bowel function. The methods of achieving these are 
also included in this section. 
 
7.8.1 Medical notes 
As a starting point and a method peculiar to this stage, the researcher decided to review any 
existing medical notes. In the event it was not possible to access GP or medical notes from 
other hospitals but those that were available locally (the Unit and the adjacent cancer centre) 
were scanned.  The medical notes proved to be useful in providing initial and then 
supplementary data regarding the individual’s social and medical history which otherwise 




spanning several years, the contents of which may have not been recalled by the patients or 
could have caused great distress.   
 
It was noted that, in cases where constipation had been recorded in the medical notes, the 
information was generally inadequate, vague and void of assessment data or treatment plans, 
thus reflecting under identification and/or under-reporting.  From this evidence it appeared 
that local practice reflected the findings of previous studies in relation to the poor 
identification, assessment and reporting of constipation (Moore et al 1996; Glare and Lickiss 
1992; McMillan 2002; McMillan and Tittle 1995).   
 
7.8.2 The consultative-interview 
Due to patients’ frankness and openness during the interviews (Chapter 5), the researcher 
adopted an approach that was influenced by the semi-structured interview methods (Chapter 
4), thus resulting in a consultative-interview.  The aim of this process was to capture as much 
salient information as possible which was subsequently used to inform constipation 
management strategies and in an attempt to optimise concordance (Usherwood 1999; Collins 
et al 2006).  Patients were advised to allow approximately one hour for the initial 
consultation. 
 
7.8.3 Allowing time to elicit the patients’ perspectives 
Initial consultation 
Each patient’s initial consultation lasted approximately one hour and was sufficient in order 
to cover all the planned aspects/components.  Allowing an appropriate time to listen to and 
for patients to respond was an important factor as it ensured that those with impaired 
hearing, sight and/or cognitive function were not rushed or disadvantaged in any way.  This 
proved successful for patients as they considered they had been given a full opportunity to 
expose their concerns and, additionally, the researcher had the opportunity to collect full and 
rich data on which to base the findings of the study.   
 
Follow-up consultations 
Follow-up appointments kept to a similar format but excluded basic demographic data 
collection and previous medical history.  Follow-up appointments lasted between 10-35 




patient education and concordance.  The scheduling of the follow-up appointments was kept 
deliberately flexible as it was common for patients to be late for their appointments due other 
confounding factors such as  feeling unwell, underestimating their immobility, being reliant 
on others for transport and when other inpatients’ medical treatments took priority.  Thus, 
appointments were often rescheduled for later in the day of kept by telephone consultation to 
evaluate patient outcomes and suggest alternative actions. 
 
When constipation had been alleviated and the patients were content to maintain their 
regimen, the follow-up appointment lasted no more than 20 minutes.  For patients attending 
the Unit’s day centre appointments were made at their request.  In the interim period 
informal monitoring was assessed by day centre nursing staff who periodically asked 
patients if they required a CMC follow-up.  For other patients the CMC contact number and 
Unit’s 24-hours support line telephone numbers were given and patients advised that they 
could make contact whenever necessary.  Once severe constipation had been resolved and 
self-titration established few patients required ongoing CMC appointments.   
 
7.9 The CMC framework 
Although the study is essentially qualitative in nature, viewing constipation from the 
individual’s perspective, the researcher considered it necessary to impose some structure on 
the consultations to ensure that all the planned components were included.  It was also 
imperative that a starting point was established against which any improvement, or otherwise 
could be assessed.  Therefore central to the planning stage of the CMC the researcher set 
about developing a framework as a guide.  In operation it proved to be invaluable to the 
researcher, during CMC consultations also as a point of reference to HCP colleagues who 
generally operated within a different research paradigm.  The framework also provided, to 
HCPs, a source of transparency of the CMC process and consultations. 
 
In the clinic setting the researcher considered it necessary to be as succinct and 
comprehensive as possible in capturing base data especially those to be used as the particular 
and personal outcome measures for each patient.  To facilitate this, a draft data form was 
created. However, during the form’s creation and piloting it became evident that the resultant 
seven page document was too lengthy and complex which distracted from one of the key 
components of the CMC, that of patient communication.  Therefore, significant points were 
extrapolated from the form, categorised into five key components to produce the resultant 




data pro forma) and recorded in the field notes to detail salient points throughout the 
appointment.   
 
The CMC comprised five major components: history taking, physical examination, 
assessment, patient education and concordance.  These components were loosely structured, 
that is, all stages other than physical examination were included but not necessarily in a rigid 
format in order to encourage patients to articulate their account of events, experiences, 
beliefs and concerns.  A physical examination was performed only when necessary and its 
need based on a joint decision between patient and researcher.  The rationale for the choice 
of the five components is explored in further detail in the following paragraphs.  
 
 
7.9.1 History taking 
The researcher considered that history taking was crucial in order to identify patients’ 
misconceptions, educational needs and to inform management strategies. Without this data 
the researcher would not have had sufficient information to inform any educational needs or 
identify appropriate plans and/or management strategies, and thus unable to improve 
concordance and/or alleviate constipation.  For example, given the likelihood that over-flow 
diarrhoea might co-present with constipation was important to inform patients about the 
detrimental use of anti-diarrhoea drugs in these circumstances.  The history taking primarily 
involved a conversation with the aim of both rapport building and eliciting information.  
Open and closed questions were asked along with prompts and probes where necessary as 
reflected in Methods, Chapter 4.  
 
As aide-mémoire the researcher made brief notes on significant points arising.  For example, 
not being able to tolerate fluids and the practice of taking laxatives ‘as needed’.  Patients 
were asked to expand on key points such as using laxatives ‘as needed’ in order to explore 
exactly when and under what circumstances they identified a ‘need’  Similarly, a report 
implying that laxatives were being ‘taken all the time’ needed clarification as the statement 
is ambiguous.  Even if the point raised by patients seemed irrelevant to the researcher, 
exploring these was important in order to overcome any reticence derived from previous 
HCPs’ negativity.  For example, feeling that they were making a fuss and perhaps 







• Patient’s demographics including diagnosis, medical history, and family/support 
• The patient’s story; 
o What constipation means to them 
o How it affects them physically and psychologically 
o Management strategies used 
o Interactions with others and information received 
o Understanding of the causes and consequences of constipation 
o Understanding of the role and use of laxatives 
• Pattern of patient’s recent bowel movements 
• Patterns of pre-illness bowel movements, any previous long-term use of laxatives 
• Concomitant diseases 
 
 
• Diet and fluid intake 
• Use of potentially constipating drugs 
• Use of laxatives - frequency, dose, perceived efficacy, palatability 
• Stool form, frequency and ease of defecation 
 
Physical examination 
• Palpation of faecal masses 
• Presence or absence o faeces in the rectum  
 
Assessment 
• Current physical and psychological burdens and related symptoms 
• Consider abdominal x-ray 
• Explain findings to patient 
 
Patient education (individualised) discussion and pictorial 
• Unanswered questions, misunderstandings, inaccurate beliefs 
• The use and role of laxatives including ‘self-titration’ and outcomes 
• Side effects of laxatives 
• Provide opportunity for discussion and exploration of patient’s concerns and aims 
• Questions, addressing misconceptions, discussion: alternative management strategies 
 
Concordance 
• Reiterate actual and potential problems and highlight realistic aims and objectives 
• Identify patient’s preference of laxative regimen (+/- prescription) 
• Ongoing support and use of 24-hour telephone help line 

























































As highlighted in the interviews (Chapter 5) history taking was viewed by the researcher as 
an important element of the interaction as it implicitly proffered support, reassurance and 
displayed interest in the patients’ constipation and related problems.  In some cases when 
patients asked direct questions requiring a succinct response these were answered 
immediately, however, when a more detailed explanation was required, this was noted and 
ensured that all points were covered.  Specific CMC notes were recorded as the personal 
outcome measures for each patient. 
 
7.9.2 Defining constipation - the individual's interpretation 
It is noted in the literature reviewed for the study that frequency of defection does not 
necessarily correlate with a diagnosis of constipation or indicate its severity (Ashraf et al 
1996; MeReC 1994; Daisy et al 2002; Drossman et al 1982; Manning et al 1976).  
Therefore, the consultative-interview encompassed a fact-finding element to elicit the 
patient’s experiences, perceptions and definitions of what constipation means to them.  
Patients were advised that there is no single definition of constipation and that it was their 
beliefs, perceptions and experiences that were of relevance during the initial part of the 
consultation.  Thereafter, patients were encouraged to state the signs and symptoms which 
they contributed to their constipation.  Following this the researcher asked specific questions 
based on the literature review (Table 2) to ensure any signs/symptoms were collected that 
may have otherwise been forgotten by the patient.  The Bristol Stool Form Scale (Appendix 
1) was used to obtain objective data thus giving an indication of its form at varying stages.  
The process worked well and often signs and symptoms identified were used and 
encompassed in the individuals’ outcome measures.  The researcher made notes and referred 
to these later during the CMC and/or in the post-CMC letter to HCPs.  
 
7.9.3 Patients’ drug use  
During each patient’s first CMC consultation the researcher made a record of all the drugs 
individuals reported using including any that they had taken in the past.  These data were 
supplemented with information from the medical notes.  Whilst the researcher was aware 
that these data sources, verbal and medical notes, were unlikely to yield a comprehensive 
record (Chapters 2 and 5), it was imperative to identify any issues of concern that needed 
redressing for example, difficulty taking formulations, intolerable side effects of laxatives 





As highlighted in Chapter 5, Interview findings, all patients had some difficulty providing 
laxative information.  The researcher proposed that laxative examples could be obtained for 
the sole purpose of aiding patients’ recall of those used and reasons why they were 
discontinued.  The MDT concurred and thereafter samples were requested (Appendix 21) 
and obtained with the agreement of and from the senior pharmacist in the Unit.  The 
researcher purchased supplementary laxatives from a local chemist as often the packaging 
differs from hospital supplies.  In some cases it was the packaging that patients recognised 
rather than the product itself.  To supplement the laxative data a selection of examples were 
subsequently retrieved from a box conveniently situated in the consulting room.  In the event 
these proved to be greatly successful for patients and the researcher and led to the gathering 
of useful data.  
 
7.9.4 Assessment of present bowel status 
Identifying patients’ current bowel status and management strategies provided base data that 
informed outcome measures and acted as a check to ensure that there was not an 
advancement of their cancer or any other condition that required urgent medical intervention: 
for example, in patients presenting with severe constipation the medical team needed to 
eliminate the possibility of bowel obstruction.  In such circumstances the patients would be 
discharged from the clinic if found to be tumour related which further tests were completed.  
In addition the physical examination provided objective data to accompany subjective 
reports of severe constipation and in so doing; outcome measures.  
 
Therefore in the event specific information about current bowel function were not 
forthcoming from patients, perhaps because they had forgotten, open and closed questions 
would be asked based on the Bristol Stool Form Scale and the Rome II Criteria.  For 
example, pain during defecation, faecal incontinence and unpleasant taste in the mouth.  
Information that may be deemed personal and/or intrusive was dealt with sensitively to avoid 
patient embarrassment.  In such cases the researcher proffered information in the context as 
management strategies and experiences of other patients, thus providing the opportunity for 
patients to simply listen and form their own conclusions as to whether the information was 
useful or not.  For example, patients who suffered with faecal incontinence and endured anal 
soreness due to frequent toileting find that moist sensitive wipes alleviate this discomfort.  
Thus, in the knowledge that anal incontinence is not uncommon, (as highlighted in Chapters 
2 and 5), patients can discretely choose whether or not to articulate their concerns and/or 





7.9.5 Patient education and concordance with regimens 
Patient education is an effective method of improving individuals’ understanding and 
ultimately concordance with medication and improving outcomes (Légaré et al 2008; Elwyn 
et al 1999; Towle and Godolphin 1999).  Elwyn et al (2003) contend that doctors do not 
commonly investigate patients’ understanding of a proposed treatment or deal with any 
concerns in relation to a drug and when they do encourage patients to ask questions, patients 
rarely do.  Doctors rarely assess the patient’s ability to understand and follow a treatment 
plan, even though they report to do this in approximately 50% of their consultations (Cox et 
al 2002).  Therefore to optimise the process, information was customised to the needs of 
individuals (Cox et al 2002; Kennedy 2003) based on their history and assessment.  Access 
to further information was provided and patients were helped to interpret the data (Kennedy 
2003) through discussion, explanation and the use of tools.   
 
Lack of patient information and a poor understanding of the causes, consequences and 
management of constipation contribute to its development (Chapters 2, 5 and 6).  Emergent 
themes from the former informed the patient education component in establishing some of 
the elements requiring further exploration on an individualised basis.  For example, it was 
not necessary to categorically define constipation other than to say that such a definition 
does not exist, as in contrast, the individual’s characterisation of the condition was more 
important.  The researcher proposed that, for example, an enhanced understanding of the 
workings of a normal bowel, the transition to dysfunction, the detrimental effects of opioids 
and the role and use of laxatives may improve patients’ understanding about the causes and 
consequences of their constipation and empower them to make informed decisions on 
management strategies.  Therefore, these elements were included in the educational 
component of the CMC.  
 
Patient education focused on individuals needs.  All explanations avoided the use of 
medical/nursing terminology as this is generally not used in day-to-day conversation by 
laypeople and may lead to confusion.  For example, 'transit time', 'peristalsis', 
'prophylactic/ally' and 'gastrointestinal tract' are not commonly used outside the health care 
environment.  Patients with poor knowledge about the cause of their constipation were 
advised about the contributory factors that may have predisposed them to constipation.  In 
most cases this included opioid use, other drugs, poor mobility and reduced fluid intake.  
Supporting explanations were given using commonly used words and phrases in a step-by 
step approach.  For example, 'transit time' was covered when describing the time it take for 




was described as the need to 'take laxatives everyday to counteract the effects of...' for 
example, opioids.  
 
7.9.6 Educational tools 
As identified in Chapter 2 and postulated in Chapters 5 and 6, education was considered to 
be crucial in optimising concordance.  To assist the process three documents were obtained 
Appendices 1, 22 and 23) and one created by the researcher, the body chart, (Appendix 24) 
and used as educational tools.  These proved useful as they simplified information that may 
otherwise have been incomprehensible to patients.  For example, the Bristol Stool Form 
Scale has been validated as an objective tool for assessing stool form rather than relying on 
individuals' subjective descriptors as these may vary (Lewis and Heaton 1997).  The body 
chart was useful in aiding the researcher’s explanation of the journey and transit time of 
food, faeces and laxatives was aided by the use of the body chart as graphically it was 
possible to demonstrate why the latter often takes longer than expected before results are 
evident.  The ‘correct positioning’ tool provided practical help on easing defecation and the 
‘Human body and constipation’ chart visually shows how faecal soiling occurs. 
 
Within the philosophy of action research and its cycle, it was envisaged that if further 
educational tools and aids were required then these could be developed or obtained and used 
as required for all patients.     
 
7.9.7 Specific information to impart 
Based on the finding thus far (Chapters 2, 5 and 6), it is likely that patients’ clarification, 
education and/or further information on the following: 
 
1. Defining constipation 
2. The insidious nature of constipation 
3. Normal bowel function 
4. Factors impeding normal function  
5. Causes of constipation 
6. Consequences of constipation 
7. The detrimental effects of drugs 
8. Frequency of defecation – daily is not necessary 
9. Stool form – soft and easy to pass is more important than frequency 
10. Defining ‘regularly’ 
11. What does ‘as required’ relate to 
12. The concept of prophylactic 




14. Side effects of laxatives 
15. Titrating laxatives 
16. Making laxatives more palatable 
17. The use of moist wipes 
18. What to expect when treating an episode of constipation, especially severe 
19. Over-flow diarrhoea 
20. Who to contact for further advice and support 
21. Alleviating constipation may take several days to achieve 
22. Preparing for the ‘explosive episode’ 
 
This list is not exhaustive but gives an indication of the extent of the information gathered in 
preparation for the CMC.  Information was proffered to patients on individualised need and 
to varying degrees. For example, making laxatives more tolerable only applied to those 
taking liquid formulations whereas all patients were giving a 24-hour contact number.    
 
The majority of the information given was evidence based and is reflected in the literature 
review (Chapter 2).  For example, the adverse effect of laxatives and guidance on commonly 
used doses, time to effect and additional comments and recommendations for use (Appendix 
2) specifically for patients with cancer.  In contrast, some information was based on the 
researcher’s nursing experience and/or reports from patients about what they found useful 
and effective strategies, such as the use of moist sensitive wipes.  The following examples 
show the depth of planning and information acquired by the researcher and MDT in 
preparation for the CMC. 
 
Side effects of laxatives  
Knowledge to the potential adverse events and side effects of laxatives was important in 
limiting the number of their occurrence and in optimising concordance.  The side effects of 
laxatives occur to varying degrees in individuals.  In relation to laxatives recommended 
during the CMC, this section outlines the most common side effects and, for reasons that will 
be established, alludes to those seen infrequently.  Information about the side effects of 
laxatives was used to inform patients of actual and potential problems as this often reduces 
anxiety and/or misconceptions (Woolf et al 2005).  For example, some patients may tolerate 
flatus whereas others may find it unacceptable, therefore, methods to alleviate flatus were 
explored and/or an alternative laxative offered.  Patients who disliked the liquid formulations 





It was planned that directions for laxative use would not include ‘regular’ as individuals, (as 
highlighted in Chapter 5), interpret this differently.  Similarly, ‘as needed’ would not be used 
as constipation is insidious and patients may not have been aware that they were becoming 
constipated.  Patients were advised to take their laxatives on a daily basis, whether they 
thought them necessary or not, and to regulate the dose based on stool form and ease of 
defecation.  In the event of any adverse of unforeseen effects and as a precaution, patients 
were asked to report any subsequent changes to their bowel function, other than 
improvements in constipation, to the researcher or their primary HCP (i.e. GP, Macmillan 
Nurse) as soon as possible. 
 
Patients will be informed about the use and role of laxatives to enable them to adopt a 
regimen that encompasses both the prophylactic use of laxatives and the ability to titrate 
laxatives based on their stool form and frequency.  Although some information is offered by 
HCPs most of the information on contraindications, side effects, interactions and dose is 
provided on written patient inserts provided within the drug’s packet and is usually produced 
in minute typeface and what could for some be incomprehensible wording.  Patients often 
consider such information discouraging and not beneficial in determining the balance 
between risks and benefits (Kennedy 2003).  The CMC aimed to redress these through 
patient education and information giving based on the individuals needs.  Patients lack of 
information regarding their condition and the importance of treatment greatly contributes to 
poor compliance or concordance.  Kennedy (2003) purports that informed partnership 
decision making by patients and doctors to achieve concordance concerning treatment, 
requires the timely availability of reliable and understandable information.  
 
7.10 Outcome measures 
As indicated above the framework created used outcomes measures to establish 
improvements in bowel function.  During the interviews (Chapter 5) respondents reported 
randomly on their bowel function, constipation, definition and accompanying symptoms 
over the course of the interview.  In the CMC this information was needed as baseline data 
for setting realistic patient-focused goals and as outcome measures for subsequent 
interventions.  These data were obtained during the initial history taking component of the 
CMC.  Patients were asked open and closed questions (Chapter 4) in relation to stool form 
and frequency and what was normal for them prior to their cancer diagnosis and/or 
development of constipation.  This gave the researcher insight into what the individuals’ 
exceptions (Bassotti et al 2004) may be and gave an account of the individuals’ normal 




(Møller et al 1997; Manning et al 1976; Heaton et al 1992) which in all cases related to 
events at least three months earlier, the MDT were of the opinion that this snap-shot would 
suffice as the most pressing issues related to individuals’ current episode of constipation.  
Therefore, patients were asked how constipation currently affected them and notes were 
taken, for example, hard stools, bowels not opened for four days and the degree of straining.  
These descriptors became the individuals’ measures that were compared at subsequent 
appointments.  Therefore, primary outcome measures use were identified by and 
individualised to patients based on self-reports (Maestri-Banks and Burns 1996).   
 
Few prompts were used at this stage in order to allow patients time to think and contemplate 
their responses, thereafter prompts (as discussed in Chapter 4) and questions were asked to 
obtain supplementary data using the Bristol Stool Form Scale (Lewis and Heaton 1997) and 
based on the Rome II Criteria (Drossman et al 2000) (Chapter 2).   
 
Another outcome measure was the cessation of digital removal of faeces in patients who 
volunteered the information.  Secondary outcome measures also related to laxative regimen 
by comparing and contrasting this as a baseline with that identified during and after 
constipation had been alleviated.  Patients’ ability to self-titrate their laxatives was identified 
as a secondary outcome measure in those attempting to achieve this.  
  
7.11 Laxative regimen recommendations 
Laxative regimens were identified using a concordant approach, thus agreement based on the 
individuals’ informed decision and preference of formulation and frequency of use 
(Zeppetella 1999; Kennedy 2003).  Patients’ perseverance with agreed regimens might have 
faltered (Heath 2003) if they remained unconvinced of laxative efficacy or continued to have 
negative experiences (Marinker and Shaw 2004) thus, patient education was used as the 
instrument through which adherence was optimised as there strong evidence exists that 
certain laxatives are efficacious.  Laxative recommendations included the use of laculose, 
senna, lactulose, co-danthrusate and polyethylene glycol.  This list is not exhaustive but 
affords guidance on efficacious laxatives (Miles et al 2007) to optimise constipation 
management should the need arise.   
 
From reviewing the literature, the researcher discovered that the prevention of constipation 
requires consistent and prophylactic treatment and that not all laxatives are appropriate to use 
in patients with cancer.  For example, despite the evidence to support the efficacy of 




laxatives should not be used in patients who are: debilitated, have advanced disease and/or 
who are unable to drink the required amount of water with the administered dose (Tamayo 
2004).  This frequently includes the elderly and those who are dehydrated (Bosshard et al 
2004; Ginsberg et al 2007).  In the absence of sufficient fluids the osmotic nature of psyllium 
exacerbates dehydration and constipation.  Therefore the use of laxatives containing 
psyllium was avoided in the CMC. 
 
Patients presenting with troublesome/severe constipation were commenced on an appropriate 
laxative regimen.  Regimens were selected based on patients’ preferences (laxative, dose, 
and formulation), guided by the researcher as necessary.  In most cases increasing current 
laxative dose (and/or those most recently prescribed) was encouraged as their lack of 
efficacy was alleged by patients but not proven.  Additional guidance on how to make these 
regimens more palatable was offered when dislike deterred their use.  In contrast however, 
alternative laxatives were prescribed when side effects were deemed unacceptable. 
 
7.11.1 Drug information 
Dickinson and Raynor (2003) propose that the ideal source of drug information is accurate, 
up-to-date and practically useful.  Kennedy (2003) and Dickinson and Raynor (2003) support 
the customisation and personalisation of information and argue that there is a need to ensure 
patients are able to strike a balance between a treatment's beneficial and adverse effects, 
together with associated reliable and consistent sources of advice and information.  In the 
CMC drug information was made available and offered at the time of a consultation, thus 
accessible and consistent high quality information (Elwyn et al 2003; Dickinson and Raynor 
2003).  Ultimately, concordance was optimised, drug efficacy established and constipation 
alleviated.   
 
Drug information afforded to patients was obtained from a variety of sources.  These 
included; extrapolation during the literature review (Chapter 2), the most recent versions of 
the BNF (2008) and FCP (2007), directly from the drug’s manufacture and during 
discussions with the medical team.  Information given to patients was up-to-date and 
conveyed to patients in a simple and uncomplicated manner using the aforementioned 





7.11.2 Titration and escalating dose 
During the CMC the need to titrate, use rescue laxatives and/or use higher than normal doses 
was supported by the research evidence presented in Chapter 2 (Ramkumar and Rao 2005; 
Tramonte et al 1997; Petticrew et al 1997; Miles et al 2007; Tamayo 2004) and is supported 
by the periodical BNF (2008) and Palliative Care Formularly (2007).  However, given that 
most patients’ preferences to take as ‘little as possible’ if at all (Britten et al 2002; Britten 
1996; Conrad 1985; Donovan and Blake 1992; Morgan 1996; Rogers et al 1998; Britten 
1994) the researcher postulated that increasing and escalating laxative dose may have 
resulted in patients being reluctant to adhere to the recommendations.  The latter did not 
happen as is most cases successful prophylactic regimens were within normal ranges (BNF 
2008) and when treating severe constipation, the recommendations to use a high laxative 
dose was proffered to patients with information, education, support and advice.   
 
Regimens were not rigid.  Laxative choice, dose and efficacy fluctuated in individuals 
depending on other factors such as escalating opioid dose.  Self-titration formed part of the 
regimen in order to empower patients to make timely modifications to their dose depending 
on stool form and frequency.  Drug information and support was made available to patients 
and consistently reviewed during follow-up CMC consultations.  There is evidence to 
support the use of this approach as it ensures consistent laxative use, thus its efficacy, and 
patient concordance, both of which can be optimised through the provision of contemporary 
drug information. 
 
7.11.3 Reiterating in context: preparing for an ‘explosive episode' 
In preparation and anticipation of the outcomes of the laxative regimens aimed at managing 
‘troublesome constipation’ patients were advised that they might experience an ‘explosive 
episode’ of faeces which could induce, amongst other things, a degree of lethargy.  The 
researcher used the term ‘explosive episode’ as this was how patients had described the 
event in the past.  Patients were advised that such an event was not uncommon but if it 
caused concern or anxiety, they could telephone the researcher or any member of the 
nursing/medical team using the 24-hour support telephone number.   
 
7.12 Continuity of care post CMC consultation 
In line with normal clinical practice a letter outlining each patients CMC appointment would 
be sent to HCPs involved in their care.  This channel of communication ensured continuity 




provided a point of contact for HCPs requiring further information and raised their 
awareness of the clinic and profound impact constipation has on patients.  Patients would be 
followed-up 7-10 days after their initial clinic appointment in the knowledge that, should 
they require any further information and/or support in the interim period they could 
telephone the Unit’s well established 24-hour telephone advice line number, which 
encompasses out-of-hours5 should the need arise.   
 
The sharing of these experiences and feedback to HCPs was a central component of this 
action research study and considered a method of dissemination both within the Unit and 
externally to the GPs and community teams supporting the patients in the locality.  To 
facilitate this process the researcher forwarded a letter not only to the GP but also to the 
patient’s consultant and other known HCPs such as Macmillan and district nurse and other 
agencies involved in the individual’s care.  The letter aimed to give an overview of the 
individual and their presenting problems and afford the reader an insight into the patient’s 
causes and consequences of their constipation and the plans underway to alleviate the 
condition.  The aim was to ensure continuity of care and afford the reader further support 
with managing the individuals constipation if required.  
 
Patients were advised that follow-up should occur within 7-10 days, or sooner should they 
have any concerns or worsening symptoms.  Patients’ preferences prevailed in follow-up 
format, which was either to return to the Unit for another appointment or be follow-up by 
telephone either at their initiation or by the researcher.  The latter option was facilitated as, in 
the researcher’s experience, would lessen the burden on this vulnerable group, thus 
preventing further distress.  For patients attending the day care unit, follow-up coincided 
with these attendance dates.   
 
7.13 Evaluation of the CMC framework 
The CMC framework worked well as it afforded a structure within which comprehensive and 
timely data were obtained, assessments carried out and in which patient education prevailed.  
The cyclical nature ensured that subsequent consultations were also comprehensive, that 
information was re-evaluated and that the educational element could be refined or reiterated 
as necessary.  The CMC afforded patients with an individualised assessment, advice and 
information together with continuity of care to optimise outcomes.  The consultative-
interview proved effective in providing rich data on constipation management strategies, 
                                                 




related concerns and misconceptions which were then compared and contrasted with 
contemporary evidence-based best practices, especially the efficacy of laxatives and 
improved patient outcomes through concordance.   
 
The consultation was a consultative-interview in which patients articulated their experiences 
and concerns relating to their constipation history.  In contrast to the findings in Chapters 2, 
5 and 6, patients responded positively to the opportunity to explore their multifaceted 
problems with constipation and keenly engaged in all components of the framework.  
Foremost to their keenness was an acknowledgment that their plight had been acknowledged, 
they were being ‘listened to’ and thus appeared open and honest regarding their management 
strategies, an outcome attributed to the interview process and its techniques.  None of the 
patients reported, or appeared, distressed by the disclosure of sensitive information which 
was possibly due to the nature and context in which the consultation occurred and the fact 
that there were no time constraints.  All patients described the physical and psychological 
burdens that they believed were the result of their constipation. 
 
7.14 Summary 
This Chapter has presented the methods, preparation processes, the development and 
implementation of the CMC.  The collaborative MDT involvement was apparent throughout 
and afforded the CMC and its patients a more holistic and comprehensive approach to their 
constipation management than previously encountered. The rationale for the CMC as a 
natural progression of the study was based on the evidence presented in Chapters 2, 5 and 6.  
Plans, aims and objectives were formalised and establishment and the implementation of the 
CMC ensued, including the extensive planning which was undertaken and included the 
widening of peer support and encouraging HCPs be involved in the study. 
 
Data collection that were planned and conducted proved to be useful in establishing the 
individual’s current medical status, their support mechanisms, the identification of actual 
and/or potential problems, such as poor dexterity, anxieties and practical difficulties with 
clinic attendance all of which required addressing.  In addition, bowel habit data were 
collected despite the reported difficulties in assessment (Chapter 2) and the questionable 
validity and reliability of self-reported bowel function (Manning et al 1976), as the MDT 
considered these to be appropriate outcome measures.  
 
The rationale for the identified outcome measures is established along with justification of 




supplemented by objective data thus confirming patients’ subjective reports, the ultimate aim 
of which was to apply a sense of validation to the data and outcomes.   
 
The preparation of the researcher to lead the CMC as an effective and safe practitioner has 
also been highlighted.  This facilitated the development of enhanced knowledge and skills to 
ensure that patients’ needs could be met, problems identified and prompt action taken.  The 
parameters of sample identification and referral have been exposed along with data 
collection and outcome measures.  Some of the problems relating to constipation, such as its 
lack of definition, have been discussed in order to explain why it is not always possible, nor 
necessary, to have these precisely identified.  Being a qualitative study, the patients’ points 
of view are of more relevance to this research and are presented in detail in Chapter 8.   
 
The CMC framework has been presented as its development culminated from the research 
findings thus far and contributions from the MDT.  The application of the framework was 
underpinned by previously used methods (Chapter 4) that proved effective in obtaining in-
depth meaningful data.  These included the ‘consultative-interview’ based on interviewing 
skills and techniques and the recording of field notes which facilitated a comprehensive 
account of the individuals’ history and current bowel status. The importance of patient 
education and information has been discussed along with the need for these to be appropriate 
and contemporary in order to take full advantage of their potential benefits.  Additional 
methods used specifically for the CMC included the use of charts and laxative examples as 
part of the diagnostic and educational processes have also been explained.  Visual tools were 
used to aid and simplify the educational component as some of the information may 
otherwise be new and or cause confusion as for example, it could not be assumed that 
patients had an accurate mental image of the anatomy and physiology of the body.  The 
planning processes, informed by the interview stage, pertaining to possible problems that 
might arise due to ambiguity, subjectivity, lack of definition and/or patients’ poor 
understanding and knowledge are discussed to illustrate some of the detail of preparation 
prior to the CMC.   
 
In the event, laxative regimens were derived using a concordant approach and based on the 
individual being fully informed about the actual and potential consequences of their use and 
non-use, along with up-to-date drug information such as potential side effects.  This 
concordant approach enabled patients to make informed decisions about laxative use and 
self-titrating regimens.  The ability to self-titrate laxatives was underpinned by the 
information given to patients relating to stool form and frequency and planning for 




from making inaccurate assumptions and subsequently taking inappropriate actions such as 
ceasing laxatives based on their misdiagnosis of diarrhoea.  Follow-up consultations 
provided continuity of care and ensured that patients’ constipation and its management were 
maintained.  As death approaches the causes and consequences of constipation might change 
and management strategies will likely need modifying.  For example, although constipation 
may have been resolved and prevented for a period of time as a result of their CMC 
attendance, the subsequent development of tumor related bowel obstruction is likely to occur 
in some patients. 
 
The findings of the CMC are presented in Chapter 8.  The process of dissemination appears 
at the latter part of Chapter 8 as this occurred concurrently throughout this research and 





The Constipation Management Clinic findings 
 
8.1 Introduction 
This Chapter presents the findings from the CMC and represents the cornerstone of this 
action research study.  The main aim of this stage was to reduce the incidence and/or severity 
of constipation in patients with cancer.  The aims and objectives were informed by the 
literature review, the patient interviews and HCP focus groups.  Through the use of a 
qualitative approach, the researcher utilised the individuals’ (HCPs and patients) perceptions, 
beliefs and attitudes which were considered to be inherently meaningful (Denzin and Lincoln 
2003a) and are therefore reflected in the main themes and outcomes emerging from the 
CMC.  This CMC stage of the study also set out to improve local HCPs’ practices through 
the ongoing dissemination which included contemporary study findings, thus bringing  
together the collaborative multiprofessional approach and the multidimensional components 
that are explored and presented.  The means of dissemination of all the findings are included 
in this Chapter. 
 
The first section reports the overall findings from the patients perspective and the remainder 
of the Chapter expands on these main themes and introduces the researcher’s findings that 
were gleaned from medical notes, where available and perhaps more importantly, from the 
field notes.  Where the data originate from patient report excerpts from the transcripts are 
used as evidence to support the arguments made.  However, in instances where data have 
been gathered from either the medical or field notes the findings are presented as a general 
discussion.  The sections are presented on a time line as far as possible to allow the reader an 
easier understanding of the findings. 
 
The CMC laxative regimen identification, prescribing and patient self-titration are presented 
followed by the benefits adopting a concordant approach to constipation management and 
providing continuity of care.    The evidence illustrating how and to what extent the CMC 
achieved its aims and objectives are presented.  These are offered as themes along with 
respondents’ narratives in order to present the data in context thus affording verification to 
the reader as to the appropriateness of the overall evaluation of the CMC presented in 




presented followed by patient education and information giving which formed a major 
component of the CMC.   
 
The remainder of the Chapter highlights the value of working collaboratively with the MDT 
when trying to resolve problems and improve constipation management in patients with 
cancer.  To this end, the role and impact of dissemination is followed by the informal 
evaluation of the CMC which is offered as this emerged from the data, along with patients 
unmet needs. 
 
8.2 The effectiveness of the CMC 
In order to maintain the central importance of the patients’ perspectives to this qualitative 
study this section presents findings that represent the data as reported by them.  Some of the 
points made are purely introduced without great discussion at this point but are returned to in 
other guises and places throughout the Chapter.  
 
8.2.1 Welcomed by patients 
Perhaps the main finding of the CMC was that the patients were generally excited and 
welcomed it as being innovative and from their perspective, much needed.  Patients appeared 
relieved that a clinic which focused on constipation had been initiated, not least of all 
because of its uniqueness but also because they became optimistic about finding a solution to 
their constipation.  Patients seemed relieved that there was ‘somewhere to go’ where they 
could discuss their constipation and resulting problems in private and consequently they 
were eager to attend their first appointment as soon as possible despite previously being 
advised that positive outcomes could not be guaranteed.   
 
“… (constipation) It’s awful, you just can’t imagine…..  Takes over your 
life…..  If only I could get rid of it I’m sure I’d feel so much better.  My 
doctor says I’m bound to feel rough but I’m sure if I could get rid of this 
constipation and feeling bloated all the time it would help.”  (MH)  
 
“I get so embarrassed all this leaking and down my legs.  You sit down and 
sometimes I think Oh, I better not get up in case I’ve made a mess on the 
settee or something.”  (JT) 
 
“… It really hurts when it gets stuck half in and half out. Then my head 
pounds and my heart starts to thump and I begin to panic.  When it’s out I 





Patients were advised that outcomes might be variable and, although evidence based 
interventions were utilised, success was also dependent on patient-clinician (researcher) 
concordance.  This patient enthusiasm in regard to the CMC reflected the desires of some of 
the patients interviewed in stage one of the study. 
 
8.2.2 Alleviating constipation  
The second overarching finding was that the patients perceived the CMC to be successful.  
The data revealed that of the 29 patient recruited, 21 reported ‘an alleviation’ (to varying 
degrees) of their constipation and therefore the focus of the consultations was able to 
progress to that of laxative titration and prophylactic use rather than initial resolution.  It was 
found that the remaining eight patients required further increases in their dose, or, due to an 
agreed lack of efficacy and/or dislike of their current regimen, justified the use of an 
alternative laxative, therefore a prescription was raised by the researcher. 
 
The measure of success of the CMC was achieved through patients’ self-reports of 
constipation in line with the tenets of qualitative research from the individual’s perspective 
(Polit and Beck 2008) and set against the personal outcomes measures that were established 
on initial consultation.  Within 10 days of their first CMC appointment several patients 
reported ‘complete alleviation’ of their constipation whilst others describe improvements in 
stool form, frequency and/or ease of defecation.  Patients recognised that their constipation 
had been eased because they took their laxatives regularly and consistently.  Furthermore 
patients understood the need for prophylactic use of laxatives and the consequences of none 
adherence to their regimen. 
 
Sadly, not all patients accomplished an ideal laxative regimen based on self-titration as death 
preceded this.  Nonetheless, identification and concordance was achieved in all cases, as 
patients reported having ‘taken daily without exception’.   However, not all patients achieved 
alleviation of constipation as quickly as they would have liked but expressed a willingness to 
persevere on the basis that ‘things had already improved’.  
 
“…….I did pass a lot but it was quite lumpy and hard but not as bad as it 
use to be … (EB) 
 
“…….I thought it was a bit softer but I still have to strain quite a bit” (DP) 
 






“I’m getting my life back.  I’m tempted not to wear pads but I’ll wait a bit 
longer.”  (EE)  (Appendix 25) 
 
Five patients who reported the need to remove faeces digitally stated that this was no longer 
necessary and expressed a desire to avoid recommencing the practice. 
 
“No, I don’t do that (digital removal of faeces) anymore…. it’s nice and 
soft” (JS) 
 
“… and I don’t have to take it out myself now.” (EE) 
 
Patients identified their personal outcome measures explaining specifically what constituted 
an improvement in their constipation.  As these outcomes were subjective and varied 
between individuals it was not possible to compare, contrast and/or assimilate various 
components.  However, given the qualitative nature of this study these data are evidence that 
patients believed they benefited from the CMC. 
 
8.2.3 Patients’ subjective outcome measures 
To enable success to be claimed and congruent with an essentially qualitative approach 
subjective personal outcome measures were established to provide base line information 
against which any achievement of the CMC could be assessed.  The outcome measure of 
self-reported constipation worked effectively as all patients had at least three descriptors that 
they considered problematic.  Descriptors used by patients to define constipation are as 
reflected in Chapter 2.  These were recorded as base line information. Most common were 
hardness of stools and difficult defecation.   
  
“The best outcome to me…. to be able to pass a soft motion rather than 
having to struggle to pass anything at all……that would be great!” (EE) 
 
“….it is so difficult and painful to have my bowels open… it would be much 
easier if my motions were softer…… I would do anything that you think I 
should to achieve it!” (AB) 
 
In all instances patients were desperate to be relieved their constipation.  In describing the 
severity of their constipation patients often used words such as ‘not too bad’, ‘quite bad’, 
‘awful’, ‘troublesome’ or ‘very bad’.   
 
“It’s been really bad for weeks…..” (JL) 
 





“Not so bad this week… but I suppose that it quite bad if that makes sense? 
(JL) 
  
The term ‘severe’ was a descriptor predominantly favoured by HCPs, whereas, patients used 
words such as ‘bad’ or ‘troublesome’ to indicate severity.  HCPs use of the word ‘severe’ 
may be influenced by their predominantly medical and quantitative backgrounds which 
could be further compounded by the problems of identifying and defining constipation as 
previously discussed (Herz et al 1996; Anton 2002; Lembo and Camilleri 2003; Boyle 1970; 
Cash 2005).  Due to the subjective nature of these descriptors it could be that patients and 
HCPs interpret these words with varying degrees of emphasis, thus, HCPs only identify 
‘severe’ and a significant problem whereas the patient describes the experience as ‘quite 
bad’.   
 
Nonetheless, patients’ descriptors were used and when co-presented with a degree of 
severity, these became the initial outcome measures by which subsequent consultations were 
compared.  As indicated as evidence of CMC success, seven patients reported using digital 
removal of faeces and their cessation of this in all cases were considered an outcome 
measure.   
 
8.2.4 Reducing stress 
As previously discussed in Chapter 7, patients were given the Unit’s 24-hour telephone 
support and advice number to use in the event they had further questions and/or concerns 
about their constipation or its management.  Patients reported that being aware of these 
resources was extremely useful as it dispelled their fears and anxieties, especially out-of-
hours when patients felt unsupported and vulnerable and community teams were unlikely to 
be accessible for example; 
 
“I didn’t have to use the number but knowing I could was useful.  I think I 
was less worried because when you live alone there is no one else to ask.”  
(LL) 
 
“I didn’t worry so much cos when I phoned before they told me what to do 
and things got sorted.”  (SS) 
 
“It is really helpful knowing there is someone to talk to even at night.”  
(KW) 
 
Patients stated that they were less stressed and able to enjoy life more.  Maintaining 




pleasurable as soon as their constipation had been relieved.  Furthermore, both hospital 
appointments and social engagements became not only possible but pleasant.  Fears, that the 
signs and symptoms of constipation were in fact not constipation but something more sinister 
such as disease progression, predictably resulted in patients’ being anxious.  
 
“I thought the cancer was just getting bigger.”  (TM) 
 
(Crying)  “... this is the first time I have admitted that (fears of disease 
progression) .... I just couldn’t tell my wife....”  (JM)  (Appendix 26) 
 
“You just think well, this is as good as it gets and carry on.”  (BF) 
 
These conversations were initiated by patients during the CMC consultation and it appeared 
that they had been reticent about raising such issues with HCPs, including their GP and 
cancer specialist, mainly because they had ignored the patients’ plea for help in the past.   
  
8.3 The physical examination 
It was possible to correlate some elements of self-reported constipation in seven patients who 
underwent a physical examination thus providing objective data to supplement patients’ 
subjective accounts.  These included patients’ reports of bowel not opened for several days, 
frequent and ongoing loose stools, distended abdomen and the individual’s sensation that 
their rectum was ‘blocked’.  Patients’ verbal consent was obtained prior to the procedure.   
 
The researcher found that seven patients had a palpable mass in their colon and of these five 
had evidence of firm-hard stools in the anal canal.  The physical examination confirmed the 
severity of the individual’s constipation and offered reassurance to patients that their 
concerns were justified and important.  The information pertaining to the location of their 
faeces was used during the patient education element of the clinic.  The location and 
confirmation of their constipation was also of benefit to patients in as much that they 
described being ‘pleased’ that the researcher had been so thorough and ‘taken them 
seriously’.   
 
8.3.1 Benefits of a physical examination: reducing anxiety, stress and fear 
The benefits of undertaking a physical examination were various and although the process 
was viewed as being necessary as a safety intervention it proved to hold more, perhaps 
unforeseen, outcomes.  The most commonly reported positive outcome was that it allayed 




that although they had not raised these anxieties with their cancer specialist they had been 
concerned that their constipation was something ‘more sinister’.  Therefore, such a 
systematic and comprehensive assessment of constipation was met with relief.  This 
sentiment is indicated in the excerpt below which was gained from a patient who reported 
that the physical examination not only diminished their fears that their cancer had 
progressed, but gave them more confidence that the researcher ‘as clinician’ was competent 
to deal with their constipation, for example; 
 
“I must say, you obviously know what you are doing which is more than I 
can say for my GP.  He never once examined me.”  (EE) 
 
“The doctor said the district nurse would do it (PR examination) but she 
didn’t.”  (AB) 
 
“My wife tried to put those things in (suppositories) but she couldn’t do it.  I 
said something felt like it was stuck there (in the anal canal) but she didn’t 
want to force it because I wasn’t sure what it was.” (JL) 
 
 “My husband said “Oh dear you look 8-months pregnant (laughing).  I 
made a joke of it but really I didn’t want to worry him in case it was the 
cancer.  But I did feel constipated too, so you don’t know do you?  It’s a 
relief to know it is constipation…...”  (BW) 
 
The physical examination not only reduced the patients’ anxiety levels but also ensured that 
the researcher subsequently provided appropriate information and advice based on the 
individuals’ needs, namely, treating troublesome constipation.  Treating troublesome 
(severe) constipation was achieved with optimal doses of oral laxatives, the identification of 
which derived through patient education and concordance.   
 
8.3.2 Haemorrhoids: treatment and reassurance 
It is not surprising that approximately a third of patients presented with painful and itchy 
haemorrhoids which were subsequently addressed at the clinic with simple and effective 
practical advice.  This comprised the suggestion to use sensitive wipes instead of toilet paper 
and haemorrhoid cream to relieve the itching.  In some instances rectal bleeding had created 
additional pressure and anxiety.  Whilst referral back to the GP may have been appropriate, 
some patients declined as they reported being faced with a similar ambivalence to their 
constipation.  For example, when the following patient mentioned her haemorrhoids (which 





“Oh that is the least of your problems…”  “I was surprised when he said 
that because it really bothers me but there’s obviously nothing he can give 
me for it.  I thought he would but he didn’t.”  (EE)  
 
The GP failed to give any support or advice.  EE suffered unnecessary discomfort and 
distress.  Patients were advised by the researcher that haemorrhoids may subside as a result 
of constipation alleviation (softer stools).  The presence of haemorrhoids and advice given to 
patients was conveyed to HCPs in the post-CMC letter.  It is not known why the GP failed to 
provide this simple and straightforward advice that took only a few minutes to impart, 
however, exploration of issues pertaining to GPs attitudes is outside the remit of this 
research.  
 
8.4 Researcher’s skills and medical support 
The CMC process worked well as in most cases constipation was confirmed.  Medical 
support was sought for three patients in who concerns were raised during the physical 
examination.  Two patients presented with a distended abdomen that was sensitive to gentle 
touch.  A third patient presented with ‘something stuck’ in his rectum and reported that he 
had not had his bowel open for seven days.  On examination, a palpable mass was felt in his 
transverse and distending colon.  A very hard mass was also evident in his rectum.  The 
medical team concurred with the researcher’s suspicion that all three referrals to them were 
appropriate and the patients’ subsequent x-ray confirmed tumour bowel obstruction in one 
case, ascities in the second and severe faecal impaction in the third.  Suspecting only 
constipation none of these patients were being monitored by their HCPs.  The patient with 
faecal impaction was admitted to the inpatient Unit and maintained contact with the CMC 
whereas those with tumour obstruction were discharged from the CMC. 
 
Three further patients were referred for abdominal x-rays the findings of which all confirmed 
constipation.  Furthermore, as the results of x-rays were usually sent for the doctor’s 
attention it was quite reassuring that the investigation results were promptly conveyed to the 
researcher so that patient management could proceed without delay.  The timely reporting of 
patients x-ray results to the researcher was in an acknowledgement by the reviewing doctor 
that the individual was severely constipated (as opposed to suffering with tumour 
obstruction) and therefore needed appropriate judicious interventions as soon as possible to 
alleviate symptom distress, (such as pain and/or nausea) or other complications such as 





It was reassuring for the researcher to discover that, based on her abdominal examination of 
six patients and speculation that severe constipation was likely.  If the x-ray had revealed a 
tumour mass the patient would have been referred back to the medical team, however, in 
these six cases severe constipation was confirmed as a result of the abdominal x-rays, thus 
reaffirming the newly acquired skills, knowledge and confidence acquired by the researcher.  
By way of ongoing researcher education, doctors were keen to show the researcher the x-ray 
and identify areas of interest including evidence of faeces and/or air in the colon and how to 
differentiate between the two.  The researcher did not adopt a diagnostic role but did find 
such information beneficial in informing and underpinning her own knowledge and practice.  
This subsequently was used to impart a more simplistic explanation of constipation and its 
management to patients, carers and colleagues.   
 
At their first CMC appointment over half the patients had ‘troublesome’ constipation and in 
the remainder it was less severe.  Following assessment by the researcher some patients were 
identified as being ‘severely’ constipated despite their reports that it was “not too bad at the 
moment”.  It appears from the narratives that the former comment occasionally related to the 
patient’s attempts to manage their constipation rather than the actual condition itself.  For 
example, when asked to report on how bad their constipation was currently (at the time of 
the consultation) the reply was often ambiguous, for example: 
 
“Quite bad but it has been worse.” (JM) 
 
“Well it’s not too bad at the moment because……I’ll take some laxatives 
tonight and perhaps they will work.”  (EM) 
 
“… I’ve had all this diarrhoea so I can’t be constipated but it keeps coming 
back.” (PP) 
 
“I don’t know.  I feel so awful, perhaps it’s the cancer and well..…” (JA) 
 
“My doctors don’t seem bothered so I suppose it’s not that bad… (EY) 
 
Following the physical assessment the researcher considered three of the above patients (PP, 
JA and EY) to be severely constipated.  All patients reported being worried by their 
constipation, not least of all, because their attempts to ease it had failed and HCP support 
was absent.  For the researcher, what had once been perceived as the domain of the ‘doctor’ 
it had become evident that working more collaboratively and challenging the status quo can 
improve patient outcomes.  The researcher was surprised how keen colleagues were to 
accept advice and guidance on constipation management and laxative regimens.  Similarly, 




prescription, the researcher found it useful and productive that doctors either accepted the 
researcher’s decision and/or, following usually minimal clarification, agreed with the 
researcher’s findings and recommendations.   
 
8.5 Patient education 
The flexibility of the CMC framework ensured that an ongoing assessment of the 
individuals’ needs was maintained and appended to the researcher’s clinic notes as 
necessary.  Education was interactive and became a focal point during the appointment and 
one in which patients came to recognise the actual and potential causes of their constipation 
and the use and role of laxatives.  In many cases patients arrived at their own conclusions as 
to why they had become constipated and how this could be alleviated, however, these 
conjectures were now evidence based and supported with confirmation from the researcher, 
thus validating that patients’ education had improved and thus concordance more likely to be 
attained.  The CMC framework was also informed by patient reporting which enhanced the 
process insomuch as when new problems arose they were explored and resolved, and thus 
afforded an ongoing evidence base on which to make suggestion to other patients and HCPs 
during dissemination.  For example, ‘specific information to impart’ (Chapter 7) was 
appended to include the use of sensitive wipes which was proffered by the third clinic 
attendees who advocated their use.   
 
Overall, the framework embraced the philosophy of action research as it was cyclical in 
nature and facilitated problem identification, planning, action taking, resolution, evaluation 
and assessment at each stage.  Furthermore, the framework was created collaborative by the 
MDT and encapsulated contributions from patients.  The framework was practical, easy to 
understand and comprehensive. 
 
8.5.1 The use of visual aids 
The educational element was led by the researcher whom identified key issues of concern 
that appeared to have been exacerbating constipation, such as opioid use and/or the 
suboptimal use of laxatives.  This process facilitated the provision of individualised 
information to patients at a pace to suit them. The evaluation of the patients’ understanding 






For those patients who had a limited understanding of the workings of the bowel the 
researcher utilised the pre designed visual learning materials.  In reality this group comprised 
nearly all the patients attending the CMC.  A verbal dialogue by the researcher accompanied 
the use of visual aids.  A two-way discussion always ensued as patients asked questions and 
summarized their thoughts as reflected in the narratives presented in this section.  These 
tools were welcomed by patients and proved effective in explaining salient points in simple 
terms accompanied by graphical representations, thus facilitating patients understanding.  
The latter was tested by the researcher asking salient questions, such as “how do you think 
your constipation could have been prevented?” which was reported upon by some patients as 
“taking laxatives every day without exception”. 
 
The body chart 
To demonstrate how the bowel worked the researcher used a diagrammatic body chart.   This 
proved to be of practical use as patients reported that it was straightforward and easy to 
understand.  Using different coloured pens the researcher drew on the chart using a 
systematic approach.  Firstly, the path of a meal from mouth, stomach, small intestines, large 
bowel then rectum/defecation.  A brief explanation about transit time and peristalsis 
followed.  The transition to bowel dysfunction was then explained and an impression of hard 
faeces drawn on the body chart.  The problems of using laxatives after the onset of 
constipation were then explained.  These were depicted on the body chart as laxatives in the 
stomach and hard faeces.  A verbal explanation highlighted the distance between the two and 
the duration of time before the laxative is able to take effect.  
 
 “…it makes sense once it’s explained.”  (TJ) 
 
“… getting rid of all the waste in your body would be good otherwise it will 
be sort of rotting inside, stagnant like.”  (JM) 
 
“… people (HCPs) just assume we (patients) know all this but we’re not 
doctors so why should we but …  I know now and it’s not difficult when you 
think about it.”  (CH) 
 
“It is clear.  I explained it to my wife and even she said it made sense …” 
(EM) 
 
“Well you see, I thought I had a valve here and it was blocked … I didn’t 
know the bowel was that long … I didn’t really know how it worked I 






The researcher also proffered an analogy which was that unlike many medicines that patients 
take ‘as required’, such as paracetamol for a headache (for which all patients confirmed they 
had done), laxatives do not work immediately nor are they just treatment for constipation, 
thus the importance of preventing the condition. 
 
The use of pictorial representations was well received and identified by patients as being an 
excellent medium for improving their understanding.  Patients often commented that the 
visual aids were uncomplicated and improved their comprehension and reinforced the verbal 
information given.  All patients reported that this use and role of laxatives had never been 
explained to them and that the causes and consequences of constipation had only been 
alluded to briefly by HCPs, if at all.  Patients had only used laxatives ‘as required’, which 
was interpreted by them to mean once they felt constipated.   
 
The body chart not only proved to be a useful teaching aid but also as a document to record 
patients’ progress and facilitate explanations of change by comparing and contrasting their 
previous consultations.  Seven patients requested a photocopy of their completed body-chart 
to take home to aid explanation to another family member or as an aide-mémoire to assist 
their constipation management.   
 
The Bristol Stool Form Chart 
In similar fashion to the body chart the researcher utilised the Bristol Stool Form Chart to 
assist the educational component of the consultation.  It again proved to be successful in 
establishing semi-objective data on current stool form but the conversations invariably 
proceeded to elicit data pertaining to individuals’ varying and past stool forms.  None of the 
patients had seen the Bristol Stool Form Chart prior to the CMC and found that by pointing 
at a particular form they could accurately indicate the nature of their stool.  The following 
narratives referred to usefulness of the Bristol Stool Form Chart. 
 
“Ah, this is good… saves you having to describe it which doesn’t always 
sound very nice does it.”  (EM) 
 
 “…(laughing) … this is clever actually.”  (JE) 
 
“Yes, it’s like that one but sometimes a bit of that.  This is good, makes it 
easy for me to explain.”  (DW) 
 
In many cases patients were unable to distinguish between symptoms presenting as a result 




CMC appointments however, patients were able to correlate improvements of other 
symptoms as their constipation abated, for example back pain, lethargy and nausea.  When 
asked how the association had been made patients attributed it to a better understanding of 
how their bowels worked and the use and role of laxatives. 
 
Heath care professionals response to visual aids 
Interestingly, several HCPs, particularly nurses, requested copies of the charts and 
commented on their potential value for use in their own practice, especially patient education 
and assessment.  This not only indicated the nurses’ recognition that the management of 
constipation might be improved but also their receptiveness to respond to such needs.  This 
interest is in contrast to the literature whereby the apparent gap in nurses’ knowledge and 
understanding of constipation (George et al 1996; Moore et al 1996) which is further 
compounded by a reluctance to under-report bowel habits and related subjects (Robinson-
Wolf 1996).   
 
The positive approach by HCPs provided further validation of the success of the clinic and 
the benefits of using an action theory methodological approach in this research which set out 
to incorporate a multidimensional and MDT approach to alleviate constipation in patients 
with cancer.  It was also considered to represent a form of dissemination of findings and 
practice and therefore a robust conduit for a change in knowledge, and thus practice, which 
in itself should enhance patient outcome. 
 
In summary, it appears that the aforementioned charts and explanations were effective in 
improving patients understanding of bowel function and the use and role of laxatives.  It is 
likely that the patient-focused approach lends itself to identifying individuals’ needs and was 
proffered at a pace to suit the patients and without time constraints.  Checking the patients 
understanding was achieved through direct questioning and prompts, for example when 
asked how their constipation might have been prevented all patients reported daily use of 
laxatives.  
 
8.5.2 The use of example laxatives  
As indicated previously the researcher found that the problems of identifying patients’ 
previous or current laxative use resolved with the aid of the laxatives examples.  The 
examples proved effective as all patients identified additional laxatives that they had not 




merely as result of the patients’ forgetfulness, or perhaps they had been considered 
unimportant, or deemed ineffective and/or intolerable.  For example; 
 
“Oh yes, I’ve had that (indicating senna) but it gave me cramps.”  (DC) 
 
“I’ve tried that (indicating ispaghula husk) but I can’t take that again.  I 
only used one but just couldn’t swallow it, made me feel sick.”  (VE) 
 
“I’d forgotten about that one (lactulose).  It worked okay, made it (stools) 
soft like but it’s so sticky and sweet.”  (EE) 
 
“… yes…. ages ago.  Seemed to work….  Can’t remember why I stopped 
taking it now.”  (ML) 
 
Throughout the example laxative stage the drug most frequently identified as having been 
used was senna.  In most cases senna had not been highlighted because its use had originated 
from an over-the-counter purchase rather than from the patients’ GP.  Ispahula husk and 
lactulose were also recognised but these had more often than not been discarded due to a 
perceived lack of efficacy.  They were remembered as a result of packaging/item recognition 
during the CMC. 
 
To achieve optimum effect the example medications were positioned within reach of patients 
who were encouraged to handle and examine them.  The underpinning rationale for this was 
identified following the patient interviews (stage one) and proved to be valuable for several 
reasons. Firstly and previously acknowledged, patients identified additional laxatives that 
they had used in the past but had failed to recall usually because they had forgotten the name 
of the laxatives or simply that they had used them until they recognised either the laxative 
box/container or the tablet/capsule.  Secondly and as it transpired the, patients became aware 
that there were additional laxatives that could be tried therefore appeared to be more 
optimistic that ‘something’ may be available that would alleviate their constipation.  To this 
end, the example laxatives facilitated a more comprehensive account of laxative and it was 
also possible to ascertain remaining supplies that patient had which could potentially be 
recommenced without incurring further burdens such as financial costs and pharmacy visits.   
 
On reviewing the examples patients expressed a ‘wish’ to find a laxative that worked but this 
was in the absence of the knowledge that they needed to be taken consistently and 
prophylactically, therefore, alternatives were not always necessary.  Again the lack of 
understanding of the need to take laxatives regularly and at an appropriate dosage emerged 
as a finding as it had done throughout the data gathering processes of the study.  However, 




personal preference, especially in relation to formulation: tablet, capsule or liquid and thus 
harnessing the ethos of a concordant approach (Dickinson and Raynor 2003; Jones 2003; 
Britten et al 2002). 
 
In summary, the use of laxative examples proved extremely useful in facilitating a more 
comprehensive account of laxative use than identified during the patient interviews.  
Furthermore, it enabled the researcher to encourage patients to try alternatives if necessary 
when side effects and/or lack of efficacy had deterred their use.  The researcher raised 
prescriptions for six patients who required alternative laxatives.  As reflected in the literature 
review this concordant approach is more likely to facilitate compliance with laxative 
regimens and empower patients to take more control over their use (Dickinson and Raynor 
2003; Jones 2003; Britten et al 2002). This was achieved as patients began to successfully 
self-tritate their laxatives to attain maximum effect and control.  
 
“Oh, I didn’t realise I could take a tablet.  I would prefer that really.” (LC) 
 
“I can’t manage those tablets, they are like bullets.  My’ GP didn’t say I 
could have it like this (liquid).  (TM) 
 
“He (GP) just told me to take this (ispughula husk) but I can’t.  It goes all 
thick and blobby, makes me wretch.  Can I have something else, perhaps 
something easier to swallow?”  (SS) 
 
“I will try what you asked me to do (optimising current regimen) but if it 
doesn’t work,……I did have it before (in hospital) but they didn’t give me it 
when I went home….. I didn’t mind that.”  (PJ) 
 
 
The use of examples also raised patient’s awareness that, in contrast to the interview findings 
more could be done to ameliorate their constipation.  In addition the patients’ newly acquired 
knowledge of different laxatives led to some degree of incredulity as they challenged the fact 
that alternative laxatives had not been introduced in the past, especially when unacceptable 
side effects had resulted in poor levels of laxative adherence. 
 
“Why didn’t my doctor give me this then?”  (MV) 
 
“I don’t understand why….my doctor is good ….. he didn’t tell me I could 
try these.”  (EE) 
 
“… no he didn’t say a thing my doctor….. either he doesn’t know about 





“…… I took it and it does seem better but I still would like to try that one 
(pointing to an alternative) because taking mine is not very nice when you 
need so much (20mls of lactulose three times a day).”  (EE) 
 
The educational element became more interactive at this stage as patients asked direct 
questions relating to how their bowels worked and the use and role of laxatives.  Most 
patients were unaware of the duration of transit through the gastrointestinal tract so the use 
of pictorial tools facilitated a clearer understanding of why laxatives often take longer than 
expected to work.   
 
“It does make sense you know.  It seems obvious now but….. I’m I wish 
someone had explained that earlier.”  (JL) 
 
“I feel such a fool.  I could have worked that out for myself if you think 
about it.”  (SS) 
 
“You should be told about these things when they give you these drugs.  I 
understand why now, it is easy to see what is happening to me.”  (CY) 
 
Furthermore, education reinforced the importance of taking laxatives every day, without 
omission, as the dose taken on day 1 may not take effect and/or be passed rectally until day 3 
or longer.  As the process of bowel function had been clearly explained during the CMC, 
incorporating bowel stasis and peristalsis insufficiency, patients reported a better 
understanding of how constipation manifested and the use and role of laxatives.  Some 
patients explicitly stated that it would have been useful if someone had explained such things 
in this way before as it had now become clear and obvious to them.  
 
The importance of patient information and education was viewed as being central to 
achieving an optimum level of concordance and through this, constipation could be reduced 
(Dickinson and Raynor 2003, Jones 2003; Britten et al 2002; Zeppetella 1999).  The 
researcher made full use of the information sheets and charts as discussed in Chapter 7.  It 
was apparent that the patients generally had little or no knowledge of how their bowels 
worked and therefore did not fully understand their constipation.  This is unsurprising given 
the seriousness of their conditions and the resultant vital treatments and adjustments to 
diagnosis.   
 
Patients were also afforded information on how to make some laxatives more tolerable rather 
than discontinuing them completely, as found in Chapters 2 and 5.  For example, fruit squash 
can be added to polyethylene glycol (minimum 125 mls of water per sachet plus fruit juice or 




confirmed this to be safe practice as it would not impair the drug's efficacy, however, they do 
not advocate the use of carbonated/fizzy drinks as the latter not evidence based.   
 
Generally, patients had inadequate knowledge about the causes and consequences of their 
constipation.  The data revealed that the onset of the patients’ constipation varied from those 
who had suffered with chronic pre existing constipation which had greatly worsened since 
their cancer diagnosis and those with secondary constipation as a result of their morbidities.  
The use of opioids was considered, by the researcher, to be the most likely cause in most 
cases. 
 
“You know, these doctors….. should have known this (pointing to body 
chart) ….. if this had been explained to me before… I spoke to so many of 
them (HCPs) and they didn’t show me anything like this.  It makes it so easy 
to understand.”  (TM) 
 
“I like your pictures.  I used to be a teacher but I’d forgotten how simple 
things are to understand with them…. It does make sense what you say.”  
(MH) 
 
The relief that the patients felt was almost palpable.  There was a certain reflective 
accusation that, from the patients’ perspective, they considered that they had not been given 
enough information relating to constipation thus far during their treatment.  Of course, this 
may have been offered by HCPs but at a stressful time in the patients’ lives had not been 
fully understood.  On the other hand it has to be considered that they may have not been 
offered any meaningful information.  In contrast it may be that patients failed to articulate 
their problems with constipation because they had not been specifically asked (McMillan 
and Tittle 1995; McMillan 2002).  By eliciting patients’ perceptions, experiences and 
understandings it was possible to individualise educational needs.  This represents a new 
approach and was considered pivotal to the success of the CMC. 
 
8.6 Laxative regimens 
This section brings together patients’ laxative use insomuch as their use in the past, their 
current use (at the point of first consultation) followed by regimen recommendations during 





8.6.1 Establishing the current situation 
The medical records and patient’s self report, in several instances obtained with the 
prompting of the example laxatives indicated that only six patients had been co-prescribed 
senna and lactulose but had not taken them prophylactically or consistently.  The remaining 
15 patients had used senna and lactulose but contrary to recommendations, these had been 
prescribed as a sole agent and often one subsequently to the other when the first product 
appeared to lack efficacy.  In most cases, lactulose 5-10 mls once or twice a day, and/or 1-2 
senna at night had been prescribed accompanied by the advice to take ‘as required’ and in 
some cases patients had up to five different laxatives at home.   
 
It would appear that, prior to their attendance at the CMC none of the patients were currently 
undertaking appropriate laxative therapy nor, as it became apparent later, were they aware of 
the proper use and role of laxatives and the HCPs and patient disparity on assessment, 
identification and under reporting was also evident (Herz et al 1996; Boyle 1970; Cash 2005; 
McMillan and Tittle 1995; Moore et al 1996; Oxenham et al 2003; Walsh 1984; Donnelly et 
al 1994; Addington-Hall et al 1991; Vainio and Auvinen 1996; Sykes 1998).  It was possible 
to redress these issues, along with others that are outlined below, by utilising the specifically 
developed CMC framework to provide a comprehensive and individualised approach to 
constipation management.   
 
As indicated previously, none of these patients were using their laxatives prophylactically or 
consistently. In most cases, lactulose 5-10 mls once or twice a day, and/or 1-2 senna at night 
had been prescribed accompanied by the advice to take ‘as required’.   
 
“Those (liquid paraffin and senna) he (the GP) gave me ages ago but they 
didn’t work then the Mac nurse…. said to take this (lactulose) and well, have 
you tasted it?,…awful, made me feel sick.  I had senna in the house so I tried 
that, then someone else gave me this (psyllium based product) and it made 
me worse.  About four or five weeks ago….. the Mac nurse said try this 
(polyethylene glycol) and I suppose it helped a bit.”  (DR) 
 
“I’ve got so much stuff at home. I don’t use it though which makes me think 
why am I keeping it.  It seems such a waste.”  (GG) 
 
“... I could open a shop”  If I bring it in here you could add it to your 
collection (laughing) .. some I bought in the shops and I don’t think you have 
them in there (pointing to the examples)...”  (NJ) 
 
 
All patients had adopted an ‘as required’ regimen, in the belief that this was appropriate, 




laxatives in the past and in some cases reported having up to five different types which they 
had discarded due to a perceived lack of efficacy or dislike of formulation.    
 
8.6.2 Researcher’s recommendations 
In most cases the researcher’s recommendations amounted to an increase in individuals’ 
current laxative/s to a therapeutic dose.  The therapeutic dose included taking laxatives every 
day without omission whether patients considered that they needed them or not.  That is, 
regardless of whether they deemed themselves to be constipated.  This was important as all 
patients had at least three predisposing factors to their constipation most commonly that of 
opioid use.  The aforementioned therapeutic dose subsequently became the regimen that 
patients used for self-titration purposes and in the knowledge that, if these laxatives 
remained ineffective, they could obtain alternatives at the CMC.  In most cases increasing 
current laxative dose, together with consistent and prophylactic use, was successful in 
alleviating constipation. 
 
Patients presenting with troublesome/severe constipation were commenced regimens at 
higher doses than would be used for prophylactic use. Regimens were selected based on 
patient’s preferences (laxative, dose and formulation), guided by the researcher as necessary.  
Eight patients required further increases in dose or an alternative laxative.  A concordant 
approach was used to identify an appropriate laxative regimen for each patient, that is, 
patients acknowledged that they had failed to use the drug appropriately and were therefore 
willing to try it again in the knowledge that it was much more likely to be efficacious when 
used consistently and prophylactically.  Patients, in partnership and guided by the researcher, 
were pivotal in the decision making process regarding the identification of their laxative 
regimen coupled with an agreement to test its efficacy.  Regimens recommended to patients 
were mainly those known to be efficacious when taken in optimal doses, as reflected in 
Chapter 2: lactulose, senna, lactulose plus senna, co-danthrusate and polyethylene glycol.  
Laxative efficacy was subsequently experienced by patients in most cases. 
 
Alternative laxatives were prescribed when patients found their existing regimen either 
unpalatable or not as efficacious as anticipated.  In some cases patients taking 10mls of 
lactulose once or twice a week was tolerable whereas taking 20mls three times a day became 
unacceptable and often caused excessive wind.  Whilst some patients were not disturbed by 
such regimens and/or side effects some preferred to try an alternative laxative.  In most 
cases, patients using methods to make laxatives more tolerable found the intervention useful, 





“I was really surprised, my wife got some of the grape juice and I added 
some of that.  It’s OK you know, taste just fine.”  (JL) 
 
“Yes, that worked, I was really surprised.  I couldn’t taste it at all after 
that.”  (MF) 
 
“I found the orange juice worked well because generally I found that a bit 
sharp so the sweetness of the lactulose sort of counterbalanced that.  I don’t 
mind taking it now.”  (RP) 
 
Several other patients using techniques to camouflage liquid formulations also reported that 
this process was successful and had enabled them to tolerate the laxative and thus adhere to 
their regimens. 
 
The prescribing of laxatives was generally uncomplicated however the researcher raised a 
concern about the use of polyethylene glycol in one patient prone to electrolyte imbalance. 
The Unit’s doctors were also unsure about the safety of polyethylene glycol under such 
circumstances. As a result it was decided that the researcher liaised with the drug’s 
manufacturing company. This scenario is discussed later under ‘Problem resolution - the 
MDT approach’. The patient was subsequently prescribed polyethylene glycol with excellent 
results despite previously discarding the product for lack of efficacy some months earlier. 
 
As predicted, most patients held supplies of unused laxatives that were subsequently utilised.  
When prescriptions were raised by the researcher they were countersigned by one of the 
doctors as planned.  Some doctors embarked on discussions with the researcher about her 
choice of laxatives to ensure choices made were evidence based and appropriate to the 
individual.  Comments made at the time generally indicated that the doctor considered the 
researcher’s choice of regimen appropriate and probably more evidenced based than their 
own laxative prescribing patterns. 
 
Patients were pleased that they were able to obtain laxative directly from the pharmacy 
following their CMC appointment thus timely commencement of regimens.  Similar to the 
findings in Chapter 5, patients reported that they lacked confidence in the community teams 
in affording appropriate support and advice on constipation management.  However, patients 
did not raise any concerns about the need to contact their GP for repeat prescriptions despite 
describing events which implied this support mechanism had failed in the past.  It may be 
that patients were happy to obtain repeat prescriptions as obtaining these did not require 





8.6.3 Laxative titration 
During the CMC the need to titrate, use rescue laxatives and/or use higher than normal doses 
was supported by the research evidence (Ramkumar and Rao 2005; Tramonte et al 1997; 
Petticrew et al 1997; Miles et al 2007; Tamayo and Diaz-Zuluga 2004) and is supported by 
the periodical BNF (2008) and PCF (2007).  However, given that most patients’ preferences 
to take as ‘little as possible’ if at all (Britten et al 2002; Britten 1996; Conrad 1985; Donovan 
and Blake 1992; Morgan 1996; Rogers et al 1998; Britten 1994) the researcher postulated 
that increasing and escalating laxative dose may result in patients’ reluctance to adhere to the 
recommendations.  The latter did not occur as in most cases successful prophylactic 
regimens were within normal ranges (BNF 2008) and when treating severe constipation, the 
recommendation to use a high laxative dose was proffered to patients with information, 
education, support and advice.  As reflected in the literature review (Chapter 2) this 
concordant approach to prescribing is more likely to facilitate compliance with laxative 
regimens and empower patients to take control over their use, which also appeared to be 
evident in patients attending the CMC. 
 
Whilst the choice of laxatives and doses varied between patients, the important outcome 
reported by all patients was that they took laxatives consistently, and in most cases daily 
without omission, because they understood the importance of doing so.  Laxatives were only 
omitted as part of the titration process and/or to facilitate social events thereafter resuming 
the regimen became ‘the norm’ as prophylactic use.  Two patients reported running out of 
supplies of their laxatives and attributed responsibility for this to themselves in terms of they 
should have ‘known better’. 
 
One of the aims of the CMC was to enable patients to titrate their laxatives to self manage 
their constipation.  Overall, patients reported that they deemed themselves confident in their 
ability to titrate laxatives based on stool form, frequency and ease of defecation.  When 
familiarising themselves with laxative choice and/or dose, patients tended to raise questions 
that merely required reassurance from the researcher.  This input mainly concerned 
confirmation that adjustments made to laxative regimens were appropriate and would 
probably maintain therapeutic benefit.  For example, 
 
“My bowels are much better now with the 20mls (of lactulose) twice a day 
but they (the stools) are still a bit firm…...  It is OK to take a bit more, 
maybe another spoonful (5mls)?”  (SS) 
 
“I don’t think I need three (polyethylene glycol) now, it (stool) is quite soft.  





“I took two senna at night and then one spoonful (5mls) of lactulose in the 
morning, it’s OK but I thought I’d try a bit more lactulose and only one 
senna because I sometimes I get a bit of gripe.”  (TS) 
 
“…so just sticking with 1-2 senna at night and lactulose in the morning and 
in the evening works.  I don’t change it….., I know I can but really I think I’ll 
just make sure I take it every day. I do take it every day.  I never used to but 
then…. I didn’t know …” (GT) 
 
 
Some patients developed regimens that were unusual however if they were considered 
successful by the patients they were deemed appropriate. These had all been reviewed by the 
researcher and regarded as safe doses and/or combinations of laxatives.  For example, one 
patient reported being relieved of her constipation and satisfied with her bowel function 
when using one polyethylene glycol on alternate days. This would normally be regarded as a 
suboptimal dose especially in light of the patient’s opioid dose which would have 
exacerbated her constipation.  However, this particular patient had a history of irritable 
bowel syndrome and laxative abuse which may have impacted on her constipation and/or 
laxative regimen.  The important outcome was that the patient reported that she had, for the 
first time in her life, identified a regimen that alleviated her troublesome constipation and 
therefore success was achieved.   
 
Whilst some of the regimens may be considered unusual, it is important to note that they 
were resultant of the patients’ titrating their laxatives themselves and finding a level that 
worked effectively in alleviating their constipation.  The most common confirmation sought 
by patients was to establish that their regimen was safe and might prove efficacious.  For 
example 20-30mls of lactulose twice a day +/- 2-4 senna at night which was a higher dose 
than previously prescribed.   
 
Another patient’s regimen consisted of one polyethylene glycol in the morning, one senna 
tablet at lunch time and two co-danthrusate tablets at night.  It is possible that co-danthrusate 
or polyethylene glycol used as a sole agent may have been of equal efficacy, however, the 
patient’s development and acceptance of this regimen was of more importance since he had 
assumed control and was confident in his ability to manage his current, acceptable, bowel 
function.  On discussion with the medical team and further investigation, the researcher 
could not locate any evidence to indicate that this combination of laxatives could be 





As time elapsed, patients reported varying their doses of laxatives based on their stool form 
and frequency.  This was supported by comments including; 
 
“I would be eating my toast and all of a sudden I have to go.  I rush to the 
loo, we’ve got one downstairs which is good because I wouldn’t get to the 
one upstairs in time. I’ve been caught short a couple of times, but I usually 
make it.”   (SS) 
 
“I felt it was a bit too soft so I missed the evening dose for a couple of days.”  
(JH)   However patient continued with the morning dose. 
 
“It was becoming a bit, I wouldn’t say hard not like before, but a bit firmer 
so I took another one (polyethylene glycol) that night.  I will take an extra 
one tonight too I think… it will help.”  (MH) 
 
The ability to titrate and predict stool frequency and/or consistency was reported as being of 
central significance as it was employed to maximise opportunities and arrangements for 
outings and social events.  One patient reported experiencing extremely soft motions daily 
between 08:00 - 09:00 hrs and was therefore aware of the urgency urgent access to a lavatory 
to open his bowels.  Although this was not particularly troublesome to him in his own home 
there were occasions when the fear of faecal incontinence caused him extreme distress.  For 
example, once a month he was required to leave home before 07:30 hrs to undertake a 
lengthy car journey to a hospital in central London.  The journey could take 1.5 hours and 
toileting facilities were unavailable until reaching his destination.  Following three clinic 
appointments this patient considered that he had ‘become empowered’ as he had established 
a laxative regimen that included omitting his laxatives two days before the hospital visits; 
which had resolved the problem.  He subsequently resumed his laxative regimen recognising 
that his stools would become somewhat harder in the short term. Thus illustrating that 
patients can successfully titrate their laxative to reduce embarrassment and accommodate 
activity.   
 
8.7 Communication to HCPs 
To ensure that HCPs were appraised of any changes to their patients’ regimens a 
comprehensive letter (examples Appendix 26 and 27) outlining the current situation was sent 
after each CMC appointment. The letter contained an overview of the individual’s presenting 
problems with constipation and highlighting possible causes and outlining the CMC plan to 
alleviate the condition.  The proposed laxative regimen was identified so that GPs could 
source repeat prescriptions as necessary, which is normal practice when prescribing from the 




(Appendix 28 and 29) and consistent use of laxatives (Appendix 30 and 31)  to ensure that 
all HCPs involved in the individuals care were kept informed and were also proffered the 
researcher’s contact number should any issues of concern arise.  It is noteworthy that none of 
the patients’ GPs raised questions or concerns in relation to their patients’ constipation 
management based on the researcher’s recommendations and in all cases continued to 
prescribe the proposed laxative and dosage.  Due the constraints of this study it was not 
possible to explore GPs views on the researcher’s recommendation. 
 
It is perhaps outside of the parameters of this study to make any inference or draw 
conclusions as to the reasons why HCPs had failed to use alternative laxatives.  However, as 
a result of the post-CMC letter it may be that these ‘prescribers’ adopt a more proactive 
approach to their patients’ constipation management rather than merely, due to an inadequate 
understanding or choice of preparation, provide repeat prescriptions of a laxative that had 
minimal effect.  Within the philosophy of action research this process of follow-up 
information to HCPs was considered to be an additional opportunity to disseminate the CMC 
findings.   
 
8.8 Patient empowerment: taking control 
As alluded to in several previous sections, one of the finding of the CMC patients became 
more confident and empowered.  This was apparent as patients grew to understand their 
constipation more fully and were able to titrate their laxatives to achieve the best personal 
outcome.  The researcher drew the conclusion that patients became empowered because they 
understood how constipation manifested and the use and role of laxatives. Patients assumed 
control of their constipation management by liaising with other HCPs and being more 
proactive in identifying appropriate management strategies.  This was evidenced by the fact 
that some patients reported that they had requested further supplies of laxatives to 
accommodate an increase in dose to achieve titration. These requests had been made to the 
researcher, to the patients prescribing doctor or pharmacist (in the form of repeat 
prescription) as appropriate to the individual and their circumstances. 
 
 
“…I just asked my GP for more…… because I need them to be of any use… 
to make me go as you said…”(GT) 
 
“…. I think that I need more ….. can you sort it out for me?.... (TM) 
 
“…. I just made sure that I kept ordering them when I got all the other 






Some patients recounted how during periods of admission patients they had ensured that 
their titrated laxative regimens were reflected on their drug charts, which was also 
considered to demonstrate empowerment.   
 
“I told them when I went in what I wanted as it works…..and makes me feel 
much better” (SS) 
 
Patients declared that they had reported to HCPs, with whom they subsequently came into 
contact, how much better they felt as a result of their improved bowel movements.  They 
also considered that their new appreciation of the manifestation of constipation and the role 
and actions of laxatives had greatly assisted in the success of laxative titration.  This 
anecdotal evidence was supported by several HCPs who made contact with the researcher to 
confirm and/or clarify laxative regimens.  For example, HCPs frequently sought 
confirmation of laxative regimens and advice for constipation management per se, thus 
developing their own knowledge to the benefit of patients in the future.   
 
Similarly, patients recounted that they been empowered to manage their own constipation.  
For example, following seven years of struggling with constipation, one patient emotionally 
reported how pleased she was that finally her constipation was being resolved.  The 
knowledge she had acquired during the consultation had promoted an understanding of 
“what was going wrong” and “what she could do” to compensate for the adverse affects of 
her illnesses and medications.  Being capable of assuming control and make positive 
changes, without relying on HCPs who had been either uninterested or indifferent to her 
plight, became so empowering that she described how she felt;  
 
“I’ve got my life back.....and I know how to prevent it (constipation) 
happening again.  And if I can’t sort it I’ll contact you if that’s OK because I 
know my GP won’t be interested.”  (EE)    
 
“Yes, it’s (constipation) much better, I’ve passed a lot of stuff but.... I still 
feel like its stuck, you know.... in my bottom (anal canal).”  (JM) 
 
“… and I don’t get so much back pain now which used to bother me a lot.” 
(CW) 
 
It is noteworthy that generally patients preferred a softer stool.  Three patients reported that 
their stools had become a softer than anticipated but preferred this to being constipated.  Fear 




appears that, for some patients, once bowel function had resumed to their acceptable norm 
(soft, frequent and easy to pass) patients refrained from jeopardising this delicate balance 
(Appendix 28).  Living with stools ‘a little too soft’ was acceptable to them as this was 
manageable, less painful and a lot less distressing. 
 
 “I never want that (constipation) to happen again, I’d rather go to the toilet 
four or five times a day than risk that again.” (PJ) 
 
“No, that’s OK.  I’m happy with this (slightly too soft stool) can’t risk that 
again.  Give me a week or two and then maybe I’ll cut down a smidge, but 
let me enjoy getting it out for now.”  (BM) 
 
Any misconceptions relating to their drug regimens were also discussed.  For example, 
patients were advised that opioid use would induce or exacerbate constipation but it was not 
necessary to reduce their use in order to minimise constipation, on the contrary, preventing 
constipation could be achieved by optimal laxative use.  The difference between diarrhoea 
and overflow was explained using the body chart and a rationale given as to why laxatives 
would be needed to remove the offending faecal blockage causing the 'overflow'.  Patients 
accepted that indefinite prophylactic and consistent use of laxatives would be necessary in 
order to lessen/prevent constipation since they understood the rationale for this need and that 
partial alleviation of their constipation might be the best outcome. 
 
“If I go out I sometimes use a pad just in case but I would rather do that 
than become constipated again.  When I was constipated I couldn’t even go 
out you see, so (laughing) let’s just keep it like this (soft).” (TM) 
 
This example and the previous ones highlight that patients’ preferences vary insomuch as 
some prefer being a bit ‘too soft’ whilst others are not disturbed by the occasional ‘firmer’ 
stool.  The ability to self-titrate laxatives ensured that individual preference could be 
achieved and maintained, and in most cases, until the terminal phase of their illness.  
However, it is worth noting that patients could still choose how they prefer their bowels to be 
managed, even when they experienced a degree of faecal incontinence which is not 
uncommon in this client group. 
 
The realisation that their laxatives may not be taken for a couple of days resulted in a 
concerted effort to obtain more supplies as soon as possible to prevent another episode of 
constipation.  Responsibility for bowel management had shifted from the HCPs to the 
patients themselves and it became apparent that the latter were no longer reliant on others to 





“I should have known, I usually ring the GP but I forgot.”  (SS) 
 
“… my husband is going today, I said to him “don’t you dare come home 
without it (laughing)”.  I don’t want that (constipation) happening again.”  
(BW) 
 
It is worth noting that in these instances the community teams (GP, Macmillan nurse and 
district nurse) also failed to notice the patients need for repeat laxative prescriptions. This 
depletion of medication not only applied to the patient’s laxatives; other drugs were in short 
supply as well.  To this end one housebound man who lived alone reported waiting 10 days 
before getting more supplies of his antiemetics and laxatives.  Conversely, one patient had 
three bottles of lactulose each labeled with differing instructions for use.  The failure of some 
HCPs to be more diligent with this vulnerable group may be due to the reported indifference 
to constipation and its management. 
 
8.8.1 Moving from describing constipation to prediction and prevention 
Over the following weeks and in some cases months, none of the patients reported 
experiencing an episode of constipation similar to, or as severe as, that which had prompted 
their initial referral to the clinic.  Whereas previously, stool form and frequency had been 
used solely as descriptors to report constipation, now, in contrast patients monitored these as 
indicators that laxative doses might have needed adjusting.  This step forward indicated that 
patients had become empowered and had taken control since the emphasis had altered from 
‘describing constipation’ to ‘predicting constipation’. Ultimately, this reinforced the act of 
self-management including titration of laxatives. The management of the patient’s 
constipation shifted from the referring doctor, to whom patients were dependent, to the 
researcher (as clinician), thus facilitating the interventions that potentially empowered the 
patients to take control themselves, which was one of the clinics objectives. 
 
8.8.2 The ‘explosive episode’ experience 
As part of the initial consultation the researcher had cautioned patients that they might 
experience ‘an explosive episode’. Two days following her first consultation one patient 
eagerly telephoned the researcher to report that she had experienced a ‘massive’ bowel 
evacuation and now felt “so much better”.  She further recounted that she was “delighted” 
with the outcome and described the information received during the consultation as of 
“immeasurable” use as she considered herself more involved and therefore less anxious 





The feedback and general liaison with the researcher following an ‘explosive episode’ was 
considered vitally important in order to assess the efficacy of the laxative and bowel function 
and facilitated the titration of laxatives as necessary.  Following the explosive episode 
adjustments to laxative doses were made using a concordant approach between clinician and 
patient, based on the patient’s preference together with descriptions of their stool form and 
frequency.  Thereafter, patients acquired further control of their laxatives and became more 
independent with regards to titration and without exception reported improvements in their 
bowel function. 
 
“… I’m glad you told what could happen because I think I would have 
panicked….. what a relief though…… I just can’t explain it… how much 
better I felt.”  (BW) 
 
“… what a relief… what a relief… I felt so much better in all ways…” (FJ)  
 
Those who experienced a predicted ‘explosive’ episode described how physically and 
psychologically relieved they were immediately post defecation, especially in the hope that 
the buildup of constipation over the preceding days or weeks had been resolved.  Patients 
reported that being forewarned of what to expect during an ‘explosive episode’ made it a less 
stressful (Appendix 30) experience as they felt reassured and optimistic that the situation 
would subsequently improve.  When asked if the episode had distressed them, patients 
reported that it had not because they had known what to expect and, in the knowledge of the 
24-hours telephone support line, knew what to do if they had any concerns.   
 
8.8.3 Loss of rectal sensation 
As the CMC progressed two patients reported that they were concerned that they had been 
soiling their undergarments and leaking soft stools without realising that, faeces was being 
passed at the time.  As a result they were using incontinence pads continuously.  In both 
cases this occurred approximately 3 months following clinic attendance and initial 
alleviation of their constipation.  On further medical exploration both patients had developed 
spinal cord compression which had resulted in loss of rectal sensation and faecal 
incontinence. 
 
Faecal incontinence is extremely distressing however one patient chose to manage this by 
continuing with his laxative regimen and thus prevent constipation even though this meant 
he continually wore an incontinence pad.  The remaining patient became bed-bound and 




to remove the resultant firmer/solid faeces.  The recognition by patients that they could 
influence their stool form and frequency was underpinned by their confidence in titrating 
their laxative regimens. 
 
8.9 Positive comments received from patients 
All patients reported some alleviation of their constipation and were therefore very positive.  
Defecation was generally reported as being easier and less problematic to manage.  In some 
cases other symptoms identified (by individuals) as being related to their constipation had 
eased, especially back pain. All patients reported, to varying degrees, improvements in their 
constipation. This was expressed during follow-up consultations where patients appeared 
surprised and delighted by the improvement in their bowel function.  The ‘surprise’ may be 
because the intervention, taking laxatives daily without omission was, as reported by several 
patients, ‘simple’ and ‘obvious’. However, this ‘simple’ approach only became ‘obvious’ to 
patients following the initial consultation which included a clear explanation about the role 
of laxatives and the exact nature of how they worked. Therefore the implications gleaned by 
the researcher are that patient’s knowledge had been generally improved and that they 
considered themselves ‘delighted’ with the outcomes, which were alleviation of constipation 
and its symptoms. 
 
All patients reported that their constipation has been completely, or partly, relieved which 
was the main aim of the CMC, thus demonstrating its effectiveness.  Descriptions of ‘having 
a good clear out’, ‘feeling much better’, ‘frequent stools that were easier to pass’, and not 
having to remove faeces digitally were all attributed to the relief of constipation. 
 
“I couldn’t believe it.  It was so nice to have a good clear out and I thought 
at one point this is never going to stop but it did.  I just couldn’t believe 
there was so much there…..  I do feel so much better.”  (JE) 
 
“I go every day now and….. it’s really soft.  I used to have to…. put my 
finger in a help it out but I don’t have to now.”  (JH) 
 
“I may not go every day but when I do its soft and easy to pass” (TM) 
 
“I just can’t believe how use this has been…  I thought well there’s nothing 
to lose by coming (to the CMC) but I really didn’t expect it would be so 
simple.”  (KK) 
 
In contrast to the interview findings (Chapter 5) patients no longer described, or discussed, 
how difficult defecation was but rather, how easy it had become. Related narratives imply 




intervention was obvious and easy to adhere to. Interactions with patients changed from 
them reactively conveying the symptoms and burdens of constipation to an 
acknowledgement of how that they could overcome and/or prevent the problem by utilising 
simple methods.  In most cases patients now considered themselves capable of managing 
their constipation and only liaised with the researcher as required, usually seeking 
confirmation that their self-titrated laxative regimens were appropriate and/or safe to use.  
 
Patients were less concerned that HCPs displayed ambivalence or disinterest to their 
predicament other than a reflective sadness and realisation that they had probably suffered 
unnecessarily for so long.  If constipation had been prevented sooner it is likely that related 
signs and symptoms would also have been abated during their advancing disease. 
 
8.10 Achieving concordance  
Concordance was based on identifying what patients felt was important and agreeing how 
they feel their constipation would be better managed in a ‘shared decision making’ which 
leads to ‘shared understanding’ (Jones 2003;  Dickinson and Raynor 2003).  The process 
worked well and was supported by the education component in which provided 
contemporary information of constipation and its management, especially in relation to 
laxatives and their use which is in contrast to the finding of Elwyn et al (2003) who note that 
patients often leave consultations with questions unasked or unanswered.  In the CMC the 
researcher ensured that questions were encouraged and answered.  In the absence of the 
aforementioned, Dickinson and Raynor (2003) state that television and the internet may be 
used as an alternative source for information but Jones (2003) points out that such 
information is often untailored, incomplete, irrelevant or wrong and therefore can add to the 
patients’ feelings of anxiety, uncertainty and confusion.  
 
An appreciation of the philosophy of concordance appeared to be underpinned by the patient 
education insomuch as patients reported having a better understanding of how constipation 
develops and the use and role of laxatives. By combining the CMC framework elements 
most patients adopted responsibility for laxative titration based on their efficacy.  The 
researcher is of the opinion that the time afforded to these patients during the CMC enabled 
them to relax and embrace the ethos of concordance through discussion and information 
sharing.  
 
To achieve the most favourable outcomes for the patient the ideal should be that he or she 




the issue of patient concordance with their laxatives was of great importance not only in 
order to optimise laxative efficacy and patient outcomes, but also in terms of data collection 
and ultimately in addressing the research aim and objectives. 
 
8.11 Follow-up appointments 
Each patient had a planned follow-up appointment that occurred within 10 days of their 
initial clinic attendance.  The average number of CMC appointments was 3 (range 1 – 9) and 
follow-up telephone calls 2.5 (range 0 – 13).  In most cases patients reported adherence to 
their new daily regimen.  Follow-up appointments were also guided by the CMC framework 
other than the initial history taking which was omitted.  A CMC follow-up consultation letter 
was sent to HCPs and filled in the medical notes along with a record of patient’s telephone 
calls (Appendices 32 and 33).  
 
Once the patients had achieved self titration there was minimal need for them to return for 
monitoring or any ongoing intervention.  Some patients telephoned the researcher to report 
their current situation but this was more to maintain general support rather than any specific 
reason associated with the study.   
 
8.12 Patients’ evaluation of CMC 
The patients appeared relaxed throughout the CMC consultations and freely discussed their 
management strategies that may have otherwise been considered personal and intrusive, thus 
implying trust. 
 
8.12.1 Informal evaluation 
During the CMCs conception there were no plans to formally evaluate the patients’ 
satisfaction with the service and/or interventions as this process would have introduced a 
fourth stage to the research.  However, in order to obtain an insight into patients’ satisfaction 
a convenience sample of five patients who were no longer attending the CMC was 
informally asked, by the Day Care Sister, about their constipation and its management.  All 
patients reported an easing of their constipation and that they found the CMC to be 
extremely beneficial.  It was reassuring to note that patients had not sought further support 
from the CMC as they no longer experienced problems with constipation, and that self-





Other patients voluntarily proffered evaluative feedback of their satisfaction with the CMC.  
Most commonly patients reported relief that, finally, someone had been of assistance in the 
resolution of their constipation.  The three patients who had reported that their stools were 
softer than they would have preferred and/or were experiencing faecal incontinence 
subsequent to the alleviation of their initial constipation, reported that this outcome was 
more acceptable than being constipated.  In the latter instance the cause of incontinence was 
identified as being related to disease progression and a lack of rectal sensation as a result of 
the development of a degree of spinal cord compression (within the last few weeks of life). 
 
“Fantastic, explained everything, don’t know why this helps but it does, I 
really don’t know what I would have done if you hadn’t been able to help, 
the education was really useful, I’m so delighted…….  I can’t tell you how 
much better my life is now.”  (EE) 
 
 
Even in the absence of a formal assessment, some CMC patients identified their symptom 
mitigation due to the Clinic.  For example, during the Unit’s day centre periodical 
assessment of patients’ symptoms and severity it was noted that patients attributed 
alleviation of their constipation and other symptoms to the CMC (Appendix 34). 
 
Similarly, nurses in the adjacent cancer centre received positive feedback from their patients 
and subsequently the nurses became more proactive in referring patients to the clinic.  In 
addition, a number of nurses became more diligent when they encountered patients with 
constipation and sought advice from the researcher regarding constipation management and 
identifying appropriate regimens. 
 
A community specialist palliative care consultant relayed with excitement the positive 
feedback she had received from one of her patients.  Seemingly, the consultant had struggled 
for several months to resolve the patient’s constipation, however, to no avail.  However, 
within two weeks of attending the clinic the patient reported to her consultant that her 
constipation had resolved and that she knew exactly what to do to prevent it reoccurring.  
The consultant was so delighted that she made a point of contacting the researcher to convey 
the feedback.  The following comments were recorded in the field notes: 
 
“I reviewed Mrs. Jones last week and she just told me how you had helped 
her with constipation.  She was so pleased, I’ve never seen her so happy.  
She says it (her constipation) has completely resolved……..  I wanted to 
make sure you knew what affect you were having on people….”  (Specialist 





This sentiment was also reported by the sister of another patient. 
 
“Oh, I saw EE’s sister today and she told me that EE is so much better now 
(that her constipation has been alleviated).  She asked me to thank you for 
your help.” (Specialist Palliative Care Consultant 2) 
 
Overall, feedback indicated positive outcomes, both in the amelioration of the patients’ 
constipation and their general well being. 
 
8.13 Problem resolution - the MDT approach 
On the whole the CMC ran smoothly and successfully but there were occasions when the 
researcher sought additional support and guidance from members of the MDT to assist in the 
resolution of emerging issues.  These were generally debated amongst the team members and 
resulting action plans were pursued by the researcher.  Examples of such situations are 
presented in the following sections. 
 
8.13.1 The ghost matrix 
Two patients reported passing what they considered to be undigested food in their stools. 
One person described passing ‘peas’ whilst the other reported ‘corn’. The researcher 
discussed these scenarios with medical colleagues and a suggestion that these patients were 
taking excessive amounts of laxatives was ruled out as their stools were otherwise firm, 
frequent and easy to pass.  Another theory proposed by one doctor was that, in his 
experience, some patients taking the opioid analgesia oxycodone hydrochloride have been 
known to pass the capsule of the drug in their stools.  This discussion and a subsequent 
telephone call to the drug manufacturer confirmed that the patient's analgesia, oxycodone 
hydrochloride, was impregnated into a ‘ghost matrix’ capsule which or that could be passed 
undigested.  Furthermore, provided the drug was maintained in the gastrointestinal tract for a 
minimum six hours all the analgesia would have been absorbed thus optimising the efficacy 
of the analgesia.  As neither patient reported experiencing recent escalating pain it was 
commented upon, by the medical team, that what had been expelled via the gastrointestinal 
tract was the ‘ghost matrix’ capsule which was evident on defecation and thus incorrectly 
assumed, by patients, to have been undigested food.  The difference in colour (green peas 
and yellow corn) related to the different strengths of oxycodone hydrochloride   This 
information proved not only to be reassuring to patients that this was not necessarily as a 




similar conclusion, that of undigested food.  This information was disseminated to HCPs 
within the Unit and via patients' post-CMC letter (Appendix 35).   
 
It was important to disseminate this information given that this drug is commonly used in 
this client group and it was therefore important that HCPs were cognisant of these potential 
occurrences so that appropriate advice could be offered to patients.  Failure to do so might 
result in patients being unnecessarily concerned in relation to their disease and its 
progression.  Furthermore, without this knowledge HCPs could embark upon unnecessary 
time consuming and expensive tests and investigations.  These would burden patients with 
the unpleasant task of stool sample collection, storage and delivery to the hospital or 
pathology laboratory.   
 
It is acknowledged that the passing of undigested food may occur as a result of the cancer 
disease progression or patient’s co-morbidities, for example malabsorption syndrome 
resulting in steatorrhoea (faecal matter that is frothy, foul-smelling and floats because of a 
high fat content), however, in the aforementioned case the medical team agreed that no 
further investigations were necessary unless further problems or symptoms arose which may 
be indicative of disease progression.  
 
8.13.2 The use of polyethylene glycol 
A situation arose whereby the researcher sought advice from medical colleague regarding a 
34-year patient predisposed to an electrolyte imbalance as a result of one of her chronic co-
morbidities.  The question posed related to the safe use of polyethylene glycol, which 
contains electrolytes as a potential laxative for this patient.  None of the medical team could 
afford advice, nor was it clear from drug information sheet or available literature (BNF 2008; 
PCF 2007).   
 
A telephone call to the drug’s manufacturing company assured the researcher that 
electrolytes in the product remain within the compound and are not absorbed systemically. 
When asked specifically if the drug could safely be used by a patient with renal acidosis the 
answer was in the affirmative.  The aforementioned information relating to polyethylene 
glycol use was disseminated to all relevant HCPs (Appendix 36).  The Unit’s nursing and 
medical teams were also advised of the safety of polyethylene glycol for patients with renal 
acidosis thus contributing to their knowledge.  The patient was advised and she subsequently 





Concerns were raised, by HCPs, about the use of polyethylene glycol. Often patients 
reported not linking the taste, therefore discarding it after a few sips.  As a result, nurses 
were asking doctors for an alternative laxative before its efficacy was established.  Due to 
the products known efficacy in patients with cancer the medical team were keen to continue 
the therapy at least until those with severe constipation had been resolved.  When the 
researcher spoke with the nurses and observed their practices it became clear that the product 
was not being used appropriately for the client group or to its best advantages to make it 
more palatable to patients.  In some cases the product, one sachet of polyethylene glycol, 
was being mixed in a tumbler of water (200-250 mls) as opposed to the recommended 125 
mls.  Nurses acknowledged that they simply ‘guessed’ the volume on the basis that ‘a little 
extra fluid’ would not do the patient any harm but in on reflection their actions were 
counterproductive as patients could not tolerate the volume.  In order to ensure that future 
doses were mixed in 125 mls of water, a plastic cup was marked to indicate the volume and 
then pinned to the wall in the treatment room as a guide.  Other questions were also raised 
about the use of polyethylene glycol therefore the researcher contacted the drug 
manufacturing company and disseminated the information to the Unit’s staff (Appendix 37), 
during formal presentations and to patients using the product. 
 
8.14 Unmet needs      
The researcher found that not all consultations dealt solely with the management of 
constipation.  Several patients presented with other issues. Although not by any means 
exhaustive, one or two of these instances are described here by way of examples.   
 
In one instance, the CMC appointment was delayed as the patient was showing signs of 
discomfort in sitting.  On further exploration it became evident that he had developed 
bilateral thigh and scrotal oedema within the last few days and had been unsuccessful in 
getting an appointment to see his GP and therefore not received any treatment.  This 
gentleman’s distress was so palpable that on enquiry the researcher was able to secure an 
appointment with a member of the Unit’s medical team who agreed to review the oedema as 
a matter of urgency. The patient was offered the option to reschedule the CMC appointment 
but chose to continue, evidently reassured by the fact that he would seen by a specialist that 
day. In similar vein, one patient became breathless so the consultation was suspended whilst 
she recovered but was recommenced at the patient’s request following a 20-minute break.    
 
Whilst it is acknowledged that some of the actions taken fell outside the remit of this 




for the well being of these patients and considered that failure to take appropriate action 
would have been unprofessional and unethical.   
 
The researcher acknowledges that disease progression was probably present in all patients 
but it was not expressed explicitly as this might have caused a great deal of distress and/or 
distracted from the consultation in hand.  When disease progression was alluded to by 
patients the researcher suggested that individuals contact their oncologist who could advise 
them as necessary.  This was supported with the explanation that the researcher was not a 
doctor and that contemporary information in relation to their disease was not within the 
scope of the CMC.  In the event that patients became disturbed about their disease/prognosis 
the Unit’s social team members were available to provide psychological support, however, 
none of the patients required such input. 
 
8.15 Dissemination of findings to HCPs 
The dissemination of findings and advancement of practice is one of the central tenets of 
action research.  Therefore, the local MDT and the wider community of GPs and community 
nurses were involved in as many elements of the study as possible.  These opportunities were 
both informal and formal.  Some of these are indicated in this section.   
 
8.15.1 Informal: through communication 
In some cases, the community teams sought advice from the researcher relating to 
management strategies.  In these instances community HCPs predominately sought 
confirmation that their patients’ self-titrated laxative regimen was acceptable.  Thus evidence 
that community HCPs were taking more interest in their patients’ constipation management, 
which is in contrast to the findings of the patient interviews and focus groups (Chapters 5 
and 6). 
 
In addition, several telephone calls were received from HCPs as a direct result from the 
sending of the aforementioned letters and through word-of-mouth as regards this research 
study.  Of the 12 telephone calls received from HCPs eight originated from community 
nurses (Macmillan or district nurses) and four from ward nurses (generally or from the Unit).  
The nature of guidance sought related to cancer patients with constipation and specifically 
advice relating to choice of laxative, reassurance regarding optimum dose, or in one instance, 





In the above scenario it was reported to the researcher that the patient had an advanced 
ovarian cancer and had not opened her bowels for nine days.  The GP, allegedly, had refused 
to see the patient and requested that an inexperienced nurse to perform a digital rectal 
evacuation and then administer an enema.  In this instance, the researcher briefly discussed 
important issues pertaining to patients with ovarian cancer and or those who may have 
obstructed.  Thereafter, the nurse reported feeling better informed and more confident in 
taking the researcher’s advice which was to seek further medical support from the GP and 
encourage a medical assessment.  Furthermore, the researcher recommended that, given the 
probability of encountering similar situations in the future, it might be useful to develop 
advanced skills of performing digital rectal examinations.   The nurse valued the advice and 
was given of a contact telephone number to explore options of digital rectal examination 
training. In addition the nurse was provided with copies of relevant literature to inform not 
only her practice but also other members of her team thus perpetuating the cycle of this 
action research which aims to improve skills, knowledge and communication to alleviate 
constipation in patients with cancer.   
 
8.15.2 Formal: presentations by the researcher 
Dissemination of research findings and educational presentations were conducted 
concurrently throughout the five-year course of this research (Appendix 38).   Furthermore, 
these meetings provided a platform for HCPs with varying status (Appendix 39) and from 
diverse settings to compare and contrast their practices: this also supported the rationale for 
this research and identify training needs.  For example, during a symposium on constipation 
management and the preliminary findings of this research, one palliative care consultant 
objected to the practice of prescribing in the CMC stating that; 
 
 “ …. to teach GPs you need to send the patient back to them to get their 
prescription.”  (Consultant) 
 
The ensuing discussion at the symposium identified several issues about health care 
profession education per se however the majority of the delegates argued that it would be 
both unethical and inappropriate to use patients as the medium for HCP education as 
palliative care patients comprise a vulnerable group.  Failure to provide prescriptions in the 
CMC would result in unnecessary time delays therefore subjecting patients to prolonged 
suffering and an increased risk of further complications such as bowel obstruction or 
perforation.  The discussion at the symposia concluded in favour of providing prescriptions 




to endeavour to alleviate their constipation as soon as possible, thus preventing further 
distress and/or complications.  In addition, the symposia delegates postulated that as a result 
of the CMC’s education element, especially the role and use of laxatives, patients would be 
more empowered in their constipation management and would therefore want to expedite 
new laxative regimens without delay.  
 
During discussions post presentation delegates expressed an enhanced understanding of the 
actual and potential problems of constipation and its management, including the need for 
patient education.  Some subsequently liaised with the researcher for advice on a named-
patient basis and appropriate prescribing.  This type of dissemination became a normal 
practice for those who joined the Unit’s medical team as part of their rotational placement.  
The researcher became a source of support to HCPs, especially those practising on the Unit 
when faced with complex problems. 
 
8.15.3 Promotion and dissemination by groups 
Community teams also became more aware and supportive of the CMC.  This was as a direct 
result of the patients reporting a successful outcome to their constipation management and 
their newly acquired ability to titrate their laxatives.  Following an explanation, supporting 
evidence and reassurance from the researcher the nurses seemed more comfortable with the 
patient’s regimen.  It also appears that the community teams were keen to maintain contact 
with the researcher as a support mechanism for help and advice when managing their 
patients’ constipation. 
 
Similarly, over a period of time, the existence of the clinic, this research, dissemination and 
the researcher and her work per se filtered to the community teams and other HCPs.  As this 
research progressed the researcher became aware that her knowledge base and skills 
pertinent to research methodology and methods in cancer and palliative care had increased 
along with her confidence.   As a result of this study and her increased skills and knowledge, 
the researcher was identified by other HCPs as reference point for advice and support on 
constipation management per se.  This role further extended to advising and supporting 
colleagues (HCPs and professionals allied to health) on other issues relating to cancer 
patients and palliative care, for example; research, audit, patient assessment, symptom 
management, service improvement and development.  As this research concludes, the 
nursing and medical team is considering a permanent provision of the CMC within the Unit 
and the resulting implications on limited resources; especially in terms of time and the 




keeping the clinic but further developing it to encompass the management of other 
distressing symptoms. 
 
One of the Unit’s consultants and two specialist registrars reported to that this research was 
alluded to by a palliative care doctor exploring the use of new drugs for constipation 
management in patients with cancer.  The palliative care doctor was aware of this study as 
she had been an attendee at one of the formal presentations made by the researcher.  It 
appears that during her presentation at a prestigious annual opioid conference in November 
2007 she made positive reference to the nature of this research and how it complemented her 
own work.  This further supports the evidence that dissemination has occurred by HCPs. 
 
8.16 Evaluation of dissemination (HCPs) 
Some attendees to these presentations subsequently worked alongside the researcher at the 
Unit and conveyed how informative the presentations had been and reported a positive 
impact on their practices, especially in relation to constipation management.  Doctors 
reported how the results of this research raised their awareness of the importance of 
appropriate constipation management.  The following examples were recorded in the field 
notes also reflect the comments from other doctors who joined the Unit as part of their 
training rotation: 
 
“I attended your talk at the Drugs and therapeutic day recently and found 
your talk really interesting.  It really opened my eyes to the problems.  I 
hadn’t realised how bad things were.  What you said really made sense, it 
was so useful.”  (GP trainee) 
 
“… I’m a lot more diligent now when talking with patients and think more 
about what I prescribe and what I say to them.”  (SpR) 
 
“Your talk was excellent.  So interesting….  we need to get this message 
across to our doctors…..  When you have finished your research would you 
consider working with us to develop an education programme for doctors 
looking at these issues?  (Consultant and SpR from a hospital in London 
specialising in oncology and palliative care) 
 
“I think some of it was basic stuff but overall there was a lot of it I didn’t 
know.  I would have liked more information on how to do digital rectal 
examinations.”  (SpR) 
 
On three separate occasions HCPs working in the day centre unit reported overhearing 
patients (study recruits) advocating the CMC to other patients and describing how valuable 




the Unit day centre where patients frequently discuss and compare their illnesses, prognosis 
and treatments.  Thus, clinic recruits encouraged other patients with constipation to seek 
referral because the CMC had worked.   
 
Although HCPs were not formally asked to comment on their perceptions of the CMC 
(advantages and disadvantages) it appeared that as the CMC evolved and became more 
established HCPs were more in favour and accepting of the service as  patients and HCPs 
appeared to benefit.  During the early implementation of the CMC two consultants regarded 
the CMC as labour intensive and of benefit to only a limited number of patients, thus not 
cost effective.  Over the ensuring years both consultants made CMC referrals and received 
thanks from their patients for doing so as in all cases constipation had been alleviated.  It is 
reassuring that this positive feed-back was conveyed to the researcher and is thus evidence of 
dissemination and CMC evaluation, albeit informal.    
 
8.17 Summary 
This Chapter has presented the finding of the CMC.  Overall, the planning, initiation and 
implementation of the CMC has been established and the advantages of collaborative 
approach outlined.  The referral process and recruitment of an appropriate sample serve to 
confirm the suitability of the methods and process utilised and the need for the CMC.  
Patient self-referral ensures patients timely attendance and renders them less reliant on an 
unsound mechanism for constipation management.  Doctors appear to endorse the process as 
no issues of complaints or concern were received.   
 
The 29 patients recruited into the CMC were identified over a two year period, thus 
affording what would be considered a robust sample size for a piece of qualitative research, 
especially as approximately half had advanced disease.  Data were collected from a variety 
of sources and, although complex and time-consuming, the resultant in-depth data is 
presented in this Chapter, along with patient narrative, as evidence of the holistic approach to 
constipation and its management afforded during the CMC.   
 
The main outcome measures relied on patients’ reports of to what extent that they considered 
that their constipation has been ameliorated and the mechanism by which this was achieved, 
such as patient education and/or ongoing support.  Support and continuity of care was 
proffered and in most cases, maintained until death.  The average number of CMC 




effective and more convenient to patients, especially those who had limited life expectancy 
and/or who had difficulties with transport.   
 
Patients had learnt that laxatives are effective provided they are used consistently and 
prophylactically.  The learnt experience was underpinned with the new knowledge patients 
had acquired as part of the clinics interventions including the acknowledgment that self-
titration was both possible and safe, and the desires of patients to wean themselves off 
laxatives would be unrealistic, especially in light of why they had developed constipation in 
the first place.  Patients reported that their increased knowledge and understanding of this 
had enabled them to be more accepting of laxative use and the clear explanation proffered by 
the researcher had made understanding the problems easier.   
 
There is strong evidence that concordance was improved, that patients took laxatives 
prophylactically and that self-titration with laxatives is both possible and effective.  Evidence 
of this was apparent when patients sought clarification and/or identified regimens that they 
planned to commence.  Following reassurance the cycle continued along with general 
information exchange that were simplified due to the patient-defined dialogue, that is 
patient’s descriptors were used by the researcher thus reinforcing their appropriateness.   
 
The collaborative MDT approach was paramount as without this support, advice and 
guidance it is unlikely that the CMC would have achieved its aims and objectives.  A sense 
of ownership prevailed and was maintained as the CMC became more established and 
assumed to be one of the Unit’s services rather than a research project.  The researcher 
disseminated extensively which not only promoted and raised awareness of the CMC but 
provided a medium for raising the profile of constipation and its management in patients 
with cancer.  Delegates and formal presentations reported improving their own practices as a 
result of these disseminations.  Whilst it was not possible to formally evaluate the CMC 
there is evidence to suggest that patients and HCPs benefited from its existence and the 
process of its development and application. 
 
This stage represented an innovative change to current practice within the Unit and emerged 
from the first two stages of the study.  The perceived benefits of adopting an action research 
methodology became evident as, intrinsically throughout the CMC, its cyclical nature 
afforded the study with evolving refinements in patients’ best interests.  In addition, the 
dissemination (amalgamated and abridged version of slides used during presentation: 




affiliated HCPs, further encompassed the philosophy of action research.  This dissemination 









Overall findings and conclusions 
 
9.1  Introduction 
This Chapter brings together the overall findings of the study and presents them as a 
discussion chapter that addresses the main findings of this action research study. It is 
presented in five sections the first of which introduces the conclusions from the research 
process and the effectiveness of the action research process and the team working of the 
HCPs.  Although the study was primarily centred on the experiences of patients, the action 
research process that guided it was found to be greatly successful in the achievement of 
improving patient outcomes.  The second section examines the change that was made, 
namely the CMC and this quite naturally leads into the third section that concludes the 
patient’s perspectives that emerged from the data.  The perspectives of HCPs are presented 
in the forth section which then introduces the researcher’s personal reflection of the whole 
process. 
 
The review of the literature that comprised of the steps of this research evidenced an 
abundance of literature relating to the causes of constipation, management strategies and 
evidence of non-compliance with laxative regimens.   However, as the researcher’s initial 
observations indicated laxatives were poorly prescribed by HCPs and used suboptimally by 
patients.  The research has therefore concentrated on the improvement of these practices and 
in so doing how to enhance patients’ outcomes.  In contrast however, there was no evidence 
suggestive that working more collaboratively with patients utilising concordance and a 
patient focused approach, such as those used and developed in the CMC, had ever been 
previously explored to improve constipation management in patients with cancer.   
 
9.2 The Research Process 
The nature of the process proved to be most successful in achieving the aims of the research. 
The process of examining various methodologies and methods afforded the researcher a 
deeper understanding of the nature and scope of the research processes and ensured that 
appropriate methods were used throughout.   The in-depth examination of research 
methodology provided a launch pad for this study.  In addition, the researcher was able to 




developing research knowledge and skills to underpin her role of research and audit sister as 
outlined in the introduction to this study.  The researcher was able to work collaboratively 
with patients and HCPs to capture data from both groups to advance the management of 
constipation in cancer and palliative care.     
 
9.2.1 Appropriateness of design 
The overall design and methods used during this study proved to be appropriate in ensuring 
that data obtained were both meaningful and constructive in informing the various stages of 
the research, thus harnessing the advantages of an action research methodology.  Due to the 
study’s nature and the methodology used it was possible to raise awareness to HCPs of the 
need for further research utilising a qualitative paradigm, as the emphasis of research inquiry 
within cancer and palliative care is located within. 
 
Thus, not only were the totality of the primary and subsequent problems explored overtly 
within the local health care profession but also the process incorporated the philosophy of 
user involvement (NICE 2004) for service planning with the resultant outcome, that of a 
patient-focused clinic that aimed to reduce the incidence and/or severity of constipation in 
patients with cancer.  In so doing, the researcher considers that the central principles of 
action research: participation, democracy with concurrent contribution to change (Meyer 
2002: Thomas O’Brien 2006) were accomplished.  
 
The flexible cyclical nature of action research, where one stage emerged from and was 
resultant of another, proved to be successful.  The modified action cycle (Figure 6) that 
emerged as the most effective to guide the process worked well for both groups of 
respondents, HCPs and patients with cancer and in palliative care.  This also encouraged a 
collaborative approach in decision making and planning with both groups and presents a 
model that will inform future like research and audit on the Unit.  The action research cycle 
proved to be efficient in gaining ongoing and meaningful data.  Formal data emerged from 
meetings, such as stage initiating, whilst individual encounters (interviews and clinic 
consultations) generated more flexible data based on individuals’ needs.  The cycle adopted 






9.2.2 The nature of the team 
One of the main tenets of this action research was to directly disseminate research findings 
into practice thus ensuring informed and evidence based care.  The central importance of the 
MDT as the vehicle for support, collaboration and dissemination in achieving and 
maintaining this has been debated at the outset and highlighted throughout the study.  As 
initially outlined in Chapter 1, identifying the primary problem of constipation management 
was based on researcher experience.  However, through the medium of the MDT forum it 
was recognised that it was a worthwhile area of practice to examine; one that could lead to a 
change in practice that would greatly benefit patients.  Therefore, the action research enabled 
an inclusive, democratic planning process where the MDT, of which the researcher was an 
equal partner, embraced the study and worked collaboratively to reach agreement regarding 
planning and ultimately change of current practice.  In the event, the MDT proved invaluable 
in the resolution of any emerging problems offering advice as appropriate.  This in itself 
reaffirmed a team ownership of the study and acted as a covert form of dissemination of 
findings.  Importantly, the patients were able to adopt an equal and central role in the 
resolution of their constipation.  They were able to offer their experiences and work with the 
researcher towards achieving titration of their laxative regimens.  The action research 
approach proved to be most effective in the breaking down of professional barriers and 
promoting true team working within the Unit and in the local community. This in itself was 
instrumental in initiating an effective change to practice, that of the CMC.  
 
The medical team offered teaching and on-going medical support as and when required. 
Although evidence has been presented that illustrates the nature of this continual support it is 
worth emphasising the value of their input in achieving the successful outcomes of the CMC.  
Again this exemplifies the team approach that was fostered and central to the success of the 
CMC.  For example, the practice of physical examinations was demonstrated, explained and 
observed by senior clinicians to ensure that the researcher’s knowledge and skills were 
appropriate.  In the few instances when advice was sought the medical team were on hand 
and willing to provide it.  Therefore, it is concluded that the availability of medical support 
and advice further enhanced the CMC’s aims and objectives thus affording patients with the 
advanced expertise afforded by the specialist palliative care medical team.   
 
9.2.3 New MDT members 
The nature of the MDT introduced a different and evolving feel to the study.  In most action 




process (McNiff and Whitehead 2006).  In this instance, the transient nature of medical 
trainees and nursing staff had to be accommodated.  As new members joined the MDT it was 
often necessary to have impromptu conversations with the replacement staff members to 
apprise them of the study and gain their support as required (Meyer 2002).  For example, 
core medical staff members were not always available to authorise patient prescriptions 
generated by the researcher. When prescriptions were proffered to junior doctors for 
authorisation a brief summary of the study was often necessary followed by an in-depth 
discussion about choice of laxative regimen. This justification of regimen was always 
appropriate and beneficial for various reasons.  Firstly, the researcher was obliged to present 
a synopsis of the patient and their respective presenting problems pertaining to constipation.  
The benefits being that the researcher was challenged to ensure that her judgement was 
evidence based and sound.  However, in relation to laxative regimens it transpired that junior 
doctors often lacked knowledge regarding constipation management and therefore the 
researcher’s recommendation met with the doctor’s acceptance of the rationale afforded and 
thus authorisation of the prescription.  Therefore, at a local level the action research cycle 
was influential in as much as when a problem was identified action was planned, taken and 
evaluated.  Once again the researcher was able to disseminate findings and the trainee doctor 
was better informed about constipation management in patients with advanced cancer.  
 
One of the unexpected outcomes of the study emerged from the aforementioned transient 
group.  As the main group of HCPs moving in and then out of the MDT consisted of 
specialist registrars and trainee GPs on rotation, they took their newly acquired knowledge 
with them to other clinical areas; some of these were in local to the Unit whilst others were 
scattered nationwide.  The results being that an understanding of constipation management, 
even if incomplete was thus disseminated to other services to the benefit of patients.   
 
9.2.4 Dissemination of knowledge and understanding to MDT and HCPs 
The dissemination of findings became a natural process and occurred at all stages of the 
research, from the initial and extensive review of the literature to the CMC and its findings.   
This was achieved at formal presentations to HCPs and informally during MDT meetings, 
patient encounters and ad hoc conversations.  Overall, the promotion and dissemination of 
the CMC and its findings were positively received and no challenges or concerns arose.  This 
section concentrates and concludes the processes of dissemination to HCPs. 
 
At the outset only a handful of referrals were received from GPs.  However, further referrals 




Whereas some HCPs referred patients to the CMC it became evident that others merely 
required a resource to gain information.  A number of HCPs requested advice regarding 
constipation management in order to expand their own knowledge and maintain optimum 
patient care.  The MDT agreed that this would be yet another opportunity to effect change to 
current practice and would provide an unplanned means of enhancing practice through 
dissemination.  In the event it proved to be simple to facilitate and the researcher, as part of 
her role, accepted the responsibility of support for HCPs.  Given the success of this resource, 
and the varying efficacy of some HCPs practices, it is concluded that a comprehensive 
constipation management support and advice help line should be maintained to benefit both 
patients and HCPs.  
 
9.2.5 Collaborative working with the MDT and other HCPs 
The researcher worked collaboratively with all the other members of the MDT and staff 
practising on the Unit throughout the action research process.  Working in partnership with 
the medical team ensured the acquisition of shared knowledge relating to the management of 
constipation and promoted implicit dissemination of findings.  Discussing specific 
management strategies created debates pertaining to the advantages and disadvantages of 
various approaches thus maintaining the best interest of each patient.  In the event of 
complex presenting symptoms and/or concerns with proposed regimens, informal meetings 
promoted the distribution of new information (such as obtained from pharmacological 
companies) and the sharing of experiences.   
 
This method of dissemination improved the researcher’s knowledge and skills of 
constipation management in patients with advanced cancer.  It also served to raise awareness 
of what was perceived, by patients, to be a lack of doctors’ interest and time in address 
constipation. All patients were receiving care from their GP and in some cases several 
doctors and HCPs were actively involved in the individuals’ care and support.  In spite of 
this medical support, in many instances constipation identification and/or assessment had not 
occurred.  Frequently offered reasons for this shortfall were that the patient had not 
highlighted constipation as a problem.  The subsequent post-clinic discharge letter revealing 
the severity of patients’ constipation, discussions and management strategies proved 
effective in highlighting this lack of diligence of medical assessment.  Without this action 
research the opportunity to draw doctors’ attention to the impact of their suboptimal 





9.2.6 Rigour: Issues of trustworthiness 
Through the processes adopted and previously debated, the researcher believes that the study 
has demonstrated a high level of credibility, dependability and confirmability which are 
viewed as the overriding goal of qualitative research (Polit and Beck 2008).  The emerging 
data and findings were tested by the MDT throughout the process and have been presented 
with positive response to various groups and external professionals on several occasions.  
The feedback gleaned from the dissemination of the findings leads the researcher to consider 
that they could be transferred to other similar specialist settings.     
 
9.2.7 Success of an action research approach 
Proactive measures enabled change, enquiry and service development.  In contrast to pre-
study experiences (such as those outlined in Chapter 1) the researcher found that initiating 
changes and challenging the status quo in the guise of ‘doing research’ was more acceptable 
to clinicians.  HCPs appeared less defensive and more co-operative, often volunteering to 
participate in the study, or at least, provide guidance and advice when necessary.  Thus, 
evaluating proactive measures and assessing their value became issues of debate in which 
HCPs were keen to be involved, provide theories and suggest further solutions.  In many 
ways dissemination became a natural phenomenon that occurred during day-to-day 
discussions and by request at formal meetings and presentations at a local and national level.   
 
9.3  The change: CMC 
The change of practice, namely the introduction of the CMC, proved to be most successful in 
the amelioration of constipation in patients with cancer and in palliative care.  The CMC 
represents an innovative addition to the provision of care in the Unit and the local 
community and, as far as can be established, is the first to be developed nationally.  It arose 
out of the findings of the patient interviews and the HCP focus groups.  The MDT members 
embraced the process and worked collaboratively with the researcher throughout. 
 
9.3.1 Benefits of the CMC 
By listening and encouraging patients to articulate their experiences, concerns and 
understanding of the reasons why their constipation had become problematic provided a 
structure on which to plan individualised patient-focused care.  Thus, misunderstandings, 
poor management strategies and non-compliance were addressed during the remaining three 




conducting a physical examination was perceived by patients as being thorough and 
comprehensive.  The physical examination proved to be a useful way of affording patients 
and the researcher with an objective evaluation of the individuals’ constipation, often 
confirming patients’ subjective accounts and dispelling fears and/or anxieties that their 
cancer had progressed.  Whilst it is acknowledged that, in many cases, disease progression is 
also likely to have taken place, patients were reassured that endeavours to alleviate 
constipation and its related symptoms would be made on the basis that they were also 
suffering with a degree of constipation.   
 
Not only did the physical examination serve to identify and subsequently monitor the extent 
of patients’ constipation but also appeared to convey to them that the clinician was both 
knowledgeable and interested in alleviating constipation, which was in contrast to their 
experiences in the past with HCPs who rarely conducted physical examinations in relation to 
constipation management.  This enhanced perceived credibility became central to the success 
of the CMC as it encouraged the patient to adhere to any subsequent advice and constipation 
management strategies.  It is concluded that all HCPs should ensure that patients, when 
necessary, have access to timely physical examinations (abdominal and/or rectal) as part of 
the constipation assessment process.  Initially it will be necessary for each clinician to 
establish who is responsible for conducting physical examinations, especially between GPs 
and district nurses, as this is unclear locally. 
 
9.3.2 Identifying appropriate laxative regimens 
It is concluded that by utilising the abundance of reliable knowledge available in relation to 
laxative pharmacology, HCPs can offer safe and effective laxative advice to their patients, 
which is in contrast to current practices where under-prescribing prevails.  
 
The efficacy of laxatives is generally recognised and has been highlighted in the literature 
review.  However, it became apparent during the research that patients for reasons that have 
been previously highlighted failed to take them appropriately.  The success of the CMC was 
achieved quite simply through the process of partnership that included an explanation of the 
causes of constipation, the nature of laxatives and the manner in which laxatives work.  This 
educational process was enabled by the preparation of the researcher who informally studied 
the pharmacology of laxatives in preparation for the CMC including regimens and 
combinations, dose ranges and side effects thus, ensuring any advice given was evidence 
based, safe and likely to be efficacious.  Whilst this knowledge is considered invaluable, the 




of laxatives (as opposed to escalating and higher doses than considered the norm) the 
benefits being acquired through consistent and prophylactic use.  For those experiencing 
unacceptable side effects from previous regimens, alternatives were prescribed with good 
effects and to patients’ satisfaction.  In instances when concomitant illness and potentially 
distressing side effects of laxatives caused concern, the researcher’s knowledge informed the 
process and prevented unnecessary problems.  In addition, the raising of prescriptions for 
laxatives by the researcher, that were signed for by medical colleagues, worked effectively 
and demonstrates a process that was both timely and beneficial to the patients.  
 
9.3.3 Patient self-titration of laxatives 
Through partnership working with the patients, all patients (other than those who died 
shortly after recruitment) demonstrated the ability to self-titrate laxatives which they 
reported to be efficacious.  Self-titration was always based on stool form and ease of 
defecation and subsequently monitored for changes; all of which were identified by patients 
themselves.  The researcher considered all patient self-titrated regimens to be safe and 
appropriate.  Therefore, it is concluded that patients are able to safely titrate their own 
laxatives, however, this needs to be underpinned by appropriate education and ongoing 
advice and support, either by telephone or follow-up appointments.   
 
9.3.4 Education: causes and consequences of constipation 
The findings of the research indicate the centrality of education to achieve optimum 
management of constipation in patients with cancer and in palliative care.  The dissemination 
of findings to HCPs has been highlighted in the previous section and here this is extended 
perhaps equally importantly to the patients themselves.  Through the medium of interview 
the researcher was able to proffer advice and support to those suffering with severe 
constipation and redress misconceptions. Generally, patients were ill informed about the 
causes and consequences of constipation per se and overall were unaware of the contributory 
factors and profound effects resulting from cancer and its treatments.  Without such 
knowledge is it understandable that patients assumed that nothing could be done as, for 
many, living with a degree of constipation had become the norm.  However, it is concluded 
that reversing the causative factors in patients with advanced cancer in itself may be 






In order to facilitate a concordant approach to laxative use it is important to address patients’ 
misconceptions that may otherwise deter their use.  Being aware of the ‘explosive episode’ 
and often accompanied overflow diarrhoea was identified as a positive step toward 
alleviating constipation which was in contrast to patients previous beliefs whereby they had 
assumed that they had taken too much laxative and therefore subsequently stopped taking 
them.  Similarly, to dispel the belief that ‘nothing else can be done’ it is important to make 
patients aware that alternative laxatives are available should their current regimen be 
unacceptable, thus ensuring alternatives can be tried as and when appropriate. 
 
By affording patients with such information it is concluded that adherence to laxative 
regimens are optimised and subsequently titrated based on stool form and ease of defecation, 
thus harnessing the benefits of prophylactic use. 
 
9.3.5 CMC: resources  
This section has discussed the overall success of the CMC which generally ran smoothly.  
However, one problem was not foreseen at the planning stage and essentially arose out of the 
success of the CMC.  Despite the overall achievements relating to the establishment of HCP 
and patient support for the CMC one shortfall was quickly identified. Whilst the need for 
resources during the development and setting-up of the clinic was viewed as inevitable, once 
established, additional administrative support became necessary and this had not been 
predicted.  Few additional resources had been anticipated or were readily available as 
referrals increased. This situation was eventually resolved through negotiation within the 
MDT where secretarial support was identified.  Although problematic at the time it is worth 
noting that without the study the demand, nature and extent of resources needed would not 
have been identified. 
 
9.4 Patients’ perspectives 
The study set out to explore the patients’ perspective and these were initially explored in 
stage one interviews and thereafter in the CMC.  The patients provided insightful 
information that was vital to the study and the advancement of patient care.  It is apparent in 
the data that the patients and HCPs had very different perceptions and priorities relating to 
the management of constipation.  The HCPs pursued the medical imperatives of saving life 
and therefore concentrated their input and interest to this end.  Whereas the patients were 
obviously anxious to be cured of their cancer they were also concerned with the management 




where patients were central to data collection, it was evident that they considered that their 
reports of constipation had more or less been ignored, treated as something that was of little 
consequence or as a result of non-compliance with their medication. 
 
The fact that the researcher had dedicated time for patients to talk about their constipation in 
itself worked extremely well.  The four key areas identified in the CMC framework (history 
taking, assessment of current constipation status, education and concordance) were covered 
at a pace to suit each patient and to meet their individual needs.  The patients reported the 
extent to which they appreciated the opportunity to discuss their constipation with an HCP 
who was actually not only willing to listen to their concerns but also make a concerted effort 
to work towards a resolution.   By listening to and working in partnership with patients they 
became empowered which was instrumental in achieving the self titration of their laxative 
regimen.  The interviews highlighted that patients often found HCPs to be ‘too busy’ in 
general, thus both parties appeared reticent when discussing constipation.  Given the current 
climate of limited health care resources it is unlikely that patients will be afforded more time 
to manage their constipation, especially from GPs whose average consultation time is only 
11.7 minutes (DH 2007). 
 
The ability to manage their constipation emerged from a rigorous effort to provide patients 
with the knowledge and understanding of the condition and the purpose and role of their 
laxatives. This in itself was viewed as a relief by some and a regaining ‘a life’ by others.  
The educational tools that were used in the clinic but arose out of the interview data were 
most effective as illustration and explanation of the workings of the bowel and possible cases 
of their constipation.  These were readily assimilated into current practice both on the Unit 
and by other HCPs as tools to aid future practice.  
 
9.4.1 The impact of constipation 
The added burden that constipation placed on patients at an extremely distressing time of 
their lives was a constant theme that ran through all the data and patient encounters.  Being 
diagnosed with cancer immensely impacted on patients physically and psychologically and 
engendered fears about treatments, prognosis, death and dying.  Although patients regarded 
their constipation as troublesome the fact that HCPs disregarded it conveyed to the patient 
the sense that it was unimportant.  The level of disinterest afforded to patients engendered 
feelings of helplessness and one of being relegated to suffer in silence because no one really 
wanted to listen, the effects of which had a detrimental impact on their quality of life.  




be addressed accordingly.  The most effective method of achieving this is to initiate 
appropriate and timely interventions to alleviate unnecessary suffering in a vulnerable group 
with limited life expectancy.   
 
9.4.2 Psychological affects: reducing anxiety, stress and fear 
The introduction of the CMC enabled patients to articulate their fears and anxieties in a way 
that they had not been able to do in the past.  Such expressions in themselves enabled 
patients to unload and feel less stressed and anxious in the knowledge that assistance and 
resolution of their constipation may be forthcoming.  An alleviation of constipation reduced 
patients’ anxiety, stress and fears which further impacted on their relationships with family 
and friends, whereby enjoyment in their company returned.  Constipation was one less thing 
to worry about and it actually became manageable to facilitate social engagements thus 
eliminating anxiety and stress.  Outings and engagements were more manageable and 
pleasurable.  Misconceptions about disease progression meant that fears had, albeit 
temporarily, subsided as had associated physical and psychological symptoms.  Fears of 
imminent death, resulting from incorrect physiological assumptions, were allayed thus 
reflecting a more realistic prognosis, thus further reducing anxieties around death and dying.   
 
Suffering in silence was no long necessary as concerns were believed and action taken that 
reflected an appreciation of the reality of the profound impact constipation had had on their 
lives.  Stress and anxiety changed to optimism and hope and subsequently jubilation when 
constipation had been relieved.  Patients were psychologically less concerned that HCPs 
were ambivalent or disinterested in their constipation management as support from the CMC 
was always available.   
 
It is concluded that patients report a reduction in their stress, anxiety and fear as a result of 
the CMC, even prior to alleviation of their constipation, thus having a positive impact on 
their quality of life. 
 
9.4.3 Empowerment: shifting the focus 
Empowering patients allowed them to take control at a time when facing impending death 
often renders individuals as powerless and without hope.  Making choices and influencing 
their management strategies demonstrated to individuals that their ability to alleviate their 
constipation resulted in reduced physical and psychological burdens thus improving their 




reassuring that improvements in quality of life can be achieved by focusing on alleviating the 
physical and psychological impact of constipation. 
 
Patients’ misconceptions that constipation was inevitable and untreatable changed to reflect a 
more positive approach encompassing possible methods of preventing recurrence based on 
their new knowledge base.  Patients no longer used negative descriptors to explain their 
experiences of constipation but rather as a measurement to predict a degree of constipation 
for which they would titrate their laxatives.  Patients were less reliant on HCPs and more in 
control and empowered to take appropriate action to prevent and/or alleviate constipation as 
necessary.  It is concluded that the negative beliefs of patients and their dependence on HCPs 
can be modified to empower patients to take more control with their constipation 
management.    
 
9.5 HCPs perspectives 
The findings of the study indicate that HCPs perceptions of constipation management varied 
from those of the patients.  The researcher considered that the HCPs that comprised the focus 
groups were taken aback by the comments made by some of the patients that were 
interviewed.  The GPs in the groups had not previously viewed constipation management as 
being of particular importance to them: often considering management to fall within the 
scope of district and Macmillan nurses.  Conversely the district and Macmillan nurses judged 
it to be within the role of the GP.  Of particular importance was a lack of insight about the 
complexities surrounding identification of constipation, reliability of patient report and HCP 
data, patient assessment and responsibilities, concordance and the additional challenges 
presenting in patients with advanced cancer.  The only consensus reached related to the 
prevalence of constipation and the fact that no one accepted responsibility for its 
management.   
  
The GPs initial reactions to the invitation to participate in the study were interesting in as 
much as they were surprised that such research was being undertaken.  On the other hand the 
nursing members of groups appeared to recognise the importance of constipation 
management to their patients. There are many reasons why this should be the case.  The 
medical HCPs quite naturally were more concerned with initiating and monitoring life 
saving interventions.  This is also the expectation of the patients, some of whom were 
reticent in raising the issue of their constipation in what was a limited time opportunity.  The 




differently by them culminating in the situation where the patients were more likely to raise 
their concerns.    
 
The researcher considered that the HCPs, especially the doctors were sometimes locked into 
their pre-conceived ideas of what constituted scientific evidence and sometimes struggled to 
fully appreciate a qualitative research study.  As the study progressed they became more 
accustomed to the processes and ultimately they embraced the process in its entirety. 
 
9.5.1 Dissemination 
Following dissemination, HCPs reported having an enhanced understanding of the totality of 
the problem and in most cases stated being, or at least aiming to be, more diligent in their 
practice.  The latter intention was more evident in focus group participants, probably due to 
the small number of HCPs being provided with contemporary findings relating to their 
patients. 
 
The process of dissemination occurred concurrently throughout this research and afforded 
contemporary research finding to HCP who will care for patients with advanced cancer.  
Although each HCP would be involved with such patients to varying degrees, it is concluded 
that through dissemination the profile of constipation and its management have been raised.  
All HCPs were afforded the message that patients with advanced cancer are suffering 
unnecessarily with constipation because doctors and nurses are remiss in their identification 
and treatment of the condition.  The contemporary findings of this study were afforded 
during dissemination as they demonstrate that constipation in patients with advanced cancer 
can be alleviated by adopting a patient-focused holistic approach that encompasses patient 
education in order to facilitate joint decision making with patients and improve concordance.  
Many HCPs reported being more diligent in their practice and all were afforded the 
researcher’s contact number should they require further advice or support on constipation 
managements and/or to request further dissemination. It is reassuring that a snowballing 
effect occurred in which HCPs disseminated knowledge of this researcher to their peers and 
that, following her agreement, the researcher has been included in HCPs educational 
programmes.   
 
Dissemination, presentations and teaching continued throughout this research (Appendix 37) 
including a poster at an annual nursing conference (Appendix 41).  Evidence suggests that 
delegates found these clear and easy to understand and that they learnt something valuable 




professional bodies (Appendix 43, 44 and 45) and as initiated by the researcher to a wider 
audience via a second proposed national poster (Appendix 46). 
 
9.6 Researcher learning: reflection 
On reflection the researcher considers that the action research study was most successful.  
The involvement of both HCPs and patients as respondents and referring to the MDT for 
guidance and support proved to be quite challenging at the outset.  However, as the research 
process unfolded and the researcher became more confident in her research knowledge and 
skills these interactions became more manageable.  The researcher, although part of the 
MDT from the outset in her role as research and audit sister developed in professional stature 
and credibility not only in her clinical expertise but also her research knowledge and skills.  
This element was important as during the span of this study the researcher was also 
responsible for the conduction of other various research studies and drug trials.  It also 
constituted one of the main triggers for undertaking the study.   
 
On reflection, the researcher considers that the action research approach that was adopted 
after reviewing several alternative qualitative research paradigms was most valuable in 
harnessing the MDT and Unit staff in the development of nurse-led services within the local 
area.  The methodology provided the researcher with knowledge and commitment to advance 
collaborative partnership working with HCPs and patients.  The researcher agrees with the 
advocates of action research such as Glasson et al (2006) and Meyer (2002) that consider 
action research promotes learning throughout the process and therefore has an appeal to 
practitioners. It is able to focus on the resolution of real problems arising from genuine 
situations from practice. Therefore it will form the basis of further studies aimed at the 
symptom management of patients in the future.  
 
The researcher has learned that the cyclical nature of the process afforded time for patients, 
HCPs, the MDT and herself to develop their expertise, commitment, partnership and 
ownership of a person centred service that in the event was enthusiastically welcomed by 
patients.  On reflection the ethos of clinical research in a local setting working through 
partnership, ownership and evaluation and enabled the researcher to achieve one of her 
professional goal that of developing a research and audit culture within the Units MDT.  The 
skills and knowledge acquired during this study have informed the researcher’s professional 
role and resulted in the production of the Unit’s comprehensive portfolio of research and 










This study demonstrates the importance and benefits of adopting an action research approach 
into clinical practice in cancer and palliative care.  The advantages of this approach are 
evident throughout this study and benefits are afforded to both HCPs and patients.  In 
relation to constipation and its management, the resultant three stages of this research have 
improved patient outcomes and increased HCPs’ knowledge and awareness about the 
condition’s profound impact.  In addition, the researcher gained experience and improved 
her own knowledge in several key areas, these are outlined in the following. 
 
10.2 Patient interviews focussing on constipation 
Sufferers of constipation in patients with cancer should be afforded assessment utilising a 
‘consultative-interview’ approach to establish the totality of the condition and their 
management strategies as the latter are not identified during the routine HCP assessment.  
All those participating in this stage of the study reported that, in contrast to previous 
experiences, just talking about their constipation and its related problems helps either 
physically and/or psychologically.  Interview respondents were central contributors to this 
study providing data that supported the rationale for the CMC.  All the patients were keen 
and enthusiastic to participate thus confirming the value of user involvement in research and 
service development.  Therefore, their participation should be further encouraged and 
maintained in future nursing research. 
 
10.3 HCP focus groups 
The use of HCP focus groups should be encouraged by nurses as they constitute a 
mechanism for raising awareness of areas of practice that might be explored in future study.  
Focus groups have the potential to expose contrasting practices, beliefs and attitudes which 
in themselves can be harnessed to optimise and facilitate best practice.  Furthermore, focus 
groups provide specialists the opportunity to impart contemporaneous research findings to 




vulnerable group who represent a minority of their workload.  Conducting focus groups 
during this study had a positive impact on participants who subsequently reported being 
more diligent in their practices, especially with prescribing.  The HCP focus groups 
encouraged collaboration and promoted ownership of the study and minimised the risk of 
professional gate-keeping, therefore, affording better patient outcomes.  The use of HCP 
focus groups should be encouraged as the data afforded can improve symptom management 
in patients with advanced cancer. 
 
10.4 Availability of a CMC 
Patients with advanced cancer should be afforded the benefits of a CMC as their needs are 
not currently being met.  All patients have the potential to benefit from attendance at a CMC 
even in the event that their constipation transpires to be obstruction, thus affording timely 
and alternative management strategies to be put in place.  Patients recruited in this study 
appeared to freely seek support at the CMC and embraced the advice and on-going support 
afforded.  The CMC’s philosophy and emergent findings confirmed patients’ preference for 
empowerment over their constipation and their ability to self-titrate laxatives to prevent the 
condition or manage stool form.  In may be that all patients with cancer, regardless of 
stage/advancement, benefit from attending a CMC as its components embrace patient 
education and concordance, thus preventing the onset of constipation during the advancing 
stages of their disease. 
 
10.5 Laxative examples should be encompassed in routine practice 
It is recommended that laxative examples should be made available for use in routine 
practice.  It may be that each patient’s laxative history use can be improved by utilisation of 
example laxatives.  This does not necessarily need to be in a clinic environment, but rather 
routinely during constipation assessment.  Given the problems of identifying drugs per se, it 
may be worthwhile exploring the use of other example drugs, such as analgesics, as this may 
alleviate the problems associated with patients who are unable to remember the names of 
their medications.  All patients with advanced cancer should be afforded example laxatives 
in order to identify their use and reasons for non-use.  This method proved extremely 





10.6 Patient education needs to be improved 
It is recommended that patient educational should be meaningfully included in practice.  
This study demonstrates that improved patient education in patients with advanced cancer 
increases their compliance with laxative regimens.  Furthermore, patients’ appreciations of 
the actual and potential problems of constipation and its management, including the pros and 
cons of laxative use, should be encompassed during patient education along with the 
supporting educational literature used in this study.  It is likely that the totality of the 
information is too extensive for individuals to accept and comprehend during each 
appointment.  To overcome this, patient education and information giving needs to be 
patient-focused and proffered using aids and a systematic approach where necessary.  Salient 
points need reiterating during subsequent discussions and new information or educational 
needs identified and offered.   
 
10.7 Encourage patient self-titration of laxatives 
HCPs need to make a more concerted effort to facilitate patients’ ability self-titrate their 
laxatives based on stool form and ease of defecation.  This study demonstrates that patients 
with advanced cancer are receptive to the notion and are able to establish a fluctuating 
laxative regimen that is efficacious.  Underpinned with appropriate patient education and 
follow-up, self-titration of laxatives leads to patient empowerment and a degree of 
independence to manage bowel function based on individuals’ preferences and 
commitments.  Consistent advice and support from HCPs must accompany the process of 
patient’s self-titration of laxatives until accomplished to the individuals satisfaction.   
 
10.8 Evaluating the CMC 
As part of the on-going audit of the cancer services it is recommended that the CMC should 
be formally evaluated.  This study was not able to undertake this element due to study 
limitations.  Comments appraising the CMC were collected informally when proffered by 
patients and HCPs and these preliminary data suggest that patients considered that they 
benefited and were satisfied with the service.  A formal assessment and evaluation of the 
CMC from patients and HCPs may highlight strengths and weakness of the CMC thus 





10.9 The CMC as a resource 
The CMC became a resource to which a variety of HCPs referred to in order to improve their 
practice and knowledge.  Thus, contemporaneous data pertinent to constipation management 
in patients with advanced cancer should be established and maintained in the varying local 
service settings.  Given the literature base generated, which often focused on specific issues 
and/or problems, it is postulated that other symptoms may be better managed using a similar 
focused approach, thus exploring contemporary symptom management strategies. 
 
10.10 Changing HCPs’ attitudes 
The ongoing dissemination of the findings of this study should continue locally and 
nationally.  By concomitantly disseminating the results of this study there is strong evidence 
to suggest some HCPs become more diligent about constipation and its management.  
Raising the profile and engendering the ethos of the CMC has resulted in HCPs adopting a 
positive attitude and proactive approach to constipation management.  Therefore further 
dissemination of this study and its findings has been requested and will be maintained in 
association with the researcher’s role. 
 
10.11 HCP education – a more holistic focus  
It is recommended a survey is undertaken to identify educational and training needs of local 
HCPs.  The majority of literature captures, for example, the causes and consequences of 
constipation, the use and efficacy of laxatives, and constipation assessment tools, however, 
this is rarely compared and contrasted with reliability or dependability of patient-reported 
data or the under-reporting of constipation by HCPs.  It may be worthwhile exploring the 
latter at a local level thus raising awareness of contributory factors less commonly 
highlighted in the literature which predominantly influence practice.  If found to be 
suboptimal at a local level the resultant findings may engender a more positive approach to 
constipation management whilst encapsulating the philosophy of action research and 
experiential learning, of which the latter two were found by the author to be invaluable 
during this study and her role. 
 
10.12 Affording patients time 
Patients should be afforded more time to discuss their constipation.  The allocation of time 




running a CMC.  Whilst it is challenging to envisage how, within the current NHS climate 
and limited resources, HCPs can afford patients more time, this may in itself alleviate 
constipation.  Further research needs to explore precisely what factors result in disinterest 
and ambivalence to constipation as redressing these attitudes may motivate HCPs to 
proactively change their priorities and thereby effectively manage the patients’ constipation.  
Ultimately such measures may lead to better use of limited resources as patients become less 
constipated and require fewer HCP consultations following appropriate management and 
self-titration of laxative regimens. 
 
10.13 Laxatives should not be taken ‘as required’ 
It is clear from the evidence in this study that the taking of laxatives ‘as required’ is 
inappropriate for in this client group.  Therefore, patients should be advised to ‘take their 
laxatives whether they feel they need they or not’. However, these instructions must be 
underpinned with the patients’ understanding of prophylactic use together with a physical 
and verbal assessment to confirm the presence and/or risk of constipation in this vulnerable 
and predisposed group.  
 
10.14 Final conclusion to the study 
It is concluded that the approach employed in this research could be taken forward as a 
useful design template when assessing and aiming to improve the management of other 
distressing symptoms in patients with cancer.   
 
For the researcher, the experience, knowledge and accomplishments afforded by this study 
are numerous and include, 
• A raised awareness of varying methodologies and the benefits of their application. 
• The practical application of action research and the use of varying methods when 
exploring complex problems in patients with advanced cancer. 
• The opportunity to develop and work collaboratively with patients and HCPs 
• Participating in the development and implementation of a service provision which 
improves patient outcomes and HCP practice. 
• A deeper understanding of the complexities and needs of patients with advanced 
cancer. 
• Growth in her professional role, that of providing appropriate support, advice and 





This study has demonstrated the effectiveness of an action research approach to facilitate a 
holistic approach to constipation management in patients with cancer in palliative care.   
Furthermore, this study highlights the value of a nurse-led clinic and the importance of 
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